data_2k1x_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k1x _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.931 0.396 . . . . 73.54 110.882 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 89.7 t -110.6 111.24 35.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 71.11 111.116 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.0 tp -106.34 110.91 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 73.34 111.127 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.8 t -131.54 138.8 52.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 71.23 111.138 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -94.5 137.22 33.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 74.13 110.863 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -93.98 42.94 1.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 75.15 110.902 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 174.52 -169.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 63.23 110.852 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.0 t -64.68 160.97 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 74.21 111.17 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -87.34 53.79 2.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 73.32 110.923 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.441 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.12 28.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 72.52 110.911 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.19 52.73 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.726 -0.75 . . . . 74.12 112.486 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.96 171.52 24.48 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.798 -0.715 . . . . 63.41 112.513 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.43 134.34 35.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.77 0.319 . . . . 74.34 110.893 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.48 153.04 34.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 71.03 110.88 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -148.64 141.35 24.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 72.42 110.901 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.8 t0 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 73.53 110.907 179.98 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.784 0.325 . . . . 74.41 110.914 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 pt -153.11 109.72 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 75.54 111.127 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.0 p -165.01 -168.35 1.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 64.11 110.843 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -124.07 152.05 43.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 70.43 110.828 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.5 mp -120.91 139.33 48.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.51 . . . . 74.13 111.116 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.4 tttt -138.04 125.92 22.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 75.34 110.915 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.2 p -125.58 139.02 52.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.433 . . . . 70.31 111.158 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.88 39.39 1.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 74.23 110.861 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.93 110.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 62.31 110.855 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.94 -150.21 50.28 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.78 -0.724 . . . . 75.55 112.451 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.9 p -148.4 160.61 42.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.759 0.314 . . . . 74.04 111.146 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -124.53 177.48 5.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 74.13 110.953 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.57 111.92 16.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.273 -0.421 . . . . 74.44 110.864 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -101.01 123.95 45.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 75.15 110.916 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -139.97 126.63 20.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 74.34 110.945 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -104.09 89.57 3.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 74.11 110.871 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 177.27 -174.34 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 74.24 110.958 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.0 pt -54.88 174.15 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 74.13 111.099 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -83.07 10.12 8.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.14 -0.482 . . . . 71.54 110.881 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.45 67.27 1.26 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 73.52 110.937 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 116.39 121.08 3.27 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.757 -0.735 . . . . 73.42 112.503 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -177.35 174.48 47.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 71.03 112.486 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -64.62 95.93 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.844 0.354 . . . . 73.54 110.918 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -76.38 111.86 12.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 64.23 110.933 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -138.32 105.86 5.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.144 -0.48 . . . . 73.15 110.924 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -90.65 137.61 32.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.259 -0.428 . . . . 61.15 110.916 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -104.81 142.11 35.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 74.01 110.879 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -113.79 -168.63 16.63 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.781 -0.723 . . . . 75.41 112.54 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -46.84 109.89 0.24 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.699 2.266 . . . . 74.34 112.304 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.93 158.48 8.84 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.732 -0.747 . . . . 70.43 112.505 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.59 143.86 49.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.861 0.362 . . . . 63.25 110.891 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -148.63 160.12 43.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 72.13 110.898 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 99.0 p -140.69 78.04 1.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.094 -0.503 . . . . 62.31 110.837 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.4 m -86.64 153.05 22.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 62.53 110.843 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.1 m -153.43 23.92 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 73.03 111.114 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -179.52 39.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 75.13 110.9 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.85 -40.2 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 74.25 110.852 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.28 -75.79 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.114 -0.493 . . . . 71.05 111.095 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.85 90.15 0.1 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 73.33 112.516 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.15 67.07 72.89 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.644 0.735 . . . . 74.15 111.165 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -80.46 -52.21 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.663 2.242 . . . . 73.34 112.343 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 179.82 -51.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.264 -0.426 . . . . 74.53 110.845 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -173.75 130.14 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 74.44 110.861 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.17 178.69 2.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 73.42 110.891 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.4 mm -100.45 155.19 4.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 74.15 111.111 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.7 p -155.62 155.75 33.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 71.33 110.851 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -165.27 158.15 16.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 75.13 110.838 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -150.55 135.66 17.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 62.51 110.885 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -89.68 119.71 30.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 74.21 110.901 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -79.77 99.62 7.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 73.55 110.906 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 73.35 111.103 179.988 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.865 0.364 . . . . 73.24 110.898 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.5 t -100.85 114.65 40.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.484 . . . . 71.54 111.141 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.5 tt -115.41 110.53 32.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 74.12 111.131 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.5 t -128.79 145.09 36.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 73.35 111.132 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -97.81 136.7 37.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.476 . . . . 74.42 110.911 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.77 44.68 1.1 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.49 . . . . 74.34 110.872 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 173.42 -171.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 74.21 110.824 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.3 t -64.58 160.57 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 73.24 111.161 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -87.28 53.94 2.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 74.44 110.883 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.443 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -176.92 28.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 70.54 110.872 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.4 52.79 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.714 -0.755 . . . . 74.52 112.438 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.07 171.42 24.55 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.76 -0.733 . . . . 52.42 112.481 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.04 135.15 34.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.779 0.323 . . . . 73.22 110.912 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.65 154.35 32.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 74.12 110.882 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -148.65 151.97 35.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 73.33 110.878 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.0 t0 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 70.44 110.838 179.927 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.796 0.331 . . . . 71.01 110.858 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 pt -154.49 106.08 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 73.21 111.14 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 56.6 p -151.08 -168.4 3.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 74.3 110.848 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.46 152.22 50.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.087 -0.506 . . . . 72.14 110.847 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -122.14 141.52 42.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 73.44 111.103 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.2 tttt -140.99 135.61 31.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 73.21 110.841 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.4 p -162.91 139.23 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 72.31 111.109 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.06 40.65 3.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 75.02 110.891 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 t 178.94 138.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 74.35 110.833 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.78 -177.87 1.89 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.705 -0.76 . . . . 71.54 112.524 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.5 p -145.49 147.65 32.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.754 0.311 . . . . 71.42 111.156 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -116.98 175.43 5.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 65.12 110.953 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -117.69 118.93 33.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.413 . . . . 71.35 110.906 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -107.63 125.93 51.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 75.45 110.871 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.18 126.64 20.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.143 -0.48 . . . . 74.44 110.952 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -99.25 89.13 4.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 74.52 110.868 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.404 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 170.95 -178.01 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 75.24 110.961 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.1 tt -54.94 163.34 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 74.13 111.119 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -76.29 55.84 1.01 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 72.23 110.886 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -153.5 -37.72 0.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 72.41 110.938 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -146.27 -144.27 4.04 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.699 -0.762 . . . . 75.13 112.427 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.404 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 108.18 -170.54 15.17 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.765 -0.731 . . . . 54.13 112.469 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -83.61 105.36 14.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.841 0.353 . . . . 74.03 110.852 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -78.16 106.84 10.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 73.43 110.932 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -138.1 108.35 6.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.48 . . . . 73.41 110.941 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -92.83 135.07 34.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.436 . . . . 71.51 110.877 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.3 pp -99.22 140.41 33.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 71.25 110.922 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -107.45 -159.18 20.92 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.773 -0.727 . . . . 62.43 112.475 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.37 88.06 0.13 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.672 2.248 . . . . 74.23 112.39 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.3 160.52 29.22 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.751 -0.737 . . . . 55.12 112.504 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -118.61 135.55 54.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 61.42 110.852 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -143.45 160.09 41.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.129 -0.487 . . . . 73.24 110.878 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 97.8 p -141.14 78.06 1.63 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.086 -0.506 . . . . 73.24 110.853 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.2 m -88.39 148.81 24.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.491 . . . . 75.23 110.858 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.5 m -150.68 24.05 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.495 . . . . 72.22 111.154 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -179.47 36.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 74.32 110.858 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.99 -43.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 75.22 110.831 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.59 -42.94 62.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 71.32 111.104 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 166.88 91.99 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.766 -0.73 . . . . 43.51 112.503 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 15.0 mm -131.46 69.21 81.74 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.638 0.733 . . . . 72.22 111.173 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -81.02 -66.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.701 2.267 . . . . 74.25 112.379 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -179.95 -73.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.266 -0.425 . . . . 75.33 110.874 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -66.09 -169.8 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 70.22 110.885 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.93 110.07 6.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 74.53 110.826 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.6 pt -152.92 22.79 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 74.24 111.096 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.6 p -79.78 160.54 26.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 73.05 110.861 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.62 156.69 13.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 75.14 110.854 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -148.58 138.37 22.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.49 . . . . 72.13 110.837 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.97 120.59 34.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 75.43 110.875 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -79.28 111.05 15.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 72.51 110.925 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.5 pt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.46 . . . . 73.31 111.132 179.969 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.888 0.375 . . . . 74.53 110.88 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.4 t -117.71 118.63 59.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 75.44 111.119 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 tp -136.69 116.65 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 63.2 111.102 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 m -133.12 160.33 42.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 73.2 111.122 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -113.15 141.21 47.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 75.54 110.952 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -95.46 37.0 1.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 74.2 110.869 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 175.62 -169.63 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 72.24 110.868 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.6 t -63.65 160.28 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 75.41 111.18 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -85.87 53.81 2.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 74.13 110.899 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.44 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.14 28.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 74.21 110.86 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.54 39.26 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.718 -0.754 . . . . 55.41 112.47 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -129.16 171.61 19.92 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.725 -0.75 . . . . 72.04 112.462 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.25 131.01 34.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.773 0.32 . . . . 73.42 110.921 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.57 145.26 45.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 72.02 110.855 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -148.77 128.71 13.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 74.21 110.875 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 74.33 110.927 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.75 0.31 . . . . 75.43 110.906 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.94 124.68 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 74.01 111.143 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.0 p -167.86 -166.78 0.77 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 73.32 110.81 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.8 t -125.54 164.12 21.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.067 -0.515 . . . . 60.13 110.867 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -130.42 140.33 49.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 75.22 111.127 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -138.58 132.15 30.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 74.41 110.913 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.6 p -133.0 139.2 50.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.258 -0.428 . . . . 73.43 111.108 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.62 41.91 1.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.472 . . . . 61.23 110.927 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -173.44 110.83 0.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 70.44 110.861 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 56.63 -137.76 47.77 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.729 -0.748 . . . . 72.33 112.483 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 64.3 p -150.21 141.25 22.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.339 . . . . 75.24 111.095 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -109.72 168.45 9.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 74.51 110.891 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -110.2 120.89 43.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 74.23 110.917 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -110.95 127.72 55.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 72.52 110.936 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.73 126.15 18.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.471 . . . . 73.55 110.907 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -99.12 88.69 4.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.076 -0.511 . . . . 73.41 110.902 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 173.4 -177.85 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 73.21 110.903 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.0 pt -58.66 172.32 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 73.14 111.145 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -84.49 51.95 2.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 74.13 110.866 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -152.74 -47.87 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 74.41 110.918 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -149.75 125.05 1.89 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.742 . . . . 72.31 112.515 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.44 173.12 38.67 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.746 -0.74 . . . . 71.22 112.483 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -61.75 105.94 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.836 0.35 . . . . 74.22 110.921 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -77.04 103.32 6.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 74.12 110.922 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.9 t90 -138.19 107.91 6.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.496 . . . . 75.54 110.925 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -82.31 153.93 25.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 72.34 110.841 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.4 tp -104.79 133.68 49.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 75.33 110.947 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -111.08 178.79 19.76 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.733 -0.746 . . . . 75.0 112.486 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -46.99 100.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.652 2.235 . . . . 65.41 112.367 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 161.88 164.13 16.18 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.724 -0.751 . . . . 74.33 112.476 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -124.1 140.27 53.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.89 0.376 . . . . 73.42 110.868 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -140.77 144.23 35.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 72.25 110.939 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.1 t -126.18 74.8 1.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 74.01 110.895 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.6 m -87.27 159.01 18.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 72.54 110.823 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.5 m -151.29 21.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 74.54 111.166 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -179.37 58.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 73.23 110.881 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.55 -49.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 54.34 110.819 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.61 -62.01 1.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 72.31 111.115 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -164.74 88.94 0.1 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.722 -0.752 . . . . 63.11 112.463 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.8 mm -132.2 67.35 78.89 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.623 0.725 . . . . 74.31 111.14 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -80.25 -51.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.69 2.26 . . . . 74.11 112.381 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.86 -34.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 72.01 110.85 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -141.23 -176.77 4.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 71.03 110.871 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.34 111.68 23.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 75.42 110.889 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.98 11.1 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 72.14 111.086 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.4 p -83.37 170.64 14.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 72.22 110.843 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.64 152.66 10.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 73.01 110.859 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -150.19 139.9 21.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 74.54 110.919 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -109.33 130.62 55.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 70.43 110.86 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -89.38 131.41 35.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 54.11 110.899 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.6 pt . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 72.12 111.099 179.975 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.929 0.395 . . . . 74.45 110.879 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.6 t -111.95 111.77 37.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 75.14 111.117 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.3 tp -117.52 110.03 29.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 74.01 111.118 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 m -130.79 159.9 42.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 73.04 111.144 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -112.14 146.2 38.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.462 . . . . 75.12 110.938 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -101.18 38.9 1.48 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.477 . . . . 73.5 110.904 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 175.04 -171.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 74.25 110.845 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.7 t -63.33 160.61 2.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 65.2 111.105 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -84.19 53.74 2.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 74.41 110.917 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.446 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -178.06 28.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 73.42 110.84 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 158.88 38.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.753 -0.737 . . . . 73.32 112.495 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.3 171.51 20.57 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.756 -0.735 . . . . 74.52 112.464 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.91 149.79 21.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.798 0.332 . . . . 73.3 110.915 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.98 149.12 50.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 75.54 110.831 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -146.39 129.45 16.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 72.43 110.886 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 74.03 110.896 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.762 0.315 . . . . 74.14 110.908 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 tt -176.76 102.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 73.35 111.135 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.7 p -168.84 -164.18 0.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 65.52 110.869 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.5 t -125.41 149.34 48.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 74.43 110.883 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.5 mp -120.91 131.26 73.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 74.22 111.145 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -132.51 142.32 49.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 74.52 110.875 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.2 p -143.74 126.43 12.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 74.01 111.121 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.67 41.1 3.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 75.23 110.928 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.9 t -179.1 110.8 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 75.11 110.878 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.3 -151.24 52.12 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.67 -0.776 . . . . 75.13 112.508 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.1 p -150.07 153.39 36.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.798 0.332 . . . . 74.33 111.15 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -123.45 179.07 4.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 75.24 110.935 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -124.44 136.09 53.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.434 . . . . 74.1 110.823 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -120.12 129.88 54.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 75.43 110.878 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.71 126.14 20.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.164 -0.471 . . . . 74.41 110.95 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.78 89.04 3.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 65.44 110.918 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 175.38 -169.44 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 74.44 110.915 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.2 tt -58.6 163.06 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 73.12 111.113 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -76.24 55.3 0.95 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 75.32 110.871 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -153.76 -38.02 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 73.51 110.936 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -145.53 -138.82 3.31 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 72.24 112.509 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.06 177.37 22.16 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.796 -0.716 . . . . 73.2 112.5 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.3 109.48 5.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.81 0.338 . . . . 72.53 110.859 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -77.59 108.71 10.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 75.43 110.927 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -138.31 106.72 5.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 72.44 110.88 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -89.13 157.7 18.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 73.41 110.878 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -118.5 149.71 40.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 75.03 110.944 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -127.88 -166.6 12.09 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.72 -0.752 . . . . 75.4 112.493 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -46.41 101.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.7 2.267 . . . . 62.53 112.317 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.79 165.39 16.63 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.749 -0.738 . . . . 74.05 112.484 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.44 145.84 47.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.865 0.364 . . . . 74.33 110.858 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -154.75 156.65 36.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 75.44 110.924 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 95.8 p -130.4 85.88 2.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 70.21 110.854 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.1 t -86.01 153.21 22.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 60.31 110.86 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.7 m -149.65 18.03 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 61.3 111.163 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -178.7 40.94 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.117 -0.492 . . . . 75.01 110.863 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 t -158.44 -45.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 74.11 110.852 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.45 -61.26 2.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.486 . . . . 75.41 111.097 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 166.62 103.7 0.17 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.717 -0.754 . . . . 73.33 112.449 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.8 mm -115.76 74.66 4.95 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.666 0.746 . . . . 74.14 111.14 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.96 -165.54 0.31 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.701 2.267 . . . . 72.54 112.359 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -51.32 -74.85 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.265 -0.425 . . . . 73.31 110.834 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -179.41 33.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 74.44 110.857 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.3 p 178.95 -174.84 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 74.04 110.859 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.2 mm 66.8 62.13 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 74.53 111.151 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.2 p -165.94 137.88 3.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 65.43 110.895 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -158.53 166.75 31.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 75.13 110.864 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -151.12 142.51 23.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 62.55 110.886 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.86 159.0 26.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 74.52 110.932 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -128.52 92.53 3.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 63.4 110.934 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 pt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 74.31 111.111 179.981 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.919 0.39 . . . . 74.51 110.878 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.3 t -111.92 128.65 68.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 74.1 111.128 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.9 tt -126.68 110.56 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 74.43 111.155 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.4 t -136.54 143.81 34.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 71.11 111.112 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.85 138.2 40.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 74.32 110.89 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -93.25 42.67 1.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 75.03 110.885 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 173.93 -169.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 72.33 110.858 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.2 t -63.95 160.3 3.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.218 -0.447 . . . . 74.22 111.178 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -86.42 53.97 2.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 74.41 110.858 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.434 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.04 28.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 73.24 110.895 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.36 47.33 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.692 -0.766 . . . . 72.42 112.424 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.97 171.96 24.3 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.714 -0.755 . . . . 62.52 112.466 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.2 163.86 15.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.829 0.347 . . . . 72.45 110.924 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.1 p -144.52 165.44 27.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.434 . . . . 74.12 110.836 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -124.88 110.89 14.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 75.42 110.838 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 75.42 110.862 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.753 0.311 . . . . 63.4 110.921 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 pt -156.1 119.28 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 74.12 111.159 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.2 p -161.84 -169.08 2.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 72.03 110.838 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.85 149.18 50.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 62.14 110.875 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.5 mp -124.35 138.96 52.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 74.34 111.161 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -142.49 138.67 31.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 73.12 110.945 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.4 p -132.87 139.15 50.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 74.45 111.095 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.3 39.93 2.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 72.35 110.89 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.87 120.24 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 73.5 110.853 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.23 -143.23 21.68 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.725 -0.75 . . . . 74.54 112.55 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 63.8 p -146.72 156.58 43.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.724 0.297 . . . . 74.15 111.126 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.7 m0 -125.32 169.81 11.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.218 -0.446 . . . . 64.04 110.919 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -112.11 121.59 45.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 73.53 110.911 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -113.65 120.07 39.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 74.21 110.901 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -139.88 126.78 20.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.153 -0.476 . . . . 64.44 110.933 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -100.72 89.98 4.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 73.32 110.909 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.402 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 170.96 -169.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 74.51 110.905 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.7 tp -64.87 159.41 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 75.34 111.104 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 -78.0 45.7 0.54 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 74.34 110.913 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -152.83 17.06 0.58 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 74.31 110.93 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 168.32 -118.18 0.77 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.754 -0.736 . . . . 75.14 112.492 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.402 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 71.56 -179.27 33.9 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.745 -0.74 . . . . 75.33 112.5 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.02 108.39 14.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.828 0.347 . . . . 73.15 110.87 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -78.35 106.88 10.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 75.53 110.897 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -138.15 106.2 5.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.112 -0.494 . . . . 73.24 110.906 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -84.76 157.41 21.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 74.22 110.857 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.7 tp -109.75 134.7 51.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 71.0 110.909 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -110.32 -178.55 20.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.668 -0.777 . . . . 74.21 112.493 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -47.88 100.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.747 2.298 . . . . 73.43 112.314 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.46 165.42 14.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.71 -0.757 . . . . 61.33 112.428 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -93.48 165.08 12.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.86 0.362 . . . . 63.43 110.941 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -160.24 105.03 1.49 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 75.24 110.928 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.6 m -96.45 91.13 5.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 71.45 110.837 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.18 131.81 34.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 75.24 110.838 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.8 m -150.05 18.67 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.119 -0.492 . . . . 73.24 111.14 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 173.45 -17.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 73.3 110.905 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.34 -49.73 9.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 71.55 110.867 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.31 -70.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 64.31 111.064 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 173.07 119.8 0.54 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.739 -0.743 . . . . 72.14 112.473 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.5 mm -129.5 67.14 78.52 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.645 0.736 . . . . 75.53 111.135 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -81.38 -69.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.704 2.269 . . . . 72.01 112.335 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.2 t70 179.08 -40.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 71.1 110.91 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -176.71 107.46 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.47 . . . . 72.31 110.865 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.2 m -140.8 -169.97 2.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 75.53 110.824 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.9 mp -106.19 150.1 9.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.485 . . . . 74.34 111.17 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.6 p -165.51 146.8 7.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 63.14 110.861 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.04 158.94 31.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 74.03 110.863 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -150.63 135.78 17.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 74.44 110.862 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -88.59 120.73 30.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 72.3 110.911 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -81.36 92.64 6.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 72.21 110.904 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 74.22 111.121 179.971 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.891 0.377 . . . . 74.23 110.903 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 86.0 t -115.93 127.58 73.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 75.02 111.095 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.8 tt -125.03 110.81 25.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 72.22 111.134 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.1 t -123.02 143.84 34.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 72.0 111.113 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -105.12 138.47 41.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 75.43 110.909 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -94.7 43.34 1.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.085 -0.507 . . . . 75.54 110.852 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 173.0 -170.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 71.44 110.852 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.15 159.71 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 75.44 111.112 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -86.1 53.9 2.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 73.53 110.869 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.441 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.05 28.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 74.25 110.882 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.35 51.69 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.758 -0.734 . . . . 55.53 112.484 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.07 171.38 24.57 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.715 -0.755 . . . . 72.12 112.501 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.54 133.92 35.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.806 0.336 . . . . 64.41 110.903 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.76 155.08 33.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 74.21 110.885 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -148.45 117.56 6.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 74.1 110.936 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 73.55 110.908 179.978 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.754 0.311 . . . . 75.13 110.915 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 pt -153.41 107.93 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 73.41 111.143 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 63.7 p -149.86 -172.3 4.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 75.43 110.892 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.22 149.53 49.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 74.54 110.859 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.9 mp -120.83 109.89 26.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 74.22 111.171 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -95.04 127.69 41.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 74.12 110.919 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.68 139.03 38.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 75.44 111.107 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.93 40.55 1.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 74.13 110.911 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.3 p -179.4 137.67 0.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 72.13 110.861 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.22 -155.3 4.75 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.753 -0.737 . . . . 70.24 112.474 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.3 p -150.03 150.13 31.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.806 0.336 . . . . 71.22 111.134 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.6 m0 -123.37 169.62 11.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 74.43 110.923 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -121.5 128.51 52.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 75.22 110.847 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -114.33 128.53 56.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 73.43 110.884 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.2 126.47 19.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.136 -0.484 . . . . 73.03 110.914 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -101.46 89.21 3.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 75.33 110.855 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 171.66 -165.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 73.32 110.926 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -52.01 173.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 73.31 111.157 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -85.52 49.81 1.83 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 75.11 110.922 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 22.3 p90 176.86 41.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 70.05 110.905 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.12 -154.21 24.62 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.718 -0.753 . . . . 74.41 112.444 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.73 -177.06 35.48 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.767 -0.73 . . . . 74.15 112.483 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.29 110.8 9.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.826 0.346 . . . . 71.33 110.893 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -78.03 109.7 12.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 64.24 110.934 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -138.3 106.26 5.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.11 -0.495 . . . . 74.43 110.952 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.0 p30 -94.57 153.76 17.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 74.21 110.817 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -117.11 136.08 53.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 74.51 110.931 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -102.81 -162.68 25.91 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 61.33 112.484 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.27 105.39 0.29 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.685 2.257 . . . . 74.32 112.342 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.95 151.92 6.07 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.756 -0.735 . . . . 70.35 112.509 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.9 144.97 32.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.855 0.36 . . . . 71.11 110.869 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -124.35 157.28 35.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.095 -0.502 . . . . 73.32 110.896 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.1 t -160.05 68.31 0.38 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 61.54 110.866 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.98 146.68 26.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 72.31 110.89 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.9 m -150.58 18.81 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 75.23 111.141 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -179.05 34.19 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 75.22 110.888 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 37.8 t -160.9 -40.64 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 74.32 110.867 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.38 -44.18 62.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 65.43 111.131 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 166.73 95.0 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.722 -0.752 . . . . 73.14 112.472 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.9 mm -129.5 67.14 78.53 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.65 0.738 . . . . 64.41 111.124 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -80.83 -60.79 0.03 OUTLIER 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.667 2.245 . . . . 61.32 112.362 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 179.23 -33.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 75.35 110.81 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -141.17 -177.82 5.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 74.31 110.917 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.1 t -58.54 -96.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 64.54 110.889 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 mp 47.94 54.26 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 74.34 111.121 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.6 p -155.03 163.0 40.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 75.4 110.816 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.94 159.82 16.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.074 -0.512 . . . . 71.43 110.878 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -150.14 135.71 18.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 74.15 110.847 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -93.21 133.38 36.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 74.14 110.919 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -105.84 131.43 53.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 74.42 110.967 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.3 pt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 62.34 111.141 179.993 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.875 0.369 . . . . 72.34 110.897 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 94.3 t -113.11 105.59 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 73.12 111.109 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.5 tp -117.07 110.3 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 72.24 111.12 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.2 m -133.15 159.29 43.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 74.32 111.116 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -112.18 142.3 44.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.127 -0.488 . . . . 75.24 110.92 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -95.35 31.85 1.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 73.32 110.924 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 175.52 -169.68 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 74.34 110.855 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.9 t -62.75 159.9 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 71.22 111.149 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -84.51 54.07 2.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 74.52 110.907 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.436 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.66 28.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 74.32 110.88 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.12 47.61 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.689 -0.767 . . . . 62.01 112.486 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.8 171.48 24.06 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.709 -0.757 . . . . 75.45 112.501 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.3 tmmt? -91.01 122.83 34.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.803 0.335 . . . . 75.32 110.862 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.97 148.54 43.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 74.44 110.827 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -148.77 139.73 22.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 74.22 110.894 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 60.25 110.873 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.724 0.297 . . . . 75.43 110.932 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.2 pt -153.49 104.13 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 74.35 111.121 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.9 p -157.16 -166.53 2.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 64.51 110.819 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.2 t -127.14 154.46 44.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 71.11 110.828 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.5 mp -125.52 139.01 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 75.4 111.128 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -145.35 147.83 32.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 74.2 110.875 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.2 p -161.52 138.82 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 71.44 111.115 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -134.58 40.92 2.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 74.13 110.898 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.8 t -179.62 119.4 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 74.33 110.89 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.08 -163.45 50.82 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.757 -0.735 . . . . 71.45 112.522 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.5 p -149.83 147.7 28.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.796 0.331 . . . . 74.44 111.166 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -117.37 171.94 7.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 75.22 110.946 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -112.98 124.26 52.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 75.24 110.87 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -113.73 125.87 54.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 74.23 110.925 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.48 126.9 23.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 72.34 110.91 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -102.09 89.75 3.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 73.13 110.896 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.462 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.1 OUTLIER 170.72 -166.87 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.161 -0.472 . . . . 75.2 110.917 -179.873 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -51.98 172.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 70.41 111.102 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -86.06 50.08 1.91 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 63.41 110.897 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.1 p90 174.88 45.12 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.474 . . . . 64.22 110.905 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.22 -150.14 18.08 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.724 -0.75 . . . . 65.3 112.465 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.462 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 87.37 -171.51 42.06 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.689 -0.767 . . . . 71.03 112.497 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.47 112.39 17.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.817 0.342 . . . . 74.11 110.886 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -79.23 101.04 7.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 74.22 110.943 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -133.86 107.54 7.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.119 -0.491 . . . . 74.21 110.914 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -83.85 154.21 23.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 74.34 110.849 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.8 tp -99.34 148.34 24.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 73.13 110.934 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -129.55 -165.16 11.61 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.723 -0.751 . . . . 61.1 112.489 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.26 89.73 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.667 2.245 . . . . 75.41 112.339 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.32 171.18 40.57 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.761 -0.733 . . . . 74.21 112.513 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.8 143.83 50.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.833 0.349 . . . . 71.34 110.898 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -152.55 149.03 28.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 74.31 110.951 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.2 p -130.33 82.44 2.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 74.14 110.845 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 40.4 m -86.66 147.07 26.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 63.14 110.819 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.7 m -150.69 19.04 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.074 -0.512 . . . . 74.41 111.164 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -179.46 34.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 73.32 110.905 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.1 t -160.74 -40.84 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 73.22 110.851 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.3 -54.25 33.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 74.22 111.111 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.37 85.74 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.815 -0.707 . . . . 75.44 112.481 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.9 mm -123.89 67.55 42.17 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.64 0.733 . . . . 75.4 111.132 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -74.35 -53.86 0.1 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.689 2.259 . . . . 75.01 112.377 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.3 t70 179.44 -74.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 62.34 110.855 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -93.04 -169.85 2.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 64.41 110.918 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.92 114.49 26.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 74.05 110.882 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -152.64 69.52 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 74.44 111.12 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.7 p -158.76 161.63 37.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 75.02 110.851 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.74 163.24 18.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 72.41 110.834 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -151.16 136.31 17.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 73.23 110.86 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -88.53 120.21 29.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 74.35 110.883 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -79.18 102.03 8.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 74.34 110.896 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 pt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 75.31 111.101 179.953 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.892 0.377 . . . . 63.34 110.882 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 96.7 t -115.89 136.37 52.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 73.44 111.099 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.3 tt -131.35 110.66 17.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 74.23 111.145 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.4 t -127.09 143.13 41.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 73.43 111.132 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -97.1 140.36 31.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 73.22 110.925 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -99.24 35.6 1.89 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 71.15 110.914 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 175.18 -169.73 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 72.34 110.871 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.5 t -63.64 159.52 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 74.24 111.112 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.5 p30 -85.78 54.19 3.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 72.43 110.902 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.441 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.1 28.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 75.33 110.881 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.22 50.28 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.726 -0.749 . . . . 65.13 112.505 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.1 171.51 24.53 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.761 -0.733 . . . . 64.34 112.529 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.21 126.06 42.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.764 0.316 . . . . 73.13 110.906 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.7 p -118.29 156.5 28.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.27 -0.423 . . . . 72.3 110.824 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -111.03 107.97 17.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 73.42 110.877 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.6 t70 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 73.11 110.884 179.96 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.728 0.299 . . . . 74.14 110.921 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.6 pt -155.23 128.92 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 72.51 111.103 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 84.8 p -167.34 -168.19 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 74.11 110.897 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.13 152.72 44.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 75.13 110.871 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.3 mp -120.91 132.64 69.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 73.15 111.114 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -130.6 131.94 45.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 73.43 110.899 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.9 p -136.45 139.24 45.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 74.51 111.098 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.6 mmpp? -143.62 45.98 1.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 75.03 110.864 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.44 124.42 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 73.22 110.831 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.01 -150.0 8.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.748 -0.739 . . . . 61.3 112.487 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.6 p -147.57 144.74 28.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.797 0.332 . . . . 74.42 111.09 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.0 m0 -115.87 173.07 6.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 73.13 110.915 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -119.11 120.76 38.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.425 . . . . 73.14 110.84 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -109.63 125.73 52.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 75.51 110.838 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.83 143.91 37.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.074 -0.512 . . . . 74.24 110.879 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -107.93 88.5 2.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.077 -0.51 . . . . 72.01 110.918 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 171.78 -166.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 71.15 110.933 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.3 mm -78.79 171.52 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 73.04 111.091 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -74.66 57.83 0.77 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 64.14 110.878 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -151.01 -34.95 0.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 73.34 110.907 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -158.74 -141.91 3.26 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.731 -0.747 . . . . 60.43 112.489 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.53 -179.97 22.88 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.709 -0.757 . . . . 64.01 112.461 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.69 105.9 6.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.813 0.339 . . . . 75.12 110.89 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -76.73 106.99 8.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 75.52 110.913 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -138.29 106.98 5.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.113 -0.494 . . . . 74.52 110.897 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -90.32 141.35 28.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 74.43 110.881 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.32 153.41 18.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 74.31 110.907 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -132.44 -168.4 12.01 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.729 -0.748 . . . . 52.53 112.487 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -46.48 101.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.645 2.23 . . . . 74.55 112.354 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.43 163.76 12.68 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.746 . . . . 71.41 112.516 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -127.52 138.43 52.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.91 0.386 . . . . 71.31 110.847 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -135.92 151.95 50.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 74.33 110.891 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 97.4 p -133.45 81.8 1.95 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 71.24 110.857 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.6 m -85.97 160.98 19.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 74.51 110.836 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.2 m -152.9 20.45 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 74.33 111.171 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -178.07 53.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 73.21 110.935 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.65 -35.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 74.31 110.851 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.97 -64.29 0.86 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 73.54 111.113 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 179.08 83.55 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.761 -0.733 . . . . 75.44 112.498 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.59 67.49 24.34 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.604 0.716 . . . . 74.32 111.171 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -80.3 -50.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.631 2.221 . . . . 74.32 112.342 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -179.56 -36.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 70.33 110.888 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -179.36 55.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 62.42 110.864 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.5 t -97.34 166.55 11.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 72.43 110.855 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.6 mt -106.16 153.51 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 73.23 111.167 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.2 p -149.98 155.91 40.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 74.23 110.835 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.38 158.15 29.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 74.14 110.839 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -150.48 135.41 17.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 75.5 110.867 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -95.1 130.8 41.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 75.51 110.833 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.28 131.64 43.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.464 . . . . 75.23 110.894 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.9 pt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 71.41 111.121 179.985 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.93 0.395 . . . . 72.4 110.86 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 98.5 t -110.32 116.03 51.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 74.23 111.169 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.9 tt -115.7 110.39 31.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 73.14 111.101 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 72.2 t -128.68 137.1 58.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 73.33 111.162 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -88.62 138.38 31.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.461 . . . . 75.44 110.949 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -96.0 47.85 1.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 74.32 110.846 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 173.29 -170.41 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 72.1 110.874 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.9 t -64.61 161.51 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 75.4 111.092 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -86.76 53.66 2.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 70.43 110.896 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.438 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.52 29.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 74.23 110.883 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.94 49.72 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.754 -0.736 . . . . 41.04 112.504 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.07 171.59 24.49 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.702 -0.761 . . . . 72.33 112.445 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.06 162.94 14.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.771 0.319 . . . . 75.04 110.903 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.0 p -145.1 153.52 41.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 60.45 110.879 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -142.27 119.82 11.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 75.04 110.887 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 p30 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 70.2 110.802 -179.963 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.763 0.316 . . . . 72.52 110.931 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 pt -153.36 103.91 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 73.44 111.136 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 78.7 p -167.74 -166.78 0.78 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 74.42 110.861 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.69 148.46 33.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 73.44 110.869 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 mp -120.85 127.77 75.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 72.52 111.164 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -126.82 133.18 50.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 75.02 110.924 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.4 p -143.55 139.02 26.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 75.32 111.167 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.6 mmpp? -142.77 40.27 1.53 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 74.01 110.879 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.49 135.04 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 73.51 110.89 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.14 -159.49 2.78 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.777 -0.725 . . . . 72.03 112.465 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.1 p -145.43 151.3 38.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.799 0.333 . . . . 63.4 111.133 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.0 m0 -124.2 175.36 7.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 75.1 110.898 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -121.48 120.54 35.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 74.53 110.904 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -107.28 126.23 52.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 75.02 110.857 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.83 142.99 36.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 73.12 110.915 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.03 88.36 2.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 64.43 110.883 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 172.01 -169.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 75.4 110.921 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 30.1 pt -69.82 172.62 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.106 -0.497 . . . . 72.3 111.127 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -78.05 56.37 1.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 73.14 110.889 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -150.93 -40.56 0.12 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.475 . . . . 73.22 110.927 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.43 -143.89 3.88 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.704 -0.76 . . . . 73.14 112.476 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.11 176.18 22.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.781 -0.723 . . . . 62.41 112.506 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.03 104.78 3.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.785 0.326 . . . . 72.42 110.826 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -76.54 107.49 8.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 75.1 110.888 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -138.13 106.3 5.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 70.24 110.958 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -88.83 140.52 29.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.261 -0.427 . . . . 71.33 110.843 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.3 156.82 16.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 75.55 110.934 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -131.54 -173.17 13.27 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.699 -0.762 . . . . 54.31 112.509 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -46.21 101.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.691 2.261 . . . . 71.41 112.307 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 158.74 157.39 8.47 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.713 -0.756 . . . . 62.42 112.457 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -117.68 148.24 42.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.83 0.348 . . . . 71.54 110.909 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -160.28 160.06 32.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.161 -0.472 . . . . 72.43 110.925 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.2 p -115.22 80.27 1.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.092 -0.504 . . . . 63.34 110.871 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.7 m -86.26 84.69 7.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 73.05 110.881 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.2 m -89.89 -6.3 10.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.492 . . . . 55.22 111.156 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -162.62 62.53 0.21 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.487 . . . . 73.23 110.902 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.68 -34.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 74.3 110.877 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.82 -47.85 59.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 62.32 111.107 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -178.25 40.4 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.668 -0.777 . . . . 71.52 112.424 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.48 67.66 76.02 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.625 0.726 . . . . 72.33 111.156 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -81.77 -70.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.682 2.255 . . . . 74.11 112.329 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.473 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 1.9 t0 -94.17 -0.47 55.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 74.44 110.901 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 76' ' ' ASP . 5.6 m-20 81.07 89.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 74.1 110.844 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.9 m -146.04 -169.93 3.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 72.3 110.866 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.1 mt -76.23 153.31 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 75.21 111.162 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.6 t -149.05 157.42 43.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 73.13 110.872 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.37 159.54 25.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 72.3 110.89 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -150.83 136.12 17.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 74.42 110.887 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -87.44 121.62 30.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 73.54 110.926 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -79.7 93.41 5.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 75.44 110.96 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 pt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.438 . . . . 75.21 111.159 179.985 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.876 0.37 . . . . 71.44 110.884 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.4 m -116.28 138.15 47.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 73.3 111.1 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.6 tp -101.18 110.05 27.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 74.21 111.141 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.6 t -129.89 140.83 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 42.31 111.133 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -93.43 138.83 31.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 73.32 110.94 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -93.47 42.39 1.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 73.33 110.842 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 175.13 -169.5 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 73.04 110.842 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.8 t -64.1 160.61 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 75.04 111.122 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -86.44 53.89 2.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 61.23 110.871 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.444 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.23 28.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 75.12 110.903 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.0 50.34 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.764 -0.731 . . . . 71.05 112.516 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.15 171.71 23.79 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.772 -0.728 . . . . 53.43 112.54 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.51 149.84 23.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.822 0.344 . . . . 73.03 110.848 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -131.32 141.62 49.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 71.04 110.895 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -136.44 152.3 50.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 74.43 110.861 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 p30 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 72.22 110.856 179.987 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.777 0.323 . . . . 75.32 110.879 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.43 124.12 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 74.22 111.124 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.6 p -167.48 -168.34 1.02 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 54.22 110.844 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.44 158.14 38.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 75.12 110.844 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.5 mp -120.92 140.07 46.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 71.01 111.154 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 15.1 tttt -130.05 119.53 23.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 73.32 110.83 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.9 p -114.12 139.28 40.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 65.24 111.104 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.86 39.69 1.82 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 74.55 110.928 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.2 114.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 64.02 110.871 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 60.65 -143.06 48.19 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.733 -0.746 . . . . 74.43 112.51 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.9 p -150.1 154.79 38.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.793 0.33 . . . . 70.51 111.14 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -124.31 176.95 6.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.432 . . . . 74.5 110.908 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -126.49 130.8 51.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 74.54 110.84 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -115.33 126.34 54.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 75.33 110.897 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.9 126.78 20.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 73.12 110.948 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -102.89 89.56 3.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 71.53 110.902 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.431 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.1 OUTLIER 171.44 -166.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.191 -0.459 . . . . 72.31 110.959 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -52.19 173.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 70.42 111.112 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -86.32 50.15 1.93 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 74.43 110.914 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 22.3 p90 176.89 41.14 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.471 . . . . 75.44 110.946 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 165.1 -155.97 27.68 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.722 -0.752 . . . . 53.25 112.47 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.431 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 96.13 -171.33 28.26 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.724 -0.75 . . . . 74.13 112.469 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -80.93 108.68 14.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.869 0.366 . . . . 73.11 110.878 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -78.19 109.31 12.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 74.0 110.911 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -138.18 108.1 6.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 73.35 110.89 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -94.93 152.87 17.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 73.43 110.884 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -116.09 138.48 51.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 75.5 110.934 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -111.21 -170.14 19.05 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.729 -0.748 . . . . 65.2 112.461 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -46.99 99.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.628 2.219 . . . . 75.21 112.357 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.46 169.09 19.49 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.742 . . . . 72.51 112.544 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -99.5 146.22 26.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 72.32 110.875 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -130.38 151.57 50.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 73.44 110.883 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.5 t -119.11 93.23 4.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.087 -0.506 . . . . 75.14 110.846 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.95 94.61 8.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.091 -0.504 . . . . 75.13 110.813 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.8 m -150.6 32.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.492 . . . . 71.15 111.119 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -171.41 30.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.463 . . . . 72.1 110.904 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.47 -67.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 72.23 110.881 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.51 -34.85 63.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 72.45 111.107 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -65.8 -48.0 70.71 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.726 -0.749 . . . . 74.42 112.448 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.88 74.17 2.49 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.604 0.716 . . . . 73.42 111.148 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.18 -49.06 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.681 2.254 . . . . 75.33 112.38 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -175.26 -62.5 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 73.42 110.859 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -142.09 -95.68 0.13 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 73.43 110.885 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.85 52.05 1.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 62.41 110.885 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.69 85.77 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.087 -0.506 . . . . 63.01 111.14 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 79.2 p -163.19 154.07 16.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.459 . . . . 73.11 110.868 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.53 160.76 18.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 73.13 110.832 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -150.16 135.77 18.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 75.31 110.89 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.1 120.37 32.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 75.41 110.879 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -86.83 98.82 11.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 65.13 110.927 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 75.11 111.119 179.976 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.817 0.342 . . . . 73.32 110.897 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.8 m -117.16 138.51 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 75.35 111.114 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.8 tt -99.49 110.38 26.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 73.45 111.121 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 m -122.89 159.73 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 72.1 111.134 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -111.66 139.94 46.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.162 -0.472 . . . . 75.31 110.914 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -100.1 28.51 4.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 61.41 110.895 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 175.87 -169.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 64.31 110.836 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 t -62.98 157.37 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 71.31 111.094 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -83.22 54.88 2.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 73.11 110.905 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.443 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -177.34 27.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 75.2 110.886 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.24 45.63 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.76 -0.733 . . . . 65.12 112.493 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.27 173.68 23.67 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.778 -0.725 . . . . 71.03 112.512 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.62 146.17 26.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.821 0.343 . . . . 74.23 110.866 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.0 p -117.15 162.89 17.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 70.32 110.834 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -118.55 135.81 54.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 75.52 110.901 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.4 p30 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 74.21 110.876 179.956 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.777 0.322 . . . . 73.42 110.862 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.9 tt -174.14 102.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 74.11 111.143 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.4 p -169.21 -167.53 0.73 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 74.12 110.845 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.36 152.0 48.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.102 -0.499 . . . . 75.04 110.835 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 mp -120.99 137.93 53.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 75.54 111.153 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.35 119.69 15.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.467 . . . . 73.51 110.909 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.1 p -109.11 139.08 33.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 73.31 111.168 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.05 39.55 2.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 71.54 110.859 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.64 110.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.435 . . . . 55.22 110.859 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 56.99 -142.13 42.32 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.689 -0.767 . . . . 74.43 112.47 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 49.5 p -144.86 160.21 41.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.764 0.316 . . . . 65.44 111.14 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -123.22 -179.99 4.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 75.14 110.866 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.26 115.84 16.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 74.31 110.899 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -100.68 127.89 46.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 75.32 110.896 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.14 126.28 19.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 74.42 110.93 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -103.05 89.62 3.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 74.04 110.85 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.404 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 173.81 -171.82 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 73.52 110.904 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.6 tp -57.6 160.64 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 73.33 111.123 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -74.95 55.5 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 75.35 110.88 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -153.93 -38.27 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 74.34 110.892 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -146.61 -140.4 3.44 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 74.13 112.491 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.404 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 106.93 -175.33 20.61 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.764 -0.731 . . . . 64.13 112.51 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.7 106.48 7.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 71.51 110.873 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -79.52 109.23 13.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 73.22 110.937 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -138.07 108.32 6.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.084 -0.507 . . . . 72.22 110.951 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.66 157.37 16.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.286 -0.415 . . . . 71.3 110.87 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -121.36 153.98 37.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 74.2 110.916 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -121.12 179.32 16.32 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.751 -0.737 . . . . 62.21 112.496 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -43.97 104.82 0.06 OUTLIER 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.674 2.249 . . . . 72.54 112.35 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.52 162.59 11.43 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.731 -0.747 . . . . 72.52 112.488 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -81.11 174.0 12.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.843 0.354 . . . . 73.35 110.894 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -160.89 99.65 1.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 74.24 110.895 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.1 p -97.46 65.65 1.95 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.08 -0.509 . . . . 64.24 110.865 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.6 p -86.93 152.19 22.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 65.22 110.859 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.1 p -163.61 23.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.113 -0.494 . . . . 73.45 111.114 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 177.25 35.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 71.34 110.908 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.95 -40.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 75.32 110.863 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.29 -50.1 70.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.1 -0.5 . . . . 75.41 111.091 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 165.95 101.26 0.15 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 50.13 112.492 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.1 mm -113.29 74.83 2.11 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.604 0.716 . . . . 73.15 111.144 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -79.48 -165.62 0.35 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.665 2.243 . . . . 74.13 112.311 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -145.23 40.58 1.23 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.436 . . . . 72.21 110.853 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -175.9 -171.63 0.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 74.13 110.866 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 61.8 p -97.24 81.55 3.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 70.04 110.863 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -152.07 66.98 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 73.34 111.122 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 91.5 p -166.28 145.66 5.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 72.42 110.848 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -163.93 165.62 22.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 74.43 110.804 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -150.6 143.03 24.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 64.51 110.871 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -79.91 171.98 14.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 75.33 110.87 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -148.04 105.94 3.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 65.35 110.907 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.6 pt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 74.2 111.147 179.947 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.901 0.381 . . . . 75.52 110.853 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.1 t -112.06 119.8 60.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 72.51 111.135 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.9 tt -123.76 110.19 25.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 64.1 111.111 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.0 m -126.82 142.25 43.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 75.32 111.102 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -92.26 141.6 28.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.177 -0.465 . . . . 74.01 110.923 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -96.42 44.37 1.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 74.23 110.91 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 172.95 -170.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 70.1 110.829 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.1 t -64.47 161.27 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 73.5 111.129 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -86.75 53.74 2.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 74.34 110.919 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.445 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.41 28.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 74.1 110.879 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.88 47.11 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.762 -0.732 . . . . 74.44 112.492 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.08 171.61 24.48 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.711 -0.757 . . . . 72.52 112.506 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 ptpt -92.64 164.11 13.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.794 0.33 . . . . 75.21 110.91 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.0 p -138.98 160.33 40.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 72.34 110.833 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -121.1 110.11 15.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 72.2 110.86 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 61.34 110.838 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.749 0.309 . . . . 74.53 110.884 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 pt -152.46 118.08 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 74.41 111.091 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.8 p -167.54 -164.46 0.58 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 73.32 110.859 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.13 150.32 39.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 73.53 110.882 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.5 mp -121.57 117.0 51.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 75.2 111.142 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -113.75 127.81 56.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 74.45 110.913 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.2 t -122.33 139.31 49.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 74.11 111.134 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -151.99 39.76 0.62 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 74.14 110.893 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.5 t 179.48 115.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 75.31 110.863 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 51.74 -153.84 5.08 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.72 -0.752 . . . . 55.54 112.497 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.7 p -138.07 158.15 44.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.774 0.321 . . . . 72.55 111.113 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -125.12 170.84 10.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 74.11 110.942 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -115.44 126.42 54.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 73.32 110.892 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -112.14 127.15 55.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 72.41 110.88 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.26 137.41 34.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 75.14 110.937 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -112.25 87.9 2.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 60.21 110.867 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 170.45 -171.74 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.18 -0.463 . . . . 71.33 110.936 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.4 pt -55.0 174.35 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 63.13 111.107 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -87.63 37.84 0.81 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 71.05 110.878 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -151.86 18.67 0.69 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 73.43 110.923 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.05 -154.51 23.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 62.31 112.517 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.9 178.93 22.81 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.746 -0.74 . . . . 61.24 112.494 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.85 103.75 6.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.35 . . . . 75.53 110.868 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -76.67 110.37 11.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 73.32 110.92 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -138.11 105.82 5.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.126 -0.488 . . . . 73.35 110.925 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -90.46 133.58 34.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 63.12 110.893 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.06 165.02 11.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 72.51 110.885 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -128.7 -166.46 11.98 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.779 -0.724 . . . . 70.32 112.518 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.67 118.05 4.88 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.688 2.259 . . . . 74.12 112.313 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.96 156.31 7.76 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.797 -0.716 . . . . 62.34 112.53 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -117.99 139.17 51.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 74.12 110.892 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -160.2 160.12 32.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.115 -0.493 . . . . 72.31 110.896 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.5 m -112.43 81.7 1.52 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.053 -0.521 . . . . 65.42 110.844 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.2 m -84.98 149.03 25.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 72.02 110.874 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.0 m -152.99 22.55 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 74.24 111.129 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -165.45 60.31 0.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 72.0 110.871 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.56 -33.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 73.2 110.89 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.3 -63.81 1.0 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 74.13 111.092 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.7 79.89 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 72.43 112.486 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.69 67.23 29.16 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.62 0.724 . . . . 75.14 111.136 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -80.31 -35.3 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.655 2.237 . . . . 74.3 112.343 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -179.2 -34.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 72.4 110.877 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -140.67 164.83 29.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 74.02 110.864 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.2 t -68.3 87.38 0.29 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 72.12 110.855 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 26.1 mm -139.03 68.51 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 73.1 111.145 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.8 p -146.83 165.17 30.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 74.11 110.837 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.6 157.73 14.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 71.25 110.849 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -150.8 136.57 18.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.126 -0.488 . . . . 75.32 110.901 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.69 120.09 32.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 74.54 110.815 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -79.4 97.67 6.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 73.54 110.936 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 pt . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 75.21 111.101 179.995 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.904 0.383 . . . . 64.35 110.86 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.2 t -109.02 120.04 59.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 75.11 111.15 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.0 tt -128.84 111.54 23.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 72.34 111.107 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 m -131.21 161.56 40.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 74.3 111.12 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -114.21 148.29 37.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 73.44 110.937 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -102.24 40.68 1.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 72.42 110.897 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 172.79 -171.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 73.13 110.893 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.1 t -63.97 160.15 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.429 . . . . 73.44 111.134 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -85.79 53.96 2.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 74.13 110.903 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.419 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.25 28.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 74.11 110.878 -179.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.02 44.38 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.772 -0.728 . . . . 63.13 112.477 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.02 172.04 24.28 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.765 -0.731 . . . . 55.23 112.484 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.33 160.33 14.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.793 0.33 . . . . 72.25 110.87 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.1 p -136.37 164.56 27.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 73.04 110.838 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -123.14 113.91 19.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 63.03 110.871 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 74.44 110.866 179.972 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.771 0.32 . . . . 74.42 110.861 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.5 tt -176.77 107.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 72.53 111.151 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 83.3 p -167.88 -166.14 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 74.12 110.909 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -114.57 141.49 47.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 74.31 110.885 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 mp -124.71 118.16 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 72.42 111.092 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -123.61 135.02 53.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 73.14 110.888 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.7 t -129.17 139.57 51.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 72.33 111.143 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.99 39.35 1.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 70.21 110.907 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.8 t 177.84 120.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 70.31 110.851 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.14 -152.94 6.21 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.747 -0.74 . . . . 72.45 112.446 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.6 p -142.4 159.37 42.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.345 . . . . 74.13 111.139 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.5 m0 -123.78 176.55 6.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 74.12 110.916 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -123.84 122.03 36.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 75.22 110.86 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -107.55 125.87 51.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 75.25 110.857 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.28 126.91 20.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 75.31 110.888 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -100.69 89.91 4.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 75.34 110.864 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.431 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.1 OUTLIER 170.76 -167.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 75.51 110.921 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -52.26 173.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.478 . . . . 74.42 111.15 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -86.56 50.28 1.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 65.2 110.874 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 22.2 p90 176.98 40.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 72.55 110.903 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.92 -157.71 30.26 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.747 -0.74 . . . . 63.34 112.533 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.431 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 95.42 -171.59 29.5 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.742 -0.742 . . . . 72.1 112.488 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.51 106.77 11.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.816 0.341 . . . . 72.13 110.896 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -77.72 109.47 11.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 75.43 110.883 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.9 t90 -138.04 105.38 5.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.115 -0.493 . . . . 72.01 110.892 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -89.41 135.61 33.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 64.33 110.91 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.99 164.71 12.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.222 -0.445 . . . . 74.45 110.955 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -130.54 -174.92 13.82 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.745 -0.741 . . . . 64.42 112.52 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.54 117.04 3.26 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.708 2.272 . . . . 72.45 112.287 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.84 155.48 7.47 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.742 -0.742 . . . . 61.42 112.477 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -113.63 134.93 54.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 64.44 110.871 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -159.48 159.98 34.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 72.3 110.922 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 m -108.26 101.41 10.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 75.51 110.916 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.93 135.21 34.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 74.5 110.822 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.9 m -149.81 24.26 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 73.22 111.146 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 173.21 -16.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 71.21 110.861 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.9 t -80.76 -23.95 39.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 74.01 110.827 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -83.62 -63.62 1.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 50.02 111.108 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 166.95 124.14 0.7 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.74 -0.743 . . . . 64.41 112.488 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.1 mm -122.33 69.8 31.96 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.625 0.726 . . . . 73.12 111.13 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -78.72 -166.34 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.702 2.268 . . . . 72.35 112.362 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.62 -29.84 27.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 73.52 110.847 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -143.65 162.62 35.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 72.34 110.863 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.59 119.19 10.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 62.32 110.844 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.2 pt -153.36 24.61 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 73.31 111.158 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.8 t -110.76 164.57 12.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 72.35 110.869 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.2 m -165.46 157.33 14.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 65.42 110.881 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -150.67 135.88 17.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 74.55 110.846 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.0 mmt85 -90.7 120.8 32.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 74.44 110.846 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -79.55 94.38 5.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 75.12 110.875 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 75.01 111.111 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.899 0.38 . . . . 63.13 110.88 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 76.2 t -116.11 127.02 73.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 72.04 111.13 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.8 tt -123.14 110.89 27.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 74.22 111.138 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.1 t -124.54 140.39 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 74.35 111.103 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -90.7 139.97 30.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 75.12 110.932 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.33 35.42 1.78 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 64.23 110.917 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 177.21 -169.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.127 -0.488 . . . . 74.22 110.871 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.3 t -63.77 160.28 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.211 -0.449 . . . . 73.13 111.111 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -86.31 54.26 3.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 64.54 110.897 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.441 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.24 28.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 74.41 110.928 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.86 52.46 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.744 -0.741 . . . . 50.33 112.516 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.2 171.72 24.49 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.788 -0.72 . . . . 62.42 112.518 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.62 126.48 42.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.813 0.339 . . . . 74.13 110.883 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 82.1 p -118.0 151.98 36.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 75.2 110.907 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -109.11 133.64 52.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 75.33 110.911 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 p30 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 72.03 110.862 -179.993 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.742 0.306 . . . . 73.3 110.911 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.4 tt -152.29 102.0 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 75.25 111.135 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.9 p -171.81 -165.63 0.38 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 74.23 110.835 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.3 t -128.91 156.03 44.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 72.45 110.879 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.5 mp -121.04 140.54 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 74.35 111.12 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -141.59 119.39 11.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 74.32 110.879 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.9 p -119.97 139.64 46.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 72.41 111.115 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.76 38.23 1.65 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 74.32 110.922 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 172.86 110.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.234 -0.439 . . . . 63.52 110.831 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.17 -158.22 39.87 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.729 -0.748 . . . . 73.21 112.491 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.9 p -150.68 127.58 11.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.74 0.305 . . . . 72.51 111.177 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.517 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.5 OUTLIER -94.15 164.78 12.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 75.11 110.947 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -119.86 117.18 27.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.302 -0.408 . . . . 74.31 110.903 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -105.41 125.69 51.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 72.05 110.878 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -141.08 125.83 17.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 74.54 110.87 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.23 88.57 3.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 75.33 110.92 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 175.92 174.33 0.31 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.135 -0.484 . . . . 74.5 110.9 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.6 pt -52.39 172.88 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 75.5 111.111 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -76.75 56.47 1.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 71.32 110.902 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -149.92 -69.94 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 72.24 110.918 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.82 -135.97 5.83 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.738 -0.744 . . . . 70.02 112.523 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.7 176.61 23.11 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.806 -0.711 . . . . 72.22 112.472 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.36 103.32 8.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.848 0.356 . . . . 75.32 110.89 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -77.55 106.53 9.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 74.42 110.914 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -134.79 106.7 7.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.085 -0.507 . . . . 73.31 110.941 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -92.19 136.63 33.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 74.5 110.851 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.2 pp -100.26 140.91 33.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 71.32 110.936 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -122.45 -165.24 12.4 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.735 -0.745 . . . . 52.11 112.495 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -40.43 104.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.632 2.221 . . . . 73.15 112.354 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.88 164.35 13.16 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.788 -0.72 . . . . 64.24 112.539 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.08 148.49 50.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.898 0.38 . . . . 74.52 110.88 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -153.57 139.1 17.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 64.13 110.879 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.7 m -122.73 71.67 1.04 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 74.01 110.894 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 44.7 m -89.61 171.95 9.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 71.2 110.878 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.2 p -162.4 23.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 72.44 111.107 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -174.88 35.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 73.12 110.87 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.9 t -157.81 -40.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 64.4 110.873 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.27 -61.74 1.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 72.35 111.135 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.02 94.44 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.718 -0.753 . . . . 74.12 112.483 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.17 64.28 8.73 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.584 0.707 . . . . 63.31 111.152 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -80.86 -47.32 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.716 2.277 . . . . 73.11 112.316 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -174.0 -168.4 0.41 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 71.42 110.852 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -84.62 53.06 2.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 72.34 110.891 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.7 m -99.01 -169.63 1.8 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 72.05 110.831 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.18 137.39 21.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 74.22 111.111 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.13 143.12 18.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 74.22 110.881 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.18 168.27 22.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 73.11 110.828 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -150.82 135.6 17.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 73.31 110.879 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.0 130.62 34.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 73.34 110.884 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -79.94 108.69 13.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 75.23 110.923 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.3 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 70.32 111.118 179.94 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.909 0.385 . . . . 72.23 110.908 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.5 t -116.77 128.46 74.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 74.12 111.142 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.9 tt -128.86 110.72 21.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 71.51 111.129 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 83.0 t -129.79 144.37 38.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 74.42 111.183 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -103.11 133.86 47.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 73.03 110.937 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -94.26 48.02 1.22 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.489 . . . . 75.4 110.86 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 174.26 -169.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 74.15 110.841 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.8 t -64.83 161.23 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 73.11 111.13 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -87.93 54.11 2.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 75.32 110.87 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.432 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -176.96 28.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 62.13 110.837 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.41 50.67 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.749 -0.739 . . . . 75.35 112.477 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.08 171.62 24.48 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.707 -0.759 . . . . 61.24 112.455 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.38 163.46 14.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.767 0.318 . . . . 75.03 110.919 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.2 p -149.63 157.63 43.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 72.44 110.865 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -109.58 106.32 15.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 73.14 110.874 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.115 -0.493 . . . . 71.13 110.855 -179.993 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.779 0.323 . . . . 75.1 110.89 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.3 tt 179.1 102.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 75.11 111.142 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 52.2 p -168.35 -168.5 0.94 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 75.33 110.845 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -120.9 145.07 48.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.478 . . . . 74.02 110.867 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.4 mp -121.26 123.07 69.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 73.41 111.154 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -117.06 129.18 55.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 72.41 110.906 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.7 p -144.98 139.81 22.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 71.13 111.124 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.52 39.93 1.72 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 75.44 110.952 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 179.78 139.04 0.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 72.45 110.815 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 53.31 -165.35 1.88 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.77 -0.729 . . . . 71.12 112.485 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.5 p -144.98 144.71 31.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.79 0.329 . . . . 73.35 111.151 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -124.2 136.25 54.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.439 . . . . 72.02 110.953 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -79.96 125.56 29.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 75.43 110.857 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -113.21 124.89 53.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 75.42 110.841 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.87 126.73 20.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 74.41 110.963 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -95.4 88.8 5.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 73.32 110.874 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.405 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 172.14 -169.72 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.155 -0.475 . . . . 75.42 110.91 -179.872 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.0 pt -69.74 172.7 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.09 -0.505 . . . . 74.31 111.144 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -78.8 56.21 1.85 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 73.15 110.876 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -151.4 -40.6 0.12 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 75.44 110.868 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.51 -144.81 4.03 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.698 -0.763 . . . . 75.14 112.437 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.405 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 108.39 175.38 21.88 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.715 -0.755 . . . . 73.43 112.488 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -66.93 106.45 1.92 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.844 0.355 . . . . 74.32 110.857 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -77.96 103.17 7.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 73.13 110.92 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.0 t90 -137.6 109.28 7.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.156 -0.475 . . . . 71.22 110.949 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -84.69 144.92 28.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 73.53 110.837 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.5 tp -99.53 137.34 38.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.229 -0.441 . . . . 74.22 110.939 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -115.16 -162.32 13.58 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.739 . . . . 52.34 112.449 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -64.03 100.89 0.32 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.678 2.252 . . . . 74.15 112.335 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 158.48 157.44 8.48 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.753 -0.737 . . . . 73.52 112.485 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.05 136.67 54.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.893 0.377 . . . . 73.14 110.905 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -135.79 138.34 42.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 74.05 110.902 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 m -114.25 75.32 0.92 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 72.22 110.846 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 40.7 t -86.21 152.41 22.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 73.42 110.829 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.7 m -149.64 23.59 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 64.45 111.093 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 178.06 -16.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.477 . . . . 75.32 110.873 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.11 -32.18 64.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 64.11 110.851 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.52 -65.71 0.79 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 74.12 111.112 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 166.49 114.03 0.29 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.745 -0.74 . . . . 72.21 112.485 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.0 mm -130.54 67.23 80.04 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.671 0.748 . . . . 74.51 111.173 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -81.72 -74.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.721 2.28 . . . . 71.25 112.327 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.498 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 4.9 t70 177.44 87.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 75.22 110.861 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 76' ' ' ASP . 9.0 t-20 83.67 131.11 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 73.31 110.927 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -179.6 151.75 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 70.44 110.88 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.6 mt -108.55 153.44 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 75.12 111.084 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.6 p -154.88 158.87 39.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 73.01 110.871 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.59 157.32 27.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.495 . . . . 73.32 110.856 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -150.72 135.78 17.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 75.43 110.884 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.6 mmm-85 -93.49 126.56 38.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 72.11 110.878 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.23 131.48 36.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 60.1 110.958 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.9 pt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 74.42 111.115 179.976 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.877 0.37 . . . . 73.11 110.871 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.4 t -106.84 121.77 60.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.485 . . . . 75.15 111.12 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.0 tt -123.38 112.17 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 74.34 111.123 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.1 t -128.71 136.88 58.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 74.3 111.093 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -89.06 140.91 28.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 74.42 110.908 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -97.09 38.43 1.24 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 72.3 110.909 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 175.08 -169.53 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.482 . . . . 72.23 110.891 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.8 t -63.9 161.39 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 71.14 111.143 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -87.35 54.19 3.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 73.45 110.905 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.439 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.2 28.56 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 71.24 110.898 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.6 47.8 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.766 -0.731 . . . . 52.22 112.497 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.92 171.98 24.27 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.748 -0.739 . . . . 61.51 112.49 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.56 160.95 17.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.818 0.342 . . . . 74.41 110.865 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 78.4 p -138.24 155.76 48.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 74.45 110.874 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -117.24 104.65 11.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 73.34 110.854 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 74.24 110.868 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.737 0.304 . . . . 75.44 110.863 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 pt -148.89 103.96 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 72.3 111.118 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 79.3 p -167.7 -165.76 0.68 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 70.31 110.847 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.61 148.48 46.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 52.01 110.874 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 mp -121.02 139.07 49.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 73.53 111.141 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -141.97 134.3 27.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 75.04 110.881 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.0 p -135.57 138.95 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 75.12 111.13 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.14 39.48 2.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 63.42 110.874 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.57 110.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 74.43 110.865 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.89 -157.41 53.51 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.739 -0.743 . . . . 65.52 112.428 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 72.7 p -150.24 135.96 18.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.757 0.313 . . . . 72.15 111.161 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -99.63 168.75 9.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 72.33 110.911 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -115.05 123.29 48.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 75.21 110.9 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -110.15 123.58 50.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 74.24 110.89 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.87 126.61 20.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 73.53 110.902 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -102.62 89.86 3.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 73.22 110.89 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.407 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.1 OUTLIER 172.05 -166.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.477 . . . . 73.0 110.937 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.419 ' HB ' ' CD1' ' A' ' 54' ' ' TYR . 5.8 mm -54.98 164.57 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 75.41 111.131 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 59.4 m-20 -80.17 51.9 1.47 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 73.03 110.886 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.433 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 1.9 p90 -179.47 27.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.482 . . . . 73.23 110.931 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.33 -164.86 37.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.745 -0.74 . . . . 72.04 112.457 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.407 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 107.55 -169.68 14.87 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.757 -0.735 . . . . 74.15 112.488 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.17 105.02 12.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.356 . . . . 74.24 110.891 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -78.06 108.4 11.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 75.24 110.945 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -138.11 106.17 5.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.149 -0.478 . . . . 75.32 110.923 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -93.41 138.41 31.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.436 . . . . 75.23 110.878 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.2 pp -103.13 142.71 33.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 73.32 110.925 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -122.77 -162.85 11.65 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.753 -0.737 . . . . 72.41 112.52 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -45.5 101.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.655 2.237 . . . . 73.14 112.39 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 163.62 171.53 29.98 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.736 . . . . 72.21 112.524 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -133.84 143.92 48.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.847 0.356 . . . . 61.23 110.867 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -151.89 140.12 20.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.484 . . . . 75.32 110.942 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.8 p -124.29 72.6 1.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 73.3 110.841 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.8 t -86.06 168.97 13.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 70.24 110.891 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.9 m -152.28 23.53 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 73.11 111.132 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -176.08 57.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 62.53 110.879 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 t -175.99 -43.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 70.4 110.872 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.71 -66.09 0.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 75.54 111.124 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -176.89 93.32 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.716 -0.754 . . . . 71.2 112.462 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.3 mp -128.35 67.91 76.31 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.657 0.741 . . . . 73.33 111.109 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -76.98 -166.12 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.684 2.256 . . . . 74.14 112.37 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -91.4 -24.23 19.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 64.33 110.892 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -141.78 172.45 12.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 75.03 110.91 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.74 88.14 0.24 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 61.42 110.868 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.9 mm -134.91 61.81 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 74.22 111.177 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.8 t -163.02 156.17 19.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 72.32 110.892 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -165.54 159.32 16.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 72.01 110.917 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -150.4 135.77 17.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 71.14 110.877 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -94.27 118.35 31.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 74.42 110.92 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -79.66 93.0 5.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.458 . . . . 74.11 110.899 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 pt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 75.34 111.115 179.965 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.849 0.357 . . . . 64.43 110.875 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.9 m -112.13 138.64 40.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 74.41 111.166 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.7 tp -105.34 110.97 32.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 72.2 111.135 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.0 m -131.25 165.0 32.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 75.31 111.067 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -117.3 142.7 46.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 73.24 110.916 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -101.45 37.72 1.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.495 . . . . 73.04 110.889 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 174.02 -170.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.483 . . . . 74.12 110.816 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.1 t -64.12 160.37 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 74.41 111.103 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -87.32 54.5 3.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 73.02 110.924 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.441 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -176.91 28.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 70.54 110.883 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.9 46.16 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.786 -0.721 . . . . 75.43 112.548 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.19 172.01 24.36 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.718 -0.753 . . . . 43.03 112.484 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.42 152.26 22.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.782 0.325 . . . . 74.13 110.93 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.62 148.92 49.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 72.15 110.868 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -102.29 104.29 14.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 65.14 110.898 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 72.31 110.858 179.978 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.76 0.314 . . . . 72.34 110.931 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.4 tt -179.59 103.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 72.52 111.156 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 82.5 p -168.23 -166.92 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 75.32 110.869 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.9 t -115.35 168.22 10.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 75.21 110.879 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -145.41 139.21 21.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 74.24 111.173 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.9 119.65 13.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 74.34 110.892 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 p -113.94 139.05 41.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 73.52 111.134 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -138.04 45.26 2.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 74.2 110.908 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.72 113.68 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 73.5 110.861 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.23 -135.75 35.8 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.742 -0.742 . . . . 65.32 112.466 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.4 p -150.06 150.13 31.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.732 0.301 . . . . 71.24 111.166 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.7 m0 -117.74 171.38 8.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.247 -0.433 . . . . 75.41 110.897 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.7 mpp_? -113.85 119.73 38.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 74.25 110.909 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -108.59 126.71 53.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 71.31 110.9 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.24 126.29 19.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 74.34 110.922 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -98.44 89.54 4.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 75.12 110.88 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.409 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 172.54 -168.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.116 -0.493 . . . . 75.23 110.934 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 mm -69.82 165.98 2.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 73.13 111.137 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -74.83 56.69 0.74 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 71.21 110.902 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -153.09 -39.15 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 74.51 110.905 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -147.99 -142.36 3.65 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.757 -0.735 . . . . 72.3 112.523 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.409 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 106.55 -178.09 22.32 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.789 -0.72 . . . . 75.04 112.492 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -76.72 108.72 9.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.798 0.332 . . . . 74.55 110.884 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -78.29 100.26 6.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 74.03 110.903 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -133.41 107.53 8.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 74.04 110.923 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.88 148.14 27.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 64.25 110.862 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.7 tp -99.52 136.5 39.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 75.33 110.913 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -112.93 176.34 17.45 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.708 -0.758 . . . . 74.24 112.479 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -46.74 100.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.727 2.284 . . . . 74.33 112.334 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.46 164.6 14.99 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.746 -0.74 . . . . 70.42 112.506 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -118.52 146.94 44.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.829 0.347 . . . . 74.43 110.9 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -146.19 140.15 26.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 74.33 110.867 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.48 73.88 1.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.095 -0.502 . . . . 71.23 110.858 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 45.7 t -85.06 156.23 21.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 65.0 110.84 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.9 m -149.96 26.27 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.114 -0.494 . . . . 74.15 111.096 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 173.15 -16.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 75.54 110.884 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.02 -23.95 41.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 71.22 110.85 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.79 -71.0 0.54 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 62.05 111.114 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 166.79 124.54 0.72 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.781 -0.724 . . . . 71.15 112.502 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.4 mm -123.64 68.08 41.02 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.626 0.727 . . . . 73.11 111.111 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -79.38 -166.18 0.39 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.724 2.283 . . . . 63.34 112.332 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.62 14.81 14.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 72.21 110.874 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -157.36 113.94 2.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 74.23 110.89 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.7 m -92.28 45.0 1.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 75.34 110.855 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.4 mm -76.51 66.26 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 75.45 111.091 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.1 168.92 9.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 75.12 110.82 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.69 155.26 12.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 75.12 110.908 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -151.13 135.96 17.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 74.35 110.9 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.5 mmm-85 -95.79 126.18 40.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 73.02 110.902 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -79.26 97.03 6.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 71.03 110.909 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 63.14 111.154 179.981 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.887 0.375 . . . . 73.43 110.897 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 89.5 t -119.79 133.35 66.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 75.1 111.159 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.0 tt -122.29 109.87 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 75.41 111.133 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.0 m -132.19 164.77 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.182 -0.463 . . . . 64.1 111.153 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -113.4 138.73 49.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 73.53 110.99 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -100.73 38.21 1.57 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 71.45 110.888 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 169.26 -173.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 75.3 110.892 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.8 t -66.02 160.55 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.254 -0.43 . . . . 70.41 111.109 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -88.67 54.77 3.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 75.42 110.895 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.419 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -176.55 28.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 72.12 110.917 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.56 43.63 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.73 -0.748 . . . . 41.53 112.5 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.69 172.14 24.52 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.777 -0.725 . . . . 64.12 112.509 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.2 123.6 34.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.797 0.332 . . . . 75.21 110.905 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.3 p -121.24 135.17 55.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 70.21 110.862 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 19' ' ' PHE . 0.8 OUTLIER -124.85 136.73 54.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.15 -0.477 . . . . 75.11 110.878 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 74.41 110.828 179.979 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.759 0.314 . . . . 75.3 110.91 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.96 111.46 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 75.33 111.157 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.7 p -167.25 -166.46 0.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 74.12 110.871 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 t -117.61 159.38 23.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 72.35 110.882 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -139.53 140.96 36.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 74.32 111.155 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -151.0 147.75 27.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 72.4 110.892 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.6 p -136.03 130.98 49.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 74.33 111.135 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.03 39.51 3.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 74.31 110.837 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.59 110.63 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 60.11 110.888 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.85 -147.86 48.61 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.739 . . . . 64.3 112.508 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.5 p -150.35 147.82 28.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.762 0.315 . . . . 73.11 111.123 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.0 m0 -118.08 174.84 5.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 74.54 110.942 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -124.66 129.13 49.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 71.23 110.858 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -113.57 128.38 56.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 70.23 110.862 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.33 126.19 19.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.486 . . . . 74.4 110.928 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -101.09 88.9 3.63 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.074 -0.512 . . . . 74.44 110.873 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 172.04 -171.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 74.45 110.918 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.7 pt -54.97 174.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.499 . . . . 75.44 111.11 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -87.9 37.86 0.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 70.12 110.909 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -151.74 18.63 0.7 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 75.11 110.926 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.07 -152.34 18.95 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.74 -0.743 . . . . 63.31 112.487 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.29 176.25 22.66 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.749 -0.739 . . . . 60.43 112.478 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.49 109.42 6.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.812 0.339 . . . . 75.14 110.857 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -77.59 108.35 10.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 73.54 110.899 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -138.44 107.17 5.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.06 -0.518 . . . . 74.23 110.925 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -91.28 157.72 16.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 64.4 110.859 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -119.97 149.61 41.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 64.32 110.934 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -124.81 -173.97 13.88 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.728 -0.748 . . . . 72.22 112.525 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -43.97 101.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.731 2.287 . . . . 70.12 112.329 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 158.92 162.4 11.93 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.749 -0.738 . . . . 73.43 112.495 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.13 147.5 41.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.899 0.381 . . . . 72.04 110.882 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -132.64 160.4 36.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 74.2 110.913 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 95.8 p -140.09 62.82 1.49 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 73.43 110.889 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 71.0 m -85.8 145.81 27.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.488 . . . . 75.5 110.836 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.9 m -150.6 18.44 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.487 . . . . 73.3 111.127 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 179.3 38.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 71.23 110.841 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.53 -46.71 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.471 . . . . 71.41 110.866 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.32 -45.86 62.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.506 . . . . 60.31 111.077 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 166.93 103.68 0.17 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.769 -0.729 . . . . 73.04 112.473 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 15.0 mm -131.52 74.02 78.85 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.626 0.727 . . . . 71.31 111.095 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -77.59 -158.54 0.09 OUTLIER 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.709 2.272 . . . . 52.1 112.328 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -75.97 -22.71 55.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 72.52 110.868 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -158.65 -169.54 2.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 73.11 110.89 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.0 t -57.82 -95.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 71.45 110.888 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.2 mp 50.91 59.89 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 75.02 111.092 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 66.1 p -159.41 158.61 32.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 75.41 110.842 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.73 159.63 16.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 70.41 110.867 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -150.14 135.8 18.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 75.12 110.872 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.2 mmt-85 -90.48 117.4 29.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 74.41 110.904 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -82.28 91.85 6.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 74.44 110.909 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 74.4 111.11 179.945 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.86 0.362 . . . . 71.31 110.878 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 54.3 t -102.02 119.43 50.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 74.41 111.102 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.3 tt -120.96 109.51 25.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 74.34 111.135 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.8 t -126.41 141.37 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 72.12 111.153 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -96.04 134.6 38.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.179 -0.464 . . . . 63.35 110.892 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -94.35 44.23 1.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 70.33 110.916 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 174.79 -170.31 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 74.01 110.884 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 t -63.99 160.5 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 75.52 111.16 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -85.41 53.61 2.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 73.14 110.855 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.453 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.59 28.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 74.54 110.849 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.55 44.33 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.721 -0.752 . . . . 52.43 112.5 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -134.98 171.41 22.45 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.74 -0.743 . . . . 74.25 112.467 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.5 161.99 13.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.751 0.31 . . . . 74.42 110.92 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.7 p -151.11 155.34 38.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 65.01 110.84 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -136.34 136.7 39.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 74.05 110.858 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 72.35 110.867 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.749 0.309 . . . . 53.43 110.891 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.2 tt -162.01 115.55 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 74.33 111.13 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.9 p -167.22 -167.55 0.93 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 70.21 110.906 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.3 t -123.6 150.08 44.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 75.43 110.867 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.5 mp -120.91 115.18 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 64.02 111.117 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.6 tttm -109.88 119.26 38.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.465 . . . . 75.3 110.918 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 17.2 t -102.89 139.16 24.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 72.04 111.114 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.71 39.84 0.72 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 74.14 110.896 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 179.38 111.66 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 71.11 110.842 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.34 -142.22 24.55 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.674 -0.774 . . . . 64.14 112.523 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -149.84 124.17 9.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.795 0.331 . . . . 71.42 111.12 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -87.14 -177.08 5.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 74.53 110.922 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.25 119.95 19.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.453 . . . . 74.54 110.83 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -101.64 133.59 46.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 73.44 110.855 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.72 126.47 20.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.104 -0.498 . . . . 75.51 110.898 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -105.49 88.85 2.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.079 -0.51 . . . . 72.3 110.917 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.441 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 171.63 -168.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 71.35 110.938 -179.838 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.9 mm -54.97 158.63 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 60.51 111.138 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -76.38 58.2 1.28 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 74.03 110.945 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -167.19 -31.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.163 -0.471 . . . . 75.0 110.928 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -142.26 -152.56 5.72 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.737 -0.744 . . . . 72.31 112.467 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.441 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 108.98 -174.5 18.45 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.773 -0.727 . . . . 70.32 112.471 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.89 127.04 31.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.8 0.333 . . . . 74.5 110.901 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -96.66 108.12 20.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.236 -0.438 . . . . 70.34 110.904 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -138.08 106.74 5.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.093 -0.503 . . . . 75.43 110.914 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -95.47 157.34 15.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 64.02 110.867 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -135.96 139.1 42.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 63.04 110.916 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.52 -165.64 27.38 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.734 -0.746 . . . . 62.13 112.465 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -56.67 115.85 2.78 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.684 2.256 . . . . 70.04 112.346 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.7 151.42 5.89 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.733 -0.746 . . . . 73.21 112.504 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -79.96 155.01 27.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.845 0.355 . . . . 74.14 110.897 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -160.31 149.5 17.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.126 -0.488 . . . . 72.51 110.924 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.9 p -108.12 84.26 1.92 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 70.34 110.872 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.4 117.12 24.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 73.14 110.873 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.7 m -146.34 10.32 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 73.44 111.117 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -157.52 17.65 0.27 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 73.53 110.9 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -165.68 21.67 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 75.3 110.869 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.51 -34.67 16.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 73.34 111.101 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 165.97 41.31 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.78 -0.724 . . . . 54.21 112.495 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.45 63.13 17.92 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.62 0.724 . . . . 71.44 111.102 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.41 -47.61 0.07 OUTLIER 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.703 2.268 . . . . 54.12 112.316 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.472 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 9.3 t70 179.36 87.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 63.43 110.86 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.472 ' CB ' ' O ' ' A' ' 76' ' ' ASP . 5.4 m-20 81.41 -168.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 72.21 110.907 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.08 71.72 2.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 72.4 110.869 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.4 mm -141.79 69.64 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 72.34 111.184 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -165.99 152.59 9.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 63.52 110.834 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.71 171.54 12.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 74.52 110.841 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -152.07 135.9 16.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.134 -0.485 . . . . 75.35 110.905 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 30.5 mmm180 -98.78 116.37 30.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 72.04 110.904 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.63 103.56 13.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 74.43 110.92 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.1 pt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 75.1 111.11 179.982 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.921 0.391 . . . . 72.3 110.846 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.0 m -115.67 138.56 45.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.501 . . . . 71.24 111.136 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 tt -102.32 110.44 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 73.35 111.101 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.3 m -137.32 159.43 35.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 74.22 111.123 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -114.0 144.33 43.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 74.02 110.95 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.31 41.56 1.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 75.55 110.855 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 172.69 -170.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 72.23 110.826 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 t -63.61 159.97 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 65.04 111.076 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -85.74 53.87 2.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 74.03 110.883 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.438 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.11 28.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 73.11 110.856 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.57 41.14 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.732 . . . . 53.14 112.462 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -137.13 171.54 23.06 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.776 -0.726 . . . . 75.25 112.485 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.35 161.7 16.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.83 0.348 . . . . 74.03 110.893 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -139.07 166.9 23.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 75.4 110.86 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -129.44 113.48 14.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 71.24 110.944 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.4 t0 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 73.5 110.884 -180.0 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.787 0.327 . . . . 72.24 110.896 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -168.98 102.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 73.52 111.126 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.4 p -168.11 -167.6 0.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 73.22 110.879 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.7 t -126.66 157.86 37.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 74.34 110.866 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.69 138.06 55.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 73.54 111.113 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.1 tttt -136.03 124.31 23.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 72.41 110.853 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.5 p -120.3 139.5 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.436 . . . . 73.31 111.134 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -142.89 40.37 1.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 73.14 110.892 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.57 117.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 72.44 110.842 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 51.76 -151.45 6.84 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.696 -0.764 . . . . 73.45 112.523 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.7 p -136.62 155.95 49.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.763 0.316 . . . . 74.51 111.132 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.2 m0 -123.74 175.65 6.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 75.54 110.916 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.7 mpp_? -123.72 122.71 38.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 74.54 110.888 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -107.52 128.64 54.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 75.53 110.934 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.13 127.92 21.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 75.04 110.923 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -99.1 87.05 3.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.505 . . . . 71.24 110.853 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 170.23 -170.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.167 -0.47 . . . . 72.31 110.951 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.1 pt -54.68 174.31 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 72.44 111.139 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -87.41 36.95 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 74.01 110.945 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -151.85 19.01 0.69 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 73.55 110.925 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.61 -156.89 27.63 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.788 -0.72 . . . . 75.42 112.504 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.09 176.29 22.8 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.677 -0.773 . . . . 74.24 112.496 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -69.81 103.96 2.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.833 0.349 . . . . 74.0 110.872 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -75.05 108.4 7.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 75.33 110.957 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -138.1 106.21 5.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.138 -0.483 . . . . 75.53 110.953 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -88.49 138.41 31.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 71.43 110.845 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.18 159.44 14.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 65.3 110.928 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -128.85 175.77 18.62 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.706 -0.759 . . . . 54.34 112.483 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -42.51 107.77 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.657 2.238 . . . . 72.01 112.382 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.79 159.48 9.39 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.739 . . . . 71.4 112.489 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -102.6 144.69 30.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.843 0.354 . . . . 73.51 110.904 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -137.17 145.09 43.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.118 -0.492 . . . . 73.21 110.917 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.1 m -133.8 67.51 1.52 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 61.33 110.838 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.9 m -84.99 145.11 27.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 72.53 110.866 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.6 m -149.97 19.74 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 73.21 111.118 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -179.5 38.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 62.41 110.879 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.34 -39.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 71.3 110.894 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.17 -44.47 67.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 63.42 111.073 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 167.41 93.79 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.787 -0.721 . . . . 75.21 112.518 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.7 mm -123.98 67.27 42.37 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.613 0.72 . . . . 75.33 111.129 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -80.07 -166.38 0.41 Allowed 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.727 2.285 . . . . 72.35 112.376 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -57.67 -70.15 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.419 . . . . 72.02 110.876 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -96.68 -95.54 0.2 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 74.24 110.846 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.4 p -178.18 -95.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 73.24 110.836 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.5 mm 56.23 54.92 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 74.05 111.152 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.6 m -108.07 164.2 12.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 72.51 110.862 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.3 p -165.54 153.68 11.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 65.32 110.831 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -151.25 135.47 16.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 71.45 110.888 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.47 119.69 32.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 75.3 110.883 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -79.7 92.01 5.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 75.35 110.899 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 74.1 111.186 179.933 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.806 0.336 . . . . 74.1 110.9 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -148.11 115.2 6.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 75.14 110.876 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -155.65 66.45 0.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 53.34 111.075 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -171.95 103.69 0.18 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 71.4 111.094 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -90.0 118.76 29.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 73.54 110.882 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 89.7 t -110.6 111.24 35.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 71.11 111.116 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.0 tp -106.34 110.91 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 73.34 111.127 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.8 t -131.54 138.8 52.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 71.23 111.138 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -94.5 137.22 33.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 74.13 110.863 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -93.98 42.94 1.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 75.15 110.902 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 174.52 -169.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 63.23 110.852 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.0 t -64.68 160.97 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 74.21 111.17 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -87.34 53.79 2.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 73.32 110.923 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.441 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.12 28.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 72.52 110.911 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.19 52.73 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.726 -0.75 . . . . 74.12 112.486 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.96 171.52 24.48 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.798 -0.715 . . . . 63.41 112.513 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.43 134.34 35.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.77 0.319 . . . . 74.34 110.893 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.48 153.04 34.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 71.03 110.88 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -148.64 141.35 24.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 72.42 110.901 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -137.8 73.03 1.42 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 73.53 110.907 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.42 129.61 34.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 74.13 111.093 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.7 t -93.82 40.08 1.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 64.55 111.116 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.1 m -158.12 54.41 0.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 61.25 110.842 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 63.95 107.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.115 -0.493 . . . . 70.52 110.855 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.9 162.71 61.36 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.571 0.7 . . . . 63.24 110.945 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -47.79 -29.42 11.25 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.709 2.273 . . . . 72.23 112.359 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.81 -166.36 43.5 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.766 -0.731 . . . . 73.12 112.471 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.9 120.8 31.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.798 0.332 . . . . 73.32 111.098 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.33 -39.71 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.746 -0.74 . . . . 74.14 112.507 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -97.41 25.19 5.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.817 0.341 . . . . 65.43 110.866 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -64.31 -178.36 0.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 62.54 110.891 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -176.79 -85.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 74.42 110.89 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -159.09 -40.25 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 75.13 110.874 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -78.95 59.14 2.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 74.43 110.856 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.96 133.29 49.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 74.41 110.914 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 pt -153.11 109.72 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 75.54 111.127 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.0 p -165.01 -168.35 1.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 64.11 110.843 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -124.07 152.05 43.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 70.43 110.828 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.5 mp -120.91 139.33 48.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.51 . . . . 74.13 111.116 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.4 tttt -138.04 125.92 22.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 75.34 110.915 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.2 p -125.58 139.02 52.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.433 . . . . 70.31 111.158 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.88 39.39 1.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 74.23 110.861 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.93 110.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 62.31 110.855 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.94 -150.21 50.28 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.78 -0.724 . . . . 75.55 112.451 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.9 p -148.4 160.61 42.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.759 0.314 . . . . 74.04 111.146 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -124.53 177.48 5.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 74.13 110.953 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.57 111.92 16.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.273 -0.421 . . . . 74.44 110.864 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -101.01 123.95 45.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 75.15 110.916 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -139.97 126.63 20.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 74.34 110.945 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -104.09 89.57 3.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 74.11 110.871 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 177.27 -174.34 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 74.24 110.958 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.0 pt -54.88 174.15 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 74.13 111.099 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -83.07 10.12 8.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.14 -0.482 . . . . 71.54 110.881 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.45 67.27 1.26 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 73.52 110.937 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 116.39 121.08 3.27 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.757 -0.735 . . . . 73.42 112.503 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -177.35 174.48 47.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 71.03 112.486 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -64.62 95.93 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.844 0.354 . . . . 73.54 110.918 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -76.38 111.86 12.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 64.23 110.933 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -138.32 105.86 5.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.144 -0.48 . . . . 73.15 110.924 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -90.65 137.61 32.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.259 -0.428 . . . . 61.15 110.916 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -104.81 142.11 35.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 74.01 110.879 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -113.79 -168.63 16.63 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.781 -0.723 . . . . 75.41 112.54 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -46.84 109.89 0.24 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.699 2.266 . . . . 74.34 112.304 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.93 158.48 8.84 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.732 -0.747 . . . . 70.43 112.505 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.59 143.86 49.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.861 0.362 . . . . 63.25 110.891 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -148.63 160.12 43.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 72.13 110.898 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 99.0 p -140.69 78.04 1.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.094 -0.503 . . . . 62.31 110.837 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.4 m -86.64 153.05 22.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 62.53 110.843 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.1 m -153.43 23.92 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 73.03 111.114 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -179.52 39.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 75.13 110.9 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.85 -40.2 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 74.25 110.852 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.28 -75.79 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.114 -0.493 . . . . 71.05 111.095 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.85 90.15 0.1 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 73.33 112.516 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.15 67.07 72.89 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.644 0.735 . . . . 74.15 111.165 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -80.46 -52.21 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.663 2.242 . . . . 73.34 112.343 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 179.82 -51.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.264 -0.426 . . . . 74.53 110.845 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -173.75 130.14 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 74.44 110.861 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.17 178.69 2.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 73.42 110.891 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.4 mm -100.45 155.19 4.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 74.15 111.111 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.7 p -155.62 155.75 33.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 71.33 110.851 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -165.27 158.15 16.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 75.13 110.838 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -150.55 135.66 17.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 62.51 110.885 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -89.68 119.71 30.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 74.21 110.901 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -79.77 99.62 7.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 73.55 110.906 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 73.35 111.103 179.988 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.1 mtp . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.815 0.341 . . . . 73.14 110.833 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -90.45 142.32 27.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 72.14 110.898 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -87.0 98.53 11.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 73.43 111.117 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -169.1 108.65 0.45 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 72.4 111.105 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -88.97 97.89 11.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 73.24 110.898 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.5 t -100.85 114.65 40.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.484 . . . . 71.54 111.141 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.5 tt -115.41 110.53 32.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 74.12 111.131 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.5 t -128.79 145.09 36.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 73.35 111.132 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -97.81 136.7 37.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.476 . . . . 74.42 110.911 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.77 44.68 1.1 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.49 . . . . 74.34 110.872 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 173.42 -171.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 74.21 110.824 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.3 t -64.58 160.57 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 73.24 111.161 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -87.28 53.94 2.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 74.44 110.883 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.443 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -176.92 28.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 70.54 110.872 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.4 52.79 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.714 -0.755 . . . . 74.52 112.438 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.07 171.42 24.55 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.76 -0.733 . . . . 52.42 112.481 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.04 135.15 34.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.779 0.323 . . . . 73.22 110.912 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.65 154.35 32.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 74.12 110.882 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -148.65 151.97 35.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 73.33 110.878 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -163.18 92.57 0.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 70.44 110.838 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.99 157.9 16.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 63.44 111.129 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 m -93.88 40.01 1.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 73.54 111.141 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.4 m -146.66 -82.47 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 73.15 110.826 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -163.25 124.06 2.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.106 -0.497 . . . . 73.21 110.867 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.93 162.26 62.93 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.585 0.707 . . . . 75.11 110.888 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -72.3 -171.84 0.78 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.646 2.23 . . . . 74.23 112.357 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.62 139.78 17.53 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.768 -0.729 . . . . 51.04 112.488 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.05 -168.4 2.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.795 0.331 . . . . 75.33 111.114 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.29 87.9 1.93 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.725 -0.75 . . . . 43.43 112.485 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.42 -168.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.836 0.351 . . . . 62.42 110.851 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -63.47 -174.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 74.15 110.888 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.7 mp -56.31 -87.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 73.04 110.888 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -93.66 65.98 3.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 70.04 110.909 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -168.06 42.28 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 72.52 110.87 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.12 102.01 11.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 71.01 110.858 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 pt -154.49 106.08 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 73.21 111.14 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 56.6 p -151.08 -168.4 3.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 74.3 110.848 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.46 152.22 50.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.087 -0.506 . . . . 72.14 110.847 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -122.14 141.52 42.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 73.44 111.103 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.2 tttt -140.99 135.61 31.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 73.21 110.841 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.4 p -162.91 139.23 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 72.31 111.109 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.06 40.65 3.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 75.02 110.891 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 t 178.94 138.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 74.35 110.833 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.78 -177.87 1.89 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.705 -0.76 . . . . 71.54 112.524 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.5 p -145.49 147.65 32.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.754 0.311 . . . . 71.42 111.156 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -116.98 175.43 5.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 65.12 110.953 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -117.69 118.93 33.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.413 . . . . 71.35 110.906 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -107.63 125.93 51.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 75.45 110.871 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.18 126.64 20.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.143 -0.48 . . . . 74.44 110.952 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -99.25 89.13 4.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 74.52 110.868 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.404 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 170.95 -178.01 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 75.24 110.961 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.1 tt -54.94 163.34 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 74.13 111.119 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -76.29 55.84 1.01 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 72.23 110.886 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -153.5 -37.72 0.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 72.41 110.938 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -146.27 -144.27 4.04 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.699 -0.762 . . . . 75.13 112.427 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.404 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 108.18 -170.54 15.17 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.765 -0.731 . . . . 54.13 112.469 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -83.61 105.36 14.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.841 0.353 . . . . 74.03 110.852 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -78.16 106.84 10.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 73.43 110.932 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -138.1 108.35 6.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.48 . . . . 73.41 110.941 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -92.83 135.07 34.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.436 . . . . 71.51 110.877 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.3 pp -99.22 140.41 33.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 71.25 110.922 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -107.45 -159.18 20.92 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.773 -0.727 . . . . 62.43 112.475 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.37 88.06 0.13 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.672 2.248 . . . . 74.23 112.39 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.3 160.52 29.22 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.751 -0.737 . . . . 55.12 112.504 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -118.61 135.55 54.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 61.42 110.852 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -143.45 160.09 41.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.129 -0.487 . . . . 73.24 110.878 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 97.8 p -141.14 78.06 1.63 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.086 -0.506 . . . . 73.24 110.853 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.2 m -88.39 148.81 24.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.491 . . . . 75.23 110.858 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.5 m -150.68 24.05 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.495 . . . . 72.22 111.154 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -179.47 36.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 74.32 110.858 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.99 -43.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 75.22 110.831 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.59 -42.94 62.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 71.32 111.104 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 166.88 91.99 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.766 -0.73 . . . . 43.51 112.503 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 15.0 mm -131.46 69.21 81.74 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.638 0.733 . . . . 72.22 111.173 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -81.02 -66.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.701 2.267 . . . . 74.25 112.379 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -179.95 -73.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.266 -0.425 . . . . 75.33 110.874 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -66.09 -169.8 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 70.22 110.885 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.93 110.07 6.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 74.53 110.826 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.6 pt -152.92 22.79 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 74.24 111.096 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.6 p -79.78 160.54 26.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 73.05 110.861 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.62 156.69 13.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 75.14 110.854 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -148.58 138.37 22.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.49 . . . . 72.13 110.837 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.97 120.59 34.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 75.43 110.875 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -79.28 111.05 15.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 72.51 110.925 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.5 pt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.46 . . . . 73.31 111.132 179.969 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.795 0.331 . . . . 72.3 110.819 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -160.16 102.19 1.43 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 72.11 110.885 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -84.75 108.98 17.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 73.42 111.143 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -163.49 119.88 1.75 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 75.12 111.067 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.36 96.04 9.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 74.53 110.88 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.4 t -117.71 118.63 59.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 75.44 111.119 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 tp -136.69 116.65 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 63.2 111.102 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 m -133.12 160.33 42.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 73.2 111.122 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -113.15 141.21 47.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 75.54 110.952 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -95.46 37.0 1.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 74.2 110.869 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 175.62 -169.63 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 72.24 110.868 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.6 t -63.65 160.28 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 75.41 111.18 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -85.87 53.81 2.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 74.13 110.899 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.44 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.14 28.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 74.21 110.86 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.54 39.26 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.718 -0.754 . . . . 55.41 112.47 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -129.16 171.61 19.92 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.725 -0.75 . . . . 72.04 112.462 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.25 131.01 34.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.773 0.32 . . . . 73.42 110.921 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.57 145.26 45.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 72.02 110.855 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -148.77 128.71 13.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 74.21 110.875 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.23 71.05 0.82 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 74.33 110.927 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.433 ' H ' ' NE2' ' A' ' 25' ' ' GLN . . . -80.83 160.91 24.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 73.33 111.068 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.5 t -138.77 40.38 2.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 74.34 111.168 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.4 t -150.35 59.43 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 72.13 110.843 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 t70 63.26 87.64 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.486 . . . . 65.5 110.854 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.433 ' NE2' ' H ' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -80.14 162.44 61.74 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.593 0.711 . . . . 75.43 110.895 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.79 102.64 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.671 2.247 . . . . 74.34 112.328 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.15 148.96 10.01 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.758 -0.734 . . . . 73.45 112.438 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.26 106.86 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.839 0.352 . . . . 63.32 111.088 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.54 38.59 0.51 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.752 -0.737 . . . . 64.01 112.492 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.39 103.1 0.43 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.809 0.338 . . . . 71.32 110.881 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -174.08 -169.15 0.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 73.43 110.932 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.0 tp -142.06 -168.65 2.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 74.23 110.887 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -53.79 -27.32 28.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 74.13 110.874 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -84.7 54.25 2.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 74.12 110.891 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.01 102.32 14.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 75.43 110.906 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.94 124.68 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 74.01 111.143 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.0 p -167.86 -166.78 0.77 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 73.32 110.81 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.8 t -125.54 164.12 21.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.067 -0.515 . . . . 60.13 110.867 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -130.42 140.33 49.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 75.22 111.127 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -138.58 132.15 30.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 74.41 110.913 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.6 p -133.0 139.2 50.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.258 -0.428 . . . . 73.43 111.108 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.62 41.91 1.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.472 . . . . 61.23 110.927 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -173.44 110.83 0.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 70.44 110.861 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 56.63 -137.76 47.77 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.729 -0.748 . . . . 72.33 112.483 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 64.3 p -150.21 141.25 22.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.339 . . . . 75.24 111.095 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -109.72 168.45 9.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 74.51 110.891 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -110.2 120.89 43.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 74.23 110.917 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -110.95 127.72 55.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 72.52 110.936 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.73 126.15 18.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.471 . . . . 73.55 110.907 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -99.12 88.69 4.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.076 -0.511 . . . . 73.41 110.902 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 173.4 -177.85 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 73.21 110.903 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.0 pt -58.66 172.32 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 73.14 111.145 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -84.49 51.95 2.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 74.13 110.866 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -152.74 -47.87 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 74.41 110.918 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -149.75 125.05 1.89 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.742 . . . . 72.31 112.515 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.44 173.12 38.67 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.746 -0.74 . . . . 71.22 112.483 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -61.75 105.94 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.836 0.35 . . . . 74.22 110.921 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -77.04 103.32 6.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 74.12 110.922 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.9 t90 -138.19 107.91 6.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.496 . . . . 75.54 110.925 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -82.31 153.93 25.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 72.34 110.841 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.4 tp -104.79 133.68 49.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 75.33 110.947 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -111.08 178.79 19.76 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.733 -0.746 . . . . 75.0 112.486 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -46.99 100.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.652 2.235 . . . . 65.41 112.367 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 161.88 164.13 16.18 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.724 -0.751 . . . . 74.33 112.476 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -124.1 140.27 53.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.89 0.376 . . . . 73.42 110.868 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -140.77 144.23 35.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 72.25 110.939 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.1 t -126.18 74.8 1.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 74.01 110.895 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.6 m -87.27 159.01 18.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 72.54 110.823 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.5 m -151.29 21.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 74.54 111.166 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -179.37 58.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 73.23 110.881 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.55 -49.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 54.34 110.819 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.61 -62.01 1.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 72.31 111.115 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -164.74 88.94 0.1 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.722 -0.752 . . . . 63.11 112.463 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.8 mm -132.2 67.35 78.89 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.623 0.725 . . . . 74.31 111.14 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -80.25 -51.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.69 2.26 . . . . 74.11 112.381 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.86 -34.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 72.01 110.85 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -141.23 -176.77 4.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 71.03 110.871 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.34 111.68 23.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 75.42 110.889 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.98 11.1 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 72.14 111.086 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.4 p -83.37 170.64 14.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 72.22 110.843 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.64 152.66 10.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 73.01 110.859 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -150.19 139.9 21.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 74.54 110.919 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -109.33 130.62 55.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 70.43 110.86 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -89.38 131.41 35.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 54.11 110.899 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.6 pt . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 72.12 111.099 179.975 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.809 0.337 . . . . 71.31 110.866 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -82.57 176.12 9.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 75.54 110.865 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -155.47 51.49 0.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 74.0 111.06 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.34 144.76 25.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 74.34 111.109 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -90.47 116.17 28.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 74.45 110.879 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.6 t -111.95 111.77 37.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 75.14 111.117 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.3 tp -117.52 110.03 29.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 74.01 111.118 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 m -130.79 159.9 42.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 73.04 111.144 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -112.14 146.2 38.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.462 . . . . 75.12 110.938 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -101.18 38.9 1.48 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.477 . . . . 73.5 110.904 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 175.04 -171.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 74.25 110.845 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.7 t -63.33 160.61 2.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 65.2 111.105 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -84.19 53.74 2.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 74.41 110.917 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.446 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -178.06 28.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 73.42 110.84 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 158.88 38.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.753 -0.737 . . . . 73.32 112.495 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.3 171.51 20.57 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.756 -0.735 . . . . 74.52 112.464 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.91 149.79 21.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.798 0.332 . . . . 73.3 110.915 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.98 149.12 50.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 75.54 110.831 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -146.39 129.45 16.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 72.43 110.886 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.07 94.65 3.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 74.03 110.896 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -158.09 150.97 22.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 73.55 111.082 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -93.8 39.93 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 75.3 111.189 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.42 160.27 0.98 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 71.12 110.891 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.4 t0 52.0 32.47 10.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 61.03 110.902 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -132.4 138.99 33.41 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.548 0.69 . . . . 73.34 110.934 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -81.19 -169.05 0.71 Allowed 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.675 2.25 . . . . 75.22 112.336 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -163.55 -110.97 0.25 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.72 -0.752 . . . . 74.11 112.508 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.24 102.92 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.831 0.348 . . . . 45.32 111.089 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.06 -172.03 42.9 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.721 -0.752 . . . . 75.43 112.506 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -179.08 175.88 0.93 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.83 0.347 . . . . 72.42 110.828 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -104.55 -86.7 0.45 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 72.12 110.884 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 tp -172.47 98.51 0.15 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.218 -0.446 . . . . 70.31 110.963 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 60.23 19.46 8.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 75.31 110.878 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -103.66 39.82 1.54 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 73.32 110.849 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.49 102.96 12.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 74.14 110.908 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 tt -176.76 102.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 73.35 111.135 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.7 p -168.84 -164.18 0.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 65.52 110.869 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.5 t -125.41 149.34 48.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 74.43 110.883 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.5 mp -120.91 131.26 73.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 74.22 111.145 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -132.51 142.32 49.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 74.52 110.875 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.2 p -143.74 126.43 12.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 74.01 111.121 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.67 41.1 3.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 75.23 110.928 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.9 t -179.1 110.8 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 75.11 110.878 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.3 -151.24 52.12 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.67 -0.776 . . . . 75.13 112.508 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.1 p -150.07 153.39 36.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.798 0.332 . . . . 74.33 111.15 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -123.45 179.07 4.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 75.24 110.935 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -124.44 136.09 53.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.434 . . . . 74.1 110.823 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -120.12 129.88 54.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 75.43 110.878 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.71 126.14 20.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.164 -0.471 . . . . 74.41 110.95 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.78 89.04 3.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 65.44 110.918 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 175.38 -169.44 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 74.44 110.915 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.2 tt -58.6 163.06 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 73.12 111.113 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -76.24 55.3 0.95 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 75.32 110.871 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -153.76 -38.02 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 73.51 110.936 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -145.53 -138.82 3.31 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 72.24 112.509 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.06 177.37 22.16 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.796 -0.716 . . . . 73.2 112.5 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.3 109.48 5.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.81 0.338 . . . . 72.53 110.859 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -77.59 108.71 10.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 75.43 110.927 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -138.31 106.72 5.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 72.44 110.88 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -89.13 157.7 18.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 73.41 110.878 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -118.5 149.71 40.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 75.03 110.944 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -127.88 -166.6 12.09 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.72 -0.752 . . . . 75.4 112.493 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -46.41 101.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.7 2.267 . . . . 62.53 112.317 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.79 165.39 16.63 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.749 -0.738 . . . . 74.05 112.484 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.44 145.84 47.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.865 0.364 . . . . 74.33 110.858 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -154.75 156.65 36.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 75.44 110.924 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 95.8 p -130.4 85.88 2.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 70.21 110.854 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.1 t -86.01 153.21 22.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 60.31 110.86 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.7 m -149.65 18.03 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 61.3 111.163 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -178.7 40.94 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.117 -0.492 . . . . 75.01 110.863 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 t -158.44 -45.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 74.11 110.852 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.45 -61.26 2.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.486 . . . . 75.41 111.097 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 166.62 103.7 0.17 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.717 -0.754 . . . . 73.33 112.449 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.8 mm -115.76 74.66 4.95 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.666 0.746 . . . . 74.14 111.14 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.96 -165.54 0.31 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.701 2.267 . . . . 72.54 112.359 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -51.32 -74.85 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.265 -0.425 . . . . 73.31 110.834 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -179.41 33.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 74.44 110.857 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.3 p 178.95 -174.84 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 74.04 110.859 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.2 mm 66.8 62.13 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 74.53 111.151 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.2 p -165.94 137.88 3.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 65.43 110.895 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -158.53 166.75 31.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 75.13 110.864 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -151.12 142.51 23.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 62.55 110.886 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.86 159.0 26.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 74.52 110.932 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -128.52 92.53 3.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 63.4 110.934 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 pt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 74.31 111.111 179.981 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.4 mtm . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.771 0.32 . . . . 70.31 110.9 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -162.83 -179.91 7.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 71.33 110.881 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.0 99.15 1.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 72.41 111.094 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -146.45 139.16 25.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 74.42 111.048 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -89.45 93.31 9.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 74.51 110.878 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.3 t -111.92 128.65 68.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 74.1 111.128 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.9 tt -126.68 110.56 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 74.43 111.155 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.4 t -136.54 143.81 34.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 71.11 111.112 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.85 138.2 40.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 74.32 110.89 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -93.25 42.67 1.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 75.03 110.885 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 173.93 -169.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 72.33 110.858 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.2 t -63.95 160.3 3.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.218 -0.447 . . . . 74.22 111.178 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -86.42 53.97 2.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 74.41 110.858 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.434 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.04 28.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 73.24 110.895 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.36 47.33 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.692 -0.766 . . . . 72.42 112.424 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.97 171.96 24.3 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.714 -0.755 . . . . 62.52 112.466 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.2 163.86 15.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.829 0.347 . . . . 72.45 110.924 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.1 p -144.52 165.44 27.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.434 . . . . 74.12 110.836 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -124.88 110.89 14.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 75.42 110.838 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.96 47.24 0.88 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 75.42 110.862 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.99 -176.08 5.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 73.45 111.138 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.0 t -138.71 40.02 2.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.443 . . . . 72.22 111.111 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.1 p -179.33 38.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 71.12 110.826 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -141.98 24.65 1.99 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.125 -0.489 . . . . 64.33 110.892 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.8 mp0 -144.18 162.41 40.32 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.583 0.706 . . . . 64.44 110.938 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -74.58 -50.4 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.699 2.266 . . . . 75.54 112.346 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 162.57 -88.93 0.11 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.77 -0.729 . . . . 64.35 112.53 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -175.42 -169.08 0.35 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.846 0.355 . . . . 72.33 111.126 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.75 85.77 1.78 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.759 -0.734 . . . . 70.2 112.496 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -159.77 46.31 0.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.835 0.35 . . . . 73.43 110.876 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -88.37 53.6 2.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 71.2 110.886 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.8 mp -95.39 -178.88 4.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 73.25 110.925 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -54.53 -27.03 35.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 70.31 110.896 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -103.66 41.54 1.27 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 73.22 110.861 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.07 101.86 13.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 63.4 110.921 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 pt -156.1 119.28 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 74.12 111.159 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.2 p -161.84 -169.08 2.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 72.03 110.838 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.85 149.18 50.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 62.14 110.875 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.5 mp -124.35 138.96 52.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 74.34 111.161 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -142.49 138.67 31.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 73.12 110.945 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.4 p -132.87 139.15 50.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 74.45 111.095 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.3 39.93 2.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 72.35 110.89 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.87 120.24 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 73.5 110.853 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.23 -143.23 21.68 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.725 -0.75 . . . . 74.54 112.55 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 63.8 p -146.72 156.58 43.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.724 0.297 . . . . 74.15 111.126 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.7 m0 -125.32 169.81 11.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.218 -0.446 . . . . 64.04 110.919 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -112.11 121.59 45.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 73.53 110.911 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -113.65 120.07 39.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 74.21 110.901 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -139.88 126.78 20.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.153 -0.476 . . . . 64.44 110.933 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -100.72 89.98 4.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 73.32 110.909 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.402 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 170.96 -169.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 74.51 110.905 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.7 tp -64.87 159.41 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 75.34 111.104 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 -78.0 45.7 0.54 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 74.34 110.913 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -152.83 17.06 0.58 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 74.31 110.93 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 168.32 -118.18 0.77 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.754 -0.736 . . . . 75.14 112.492 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.402 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 71.56 -179.27 33.9 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.745 -0.74 . . . . 75.33 112.5 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.02 108.39 14.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.828 0.347 . . . . 73.15 110.87 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -78.35 106.88 10.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 75.53 110.897 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -138.15 106.2 5.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.112 -0.494 . . . . 73.24 110.906 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -84.76 157.41 21.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 74.22 110.857 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.7 tp -109.75 134.7 51.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 71.0 110.909 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -110.32 -178.55 20.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.668 -0.777 . . . . 74.21 112.493 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -47.88 100.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.747 2.298 . . . . 73.43 112.314 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.46 165.42 14.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.71 -0.757 . . . . 61.33 112.428 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -93.48 165.08 12.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.86 0.362 . . . . 63.43 110.941 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -160.24 105.03 1.49 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 75.24 110.928 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.6 m -96.45 91.13 5.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 71.45 110.837 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.18 131.81 34.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 75.24 110.838 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.8 m -150.05 18.67 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.119 -0.492 . . . . 73.24 111.14 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 173.45 -17.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 73.3 110.905 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.34 -49.73 9.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 71.55 110.867 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.31 -70.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 64.31 111.064 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 173.07 119.8 0.54 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.739 -0.743 . . . . 72.14 112.473 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.5 mm -129.5 67.14 78.52 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.645 0.736 . . . . 75.53 111.135 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -81.38 -69.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.704 2.269 . . . . 72.01 112.335 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.2 t70 179.08 -40.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 71.1 110.91 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -176.71 107.46 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.47 . . . . 72.31 110.865 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.2 m -140.8 -169.97 2.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 75.53 110.824 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.9 mp -106.19 150.1 9.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.485 . . . . 74.34 111.17 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.6 p -165.51 146.8 7.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 63.14 110.861 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.04 158.94 31.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 74.03 110.863 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -150.63 135.78 17.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 74.44 110.862 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -88.59 120.73 30.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 72.3 110.911 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -81.36 92.64 6.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 72.21 110.904 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 74.22 111.121 179.971 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.762 0.315 . . . . 75.12 110.895 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -154.11 135.29 14.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 74.25 110.925 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.22 69.27 9.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 72.23 111.12 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.35 97.4 8.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 71.23 111.066 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.12 129.58 35.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 74.23 110.903 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 86.0 t -115.93 127.58 73.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 75.02 111.095 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.8 tt -125.03 110.81 25.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 72.22 111.134 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.1 t -123.02 143.84 34.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 72.0 111.113 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -105.12 138.47 41.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 75.43 110.909 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -94.7 43.34 1.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.085 -0.507 . . . . 75.54 110.852 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 173.0 -170.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 71.44 110.852 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.15 159.71 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 75.44 111.112 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -86.1 53.9 2.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 73.53 110.869 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.441 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.05 28.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 74.25 110.882 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.35 51.69 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.758 -0.734 . . . . 55.53 112.484 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.07 171.38 24.57 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.715 -0.755 . . . . 72.12 112.501 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.54 133.92 35.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.806 0.336 . . . . 64.41 110.903 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.76 155.08 33.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 74.21 110.885 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -148.45 117.56 6.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 74.1 110.936 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -128.71 85.43 2.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 73.55 110.908 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.45 -169.54 2.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 65.41 111.117 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.4 t -137.82 39.91 2.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 62.31 111.131 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.8 p -162.7 41.99 0.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 72.41 110.832 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 t0 66.22 118.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 70.33 110.854 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -79.78 161.7 65.41 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.625 0.726 . . . . 74.32 110.912 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -82.02 68.29 7.94 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.649 2.232 . . . . 74.1 112.336 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 51.44 -166.17 0.82 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.743 -0.742 . . . . 70.44 112.454 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -152.81 31.39 0.5 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.829 0.347 . . . . 54.2 111.084 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.81 80.61 0.56 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.752 -0.737 . . . . 61.14 112.452 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -139.86 23.93 2.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.807 0.337 . . . . 73.53 110.831 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -74.13 -169.69 0.82 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 75.34 110.926 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -179.83 -169.15 0.13 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.231 -0.44 . . . . 73.31 110.957 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -65.45 -24.18 67.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 71.53 110.887 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -134.46 61.36 1.67 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 63.15 110.872 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.77 141.06 28.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 75.13 110.915 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 pt -153.41 107.93 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 73.41 111.143 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 63.7 p -149.86 -172.3 4.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 75.43 110.892 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.22 149.53 49.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 74.54 110.859 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.9 mp -120.83 109.89 26.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 74.22 111.171 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -95.04 127.69 41.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 74.12 110.919 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.68 139.03 38.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 75.44 111.107 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.93 40.55 1.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 74.13 110.911 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.3 p -179.4 137.67 0.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 72.13 110.861 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.22 -155.3 4.75 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.753 -0.737 . . . . 70.24 112.474 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.3 p -150.03 150.13 31.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.806 0.336 . . . . 71.22 111.134 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.6 m0 -123.37 169.62 11.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 74.43 110.923 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -121.5 128.51 52.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 75.22 110.847 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -114.33 128.53 56.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 73.43 110.884 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.2 126.47 19.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.136 -0.484 . . . . 73.03 110.914 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -101.46 89.21 3.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 75.33 110.855 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 171.66 -165.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 73.32 110.926 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -52.01 173.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 73.31 111.157 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -85.52 49.81 1.83 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 75.11 110.922 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 22.3 p90 176.86 41.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 70.05 110.905 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.12 -154.21 24.62 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.718 -0.753 . . . . 74.41 112.444 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.73 -177.06 35.48 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.767 -0.73 . . . . 74.15 112.483 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.29 110.8 9.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.826 0.346 . . . . 71.33 110.893 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -78.03 109.7 12.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 64.24 110.934 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -138.3 106.26 5.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.11 -0.495 . . . . 74.43 110.952 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.0 p30 -94.57 153.76 17.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 74.21 110.817 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -117.11 136.08 53.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 74.51 110.931 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -102.81 -162.68 25.91 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 61.33 112.484 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.27 105.39 0.29 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.685 2.257 . . . . 74.32 112.342 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.95 151.92 6.07 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.756 -0.735 . . . . 70.35 112.509 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.9 144.97 32.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.855 0.36 . . . . 71.11 110.869 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -124.35 157.28 35.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.095 -0.502 . . . . 73.32 110.896 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.1 t -160.05 68.31 0.38 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 61.54 110.866 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.98 146.68 26.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 72.31 110.89 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.9 m -150.58 18.81 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 75.23 111.141 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -179.05 34.19 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 75.22 110.888 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 37.8 t -160.9 -40.64 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 74.32 110.867 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.38 -44.18 62.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 65.43 111.131 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 166.73 95.0 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.722 -0.752 . . . . 73.14 112.472 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.9 mm -129.5 67.14 78.53 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.65 0.738 . . . . 64.41 111.124 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -80.83 -60.79 0.03 OUTLIER 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.667 2.245 . . . . 61.32 112.362 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 179.23 -33.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 75.35 110.81 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -141.17 -177.82 5.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 74.31 110.917 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.1 t -58.54 -96.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 64.54 110.889 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 mp 47.94 54.26 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 74.34 111.121 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.6 p -155.03 163.0 40.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 75.4 110.816 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.94 159.82 16.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.074 -0.512 . . . . 71.43 110.878 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -150.14 135.71 18.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 74.15 110.847 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -93.21 133.38 36.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 74.14 110.919 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -105.84 131.43 53.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 74.42 110.967 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.3 pt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 62.34 111.141 179.993 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.7 ttp . . . . . 0 C--O 1.23 0.037 0 CA-C-O 120.786 0.327 . . . . 72.21 110.844 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -128.63 147.46 50.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 73.24 110.913 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.32 98.05 1.68 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 71.51 111.068 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -81.11 121.28 25.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 65.14 111.085 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -89.25 104.35 16.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 72.34 110.897 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 94.3 t -113.11 105.59 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 73.12 111.109 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.5 tp -117.07 110.3 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 72.24 111.12 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.2 m -133.15 159.29 43.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 74.32 111.116 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -112.18 142.3 44.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.127 -0.488 . . . . 75.24 110.92 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -95.35 31.85 1.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 73.32 110.924 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 175.52 -169.68 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 74.34 110.855 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.9 t -62.75 159.9 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 71.22 111.149 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -84.51 54.07 2.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 74.52 110.907 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.436 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.66 28.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 74.32 110.88 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.12 47.61 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.689 -0.767 . . . . 62.01 112.486 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.8 171.48 24.06 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.709 -0.757 . . . . 75.45 112.501 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.3 tmmt? -91.01 122.83 34.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.803 0.335 . . . . 75.32 110.862 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.97 148.54 43.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 74.44 110.827 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -148.77 139.73 22.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 74.22 110.894 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.71 87.14 2.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 60.25 110.873 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.68 179.36 7.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 70.0 111.084 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.7 t -153.57 116.57 4.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 74.02 111.161 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.0 t -179.36 -82.35 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 72.15 110.837 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -141.83 38.93 1.65 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 74.24 110.862 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -80.62 162.22 61.34 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.563 0.696 . . . . 72.5 110.933 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -71.48 -169.73 0.45 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.678 2.252 . . . . 75.4 112.349 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -162.42 -71.99 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.741 . . . . 70.35 112.494 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -147.59 179.85 7.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.823 0.344 . . . . 41.43 111.097 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.27 38.66 2.08 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.77 -0.729 . . . . 74.25 112.447 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -179.3 92.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.839 0.352 . . . . 74.52 110.897 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -174.25 94.1 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 72.35 110.905 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -88.26 95.36 10.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 74.42 110.894 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.8 t30 55.85 25.51 8.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 70.13 110.852 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -133.93 39.9 3.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 62.34 110.855 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.86 102.06 14.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 75.43 110.932 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.2 pt -153.49 104.13 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 74.35 111.121 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.9 p -157.16 -166.53 2.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 64.51 110.819 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.2 t -127.14 154.46 44.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 71.11 110.828 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.5 mp -125.52 139.01 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 75.4 111.128 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -145.35 147.83 32.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 74.2 110.875 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.2 p -161.52 138.82 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 71.44 111.115 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -134.58 40.92 2.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 74.13 110.898 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.8 t -179.62 119.4 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 74.33 110.89 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.08 -163.45 50.82 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.757 -0.735 . . . . 71.45 112.522 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.5 p -149.83 147.7 28.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.796 0.331 . . . . 74.44 111.166 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -117.37 171.94 7.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 75.22 110.946 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -112.98 124.26 52.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 75.24 110.87 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -113.73 125.87 54.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 74.23 110.925 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.48 126.9 23.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 72.34 110.91 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -102.09 89.75 3.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 73.13 110.896 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.462 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.1 OUTLIER 170.72 -166.87 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.161 -0.472 . . . . 75.2 110.917 -179.873 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -51.98 172.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 70.41 111.102 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -86.06 50.08 1.91 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 63.41 110.897 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.1 p90 174.88 45.12 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.474 . . . . 64.22 110.905 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.22 -150.14 18.08 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.724 -0.75 . . . . 65.3 112.465 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.462 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 87.37 -171.51 42.06 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.689 -0.767 . . . . 71.03 112.497 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.47 112.39 17.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.817 0.342 . . . . 74.11 110.886 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -79.23 101.04 7.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 74.22 110.943 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -133.86 107.54 7.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.119 -0.491 . . . . 74.21 110.914 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -83.85 154.21 23.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 74.34 110.849 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.8 tp -99.34 148.34 24.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 73.13 110.934 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -129.55 -165.16 11.61 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.723 -0.751 . . . . 61.1 112.489 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.26 89.73 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.667 2.245 . . . . 75.41 112.339 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.32 171.18 40.57 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.761 -0.733 . . . . 74.21 112.513 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.8 143.83 50.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.833 0.349 . . . . 71.34 110.898 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -152.55 149.03 28.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 74.31 110.951 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.2 p -130.33 82.44 2.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 74.14 110.845 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 40.4 m -86.66 147.07 26.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 63.14 110.819 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.7 m -150.69 19.04 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.074 -0.512 . . . . 74.41 111.164 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -179.46 34.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 73.32 110.905 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.1 t -160.74 -40.84 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 73.22 110.851 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.3 -54.25 33.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 74.22 111.111 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.37 85.74 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.815 -0.707 . . . . 75.44 112.481 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.9 mm -123.89 67.55 42.17 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.64 0.733 . . . . 75.4 111.132 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -74.35 -53.86 0.1 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.689 2.259 . . . . 75.01 112.377 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.3 t70 179.44 -74.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 62.34 110.855 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -93.04 -169.85 2.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 64.41 110.918 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.92 114.49 26.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 74.05 110.882 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -152.64 69.52 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 74.44 111.12 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.7 p -158.76 161.63 37.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 75.02 110.851 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.74 163.24 18.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 72.41 110.834 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -151.16 136.31 17.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 73.23 110.86 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -88.53 120.21 29.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 74.35 110.883 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -79.18 102.03 8.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 74.34 110.896 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 pt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 75.31 111.101 179.953 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.802 0.334 . . . . 64.11 110.906 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -81.02 139.0 36.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 72.34 110.859 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -163.12 88.29 0.59 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 74.24 111.129 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -84.58 169.53 14.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.425 . . . . 65.34 111.129 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -91.14 109.7 20.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 63.34 110.882 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 96.7 t -115.89 136.37 52.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 73.44 111.099 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.3 tt -131.35 110.66 17.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 74.23 111.145 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.4 t -127.09 143.13 41.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 73.43 111.132 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -97.1 140.36 31.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 73.22 110.925 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -99.24 35.6 1.89 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 71.15 110.914 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 175.18 -169.73 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 72.34 110.871 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.5 t -63.64 159.52 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 74.24 111.112 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.5 p30 -85.78 54.19 3.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 72.43 110.902 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.441 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.1 28.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 75.33 110.881 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.22 50.28 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.726 -0.749 . . . . 65.13 112.505 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.1 171.51 24.53 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.761 -0.733 . . . . 64.34 112.529 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.21 126.06 42.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.764 0.316 . . . . 73.13 110.906 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.7 p -118.29 156.5 28.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.27 -0.423 . . . . 72.3 110.824 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -111.03 107.97 17.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 73.42 110.877 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -117.69 40.54 3.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 73.11 110.884 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.02 130.06 16.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 75.44 111.127 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.1 t -81.59 120.65 25.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.231 -0.441 . . . . 72.2 111.105 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.0 m -152.08 -82.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 73.21 110.857 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -174.54 72.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 71.1 110.849 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.16 162.59 53.85 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.572 0.701 . . . . 72.12 110.914 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.13 -15.71 22.92 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.67 2.247 . . . . 71.1 112.345 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.46 -80.13 1.03 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.75 -0.738 . . . . 64.45 112.5 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -147.65 -174.51 4.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.788 0.327 . . . . 63.15 111.153 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.97 19.08 9.84 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.708 -0.758 . . . . 72.31 112.501 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -148.07 68.19 1.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.809 0.338 . . . . 60.01 110.84 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -129.83 -176.18 3.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 64.21 110.899 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -175.14 -169.7 0.41 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.162 -0.472 . . . . 73.04 110.896 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -71.13 -28.18 64.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 63.12 110.878 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -98.17 39.71 1.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 75.41 110.885 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.34 133.99 50.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 74.14 110.921 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.6 pt -155.23 128.92 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 72.51 111.103 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 84.8 p -167.34 -168.19 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 74.11 110.897 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.13 152.72 44.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 75.13 110.871 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.3 mp -120.91 132.64 69.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 73.15 111.114 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -130.6 131.94 45.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 73.43 110.899 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.9 p -136.45 139.24 45.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 74.51 111.098 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.6 mmpp? -143.62 45.98 1.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 75.03 110.864 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.44 124.42 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 73.22 110.831 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.01 -150.0 8.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.748 -0.739 . . . . 61.3 112.487 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.6 p -147.57 144.74 28.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.797 0.332 . . . . 74.42 111.09 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.0 m0 -115.87 173.07 6.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 73.13 110.915 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -119.11 120.76 38.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.425 . . . . 73.14 110.84 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -109.63 125.73 52.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 75.51 110.838 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.83 143.91 37.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.074 -0.512 . . . . 74.24 110.879 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -107.93 88.5 2.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.077 -0.51 . . . . 72.01 110.918 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 171.78 -166.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 71.15 110.933 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.3 mm -78.79 171.52 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 73.04 111.091 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -74.66 57.83 0.77 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 64.14 110.878 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -151.01 -34.95 0.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 73.34 110.907 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -158.74 -141.91 3.26 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.731 -0.747 . . . . 60.43 112.489 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.53 -179.97 22.88 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.709 -0.757 . . . . 64.01 112.461 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.69 105.9 6.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.813 0.339 . . . . 75.12 110.89 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -76.73 106.99 8.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 75.52 110.913 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -138.29 106.98 5.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.113 -0.494 . . . . 74.52 110.897 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -90.32 141.35 28.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 74.43 110.881 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.32 153.41 18.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 74.31 110.907 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -132.44 -168.4 12.01 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.729 -0.748 . . . . 52.53 112.487 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -46.48 101.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.645 2.23 . . . . 74.55 112.354 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.43 163.76 12.68 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.746 . . . . 71.41 112.516 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -127.52 138.43 52.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.91 0.386 . . . . 71.31 110.847 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -135.92 151.95 50.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 74.33 110.891 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 97.4 p -133.45 81.8 1.95 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 71.24 110.857 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.6 m -85.97 160.98 19.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 74.51 110.836 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.2 m -152.9 20.45 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 74.33 111.171 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -178.07 53.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 73.21 110.935 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.65 -35.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 74.31 110.851 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.97 -64.29 0.86 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 73.54 111.113 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 179.08 83.55 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.761 -0.733 . . . . 75.44 112.498 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.59 67.49 24.34 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.604 0.716 . . . . 74.32 111.171 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -80.3 -50.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.631 2.221 . . . . 74.32 112.342 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -179.56 -36.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 70.33 110.888 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -179.36 55.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 62.42 110.864 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.5 t -97.34 166.55 11.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 72.43 110.855 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.6 mt -106.16 153.51 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 73.23 111.167 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.2 p -149.98 155.91 40.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 74.23 110.835 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.38 158.15 29.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 74.14 110.839 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -150.48 135.41 17.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 75.5 110.867 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -95.1 130.8 41.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 75.51 110.833 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.28 131.64 43.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.464 . . . . 75.23 110.894 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.9 pt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 71.41 111.121 179.985 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.063 0 CA-C-O 120.831 0.348 . . . . 73.34 110.869 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.49 157.21 47.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 71.25 110.841 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.93 61.54 0.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 72.31 111.137 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -85.0 170.51 12.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 72.02 111.046 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.18 105.49 17.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 72.4 110.86 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 98.5 t -110.32 116.03 51.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 74.23 111.169 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.9 tt -115.7 110.39 31.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 73.14 111.101 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 72.2 t -128.68 137.1 58.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 73.33 111.162 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -88.62 138.38 31.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.461 . . . . 75.44 110.949 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -96.0 47.85 1.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 74.32 110.846 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 173.29 -170.41 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 72.1 110.874 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.9 t -64.61 161.51 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 75.4 111.092 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -86.76 53.66 2.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 70.43 110.896 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.438 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.52 29.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 74.23 110.883 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.94 49.72 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.754 -0.736 . . . . 41.04 112.504 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.07 171.59 24.49 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.702 -0.761 . . . . 72.33 112.445 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.06 162.94 14.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.771 0.319 . . . . 75.04 110.903 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.0 p -145.1 153.52 41.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 60.45 110.879 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -142.27 119.82 11.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 75.04 110.887 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -102.33 41.05 1.26 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 70.2 110.802 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.43 -168.39 1.69 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 71.43 111.144 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.48 -169.58 1.97 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 74.01 111.125 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.3 m -83.51 4.36 28.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 75.44 110.851 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -84.48 -7.97 59.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 73.54 110.872 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.8 155.42 75.58 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.589 0.709 . . . . 72.4 110.893 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.13 75.83 2.73 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.625 2.216 . . . . 72.55 112.37 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.6 -69.19 1.42 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.746 -0.74 . . . . 71.41 112.48 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.35 -171.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.345 . . . . 74.23 111.096 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.28 57.69 0.59 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.751 -0.738 . . . . 54.43 112.509 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -98.15 -169.96 1.89 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.358 . . . . 73.2 110.837 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -169.45 -170.73 1.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 74.44 110.834 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.64 106.58 0.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 74.55 110.922 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 51.91 50.82 17.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 71.45 110.893 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.87 39.65 3.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 73.41 110.813 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.17 102.64 4.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 72.52 110.931 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 pt -153.36 103.91 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 73.44 111.136 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 78.7 p -167.74 -166.78 0.78 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 74.42 110.861 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.69 148.46 33.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 73.44 110.869 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 mp -120.85 127.77 75.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 72.52 111.164 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -126.82 133.18 50.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 75.02 110.924 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.4 p -143.55 139.02 26.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 75.32 111.167 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.6 mmpp? -142.77 40.27 1.53 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 74.01 110.879 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.49 135.04 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 73.51 110.89 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.14 -159.49 2.78 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.777 -0.725 . . . . 72.03 112.465 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.1 p -145.43 151.3 38.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.799 0.333 . . . . 63.4 111.133 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.0 m0 -124.2 175.36 7.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 75.1 110.898 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -121.48 120.54 35.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 74.53 110.904 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -107.28 126.23 52.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 75.02 110.857 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.83 142.99 36.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 73.12 110.915 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.03 88.36 2.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 64.43 110.883 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 172.01 -169.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 75.4 110.921 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 30.1 pt -69.82 172.62 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.106 -0.497 . . . . 72.3 111.127 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -78.05 56.37 1.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 73.14 110.889 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -150.93 -40.56 0.12 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.475 . . . . 73.22 110.927 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.43 -143.89 3.88 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.704 -0.76 . . . . 73.14 112.476 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.11 176.18 22.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.781 -0.723 . . . . 62.41 112.506 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.03 104.78 3.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.785 0.326 . . . . 72.42 110.826 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -76.54 107.49 8.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 75.1 110.888 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -138.13 106.3 5.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 70.24 110.958 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -88.83 140.52 29.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.261 -0.427 . . . . 71.33 110.843 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.3 156.82 16.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 75.55 110.934 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -131.54 -173.17 13.27 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.699 -0.762 . . . . 54.31 112.509 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -46.21 101.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.691 2.261 . . . . 71.41 112.307 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 158.74 157.39 8.47 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.713 -0.756 . . . . 62.42 112.457 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -117.68 148.24 42.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.83 0.348 . . . . 71.54 110.909 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -160.28 160.06 32.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.161 -0.472 . . . . 72.43 110.925 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.2 p -115.22 80.27 1.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.092 -0.504 . . . . 63.34 110.871 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.7 m -86.26 84.69 7.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 73.05 110.881 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.2 m -89.89 -6.3 10.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.492 . . . . 55.22 111.156 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -162.62 62.53 0.21 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.487 . . . . 73.23 110.902 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.68 -34.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 74.3 110.877 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.82 -47.85 59.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 62.32 111.107 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -178.25 40.4 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.668 -0.777 . . . . 71.52 112.424 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.48 67.66 76.02 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.625 0.726 . . . . 72.33 111.156 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -81.77 -70.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.682 2.255 . . . . 74.11 112.329 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.473 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 1.9 t0 -94.17 -0.47 55.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 74.44 110.901 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 76' ' ' ASP . 5.6 m-20 81.07 89.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 74.1 110.844 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.9 m -146.04 -169.93 3.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 72.3 110.866 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.1 mt -76.23 153.31 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 75.21 111.162 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.6 t -149.05 157.42 43.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 73.13 110.872 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.37 159.54 25.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 72.3 110.89 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -150.83 136.12 17.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 74.42 110.887 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -87.44 121.62 30.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 73.54 110.926 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -79.7 93.41 5.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 75.44 110.96 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 pt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.438 . . . . 75.21 111.159 179.985 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 ttm . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.787 0.327 . . . . 71.43 110.904 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.33 163.01 24.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 72.11 110.849 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -165.4 66.19 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 74.33 111.111 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -148.83 94.33 2.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.463 . . . . 71.34 111.075 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.96 121.06 28.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 71.44 110.884 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.4 m -116.28 138.15 47.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 73.3 111.1 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.6 tp -101.18 110.05 27.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 74.21 111.141 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.6 t -129.89 140.83 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 42.31 111.133 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -93.43 138.83 31.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 73.32 110.94 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -93.47 42.39 1.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 73.33 110.842 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 175.13 -169.5 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 73.04 110.842 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.8 t -64.1 160.61 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 75.04 111.122 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -86.44 53.89 2.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 61.23 110.871 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.444 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.23 28.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 75.12 110.903 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.0 50.34 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.764 -0.731 . . . . 71.05 112.516 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.15 171.71 23.79 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.772 -0.728 . . . . 53.43 112.54 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.51 149.84 23.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.822 0.344 . . . . 73.03 110.848 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -131.32 141.62 49.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 71.04 110.895 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -136.44 152.3 50.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 74.43 110.861 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -140.93 77.57 1.6 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 72.22 110.856 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.43 152.86 28.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 44.41 111.137 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.5 p -94.3 45.03 1.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 65.51 111.14 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.55 -172.05 1.36 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 73.25 110.886 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.42 108.38 1.32 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 75.44 110.869 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.92 162.58 61.79 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.581 0.705 . . . . 71.2 110.903 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -47.92 105.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.687 2.258 . . . . 71.51 112.375 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.52 174.75 0.36 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.797 -0.716 . . . . 72.52 112.502 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.07 -172.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.852 0.358 . . . . 72.22 111.051 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.54 112.01 2.41 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.777 -0.725 . . . . 64.22 112.493 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.03 -170.06 2.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.772 0.32 . . . . 63.14 110.885 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.08 179.24 0.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 65.44 110.923 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.2 mp -81.57 123.19 28.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.169 -0.469 . . . . 74.43 110.911 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 52.05 64.9 1.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 74.54 110.864 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -175.32 48.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 74.24 110.882 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.79 103.1 4.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 75.32 110.879 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.43 124.12 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 74.22 111.124 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.6 p -167.48 -168.34 1.02 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 54.22 110.844 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.44 158.14 38.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 75.12 110.844 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.5 mp -120.92 140.07 46.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 71.01 111.154 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 15.1 tttt -130.05 119.53 23.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 73.32 110.83 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.9 p -114.12 139.28 40.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 65.24 111.104 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.86 39.69 1.82 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 74.55 110.928 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.2 114.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 64.02 110.871 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 60.65 -143.06 48.19 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.733 -0.746 . . . . 74.43 112.51 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.9 p -150.1 154.79 38.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.793 0.33 . . . . 70.51 111.14 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -124.31 176.95 6.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.432 . . . . 74.5 110.908 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -126.49 130.8 51.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 74.54 110.84 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -115.33 126.34 54.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 75.33 110.897 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.9 126.78 20.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 73.12 110.948 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -102.89 89.56 3.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 71.53 110.902 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.431 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.1 OUTLIER 171.44 -166.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.191 -0.459 . . . . 72.31 110.959 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -52.19 173.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 70.42 111.112 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -86.32 50.15 1.93 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 74.43 110.914 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 22.3 p90 176.89 41.14 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.471 . . . . 75.44 110.946 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 165.1 -155.97 27.68 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.722 -0.752 . . . . 53.25 112.47 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.431 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 96.13 -171.33 28.26 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.724 -0.75 . . . . 74.13 112.469 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -80.93 108.68 14.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.869 0.366 . . . . 73.11 110.878 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -78.19 109.31 12.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 74.0 110.911 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -138.18 108.1 6.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 73.35 110.89 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -94.93 152.87 17.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 73.43 110.884 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -116.09 138.48 51.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 75.5 110.934 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -111.21 -170.14 19.05 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.729 -0.748 . . . . 65.2 112.461 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -46.99 99.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.628 2.219 . . . . 75.21 112.357 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.46 169.09 19.49 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.742 . . . . 72.51 112.544 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -99.5 146.22 26.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 72.32 110.875 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -130.38 151.57 50.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 73.44 110.883 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.5 t -119.11 93.23 4.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.087 -0.506 . . . . 75.14 110.846 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.95 94.61 8.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.091 -0.504 . . . . 75.13 110.813 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.8 m -150.6 32.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.492 . . . . 71.15 111.119 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -171.41 30.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.463 . . . . 72.1 110.904 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.47 -67.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 72.23 110.881 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.51 -34.85 63.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 72.45 111.107 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -65.8 -48.0 70.71 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.726 -0.749 . . . . 74.42 112.448 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.88 74.17 2.49 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.604 0.716 . . . . 73.42 111.148 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.18 -49.06 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.681 2.254 . . . . 75.33 112.38 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -175.26 -62.5 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 73.42 110.859 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -142.09 -95.68 0.13 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 73.43 110.885 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.85 52.05 1.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 62.41 110.885 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.69 85.77 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.087 -0.506 . . . . 63.01 111.14 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 79.2 p -163.19 154.07 16.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.459 . . . . 73.11 110.868 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.53 160.76 18.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 73.13 110.832 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -150.16 135.77 18.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 75.31 110.89 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.1 120.37 32.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 75.41 110.879 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -86.83 98.82 11.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 65.13 110.927 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 75.11 111.119 179.976 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mtp . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.794 0.331 . . . . 73.31 110.885 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -111.32 124.63 52.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 73.44 110.836 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.85 57.04 0.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 71.03 111.122 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -154.23 44.12 0.55 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 63.23 111.113 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -87.32 96.28 10.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.226 -0.443 . . . . 73.32 110.897 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.8 m -117.16 138.51 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 75.35 111.114 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.8 tt -99.49 110.38 26.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 73.45 111.121 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 m -122.89 159.73 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 72.1 111.134 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -111.66 139.94 46.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.162 -0.472 . . . . 75.31 110.914 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -100.1 28.51 4.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 61.41 110.895 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 175.87 -169.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 64.31 110.836 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 t -62.98 157.37 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 71.31 111.094 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -83.22 54.88 2.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 73.11 110.905 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.443 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -177.34 27.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 75.2 110.886 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.24 45.63 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.76 -0.733 . . . . 65.12 112.493 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.27 173.68 23.67 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.778 -0.725 . . . . 71.03 112.512 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.62 146.17 26.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.821 0.343 . . . . 74.23 110.866 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.0 p -117.15 162.89 17.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 70.32 110.834 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -118.55 135.81 54.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 75.52 110.901 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.4 p30 -147.2 42.13 1.09 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 74.21 110.876 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.57 158.7 25.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 75.35 111.111 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.1 m -138.68 70.85 1.38 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.456 . . . . 63.3 111.105 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.6 m -155.86 -82.6 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 63.51 110.872 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -179.14 101.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 74.43 110.881 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -80.16 161.94 63.54 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.598 0.713 . . . . 72.13 110.912 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.53 -170.54 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.715 2.277 . . . . 74.32 112.335 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.91 -98.41 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.749 -0.738 . . . . 43.03 112.44 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -173.84 154.7 2.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 70.34 111.063 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 177.3 155.97 14.99 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.729 -0.748 . . . . 60.12 112.457 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -174.74 -169.78 0.44 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.814 0.34 . . . . 75.43 110.852 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.0 167.67 6.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 74.31 110.923 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.2 mp -65.12 -87.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 64.23 110.852 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -95.11 70.33 3.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 73.34 110.88 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -154.13 59.53 0.71 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 61.33 110.856 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.74 119.62 39.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 73.42 110.862 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.9 tt -174.14 102.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 74.11 111.143 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.4 p -169.21 -167.53 0.73 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 74.12 110.845 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.36 152.0 48.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.102 -0.499 . . . . 75.04 110.835 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 mp -120.99 137.93 53.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 75.54 111.153 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.35 119.69 15.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.467 . . . . 73.51 110.909 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.1 p -109.11 139.08 33.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 73.31 111.168 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.05 39.55 2.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 71.54 110.859 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.64 110.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.435 . . . . 55.22 110.859 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 56.99 -142.13 42.32 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.689 -0.767 . . . . 74.43 112.47 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 49.5 p -144.86 160.21 41.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.764 0.316 . . . . 65.44 111.14 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -123.22 -179.99 4.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 75.14 110.866 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.26 115.84 16.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 74.31 110.899 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -100.68 127.89 46.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 75.32 110.896 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.14 126.28 19.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 74.42 110.93 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -103.05 89.62 3.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 74.04 110.85 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.404 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 173.81 -171.82 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 73.52 110.904 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.6 tp -57.6 160.64 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 73.33 111.123 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -74.95 55.5 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 75.35 110.88 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -153.93 -38.27 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 74.34 110.892 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -146.61 -140.4 3.44 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 74.13 112.491 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.404 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 106.93 -175.33 20.61 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.764 -0.731 . . . . 64.13 112.51 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.7 106.48 7.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 71.51 110.873 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -79.52 109.23 13.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 73.22 110.937 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -138.07 108.32 6.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.084 -0.507 . . . . 72.22 110.951 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.66 157.37 16.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.286 -0.415 . . . . 71.3 110.87 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -121.36 153.98 37.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 74.2 110.916 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -121.12 179.32 16.32 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.751 -0.737 . . . . 62.21 112.496 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -43.97 104.82 0.06 OUTLIER 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.674 2.249 . . . . 72.54 112.35 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.52 162.59 11.43 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.731 -0.747 . . . . 72.52 112.488 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -81.11 174.0 12.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.843 0.354 . . . . 73.35 110.894 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -160.89 99.65 1.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 74.24 110.895 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.1 p -97.46 65.65 1.95 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.08 -0.509 . . . . 64.24 110.865 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.6 p -86.93 152.19 22.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 65.22 110.859 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.1 p -163.61 23.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.113 -0.494 . . . . 73.45 111.114 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 177.25 35.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 71.34 110.908 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.95 -40.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 75.32 110.863 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.29 -50.1 70.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.1 -0.5 . . . . 75.41 111.091 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 165.95 101.26 0.15 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 50.13 112.492 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.1 mm -113.29 74.83 2.11 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.604 0.716 . . . . 73.15 111.144 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -79.48 -165.62 0.35 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.665 2.243 . . . . 74.13 112.311 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -145.23 40.58 1.23 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.436 . . . . 72.21 110.853 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -175.9 -171.63 0.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 74.13 110.866 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 61.8 p -97.24 81.55 3.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 70.04 110.863 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -152.07 66.98 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 73.34 111.122 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 91.5 p -166.28 145.66 5.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 72.42 110.848 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -163.93 165.62 22.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 74.43 110.804 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -150.6 143.03 24.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 64.51 110.871 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -79.91 171.98 14.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 75.33 110.87 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -148.04 105.94 3.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 65.35 110.907 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.6 pt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 74.2 111.147 179.947 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mtt . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.75 0.309 . . . . 71.05 110.889 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -97.65 135.7 39.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 54.4 110.942 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.91 95.32 8.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 73.3 111.115 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -167.5 141.87 3.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 64.45 111.138 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -88.16 96.26 10.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 75.52 110.853 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.1 t -112.06 119.8 60.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 72.51 111.135 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.9 tt -123.76 110.19 25.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 64.1 111.111 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.0 m -126.82 142.25 43.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 75.32 111.102 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -92.26 141.6 28.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.177 -0.465 . . . . 74.01 110.923 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -96.42 44.37 1.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 74.23 110.91 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 172.95 -170.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 70.1 110.829 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.1 t -64.47 161.27 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 73.5 111.129 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -86.75 53.74 2.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 74.34 110.919 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.445 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.41 28.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 74.1 110.879 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.88 47.11 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.762 -0.732 . . . . 74.44 112.492 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.08 171.61 24.48 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.711 -0.757 . . . . 72.52 112.506 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 ptpt -92.64 164.11 13.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.794 0.33 . . . . 75.21 110.91 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.0 p -138.98 160.33 40.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 72.34 110.833 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -121.1 110.11 15.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 72.2 110.86 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.92 48.38 0.97 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 61.34 110.838 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -98.27 149.12 22.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 72.31 111.119 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.1 m -92.36 43.69 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 63.4 111.095 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.57 -176.12 5.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 75.23 110.875 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -73.39 109.72 7.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.142 -0.481 . . . . 71.32 110.876 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.11 162.6 61.25 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.604 0.716 . . . . 73.34 110.897 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.23 106.17 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.703 2.269 . . . . 62.31 112.334 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.43 167.02 1.01 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.704 -0.76 . . . . 70.32 112.5 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.06 67.9 3.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.804 0.335 . . . . 74.23 111.094 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.24 -47.01 2.48 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.75 -0.738 . . . . 72.43 112.493 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.596 ' O ' ' CB ' ' A' ' 31' ' ' ASN . 12.9 m-20 -65.77 -171.36 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.814 0.34 . . . . 74.42 110.887 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.596 ' CB ' ' O ' ' A' ' 30' ' ' ASP . 2.2 t-20 90.88 175.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 74.44 110.874 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -153.6 63.7 0.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 75.41 110.896 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 53.5 t30 62.77 25.44 15.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 75.22 110.858 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -140.13 46.4 1.84 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 74.44 110.935 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.81 133.47 34.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 74.53 110.884 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 pt -152.46 118.08 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 74.41 111.091 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.8 p -167.54 -164.46 0.58 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 73.32 110.859 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.13 150.32 39.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 73.53 110.882 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.5 mp -121.57 117.0 51.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 75.2 111.142 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -113.75 127.81 56.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 74.45 110.913 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.2 t -122.33 139.31 49.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 74.11 111.134 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -151.99 39.76 0.62 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 74.14 110.893 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.5 t 179.48 115.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 75.31 110.863 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 51.74 -153.84 5.08 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.72 -0.752 . . . . 55.54 112.497 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.7 p -138.07 158.15 44.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.774 0.321 . . . . 72.55 111.113 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -125.12 170.84 10.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 74.11 110.942 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -115.44 126.42 54.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 73.32 110.892 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -112.14 127.15 55.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 72.41 110.88 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.26 137.41 34.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 75.14 110.937 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -112.25 87.9 2.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 60.21 110.867 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 170.45 -171.74 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.18 -0.463 . . . . 71.33 110.936 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.4 pt -55.0 174.35 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 63.13 111.107 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -87.63 37.84 0.81 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 71.05 110.878 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -151.86 18.67 0.69 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 73.43 110.923 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.05 -154.51 23.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 62.31 112.517 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.9 178.93 22.81 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.746 -0.74 . . . . 61.24 112.494 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.85 103.75 6.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.35 . . . . 75.53 110.868 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -76.67 110.37 11.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 73.32 110.92 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -138.11 105.82 5.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.126 -0.488 . . . . 73.35 110.925 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -90.46 133.58 34.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 63.12 110.893 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.06 165.02 11.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 72.51 110.885 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -128.7 -166.46 11.98 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.779 -0.724 . . . . 70.32 112.518 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.67 118.05 4.88 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.688 2.259 . . . . 74.12 112.313 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.96 156.31 7.76 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.797 -0.716 . . . . 62.34 112.53 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -117.99 139.17 51.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 74.12 110.892 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -160.2 160.12 32.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.115 -0.493 . . . . 72.31 110.896 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.5 m -112.43 81.7 1.52 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.053 -0.521 . . . . 65.42 110.844 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.2 m -84.98 149.03 25.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 72.02 110.874 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.0 m -152.99 22.55 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 74.24 111.129 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -165.45 60.31 0.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 72.0 110.871 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.56 -33.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 73.2 110.89 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.3 -63.81 1.0 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 74.13 111.092 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.7 79.89 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 72.43 112.486 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.69 67.23 29.16 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.62 0.724 . . . . 75.14 111.136 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -80.31 -35.3 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.655 2.237 . . . . 74.3 112.343 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -179.2 -34.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 72.4 110.877 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -140.67 164.83 29.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 74.02 110.864 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.2 t -68.3 87.38 0.29 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 72.12 110.855 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 26.1 mm -139.03 68.51 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 73.1 111.145 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.8 p -146.83 165.17 30.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 74.11 110.837 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.6 157.73 14.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 71.25 110.849 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -150.8 136.57 18.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.126 -0.488 . . . . 75.32 110.901 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.69 120.09 32.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 74.54 110.815 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -79.4 97.67 6.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 73.54 110.936 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 pt . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 75.21 111.101 179.995 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.2 mtm . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.822 0.344 . . . . 75.13 110.909 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -101.37 155.51 18.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 63.33 110.893 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -163.67 113.99 1.32 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 64.15 111.116 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -169.85 119.73 0.64 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 74.42 111.137 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -84.99 96.45 9.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 64.35 110.86 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.2 t -109.02 120.04 59.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 75.11 111.15 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.0 tt -128.84 111.54 23.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 72.34 111.107 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 m -131.21 161.56 40.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 74.3 111.12 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -114.21 148.29 37.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 73.44 110.937 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -102.24 40.68 1.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 72.42 110.897 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 172.79 -171.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 73.13 110.893 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.1 t -63.97 160.15 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.429 . . . . 73.44 111.134 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -85.79 53.96 2.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 74.13 110.903 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.419 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.25 28.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 74.11 110.878 -179.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.02 44.38 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.772 -0.728 . . . . 63.13 112.477 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.02 172.04 24.28 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.765 -0.731 . . . . 55.23 112.484 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.33 160.33 14.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.793 0.33 . . . . 72.25 110.87 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.1 p -136.37 164.56 27.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 73.04 110.838 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -123.14 113.91 19.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 63.03 110.871 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -127.37 67.38 1.3 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 74.44 110.866 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.78 150.96 23.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 74.45 111.096 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.6 p -93.89 40.06 1.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 75.24 111.153 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.8 m -93.94 20.3 7.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 74.23 110.855 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.2 t0 59.77 96.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 63.33 110.88 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 -80.06 162.34 62.32 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.654 0.74 . . . . 74.35 110.841 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -73.05 -170.91 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.7 2.266 . . . . 64.22 112.316 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.37 167.85 43.59 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.772 -0.727 . . . . 61.41 112.465 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.11 107.67 19.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.883 0.373 . . . . 74.34 111.071 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.41 86.39 1.82 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.771 -0.728 . . . . 74.32 112.466 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -141.88 30.11 1.66 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.813 0.34 . . . . 74.45 110.887 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 -130.88 -86.61 0.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 72.12 110.871 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.71 176.55 10.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 72.35 110.906 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -63.17 98.8 0.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 74.52 110.865 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -171.28 59.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 73.53 110.853 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.13 113.15 19.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 74.42 110.861 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.5 tt -176.77 107.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 72.53 111.151 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 83.3 p -167.88 -166.14 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 74.12 110.909 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -114.57 141.49 47.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 74.31 110.885 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 mp -124.71 118.16 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 72.42 111.092 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -123.61 135.02 53.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 73.14 110.888 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.7 t -129.17 139.57 51.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 72.33 111.143 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.99 39.35 1.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 70.21 110.907 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.8 t 177.84 120.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 70.31 110.851 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.14 -152.94 6.21 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.747 -0.74 . . . . 72.45 112.446 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.6 p -142.4 159.37 42.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.345 . . . . 74.13 111.139 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.5 m0 -123.78 176.55 6.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 74.12 110.916 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -123.84 122.03 36.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 75.22 110.86 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -107.55 125.87 51.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 75.25 110.857 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.28 126.91 20.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 75.31 110.888 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -100.69 89.91 4.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 75.34 110.864 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.431 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.1 OUTLIER 170.76 -167.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 75.51 110.921 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -52.26 173.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.478 . . . . 74.42 111.15 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -86.56 50.28 1.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 65.2 110.874 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 22.2 p90 176.98 40.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 72.55 110.903 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.92 -157.71 30.26 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.747 -0.74 . . . . 63.34 112.533 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.431 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 95.42 -171.59 29.5 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.742 -0.742 . . . . 72.1 112.488 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.51 106.77 11.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.816 0.341 . . . . 72.13 110.896 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -77.72 109.47 11.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 75.43 110.883 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.9 t90 -138.04 105.38 5.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.115 -0.493 . . . . 72.01 110.892 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -89.41 135.61 33.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 64.33 110.91 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.99 164.71 12.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.222 -0.445 . . . . 74.45 110.955 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -130.54 -174.92 13.82 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.745 -0.741 . . . . 64.42 112.52 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.54 117.04 3.26 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.708 2.272 . . . . 72.45 112.287 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.84 155.48 7.47 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.742 -0.742 . . . . 61.42 112.477 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -113.63 134.93 54.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 64.44 110.871 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -159.48 159.98 34.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 72.3 110.922 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 m -108.26 101.41 10.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 75.51 110.916 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.93 135.21 34.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 74.5 110.822 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.9 m -149.81 24.26 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 73.22 111.146 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 173.21 -16.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 71.21 110.861 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.9 t -80.76 -23.95 39.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 74.01 110.827 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -83.62 -63.62 1.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 50.02 111.108 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 166.95 124.14 0.7 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.74 -0.743 . . . . 64.41 112.488 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.1 mm -122.33 69.8 31.96 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.625 0.726 . . . . 73.12 111.13 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -78.72 -166.34 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.702 2.268 . . . . 72.35 112.362 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.62 -29.84 27.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 73.52 110.847 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -143.65 162.62 35.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 72.34 110.863 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.59 119.19 10.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 62.32 110.844 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.2 pt -153.36 24.61 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 73.31 111.158 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.8 t -110.76 164.57 12.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 72.35 110.869 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.2 m -165.46 157.33 14.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 65.42 110.881 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -150.67 135.88 17.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 74.55 110.846 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.0 mmt85 -90.7 120.8 32.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 74.44 110.846 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -79.55 94.38 5.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 75.12 110.875 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 75.01 111.111 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 ptt? . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.827 0.346 . . . . 74.24 110.927 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -80.0 120.54 24.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 74.43 110.848 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.95 76.0 9.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 75.53 111.076 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -177.45 39.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 72.0 111.092 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.54 130.6 38.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 63.13 110.88 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 76.2 t -116.11 127.02 73.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 72.04 111.13 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.8 tt -123.14 110.89 27.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 74.22 111.138 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.1 t -124.54 140.39 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 74.35 111.103 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -90.7 139.97 30.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 75.12 110.932 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.33 35.42 1.78 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 64.23 110.917 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 177.21 -169.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.127 -0.488 . . . . 74.22 110.871 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.3 t -63.77 160.28 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.211 -0.449 . . . . 73.13 111.111 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -86.31 54.26 3.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 64.54 110.897 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.441 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.24 28.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 74.41 110.928 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.86 52.46 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.744 -0.741 . . . . 50.33 112.516 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.2 171.72 24.49 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.788 -0.72 . . . . 62.42 112.518 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.62 126.48 42.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.813 0.339 . . . . 74.13 110.883 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 82.1 p -118.0 151.98 36.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 75.2 110.907 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -109.11 133.64 52.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 75.33 110.911 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -130.54 41.01 3.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 72.03 110.862 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.96 151.77 23.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 72.25 111.053 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.2 m -80.14 63.14 4.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.223 -0.444 . . . . 64.4 111.148 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.2 p -148.7 -82.52 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 64.3 110.826 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -77.54 60.08 2.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.495 . . . . 71.53 110.848 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -158.72 68.23 3.43 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.572 0.701 . . . . 73.23 110.964 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -70.18 -173.1 0.71 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.664 2.243 . . . . 73.1 112.385 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.28 -176.31 47.49 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.719 -0.753 . . . . 51.11 112.485 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.8 73.38 6.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.85 0.357 . . . . 75.02 111.122 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.52 -99.7 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.686 -0.769 . . . . 74.52 112.493 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -78.33 65.01 3.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.861 0.363 . . . . 74.23 110.845 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -64.1 179.37 0.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 73.11 110.899 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -164.52 -177.49 4.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 74.25 110.907 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -92.07 10.62 28.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 64.33 110.909 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -106.24 40.06 1.68 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 75.13 110.86 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.06 136.47 33.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 73.3 110.911 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.4 tt -152.29 102.0 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 75.25 111.135 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.9 p -171.81 -165.63 0.38 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 74.23 110.835 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.3 t -128.91 156.03 44.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 72.45 110.879 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.5 mp -121.04 140.54 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 74.35 111.12 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -141.59 119.39 11.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 74.32 110.879 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.9 p -119.97 139.64 46.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 72.41 111.115 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.76 38.23 1.65 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 74.32 110.922 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 172.86 110.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.234 -0.439 . . . . 63.52 110.831 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.17 -158.22 39.87 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.729 -0.748 . . . . 73.21 112.491 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.9 p -150.68 127.58 11.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.74 0.305 . . . . 72.51 111.177 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.517 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.5 OUTLIER -94.15 164.78 12.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 75.11 110.947 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -119.86 117.18 27.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.302 -0.408 . . . . 74.31 110.903 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -105.41 125.69 51.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 72.05 110.878 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -141.08 125.83 17.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 74.54 110.87 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.23 88.57 3.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 75.33 110.92 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 175.92 174.33 0.31 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.135 -0.484 . . . . 74.5 110.9 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.6 pt -52.39 172.88 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 75.5 111.111 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -76.75 56.47 1.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 71.32 110.902 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -149.92 -69.94 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 72.24 110.918 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.82 -135.97 5.83 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.738 -0.744 . . . . 70.02 112.523 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.7 176.61 23.11 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.806 -0.711 . . . . 72.22 112.472 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.36 103.32 8.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.848 0.356 . . . . 75.32 110.89 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -77.55 106.53 9.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 74.42 110.914 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -134.79 106.7 7.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.085 -0.507 . . . . 73.31 110.941 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -92.19 136.63 33.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 74.5 110.851 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.2 pp -100.26 140.91 33.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 71.32 110.936 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -122.45 -165.24 12.4 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.735 -0.745 . . . . 52.11 112.495 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -40.43 104.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.632 2.221 . . . . 73.15 112.354 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.88 164.35 13.16 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.788 -0.72 . . . . 64.24 112.539 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.08 148.49 50.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.898 0.38 . . . . 74.52 110.88 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -153.57 139.1 17.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 64.13 110.879 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.7 m -122.73 71.67 1.04 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 74.01 110.894 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 44.7 m -89.61 171.95 9.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 71.2 110.878 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.2 p -162.4 23.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 72.44 111.107 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -174.88 35.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 73.12 110.87 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.9 t -157.81 -40.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 64.4 110.873 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.27 -61.74 1.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 72.35 111.135 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.02 94.44 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.718 -0.753 . . . . 74.12 112.483 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.17 64.28 8.73 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.584 0.707 . . . . 63.31 111.152 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -80.86 -47.32 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.716 2.277 . . . . 73.11 112.316 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -174.0 -168.4 0.41 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 71.42 110.852 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -84.62 53.06 2.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 72.34 110.891 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.7 m -99.01 -169.63 1.8 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 72.05 110.831 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.18 137.39 21.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 74.22 111.111 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.13 143.12 18.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 74.22 110.881 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.18 168.27 22.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 73.11 110.828 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -150.82 135.6 17.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 73.31 110.879 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.0 130.62 34.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 73.34 110.884 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -79.94 108.69 13.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 75.23 110.923 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.3 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 70.32 111.118 179.94 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.762 0.315 . . . . 72.21 110.871 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -91.97 177.74 6.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 74.11 110.878 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -165.34 77.6 0.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 72.23 111.072 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -167.32 108.39 0.62 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 64.32 111.137 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -89.49 104.88 17.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 72.23 110.908 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.5 t -116.77 128.46 74.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 74.12 111.142 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.9 tt -128.86 110.72 21.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 71.51 111.129 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 83.0 t -129.79 144.37 38.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 74.42 111.183 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -103.11 133.86 47.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 73.03 110.937 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -94.26 48.02 1.22 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.489 . . . . 75.4 110.86 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 174.26 -169.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 74.15 110.841 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.8 t -64.83 161.23 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 73.11 111.13 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -87.93 54.11 2.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 75.32 110.87 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.432 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -176.96 28.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 62.13 110.837 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.41 50.67 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.749 -0.739 . . . . 75.35 112.477 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.08 171.62 24.48 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.707 -0.759 . . . . 61.24 112.455 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.38 163.46 14.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.767 0.318 . . . . 75.03 110.919 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.2 p -149.63 157.63 43.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 72.44 110.865 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -109.58 106.32 15.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 73.14 110.874 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -124.45 69.73 1.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.115 -0.493 . . . . 71.13 110.855 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -120.67 160.23 23.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 73.35 111.086 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.9 t -93.56 40.82 1.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 71.4 111.168 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.2 m -145.49 25.04 1.37 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 74.34 110.89 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 54.91 -174.22 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.1 -0.5 . . . . 73.32 110.825 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.98 159.23 73.51 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.62 0.724 . . . . 74.22 110.916 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -80.65 -169.12 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.729 2.286 . . . . 70.03 112.365 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.52 108.64 2.55 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.755 -0.736 . . . . 72.22 112.471 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.85 -86.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.865 0.365 . . . . 73.45 111.089 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.54 98.66 0.28 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 63.22 112.533 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -60.74 -171.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.833 0.349 . . . . 71.34 110.83 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.85 -172.3 2.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 75.33 110.934 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.9 mp -61.86 102.25 0.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 74.11 110.907 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 63.74 20.92 12.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 72.12 110.863 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -99.78 39.66 1.3 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 75.34 110.843 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.86 102.39 11.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 75.1 110.89 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.3 tt 179.1 102.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 75.11 111.142 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 52.2 p -168.35 -168.5 0.94 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 75.33 110.845 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -120.9 145.07 48.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.478 . . . . 74.02 110.867 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.4 mp -121.26 123.07 69.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 73.41 111.154 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -117.06 129.18 55.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 72.41 110.906 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.7 p -144.98 139.81 22.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 71.13 111.124 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.52 39.93 1.72 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 75.44 110.952 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 179.78 139.04 0.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 72.45 110.815 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 53.31 -165.35 1.88 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.77 -0.729 . . . . 71.12 112.485 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.5 p -144.98 144.71 31.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.79 0.329 . . . . 73.35 111.151 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -124.2 136.25 54.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.439 . . . . 72.02 110.953 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -79.96 125.56 29.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 75.43 110.857 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -113.21 124.89 53.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 75.42 110.841 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.87 126.73 20.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 74.41 110.963 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -95.4 88.8 5.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 73.32 110.874 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.405 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 172.14 -169.72 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.155 -0.475 . . . . 75.42 110.91 -179.872 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.0 pt -69.74 172.7 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.09 -0.505 . . . . 74.31 111.144 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -78.8 56.21 1.85 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 73.15 110.876 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -151.4 -40.6 0.12 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 75.44 110.868 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.51 -144.81 4.03 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.698 -0.763 . . . . 75.14 112.437 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.405 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 108.39 175.38 21.88 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.715 -0.755 . . . . 73.43 112.488 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -66.93 106.45 1.92 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.844 0.355 . . . . 74.32 110.857 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -77.96 103.17 7.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 73.13 110.92 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.0 t90 -137.6 109.28 7.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.156 -0.475 . . . . 71.22 110.949 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -84.69 144.92 28.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 73.53 110.837 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.5 tp -99.53 137.34 38.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.229 -0.441 . . . . 74.22 110.939 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -115.16 -162.32 13.58 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.739 . . . . 52.34 112.449 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -64.03 100.89 0.32 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.678 2.252 . . . . 74.15 112.335 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 158.48 157.44 8.48 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.753 -0.737 . . . . 73.52 112.485 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.05 136.67 54.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.893 0.377 . . . . 73.14 110.905 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -135.79 138.34 42.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 74.05 110.902 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 m -114.25 75.32 0.92 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 72.22 110.846 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 40.7 t -86.21 152.41 22.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 73.42 110.829 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.7 m -149.64 23.59 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 64.45 111.093 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 178.06 -16.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.477 . . . . 75.32 110.873 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.11 -32.18 64.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 64.11 110.851 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.52 -65.71 0.79 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 74.12 111.112 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 166.49 114.03 0.29 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.745 -0.74 . . . . 72.21 112.485 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.0 mm -130.54 67.23 80.04 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.671 0.748 . . . . 74.51 111.173 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -81.72 -74.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.721 2.28 . . . . 71.25 112.327 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.498 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 4.9 t70 177.44 87.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 75.22 110.861 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 76' ' ' ASP . 9.0 t-20 83.67 131.11 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 73.31 110.927 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -179.6 151.75 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 70.44 110.88 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.6 mt -108.55 153.44 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 75.12 111.084 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.6 p -154.88 158.87 39.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 73.01 110.871 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.59 157.32 27.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.495 . . . . 73.32 110.856 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -150.72 135.78 17.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 75.43 110.884 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.6 mmm-85 -93.49 126.56 38.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 72.11 110.878 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.23 131.48 36.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 60.1 110.958 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.9 pt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 74.42 111.115 179.976 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.806 0.336 . . . . 72.53 110.827 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -161.69 -169.13 2.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 74.25 110.889 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.19 -146.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 53.25 111.107 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.15 133.72 36.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 72.04 111.088 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -87.36 99.95 12.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 73.11 110.871 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.4 t -106.84 121.77 60.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.485 . . . . 75.15 111.12 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.0 tt -123.38 112.17 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 74.34 111.123 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.1 t -128.71 136.88 58.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 74.3 111.093 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -89.06 140.91 28.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 74.42 110.908 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -97.09 38.43 1.24 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 72.3 110.909 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 175.08 -169.53 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.482 . . . . 72.23 110.891 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.8 t -63.9 161.39 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 71.14 111.143 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -87.35 54.19 3.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 73.45 110.905 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.439 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.2 28.56 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 71.24 110.898 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.6 47.8 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.766 -0.731 . . . . 52.22 112.497 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.92 171.98 24.27 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.748 -0.739 . . . . 61.51 112.49 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.56 160.95 17.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.818 0.342 . . . . 74.41 110.865 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 78.4 p -138.24 155.76 48.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 74.45 110.874 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -117.24 104.65 11.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 73.34 110.854 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -105.34 40.01 1.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 74.24 110.868 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -127.98 -166.2 1.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 53.55 111.081 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.5 t -78.79 -170.76 2.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 63.21 111.136 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.4 m -77.16 59.38 1.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 70.43 110.9 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.1 -37.11 9.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.491 . . . . 73.22 110.893 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.97 162.96 60.27 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.565 0.697 . . . . 73.14 110.893 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -47.49 100.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.34 0.111 0 C-N-CA 122.669 2.246 . . . . 64.33 112.342 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.91 -97.64 1.02 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.744 -0.741 . . . . 64.35 112.488 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.44 60.85 5.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.778 0.323 . . . . 70.21 111.089 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 177.39 67.5 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.722 -0.751 . . . . 72.23 112.472 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -176.98 92.16 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.79 0.328 . . . . 74.24 110.871 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -174.08 176.43 2.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 73.44 110.873 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -176.65 -85.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 73.1 110.941 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -146.68 22.27 1.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 65.24 110.882 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -133.46 39.81 3.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 73.23 110.887 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.86 102.81 11.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 75.44 110.863 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 pt -148.89 103.96 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 72.3 111.118 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 79.3 p -167.7 -165.76 0.68 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 70.31 110.847 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.61 148.48 46.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 52.01 110.874 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 mp -121.02 139.07 49.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 73.53 111.141 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -141.97 134.3 27.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 75.04 110.881 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.0 p -135.57 138.95 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 75.12 111.13 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.14 39.48 2.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 63.42 110.874 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.57 110.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 74.43 110.865 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.89 -157.41 53.51 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.739 -0.743 . . . . 65.52 112.428 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 72.7 p -150.24 135.96 18.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.757 0.313 . . . . 72.15 111.161 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -99.63 168.75 9.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 72.33 110.911 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -115.05 123.29 48.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 75.21 110.9 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -110.15 123.58 50.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 74.24 110.89 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.87 126.61 20.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 73.53 110.902 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -102.62 89.86 3.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 73.22 110.89 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.407 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.1 OUTLIER 172.05 -166.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.477 . . . . 73.0 110.937 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.419 ' HB ' ' CD1' ' A' ' 54' ' ' TYR . 5.8 mm -54.98 164.57 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 75.41 111.131 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 59.4 m-20 -80.17 51.9 1.47 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 73.03 110.886 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.433 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 1.9 p90 -179.47 27.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.482 . . . . 73.23 110.931 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.33 -164.86 37.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.745 -0.74 . . . . 72.04 112.457 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.407 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 107.55 -169.68 14.87 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.757 -0.735 . . . . 74.15 112.488 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.17 105.02 12.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.356 . . . . 74.24 110.891 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -78.06 108.4 11.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 75.24 110.945 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -138.11 106.17 5.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.149 -0.478 . . . . 75.32 110.923 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -93.41 138.41 31.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.436 . . . . 75.23 110.878 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.2 pp -103.13 142.71 33.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 73.32 110.925 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -122.77 -162.85 11.65 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.753 -0.737 . . . . 72.41 112.52 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -45.5 101.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.655 2.237 . . . . 73.14 112.39 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 163.62 171.53 29.98 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.736 . . . . 72.21 112.524 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -133.84 143.92 48.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.847 0.356 . . . . 61.23 110.867 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -151.89 140.12 20.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.484 . . . . 75.32 110.942 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.8 p -124.29 72.6 1.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 73.3 110.841 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.8 t -86.06 168.97 13.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 70.24 110.891 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.9 m -152.28 23.53 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 73.11 111.132 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -176.08 57.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 62.53 110.879 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 t -175.99 -43.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 70.4 110.872 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.71 -66.09 0.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 75.54 111.124 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -176.89 93.32 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.716 -0.754 . . . . 71.2 112.462 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.3 mp -128.35 67.91 76.31 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.657 0.741 . . . . 73.33 111.109 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -76.98 -166.12 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.684 2.256 . . . . 74.14 112.37 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -91.4 -24.23 19.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 64.33 110.892 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -141.78 172.45 12.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 75.03 110.91 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.74 88.14 0.24 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 61.42 110.868 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.9 mm -134.91 61.81 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 74.22 111.177 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.8 t -163.02 156.17 19.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 72.32 110.892 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -165.54 159.32 16.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 72.01 110.917 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -150.4 135.77 17.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 71.14 110.877 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -94.27 118.35 31.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 74.42 110.92 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -79.66 93.0 5.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.458 . . . . 74.11 110.899 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 pt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 75.34 111.115 179.965 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.811 0.338 . . . . 73.1 110.899 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -148.39 170.45 17.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 54.33 110.917 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -160.68 106.11 1.44 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 61.53 111.112 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -161.89 132.61 5.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 74.2 111.092 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.62 115.4 26.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 64.43 110.875 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.9 m -112.13 138.64 40.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 74.41 111.166 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.7 tp -105.34 110.97 32.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 72.2 111.135 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.0 m -131.25 165.0 32.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 75.31 111.067 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -117.3 142.7 46.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 73.24 110.916 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -101.45 37.72 1.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.495 . . . . 73.04 110.889 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 174.02 -170.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.483 . . . . 74.12 110.816 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.1 t -64.12 160.37 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 74.41 111.103 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -87.32 54.5 3.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 73.02 110.924 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.441 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -176.91 28.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 70.54 110.883 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.9 46.16 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.786 -0.721 . . . . 75.43 112.548 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.19 172.01 24.36 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.718 -0.753 . . . . 43.03 112.484 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.42 152.26 22.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.782 0.325 . . . . 74.13 110.93 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.62 148.92 49.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 72.15 110.868 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -102.29 104.29 14.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 65.14 110.898 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -122.72 53.29 1.28 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 72.31 110.858 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -139.49 140.56 37.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 70.0 111.078 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.0 m -80.44 69.33 6.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 74.35 111.093 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.6 t -145.51 -170.05 3.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 74.41 110.812 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -90.02 77.23 6.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.124 -0.489 . . . . 74.34 110.866 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -80.07 162.32 62.38 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.582 0.706 . . . . 65.14 110.926 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -57.18 95.97 0.07 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.67 2.246 . . . . 75.22 112.314 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.34 -101.72 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.745 -0.74 . . . . 74.45 112.45 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.06 -175.08 4.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.881 0.372 . . . . 63.32 111.085 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.67 83.87 1.76 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.746 -0.74 . . . . 72.52 112.5 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -98.12 179.82 4.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.768 0.318 . . . . 73.0 110.892 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -108.19 165.76 11.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 63.34 110.902 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.1 mp -56.21 124.48 18.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 73.04 110.938 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 51.91 46.24 26.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.457 . . . . 73.35 110.893 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.53 39.93 3.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 74.11 110.882 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.94 102.84 12.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 72.34 110.931 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.4 tt -179.59 103.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 72.52 111.156 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 82.5 p -168.23 -166.92 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 75.32 110.869 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.9 t -115.35 168.22 10.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 75.21 110.879 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -145.41 139.21 21.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 74.24 111.173 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.9 119.65 13.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 74.34 110.892 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 p -113.94 139.05 41.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 73.52 111.134 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -138.04 45.26 2.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 74.2 110.908 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.72 113.68 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 73.5 110.861 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.23 -135.75 35.8 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.742 -0.742 . . . . 65.32 112.466 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.4 p -150.06 150.13 31.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.732 0.301 . . . . 71.24 111.166 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.7 m0 -117.74 171.38 8.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.247 -0.433 . . . . 75.41 110.897 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.7 mpp_? -113.85 119.73 38.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 74.25 110.909 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -108.59 126.71 53.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 71.31 110.9 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.24 126.29 19.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 74.34 110.922 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -98.44 89.54 4.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 75.12 110.88 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.409 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 172.54 -168.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.116 -0.493 . . . . 75.23 110.934 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 mm -69.82 165.98 2.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 73.13 111.137 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -74.83 56.69 0.74 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 71.21 110.902 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -153.09 -39.15 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 74.51 110.905 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -147.99 -142.36 3.65 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.757 -0.735 . . . . 72.3 112.523 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.409 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 106.55 -178.09 22.32 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.789 -0.72 . . . . 75.04 112.492 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -76.72 108.72 9.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.798 0.332 . . . . 74.55 110.884 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -78.29 100.26 6.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 74.03 110.903 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -133.41 107.53 8.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 74.04 110.923 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.88 148.14 27.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 64.25 110.862 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.7 tp -99.52 136.5 39.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 75.33 110.913 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -112.93 176.34 17.45 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.708 -0.758 . . . . 74.24 112.479 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -46.74 100.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.727 2.284 . . . . 74.33 112.334 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.46 164.6 14.99 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.746 -0.74 . . . . 70.42 112.506 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -118.52 146.94 44.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.829 0.347 . . . . 74.43 110.9 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -146.19 140.15 26.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 74.33 110.867 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.48 73.88 1.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.095 -0.502 . . . . 71.23 110.858 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 45.7 t -85.06 156.23 21.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 65.0 110.84 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.9 m -149.96 26.27 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.114 -0.494 . . . . 74.15 111.096 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 173.15 -16.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 75.54 110.884 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.02 -23.95 41.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 71.22 110.85 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.79 -71.0 0.54 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 62.05 111.114 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 166.79 124.54 0.72 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.781 -0.724 . . . . 71.15 112.502 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.4 mm -123.64 68.08 41.02 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.626 0.727 . . . . 73.11 111.111 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -79.38 -166.18 0.39 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.724 2.283 . . . . 63.34 112.332 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.62 14.81 14.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 72.21 110.874 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -157.36 113.94 2.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 74.23 110.89 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.7 m -92.28 45.0 1.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 75.34 110.855 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.4 mm -76.51 66.26 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 75.45 111.091 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.1 168.92 9.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 75.12 110.82 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.69 155.26 12.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 75.12 110.908 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -151.13 135.96 17.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 74.35 110.9 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.5 mmm-85 -95.79 126.18 40.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 73.02 110.902 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -79.26 97.03 6.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 71.03 110.909 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 63.14 111.154 179.981 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.752 0.31 . . . . 74.3 110.896 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -115.68 171.71 7.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 54.41 110.886 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.87 79.4 0.78 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 71.44 111.14 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.25 168.38 27.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 74.1 111.091 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -90.2 92.96 9.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 73.43 110.897 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 89.5 t -119.79 133.35 66.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 75.1 111.159 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.0 tt -122.29 109.87 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 75.41 111.133 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.0 m -132.19 164.77 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.182 -0.463 . . . . 64.1 111.153 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -113.4 138.73 49.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 73.53 110.99 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -100.73 38.21 1.57 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 71.45 110.888 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 169.26 -173.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 75.3 110.892 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.8 t -66.02 160.55 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.254 -0.43 . . . . 70.41 111.109 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -88.67 54.77 3.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 75.42 110.895 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.419 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -176.55 28.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 72.12 110.917 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.56 43.63 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.73 -0.748 . . . . 41.53 112.5 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.69 172.14 24.52 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.777 -0.725 . . . . 64.12 112.509 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.2 123.6 34.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.797 0.332 . . . . 75.21 110.905 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.3 p -121.24 135.17 55.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 70.21 110.862 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 19' ' ' PHE . 0.8 OUTLIER -124.85 136.73 54.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.15 -0.477 . . . . 75.11 110.878 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.94 -163.08 0.38 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 74.41 110.828 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.56 98.69 6.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 74.43 111.055 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -178.81 179.22 0.72 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 54.15 111.103 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.6 m -65.13 91.72 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 65.13 110.859 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.17 -78.54 0.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 65.4 110.843 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -153.36 67.53 6.22 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.582 0.706 . . . . 74.14 110.904 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -85.85 70.09 4.81 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.669 2.246 . . . . 72.33 112.341 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 163.01 111.56 0.26 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.759 -0.734 . . . . 71.21 112.498 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.38 124.31 35.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.84 0.352 . . . . 72.25 111.142 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.37 -58.18 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.777 -0.725 . . . . 74.5 112.491 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -71.91 80.53 0.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.825 0.345 . . . . 63.14 110.877 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -129.81 -169.95 2.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 71.22 110.911 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -168.33 -169.01 1.01 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 71.43 110.929 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -54.07 -27.55 33.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 72.25 110.877 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -82.73 58.74 4.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 75.32 110.844 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.52 102.22 14.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 75.3 110.91 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.96 111.46 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 75.33 111.157 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.7 p -167.25 -166.46 0.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 74.12 110.871 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 t -117.61 159.38 23.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 72.35 110.882 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -139.53 140.96 36.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 74.32 111.155 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -151.0 147.75 27.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 72.4 110.892 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.6 p -136.03 130.98 49.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 74.33 111.135 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.03 39.51 3.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 74.31 110.837 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.59 110.63 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 60.11 110.888 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.85 -147.86 48.61 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.739 . . . . 64.3 112.508 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.5 p -150.35 147.82 28.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.762 0.315 . . . . 73.11 111.123 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.0 m0 -118.08 174.84 5.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 74.54 110.942 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -124.66 129.13 49.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 71.23 110.858 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -113.57 128.38 56.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 70.23 110.862 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.33 126.19 19.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.486 . . . . 74.4 110.928 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -101.09 88.9 3.63 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.074 -0.512 . . . . 74.44 110.873 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 172.04 -171.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 74.45 110.918 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.7 pt -54.97 174.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.499 . . . . 75.44 111.11 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -87.9 37.86 0.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 70.12 110.909 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -151.74 18.63 0.7 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 75.11 110.926 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.07 -152.34 18.95 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.74 -0.743 . . . . 63.31 112.487 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.29 176.25 22.66 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.749 -0.739 . . . . 60.43 112.478 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.49 109.42 6.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.812 0.339 . . . . 75.14 110.857 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -77.59 108.35 10.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 73.54 110.899 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -138.44 107.17 5.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.06 -0.518 . . . . 74.23 110.925 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -91.28 157.72 16.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 64.4 110.859 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -119.97 149.61 41.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 64.32 110.934 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -124.81 -173.97 13.88 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.728 -0.748 . . . . 72.22 112.525 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -43.97 101.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.731 2.287 . . . . 70.12 112.329 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 158.92 162.4 11.93 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.749 -0.738 . . . . 73.43 112.495 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.13 147.5 41.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.899 0.381 . . . . 72.04 110.882 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -132.64 160.4 36.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 74.2 110.913 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 95.8 p -140.09 62.82 1.49 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 73.43 110.889 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 71.0 m -85.8 145.81 27.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.488 . . . . 75.5 110.836 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.9 m -150.6 18.44 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.487 . . . . 73.3 111.127 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 179.3 38.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 71.23 110.841 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.53 -46.71 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.471 . . . . 71.41 110.866 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.32 -45.86 62.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.506 . . . . 60.31 111.077 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 166.93 103.68 0.17 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.769 -0.729 . . . . 73.04 112.473 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 15.0 mm -131.52 74.02 78.85 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.626 0.727 . . . . 71.31 111.095 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -77.59 -158.54 0.09 OUTLIER 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.709 2.272 . . . . 52.1 112.328 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -75.97 -22.71 55.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 72.52 110.868 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -158.65 -169.54 2.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 73.11 110.89 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.0 t -57.82 -95.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 71.45 110.888 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.2 mp 50.91 59.89 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 75.02 111.092 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 66.1 p -159.41 158.61 32.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 75.41 110.842 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.73 159.63 16.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 70.41 110.867 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -150.14 135.8 18.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 75.12 110.872 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.2 mmt-85 -90.48 117.4 29.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 74.41 110.904 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -82.28 91.85 6.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 74.44 110.909 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 74.4 111.11 179.945 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.043 0 CA-C-O 120.854 0.359 . . . . 75.34 110.896 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -133.82 178.55 6.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 71.0 110.854 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.82 85.51 0.9 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 74.5 111.114 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -167.0 122.19 1.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 74.03 111.105 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.85 98.11 11.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.239 -0.437 . . . . 71.31 110.878 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 54.3 t -102.02 119.43 50.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 74.41 111.102 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.3 tt -120.96 109.51 25.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 74.34 111.135 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.8 t -126.41 141.37 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 72.12 111.153 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -96.04 134.6 38.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.179 -0.464 . . . . 63.35 110.892 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -94.35 44.23 1.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 70.33 110.916 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 174.79 -170.31 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 74.01 110.884 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 t -63.99 160.5 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 75.52 111.16 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -85.41 53.61 2.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 73.14 110.855 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.453 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.59 28.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 74.54 110.849 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.55 44.33 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.721 -0.752 . . . . 52.43 112.5 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -134.98 171.41 22.45 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.74 -0.743 . . . . 74.25 112.467 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.5 161.99 13.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.751 0.31 . . . . 74.42 110.92 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.7 p -151.11 155.34 38.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 65.01 110.84 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -136.34 136.7 39.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 74.05 110.858 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.7 68.03 0.66 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 72.35 110.867 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -151.72 167.21 28.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 72.3 111.093 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 m -144.97 40.73 1.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 74.42 111.134 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.1 t -172.31 36.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 64.1 110.879 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -155.72 -44.19 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.48 . . . . 63.21 110.879 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -83.05 162.24 55.25 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.625 0.726 . . . . 74.31 110.917 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.25 -173.18 1.2 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.694 2.263 . . . . 74.24 112.369 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.74 -104.57 0.71 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.695 -0.764 . . . . 64.24 112.528 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -150.91 158.2 43.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.82 0.343 . . . . 74.04 111.107 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.58 126.65 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.776 -0.726 . . . . 72.45 112.498 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -152.21 25.03 0.63 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.832 0.349 . . . . 72.41 110.903 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -174.18 -169.89 0.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 74.24 110.875 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.14 166.14 0.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 73.25 110.91 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -68.02 87.62 0.26 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.467 . . . . 74.0 110.906 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -176.02 88.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 74.3 110.827 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.69 168.11 17.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 53.43 110.891 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.2 tt -162.01 115.55 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 74.33 111.13 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.9 p -167.22 -167.55 0.93 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 70.21 110.906 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.3 t -123.6 150.08 44.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 75.43 110.867 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.5 mp -120.91 115.18 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 64.02 111.117 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.6 tttm -109.88 119.26 38.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.465 . . . . 75.3 110.918 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 17.2 t -102.89 139.16 24.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 72.04 111.114 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.71 39.84 0.72 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 74.14 110.896 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 179.38 111.66 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 71.11 110.842 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.34 -142.22 24.55 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.674 -0.774 . . . . 64.14 112.523 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -149.84 124.17 9.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.795 0.331 . . . . 71.42 111.12 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -87.14 -177.08 5.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 74.53 110.922 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.25 119.95 19.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.453 . . . . 74.54 110.83 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -101.64 133.59 46.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 73.44 110.855 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.72 126.47 20.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.104 -0.498 . . . . 75.51 110.898 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -105.49 88.85 2.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.079 -0.51 . . . . 72.3 110.917 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.441 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 171.63 -168.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 71.35 110.938 -179.838 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.9 mm -54.97 158.63 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 60.51 111.138 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -76.38 58.2 1.28 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 74.03 110.945 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -167.19 -31.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.163 -0.471 . . . . 75.0 110.928 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -142.26 -152.56 5.72 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.737 -0.744 . . . . 72.31 112.467 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.441 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 108.98 -174.5 18.45 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.773 -0.727 . . . . 70.32 112.471 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.89 127.04 31.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.8 0.333 . . . . 74.5 110.901 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -96.66 108.12 20.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.236 -0.438 . . . . 70.34 110.904 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -138.08 106.74 5.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.093 -0.503 . . . . 75.43 110.914 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -95.47 157.34 15.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 64.02 110.867 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -135.96 139.1 42.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 63.04 110.916 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.52 -165.64 27.38 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.734 -0.746 . . . . 62.13 112.465 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -56.67 115.85 2.78 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.684 2.256 . . . . 70.04 112.346 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.7 151.42 5.89 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.733 -0.746 . . . . 73.21 112.504 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -79.96 155.01 27.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.845 0.355 . . . . 74.14 110.897 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -160.31 149.5 17.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.126 -0.488 . . . . 72.51 110.924 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.9 p -108.12 84.26 1.92 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 70.34 110.872 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.4 117.12 24.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 73.14 110.873 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.7 m -146.34 10.32 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 73.44 111.117 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -157.52 17.65 0.27 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 73.53 110.9 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -165.68 21.67 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 75.3 110.869 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.51 -34.67 16.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 73.34 111.101 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 165.97 41.31 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.78 -0.724 . . . . 54.21 112.495 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.45 63.13 17.92 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.62 0.724 . . . . 71.44 111.102 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.41 -47.61 0.07 OUTLIER 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.703 2.268 . . . . 54.12 112.316 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.472 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 9.3 t70 179.36 87.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 63.43 110.86 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.472 ' CB ' ' O ' ' A' ' 76' ' ' ASP . 5.4 m-20 81.41 -168.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 72.21 110.907 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.08 71.72 2.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 72.4 110.869 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.4 mm -141.79 69.64 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 72.34 111.184 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -165.99 152.59 9.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 63.52 110.834 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.71 171.54 12.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 74.52 110.841 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -152.07 135.9 16.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.134 -0.485 . . . . 75.35 110.905 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 30.5 mmm180 -98.78 116.37 30.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 72.04 110.904 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.63 103.56 13.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 74.43 110.92 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.1 pt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 75.1 111.11 179.982 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.815 0.341 . . . . 64.44 110.93 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -93.68 160.91 14.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 73.14 110.884 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -160.77 84.75 0.69 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 75.34 111.086 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.61 134.68 34.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 74.23 111.08 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -91.65 98.99 11.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 72.3 110.846 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.0 m -115.67 138.56 45.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.501 . . . . 71.24 111.136 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 tt -102.32 110.44 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 73.35 111.101 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.3 m -137.32 159.43 35.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 74.22 111.123 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -114.0 144.33 43.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 74.02 110.95 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.31 41.56 1.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 75.55 110.855 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 172.69 -170.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 72.23 110.826 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 t -63.61 159.97 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 65.04 111.076 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -85.74 53.87 2.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 74.03 110.883 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.438 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.11 28.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 73.11 110.856 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.57 41.14 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.732 . . . . 53.14 112.462 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -137.13 171.54 23.06 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.776 -0.726 . . . . 75.25 112.485 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.35 161.7 16.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.83 0.348 . . . . 74.03 110.893 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -139.07 166.9 23.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 75.4 110.86 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -129.44 113.48 14.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 71.24 110.944 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -121.04 50.01 1.42 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 73.5 110.884 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -125.25 143.76 50.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 75.04 111.114 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.8 t -100.18 39.92 1.3 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 74.14 111.13 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.2 t -92.98 -82.66 0.33 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.45 . . . . 72.31 110.888 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.79 88.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.141 -0.482 . . . . 75.5 110.873 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -80.18 162.17 62.65 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.604 0.716 . . . . 71.11 110.91 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -74.16 -173.36 1.41 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.749 2.299 . . . . 74.35 112.366 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.7 177.63 49.88 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.763 -0.732 . . . . 74.21 112.515 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.98 122.89 34.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.812 0.339 . . . . 75.11 111.096 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.47 119.1 3.83 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.765 -0.731 . . . . 71.32 112.494 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -159.58 44.11 0.23 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.87 0.367 . . . . 74.45 110.872 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -174.2 173.58 3.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 75.21 110.914 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.2 tp -60.98 -167.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 74.51 110.882 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -52.58 102.75 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 74.52 110.911 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -167.3 39.73 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 62.35 110.839 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.85 108.97 15.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 72.24 110.896 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -168.98 102.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 73.52 111.126 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.4 p -168.11 -167.6 0.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 73.22 110.879 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.7 t -126.66 157.86 37.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 74.34 110.866 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.69 138.06 55.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 73.54 111.113 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.1 tttt -136.03 124.31 23.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 72.41 110.853 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.5 p -120.3 139.5 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.436 . . . . 73.31 111.134 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -142.89 40.37 1.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 73.14 110.892 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.57 117.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 72.44 110.842 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 51.76 -151.45 6.84 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.696 -0.764 . . . . 73.45 112.523 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.7 p -136.62 155.95 49.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.763 0.316 . . . . 74.51 111.132 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.2 m0 -123.74 175.65 6.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 75.54 110.916 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.7 mpp_? -123.72 122.71 38.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 74.54 110.888 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -107.52 128.64 54.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 75.53 110.934 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.13 127.92 21.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 75.04 110.923 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -99.1 87.05 3.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.505 . . . . 71.24 110.853 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 170.23 -170.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.167 -0.47 . . . . 72.31 110.951 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.1 pt -54.68 174.31 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 72.44 111.139 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -87.41 36.95 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 74.01 110.945 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -151.85 19.01 0.69 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 73.55 110.925 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.61 -156.89 27.63 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.788 -0.72 . . . . 75.42 112.504 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.09 176.29 22.8 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.677 -0.773 . . . . 74.24 112.496 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -69.81 103.96 2.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.833 0.349 . . . . 74.0 110.872 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -75.05 108.4 7.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 75.33 110.957 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -138.1 106.21 5.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.138 -0.483 . . . . 75.53 110.953 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -88.49 138.41 31.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 71.43 110.845 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.18 159.44 14.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 65.3 110.928 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -128.85 175.77 18.62 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.706 -0.759 . . . . 54.34 112.483 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -42.51 107.77 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.657 2.238 . . . . 72.01 112.382 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.79 159.48 9.39 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.739 . . . . 71.4 112.489 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -102.6 144.69 30.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.843 0.354 . . . . 73.51 110.904 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -137.17 145.09 43.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.118 -0.492 . . . . 73.21 110.917 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.1 m -133.8 67.51 1.52 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 61.33 110.838 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.9 m -84.99 145.11 27.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 72.53 110.866 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.6 m -149.97 19.74 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 73.21 111.118 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -179.5 38.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 62.41 110.879 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.34 -39.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 71.3 110.894 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.17 -44.47 67.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 63.42 111.073 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 167.41 93.79 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.787 -0.721 . . . . 75.21 112.518 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.7 mm -123.98 67.27 42.37 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.613 0.72 . . . . 75.33 111.129 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -80.07 -166.38 0.41 Allowed 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.727 2.285 . . . . 72.35 112.376 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -57.67 -70.15 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.419 . . . . 72.02 110.876 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -96.68 -95.54 0.2 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 74.24 110.846 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.4 p -178.18 -95.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 73.24 110.836 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.5 mm 56.23 54.92 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 74.05 111.152 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.6 m -108.07 164.2 12.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 72.51 110.862 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.3 p -165.54 153.68 11.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 65.32 110.831 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -151.25 135.47 16.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 71.45 110.888 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.47 119.69 32.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 75.3 110.883 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -79.7 92.01 5.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 75.35 110.899 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 74.1 111.186 179.933 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.931 0.396 . . . . 73.540000000000006 110.882 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.782 HG13 ' CH2' ' A' ' 46' ' ' TRP . 89.7 t -110.6 111.24 35.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 64.239999999999995 111.116 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.738 HG23 ' HB3' ' A' ' 40' ' ' LYS . 4.0 tp -106.34 110.91 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 52.109999999999999 111.127 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.8 t -131.54 138.8 52.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 65.010000000000005 111.138 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -94.5 137.22 33.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 74.129999999999995 110.863 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -93.98 42.94 1.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 75.150000000000006 110.902 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 174.52 -169.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 63.229999999999997 110.852 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.451 HG12 ' N ' ' A' ' 13' ' ' ASN . 5.0 t -64.68 160.97 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 74.209999999999994 111.17 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.451 ' N ' HG12 ' A' ' 12' ' ' VAL . 51.2 t30 -87.34 53.79 2.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 73.319999999999993 110.923 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.441 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.12 28.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 71.430000000000007 110.911 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.19 52.73 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.726 -0.75 . . . . 74.120000000000005 112.486 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.96 171.52 24.48 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.798 -0.715 . . . . 63.409999999999997 112.513 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.43 134.34 35.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.77 0.319 . . . . 74.340000000000003 110.893 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.48 153.04 34.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 54.340000000000003 110.88 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -148.64 141.35 24.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 64.200000000000003 110.901 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.447 ' HB2' HD13 ' A' ' 7' ' ' ILE . 20.8 t0 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 71.209999999999994 110.907 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.784 0.325 . . . . 71.109999999999999 110.914 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.542 ' HB ' HG12 ' A' ' 69' ' ' VAL . 1.1 pt -153.11 109.72 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 75.540000000000006 111.127 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.0 p -165.01 -168.35 1.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 64.109999999999999 110.843 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.581 ' O ' HD12 ' A' ' 39' ' ' ILE . 0.6 OUTLIER -124.07 152.05 43.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 63.149999999999999 110.828 -179.825 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.581 HD12 ' O ' ' A' ' 38' ' ' SER . 1.5 mp -120.91 139.33 48.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.51 . . . . 71.140000000000001 111.116 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.738 ' HB3' HG23 ' A' ' 7' ' ' ILE . 7.4 tttt -138.04 125.92 22.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 60.219999999999999 110.915 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.563 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 9.2 p -125.58 139.02 52.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.433 . . . . 63.450000000000003 111.158 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.88 39.39 1.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 74.230000000000004 110.861 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.93 110.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 52.229999999999997 110.855 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.94 -150.21 50.28 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.78 -0.724 . . . . 75.549999999999997 112.451 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.563 HG22 ' HA2' ' A' ' 62' ' ' GLY . 41.9 p -148.4 160.61 42.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.759 0.314 . . . . 55.229999999999997 111.146 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.782 ' CH2' HG13 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -124.53 177.48 5.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 74.129999999999995 110.953 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.411 ' HD2' HD11 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -123.57 111.92 16.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.273 -0.421 . . . . 73.239999999999995 110.864 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -101.01 123.95 45.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 75.150000000000006 110.916 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -139.97 126.63 20.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 74.340000000000003 110.945 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -104.09 89.57 3.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 73.010000000000005 110.871 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.408 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 177.27 -174.34 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 74.239999999999995 110.958 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.0 pt -54.88 174.15 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 65.319999999999993 111.099 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -83.07 10.12 8.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.14 -0.482 . . . . 71.540000000000006 110.881 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.45 67.27 1.26 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 73.519999999999996 110.937 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 116.39 121.08 3.27 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.757 -0.735 . . . . 73.420000000000002 112.503 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.408 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . -177.35 174.48 47.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 32.520000000000003 112.486 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -64.62 95.93 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.844 0.354 . . . . 73.540000000000006 110.918 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -76.38 111.86 12.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 64.230000000000004 110.933 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -138.32 105.86 5.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.144 -0.48 . . . . 73.150000000000006 110.924 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -90.65 137.61 32.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.259 -0.428 . . . . 61.149999999999999 110.916 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.714 HD21 ' CE3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -104.81 142.11 35.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 52.009999999999998 110.879 -179.931 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.563 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -113.79 -168.63 16.63 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.781 -0.723 . . . . 71.349999999999994 112.54 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -46.84 109.89 0.24 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.699 2.266 . . . . 74.340000000000003 112.304 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.93 158.48 8.84 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.732 -0.747 . . . . 52.310000000000002 112.505 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.59 143.86 49.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.861 0.362 . . . . 63.25 110.891 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -148.63 160.12 43.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 72.129999999999995 110.898 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 99.0 p -140.69 78.04 1.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.094 -0.503 . . . . 61.32 110.837 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.4 m -86.64 153.05 22.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 62.530000000000001 110.843 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.542 HG12 ' HB ' ' A' ' 36' ' ' ILE . 5.1 m -153.43 23.92 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 73.030000000000001 111.114 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -179.52 39.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 51.310000000000002 110.9 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.443 ' N ' HD11 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -157.85 -40.2 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 74.25 110.852 -179.772 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.28 -75.79 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.114 -0.493 . . . . 63.329999999999998 111.095 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.85 90.15 0.1 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 64.209999999999994 112.516 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.443 HD11 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -134.15 67.07 72.89 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.644 0.735 . . . . 74.150000000000006 111.165 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -80.46 -52.21 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.663 2.242 . . . . 52.350000000000001 112.343 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 179.82 -51.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.264 -0.426 . . . . 61.25 110.845 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -173.75 130.14 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 74.439999999999998 110.861 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.17 178.69 2.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 73.420000000000002 110.891 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.4 mm -100.45 155.19 4.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 61.219999999999999 111.111 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.7 p -155.62 155.75 33.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 71.329999999999998 110.851 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -165.27 158.15 16.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 71.120000000000005 110.838 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -150.55 135.66 17.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 62.509999999999998 110.885 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -89.68 119.71 30.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 74.209999999999994 110.901 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -79.77 99.62 7.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 73.549999999999997 110.906 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.411 HD11 ' HD2' ' A' ' 47' ' ' ARG . 1.1 pt . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 73.349999999999994 111.103 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.865 0.364 . . . . 53.200000000000003 110.898 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.749 HG13 ' CH2' ' A' ' 46' ' ' TRP . 79.5 t -100.85 114.65 40.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.484 . . . . 65.519999999999996 111.141 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.442 HG23 ' O ' ' A' ' 7' ' ' ILE . 8.5 tt -115.41 110.53 32.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 74.120000000000005 111.131 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.5 t -128.79 145.09 36.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 51.5 111.132 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -97.81 136.7 37.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.476 . . . . 73.299999999999997 110.911 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.77 44.68 1.1 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.49 . . . . 71.430000000000007 110.872 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 173.42 -171.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 65.400000000000006 110.824 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 13' ' ' ASN . 5.3 t -64.58 160.57 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 73.239999999999995 111.161 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.444 ' N ' HG12 ' A' ' 12' ' ' VAL . 11.7 t-20 -87.28 53.94 2.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 73.109999999999999 110.883 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.443 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -176.92 28.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 61.200000000000003 110.872 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.4 52.79 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.714 -0.755 . . . . 74.519999999999996 112.438 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.07 171.42 24.55 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.76 -0.733 . . . . 52.420000000000002 112.481 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.04 135.15 34.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.779 0.323 . . . . 73.219999999999999 110.912 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.65 154.35 32.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 74.120000000000005 110.882 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -148.65 151.97 35.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 72.549999999999997 110.878 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.0 t0 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 70.439999999999998 110.838 179.927 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.796 0.331 . . . . 71.010000000000005 110.858 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.441 HD12 HG22 ' A' ' 12' ' ' VAL . 1.1 pt -154.49 106.08 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 73.209999999999994 111.14 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 56.6 p -151.08 -168.4 3.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 52.420000000000002 110.848 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.609 ' C ' HD12 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -130.46 152.22 50.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.087 -0.506 . . . . 63.119999999999997 110.847 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.609 HD12 ' C ' ' A' ' 38' ' ' SER . 1.7 mp -122.14 141.52 42.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 73.439999999999998 111.103 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.2 tttt -140.99 135.61 31.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 73.209999999999994 110.841 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.4 p -162.91 139.23 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 72.310000000000002 111.109 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.06 40.65 3.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 75.019999999999996 110.891 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 t 178.94 138.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 74.349999999999994 110.833 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.78 -177.87 1.89 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.705 -0.76 . . . . 63.039999999999999 112.524 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.59 HG22 ' HA2' ' A' ' 62' ' ' GLY . 18.5 p -145.49 147.65 32.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.754 0.311 . . . . 65.099999999999994 111.156 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.779 ' CE3' HD21 ' A' ' 61' ' ' LEU . 0.7 OUTLIER -116.98 175.43 5.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 64.109999999999999 110.953 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -117.69 118.93 33.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.413 . . . . 71.349999999999994 110.906 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.432 ' CD2' HD23 ' A' ' 61' ' ' LEU . 2.6 m-85 -107.63 125.93 51.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 73.219999999999999 110.871 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.18 126.64 20.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.143 -0.48 . . . . 72.430000000000007 110.952 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -99.25 89.13 4.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 73.230000000000004 110.868 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.443 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 170.95 -178.01 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 74.140000000000001 110.961 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.1 tt -54.94 163.34 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 70.439999999999998 111.119 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -76.29 55.84 1.01 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 71.120000000000005 110.886 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -153.5 -37.72 0.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 72.310000000000002 110.938 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -146.27 -144.27 4.04 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.699 -0.762 . . . . 44.100000000000001 112.427 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.443 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 108.18 -170.54 15.17 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.765 -0.731 . . . . 54.130000000000003 112.469 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -83.61 105.36 14.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.841 0.353 . . . . 73.549999999999997 110.852 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -78.16 106.84 10.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 73.430000000000007 110.932 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -138.1 108.35 6.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.48 . . . . 70.329999999999998 110.941 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -92.83 135.07 34.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.436 . . . . 71.510000000000005 110.877 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.779 HD21 ' CE3' ' A' ' 46' ' ' TRP . 1.3 pp -99.22 140.41 33.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 71.25 110.922 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.59 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -107.45 -159.18 20.92 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.773 -0.727 . . . . 34.43 112.475 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.37 88.06 0.13 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.672 2.248 . . . . 60.109999999999999 112.39 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.3 160.52 29.22 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.751 -0.737 . . . . 52.530000000000001 112.504 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -118.61 135.55 54.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 61.420000000000002 110.852 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -143.45 160.09 41.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.129 -0.487 . . . . 71.140000000000001 110.878 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 97.8 p -141.14 78.06 1.63 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.086 -0.506 . . . . 61.130000000000003 110.853 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.471 ' HB2' ' HB2' ' A' ' 72' ' ' ALA . 14.2 m -88.39 148.81 24.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.491 . . . . 72.400000000000006 110.858 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.435 HG12 ' HB ' ' A' ' 36' ' ' ILE . 34.5 m -150.68 24.05 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.495 . . . . 51.350000000000001 111.154 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -179.47 36.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 72.219999999999999 110.858 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.99 -43.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 75.219999999999999 110.831 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.471 ' HB2' ' HB2' ' A' ' 68' ' ' SER . . . -51.59 -42.94 62.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 71.319999999999993 111.104 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.685 ' O ' HD13 ' A' ' 74' ' ' ILE . . . 166.88 91.99 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.766 -0.73 . . . . 43.509999999999998 112.503 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.685 HD13 ' O ' ' A' ' 73' ' ' GLY . 15.0 mm -131.46 69.21 81.74 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.638 0.733 . . . . 71.040000000000006 111.173 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -81.02 -66.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.701 2.267 . . . . 64.409999999999997 112.379 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -179.95 -73.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.266 -0.425 . . . . 75.329999999999998 110.874 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -66.09 -169.8 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 62.399999999999999 110.885 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.93 110.07 6.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 71.310000000000002 110.826 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.6 pt -152.92 22.79 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 73.540000000000006 111.096 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.6 p -79.78 160.54 26.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 61.149999999999999 110.861 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.62 156.69 13.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 65.319999999999993 110.854 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -148.58 138.37 22.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.49 . . . . 63.340000000000003 110.837 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.97 120.59 34.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 75.430000000000007 110.875 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -79.28 111.05 15.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 72.420000000000002 110.925 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.5 pt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.46 . . . . 65.329999999999998 111.132 179.969 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.888 0.375 . . . . 70.109999999999999 110.88 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.642 HG22 ' CZ2' ' A' ' 46' ' ' TRP . 84.4 t -117.71 118.63 59.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 53.119999999999997 111.119 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.801 HG23 ' HB3' ' A' ' 40' ' ' LYS . 4.4 tp -136.69 116.65 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 50.039999999999999 111.102 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.635 HG12 HD13 ' A' ' 39' ' ' ILE . 2.8 m -133.12 160.33 42.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 73.200000000000003 111.122 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -113.15 141.21 47.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 75.540000000000006 110.952 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -95.46 37.0 1.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 74.200000000000003 110.869 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 175.62 -169.63 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 72.239999999999995 110.868 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 13' ' ' ASN . 6.6 t -63.65 160.28 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 75.409999999999997 111.18 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.45 ' N ' HG12 ' A' ' 12' ' ' VAL . 37.2 t30 -85.87 53.81 2.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 74.129999999999995 110.899 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.44 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.14 28.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 74.209999999999994 110.86 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.54 39.26 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.718 -0.754 . . . . 55.409999999999997 112.47 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -129.16 171.61 19.92 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.725 -0.75 . . . . 33.310000000000002 112.462 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.25 131.01 34.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.773 0.32 . . . . 73.420000000000002 110.921 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.57 145.26 45.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 72.019999999999996 110.855 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -148.77 128.71 13.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 74.209999999999994 110.875 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.697 ' HB3' HD13 ' A' ' 7' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 71.010000000000005 110.927 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.75 0.31 . . . . 75.430000000000007 110.906 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.545 ' HB ' HG12 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -147.94 124.68 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 74.010000000000005 111.143 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.0 p -167.86 -166.78 0.77 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 73.319999999999993 110.81 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.8 t -125.54 164.12 21.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.067 -0.515 . . . . 44.240000000000002 110.867 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.635 HD13 HG12 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -130.42 140.33 49.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 75.219999999999999 111.127 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.801 ' HB3' HG23 ' A' ' 7' ' ' ILE . 1.7 tttp -138.58 132.15 30.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 74.409999999999997 110.913 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.665 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 3.6 p -133.0 139.2 50.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.258 -0.428 . . . . 73.409999999999997 111.108 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.62 41.91 1.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.472 . . . . 61.229999999999997 110.927 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -173.44 110.83 0.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 45.130000000000003 110.861 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 56.63 -137.76 47.77 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.729 -0.748 . . . . 41.109999999999999 112.483 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 64.3 p -150.21 141.25 22.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.339 . . . . 63.409999999999997 111.095 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.665 ' CZ2' HG23 ' A' ' 41' ' ' VAL . 2.8 m0 -109.72 168.45 9.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 74.510000000000005 110.891 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -110.2 120.89 43.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 74.230000000000004 110.917 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -110.95 127.72 55.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 72.519999999999996 110.936 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.73 126.15 18.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.471 . . . . 64.150000000000006 110.907 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -99.12 88.69 4.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.076 -0.511 . . . . 73.409999999999997 110.902 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 173.4 -177.85 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 53.539999999999999 110.903 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.0 pt -58.66 172.32 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 72.409999999999997 111.145 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -84.49 51.95 2.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 72.400000000000006 110.866 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -152.74 -47.87 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 74.109999999999999 110.918 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -149.75 125.05 1.89 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.742 . . . . 62.200000000000003 112.515 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.44 173.12 38.67 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.746 -0.74 . . . . 53.039999999999999 112.483 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -61.75 105.94 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.836 0.35 . . . . 74.219999999999999 110.921 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -77.04 103.32 6.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 72.219999999999999 110.922 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.9 t90 -138.19 107.91 6.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.496 . . . . 72.510000000000005 110.925 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -82.31 153.93 25.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 72.340000000000003 110.841 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.628 ' HG ' HG11 ' A' ' 41' ' ' VAL . 7.4 tp -104.79 133.68 49.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 74.299999999999997 110.947 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.454 ' N ' HD12 ' A' ' 61' ' ' LEU . . . -111.08 178.79 19.76 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.733 -0.746 . . . . 52.039999999999999 112.486 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -46.99 100.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.652 2.235 . . . . 65.409999999999997 112.367 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 161.88 164.13 16.18 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.724 -0.751 . . . . 72.140000000000001 112.476 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -124.1 140.27 53.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.89 0.376 . . . . 71.140000000000001 110.868 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -140.77 144.23 35.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 64.430000000000007 110.939 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.1 t -126.18 74.8 1.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 72.019999999999996 110.895 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.6 m -87.27 159.01 18.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 72.540000000000006 110.823 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.545 HG12 ' HB ' ' A' ' 36' ' ' ILE . 30.5 m -151.29 21.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 60.229999999999997 111.166 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -179.37 58.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 73.230000000000004 110.881 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.55 -49.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 54.340000000000003 110.819 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.61 -62.01 1.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 63.310000000000002 111.115 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.62 ' O ' HD13 ' A' ' 74' ' ' ILE . . . -164.74 88.94 0.1 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.722 -0.752 . . . . 63.109999999999999 112.463 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.62 HD13 ' O ' ' A' ' 73' ' ' GLY . 18.8 mm -132.2 67.35 78.89 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.623 0.725 . . . . 70.5 111.14 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -80.25 -51.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.69 2.26 . . . . 74.109999999999999 112.381 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.86 -34.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 72.010000000000005 110.85 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -141.23 -176.77 4.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 71.030000000000001 110.871 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.34 111.68 23.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 73.140000000000001 110.889 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.547 HD13 ' H ' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -141.98 11.1 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 65.230000000000004 111.086 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.4 p -83.37 170.64 14.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 72.219999999999999 110.843 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.64 152.66 10.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 73.010000000000005 110.859 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -150.19 139.9 21.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 62.439999999999998 110.919 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -109.33 130.62 55.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 70.430000000000007 110.86 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.415 ' HB3' HG21 ' A' ' 6' ' ' VAL . 2.1 mp0 -89.38 131.41 35.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 54.109999999999999 110.899 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.6 pt . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 72.010000000000005 111.099 179.975 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.929 0.395 . . . . 65.209999999999994 110.879 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.743 HG22 ' CZ2' ' A' ' 46' ' ' TRP . 87.6 t -111.95 111.77 37.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 75.140000000000001 111.117 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.561 HD13 ' HB3' ' A' ' 20' ' ' ASP . 3.3 tp -117.52 110.03 29.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 70.340000000000003 111.118 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 m -130.79 159.9 42.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 72.230000000000004 111.144 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -112.14 146.2 38.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.462 . . . . 75.120000000000005 110.938 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -101.18 38.9 1.48 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.477 . . . . 73.5 110.904 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 175.04 -171.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 74.030000000000001 110.845 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 13' ' ' ASN . 6.7 t -63.33 160.61 2.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 65.200000000000003 111.105 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.452 ' N ' HG12 ' A' ' 12' ' ' VAL . 0.7 OUTLIER -84.19 53.74 2.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 74.409999999999997 110.917 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.446 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -178.06 28.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 73.420000000000002 110.84 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 158.88 38.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.753 -0.737 . . . . 73.319999999999993 112.495 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.3 171.51 20.57 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.756 -0.735 . . . . 74.519999999999996 112.464 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.91 149.79 21.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.798 0.332 . . . . 72.109999999999999 110.915 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.98 149.12 50.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 75.540000000000006 110.831 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -146.39 129.45 16.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 62.329999999999998 110.886 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.561 ' HB3' HD13 ' A' ' 7' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 74.030000000000001 110.896 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.762 0.315 . . . . 71.430000000000007 110.908 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.556 HG13 HG12 ' A' ' 69' ' ' VAL . 2.0 tt -176.76 102.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 73.349999999999994 111.135 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.7 p -168.84 -164.18 0.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 65.519999999999996 110.869 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.548 ' C ' HD12 ' A' ' 39' ' ' ILE . 47.5 t -125.41 149.34 48.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 74.430000000000007 110.883 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.603 HG21 HD13 ' A' ' 61' ' ' LEU . 1.5 mp -120.91 131.26 73.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 42.009999999999998 111.145 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.547 ' HB3' HG23 ' A' ' 7' ' ' ILE . 3.7 tttp -132.51 142.32 49.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 74.129999999999995 110.875 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.607 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 7.2 p -143.74 126.43 12.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 60.310000000000002 111.121 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.67 41.1 3.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 74.420000000000002 110.928 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.9 t -179.1 110.8 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 61.219999999999999 110.878 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.3 -151.24 52.12 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.67 -0.776 . . . . 75.129999999999995 112.508 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.54 HG22 ' HA2' ' A' ' 62' ' ' GLY . 41.1 p -150.07 153.39 36.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.798 0.332 . . . . 74.329999999999998 111.15 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.743 ' CZ2' HG22 ' A' ' 6' ' ' VAL . 1.3 m0 -123.45 179.07 4.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 75.239999999999995 110.935 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -124.44 136.09 53.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.434 . . . . 72.230000000000004 110.823 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.441 ' HD2' HD22 ' A' ' 61' ' ' LEU . 1.7 m-85 -120.12 129.88 54.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 75.430000000000007 110.878 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.71 126.14 20.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.164 -0.471 . . . . 74.409999999999997 110.95 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.78 89.04 3.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 54.399999999999999 110.918 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.569 ' C ' HG22 ' A' ' 79' ' ' ILE . 0.2 OUTLIER 175.38 -169.44 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 74.239999999999995 110.915 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.2 tt -58.6 163.06 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 70.019999999999996 111.113 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -76.24 55.3 0.95 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 75.319999999999993 110.871 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -153.76 -38.02 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 73.510000000000005 110.936 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -145.53 -138.82 3.31 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 72.239999999999995 112.509 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.426 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 108.06 177.37 22.16 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.796 -0.716 . . . . 52.439999999999998 112.5 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.3 109.48 5.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.81 0.338 . . . . 72.409999999999997 110.859 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -77.59 108.71 10.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 75.430000000000007 110.927 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -138.31 106.72 5.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 63.450000000000003 110.88 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -89.13 157.7 18.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 73.409999999999997 110.878 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.635 HD11 ' CE3' ' A' ' 46' ' ' TRP . 1.8 pt? -118.5 149.71 40.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 73.430000000000007 110.944 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.54 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -127.88 -166.6 12.09 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.72 -0.752 . . . . 50.530000000000001 112.493 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -46.41 101.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.7 2.267 . . . . 62.530000000000001 112.317 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.79 165.39 16.63 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.749 -0.738 . . . . 71.420000000000002 112.484 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.44 145.84 47.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.865 0.364 . . . . 74.329999999999998 110.858 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -154.75 156.65 36.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 75.439999999999998 110.924 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 95.8 p -130.4 85.88 2.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 70.209999999999994 110.854 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.1 t -86.01 153.21 22.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 60.310000000000002 110.86 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.556 HG12 HG13 ' A' ' 36' ' ' ILE . 18.7 m -149.65 18.03 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 61.299999999999997 111.163 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -178.7 40.94 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.117 -0.492 . . . . 75.010000000000005 110.863 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 t -158.44 -45.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 74.109999999999999 110.852 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.45 -61.26 2.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.486 . . . . 75.409999999999997 111.097 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 166.62 103.7 0.17 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.717 -0.754 . . . . 55.539999999999999 112.449 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.8 mm -115.76 74.66 4.95 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.666 0.746 . . . . 64.019999999999996 111.14 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.96 -165.54 0.31 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.701 2.267 . . . . 71.129999999999995 112.359 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -51.32 -74.85 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.265 -0.425 . . . . 61.149999999999999 110.834 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -179.41 33.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 74.439999999999998 110.857 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.3 p 178.95 -174.84 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 74.040000000000006 110.859 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.569 HG22 ' C ' ' A' ' 51' ' ' TYR . 14.2 mm 66.8 62.13 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 73.109999999999999 111.151 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.2 p -165.94 137.88 3.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 65.430000000000007 110.895 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -158.53 166.75 31.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 75.129999999999995 110.864 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -151.12 142.51 23.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 62.450000000000003 110.886 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.86 159.0 26.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 64.430000000000007 110.932 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -128.52 92.53 3.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 63.399999999999999 110.934 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 pt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 65.409999999999997 111.111 179.981 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.919 0.39 . . . . 74.510000000000005 110.878 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.773 HG13 ' CH2' ' A' ' 46' ' ' TRP . 58.3 t -111.92 128.65 68.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 63.240000000000002 111.128 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.454 HG23 ' O ' ' A' ' 7' ' ' ILE . 9.9 tt -126.68 110.56 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 74.430000000000007 111.155 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.4 t -136.54 143.81 34.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 62.420000000000002 111.112 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.85 138.2 40.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 74.319999999999993 110.89 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -93.25 42.67 1.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 75.030000000000001 110.885 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 173.93 -169.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 71.329999999999998 110.858 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.454 HG12 ' N ' ' A' ' 13' ' ' ASN . 6.2 t -63.95 160.3 3.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.218 -0.447 . . . . 64.430000000000007 111.178 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.454 ' N ' HG12 ' A' ' 12' ' ' VAL . 24.4 t30 -86.42 53.97 2.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 74.219999999999999 110.858 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.434 ' CG ' ' O ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.04 28.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 73.239999999999995 110.895 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.36 47.33 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.692 -0.766 . . . . 72.420000000000002 112.424 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.97 171.96 24.3 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.714 -0.755 . . . . 54.009999999999998 112.466 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.2 163.86 15.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.829 0.347 . . . . 72.450000000000003 110.924 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.1 p -144.52 165.44 27.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.434 . . . . 74.120000000000005 110.836 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -124.88 110.89 14.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 75.420000000000002 110.838 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 75.420000000000002 110.862 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.489 ' O ' HD12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.753 0.311 . . . . 63.399999999999999 110.921 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.447 HG23 ' O ' ' A' ' 35' ' ' LYS . 2.4 pt -156.1 119.28 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 74.120000000000005 111.159 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.2 p -161.84 -169.08 2.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 43.310000000000002 110.838 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.657 ' O ' HD12 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -127.85 149.18 50.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 62.140000000000001 110.875 -179.821 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.657 HD12 ' O ' ' A' ' 38' ' ' SER . 1.5 mp -124.35 138.96 52.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 71.409999999999997 111.161 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.4 ' HB3' HG23 ' A' ' 7' ' ' ILE . 1.2 tttt -142.49 138.67 31.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 73.120000000000005 110.945 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.7 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 6.4 p -132.87 139.15 50.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 72.129999999999995 111.095 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.3 39.93 2.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 65.450000000000003 110.89 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.87 120.24 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 71.319999999999993 110.853 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.23 -143.23 21.68 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.725 -0.75 . . . . 74.540000000000006 112.55 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.618 HG22 ' HA2' ' A' ' 62' ' ' GLY . 63.8 p -146.72 156.58 43.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.724 0.297 . . . . 74.150000000000006 111.126 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.773 ' CH2' HG13 ' A' ' 6' ' ' VAL . 2.7 m0 -125.32 169.81 11.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.218 -0.446 . . . . 64.040000000000006 110.919 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -112.11 121.59 45.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 63.32 110.911 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -113.65 120.07 39.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 74.209999999999994 110.901 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -139.88 126.78 20.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.153 -0.476 . . . . 60.100000000000001 110.933 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -100.72 89.98 4.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 73.319999999999993 110.909 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.444 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 170.96 -169.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 74.420000000000002 110.905 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' A' ' 52' ' ' ILE . 7.7 tp -64.87 159.41 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 75.219999999999999 111.104 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 -78.0 45.7 0.54 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 54.030000000000001 110.913 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -152.83 17.06 0.58 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 74.310000000000002 110.93 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 168.32 -118.18 0.77 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.754 -0.736 . . . . 75.140000000000001 112.492 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.444 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 71.56 -179.27 33.9 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.745 -0.74 . . . . 75.329999999999998 112.5 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.02 108.39 14.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.828 0.347 . . . . 64.129999999999995 110.87 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -78.35 106.88 10.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 74.109999999999999 110.897 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -138.15 106.2 5.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.112 -0.494 . . . . 73.239999999999995 110.906 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -84.76 157.41 21.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 74.219999999999999 110.857 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.496 HD22 HG21 ' A' ' 39' ' ' ILE . 9.7 tp -109.75 134.7 51.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 64.209999999999994 110.909 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.618 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -110.32 -178.55 20.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.668 -0.777 . . . . 74.209999999999994 112.493 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -47.88 100.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.747 2.298 . . . . 73.430000000000007 112.314 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.46 165.42 14.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.71 -0.757 . . . . 43.25 112.428 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -93.48 165.08 12.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.86 0.362 . . . . 53.219999999999999 110.941 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -160.24 105.03 1.49 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 74.430000000000007 110.928 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.6 m -96.45 91.13 5.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 71.450000000000003 110.837 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.18 131.81 34.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 75.239999999999995 110.838 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.492 HG23 ' HG2' ' A' ' 70' ' ' GLU . 29.8 m -150.05 18.67 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.119 -0.492 . . . . 53.240000000000002 111.14 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.492 ' HG2' HG23 ' A' ' 69' ' ' VAL . 0.0 OUTLIER 173.45 -17.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 73.299999999999997 110.905 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.34 -49.73 9.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 71.549999999999997 110.867 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.31 -70.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 64.310000000000002 111.064 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.761 ' O ' HD13 ' A' ' 74' ' ' ILE . . . 173.07 119.8 0.54 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.739 -0.743 . . . . 72.140000000000001 112.473 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.761 HD13 ' O ' ' A' ' 73' ' ' GLY . 5.5 mm -129.5 67.14 78.52 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.645 0.736 . . . . 75.530000000000001 111.135 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -81.38 -69.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.704 2.269 . . . . 55.530000000000001 112.335 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.2 t70 179.08 -40.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 71.099999999999994 110.91 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -176.71 107.46 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.47 . . . . 72.310000000000002 110.865 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.2 m -140.8 -169.97 2.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 74.239999999999995 110.824 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.9 mp -106.19 150.1 9.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.485 . . . . 74.329999999999998 111.17 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.6 p -165.51 146.8 7.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 62.32 110.861 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.04 158.94 31.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 74.030000000000001 110.863 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -150.63 135.78 17.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 74.439999999999998 110.862 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -88.59 120.73 30.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 63.210000000000001 110.911 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.662 ' HG2' HG11 ' A' ' 6' ' ' VAL . 28.9 mt-30 -81.36 92.64 6.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 65.340000000000003 110.904 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 74.219999999999999 111.121 179.971 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.891 0.377 . . . . 74.230000000000004 110.903 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.789 HG13 ' CH2' ' A' ' 46' ' ' TRP . 86.0 t -115.93 127.58 73.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 75.019999999999996 111.095 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.707 HG23 ' HB3' ' A' ' 40' ' ' LYS . 7.8 tt -125.03 110.81 25.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 63.340000000000003 111.134 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.1 t -123.02 143.84 34.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 71.349999999999994 111.113 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -105.12 138.47 41.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 73.150000000000006 110.909 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -94.7 43.34 1.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.085 -0.507 . . . . 75.540000000000006 110.852 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 173.0 -170.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 71.439999999999998 110.852 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.635 HG22 HD12 ' A' ' 36' ' ' ILE . 6.3 t -64.15 159.71 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 72.120000000000005 111.112 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.436 ' N ' HG12 ' A' ' 12' ' ' VAL . 55.5 t30 -86.1 53.9 2.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 73.530000000000001 110.869 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.441 ' CG ' ' O ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.05 28.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 44.219999999999999 110.882 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.35 51.69 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.758 -0.734 . . . . 55.530000000000001 112.484 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.07 171.38 24.57 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.715 -0.755 . . . . 35.130000000000003 112.501 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.54 133.92 35.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.806 0.336 . . . . 54.240000000000002 110.903 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.76 155.08 33.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 72.319999999999993 110.885 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -148.45 117.56 6.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 74.099999999999994 110.936 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 73.549999999999997 110.908 179.978 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.754 0.311 . . . . 74.120000000000005 110.915 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.635 HD12 HG22 ' A' ' 12' ' ' VAL . 1.1 pt -153.41 107.93 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 73.120000000000005 111.143 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 63.7 p -149.86 -172.3 4.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 75.430000000000007 110.892 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.553 ' C ' HD12 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -135.22 149.53 49.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 74.010000000000005 110.859 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.553 HD12 ' C ' ' A' ' 38' ' ' SER . 1.9 mp -120.83 109.89 26.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 74.219999999999999 111.171 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.707 ' HB3' HG23 ' A' ' 7' ' ' ILE . 4.9 tttt -95.04 127.69 41.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 73.430000000000007 110.919 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.445 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 7.1 p -139.68 139.03 38.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 62.43 111.107 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.93 40.55 1.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 64.150000000000006 110.911 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.3 p -179.4 137.67 0.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 65.019999999999996 110.861 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.22 -155.3 4.75 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.753 -0.737 . . . . 70.239999999999995 112.474 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.471 HG22 ' HA2' ' A' ' 62' ' ' GLY . 67.3 p -150.03 150.13 31.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.806 0.336 . . . . 71.140000000000001 111.134 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.789 ' CH2' HG13 ' A' ' 6' ' ' VAL . 2.6 m0 -123.37 169.62 11.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 74.430000000000007 110.923 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -121.5 128.51 52.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 74.340000000000003 110.847 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -114.33 128.53 56.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 71.049999999999997 110.884 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.2 126.47 19.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.136 -0.484 . . . . 73.030000000000001 110.914 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -101.46 89.21 3.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 75.329999999999998 110.855 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.425 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.1 OUTLIER 171.66 -165.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 72.540000000000006 110.926 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -52.01 173.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 64.349999999999994 111.157 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -85.52 49.81 1.83 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 75.109999999999999 110.922 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 22.3 p90 176.86 41.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 63.420000000000002 110.905 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.12 -154.21 24.62 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.718 -0.753 . . . . 51.130000000000003 112.444 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.425 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 94.73 -177.06 35.48 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.767 -0.73 . . . . 74.150000000000006 112.483 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.29 110.8 9.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.826 0.346 . . . . 71.329999999999998 110.893 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -78.03 109.7 12.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 62.100000000000001 110.934 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -138.3 106.26 5.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.11 -0.495 . . . . 74.430000000000007 110.952 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.0 p30 -94.57 153.76 17.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 74.209999999999994 110.817 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.758 HD11 ' CE3' ' A' ' 46' ' ' TRP . 1.3 pt? -117.11 136.08 53.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 61.5 110.931 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.471 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -102.81 -162.68 25.91 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 61.329999999999998 112.484 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.27 105.39 0.29 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.685 2.257 . . . . 54.130000000000003 112.342 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.95 151.92 6.07 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.756 -0.735 . . . . 70.349999999999994 112.509 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.9 144.97 32.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.855 0.36 . . . . 71.109999999999999 110.869 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -124.35 157.28 35.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.095 -0.502 . . . . 60.109999999999999 110.896 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.1 t -160.05 68.31 0.38 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 61.539999999999999 110.866 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.609 ' CB ' ' HB2' ' A' ' 72' ' ' ALA . 0.4 OUTLIER -85.98 146.68 26.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 55.520000000000003 110.89 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.543 ' HB ' HG22 ' A' ' 36' ' ' ILE . 33.9 m -150.58 18.81 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 75.230000000000004 111.141 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -179.05 34.19 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 75.219999999999999 110.888 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 37.8 t -160.9 -40.64 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 74.319999999999993 110.867 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.609 ' HB2' ' CB ' ' A' ' 68' ' ' SER . . . -51.38 -44.18 62.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 61.549999999999997 111.131 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.751 ' O ' HD13 ' A' ' 74' ' ' ILE . . . 166.73 95.0 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.722 -0.752 . . . . 72.310000000000002 112.472 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.751 HD13 ' O ' ' A' ' 73' ' ' GLY . 4.9 mm -129.5 67.14 78.53 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.65 0.738 . . . . 62.25 111.124 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -80.83 -60.79 0.03 OUTLIER 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.667 2.245 . . . . 52.329999999999998 112.362 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 179.23 -33.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 75.349999999999994 110.81 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -141.17 -177.82 5.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 63.530000000000001 110.917 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.1 t -58.54 -96.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 62.43 110.889 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 mp 47.94 54.26 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 74.340000000000003 111.121 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.6 p -155.03 163.0 40.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 75.400000000000006 110.816 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.94 159.82 16.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.074 -0.512 . . . . 63.310000000000002 110.878 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -150.14 135.71 18.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 74.150000000000006 110.847 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -93.21 133.38 36.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 74.140000000000001 110.919 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -105.84 131.43 53.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 72.540000000000006 110.967 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.3 pt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 60.310000000000002 111.141 179.993 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.875 0.369 . . . . 54.409999999999997 110.897 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.769 HG22 ' CZ2' ' A' ' 46' ' ' TRP . 94.3 t -113.11 105.59 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 73.120000000000005 111.109 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.669 HD13 ' HB3' ' A' ' 20' ' ' ASP . 3.5 tp -117.07 110.3 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 72.239999999999995 111.12 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.2 m -133.15 159.29 43.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 44.509999999999998 111.116 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -112.18 142.3 44.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.127 -0.488 . . . . 74.340000000000003 110.92 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -95.35 31.85 1.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 73.319999999999993 110.924 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 175.52 -169.68 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 74.340000000000003 110.855 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.446 HG12 ' N ' ' A' ' 13' ' ' ASN . 7.9 t -62.75 159.9 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 62.549999999999997 111.149 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.446 ' N ' HG12 ' A' ' 12' ' ' VAL . 4.9 t-20 -84.51 54.07 2.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 74.519999999999996 110.907 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.436 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.66 28.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 74.319999999999993 110.88 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.12 47.61 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.689 -0.767 . . . . 62.009999999999998 112.486 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.8 171.48 24.06 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.709 -0.757 . . . . 75.450000000000003 112.501 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.3 tmmt? -91.01 122.83 34.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.803 0.335 . . . . 75.310000000000002 110.862 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.97 148.54 43.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 74.439999999999998 110.827 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -148.77 139.73 22.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 74.219999999999999 110.894 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.669 ' HB3' HD13 ' A' ' 7' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 60.25 110.873 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.724 0.297 . . . . 74.129999999999995 110.932 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.436 HG22 ' HB ' ' A' ' 69' ' ' VAL . 1.2 pt -153.49 104.13 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 74.349999999999994 111.121 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.9 p -157.16 -166.53 2.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 64.510000000000005 110.819 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.685 ' O ' HD12 ' A' ' 39' ' ' ILE . 21.2 t -127.14 154.46 44.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 71.109999999999999 110.828 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.685 HD12 ' O ' ' A' ' 38' ' ' SER . 1.5 mp -125.52 139.01 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 72.310000000000002 111.128 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.641 ' HB3' HG23 ' A' ' 7' ' ' ILE . 7.9 tttt -145.35 147.83 32.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 74.200000000000003 110.875 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 43' ' ' SER . 11.2 p -161.52 138.82 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 71.439999999999998 111.115 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -134.58 40.92 2.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 65.019999999999996 110.898 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.429 ' H ' HG22 ' A' ' 41' ' ' VAL . 1.8 t -179.62 119.4 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 73.0 110.89 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.08 -163.45 50.82 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.757 -0.735 . . . . 52.210000000000001 112.522 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.65 HG22 ' HA2' ' A' ' 62' ' ' GLY . 41.5 p -149.83 147.7 28.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.796 0.331 . . . . 64.340000000000003 111.166 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.769 ' CZ2' HG22 ' A' ' 6' ' ' VAL . 1.3 m0 -117.37 171.94 7.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 75.219999999999999 110.946 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -112.98 124.26 52.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 64.430000000000007 110.87 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -113.73 125.87 54.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 74.230000000000004 110.925 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.48 126.9 23.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 72.340000000000003 110.91 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -102.09 89.75 3.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 73.129999999999995 110.896 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.501 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.1 OUTLIER 170.72 -166.87 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.161 -0.472 . . . . 75.200000000000003 110.917 -179.873 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.404 ' HB ' ' CE1' ' A' ' 54' ' ' TYR . 1.0 OUTLIER -51.98 172.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 70.409999999999997 111.102 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -86.06 50.08 1.91 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 52.149999999999999 110.897 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.404 ' CE1' ' HB ' ' A' ' 52' ' ' ILE . 2.1 p90 174.88 45.12 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.474 . . . . 62.420000000000002 110.905 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.22 -150.14 18.08 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.724 -0.75 . . . . 54.43 112.465 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.501 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 87.37 -171.51 42.06 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.689 -0.767 . . . . 71.030000000000001 112.497 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.47 112.39 17.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.817 0.342 . . . . 73.120000000000005 110.886 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -79.23 101.04 7.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 74.219999999999999 110.943 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -133.86 107.54 7.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.119 -0.491 . . . . 71.310000000000002 110.914 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -83.85 154.21 23.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 74.340000000000003 110.849 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.549 HD12 ' H ' ' A' ' 62' ' ' GLY . 14.8 tp -99.34 148.34 24.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 44.520000000000003 110.934 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.65 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -129.55 -165.16 11.61 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.723 -0.751 . . . . 61.100000000000001 112.489 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.26 89.73 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.667 2.245 . . . . 64.140000000000001 112.339 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.32 171.18 40.57 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.761 -0.733 . . . . 74.209999999999994 112.513 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.8 143.83 50.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.833 0.349 . . . . 71.340000000000003 110.898 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -152.55 149.03 28.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 74.310000000000002 110.951 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.2 p -130.33 82.44 2.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 41.439999999999998 110.845 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.601 ' HB2' ' HB2' ' A' ' 72' ' ' ALA . 40.4 m -86.66 147.07 26.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 63.140000000000001 110.819 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HB ' HG22 ' A' ' 36' ' ' ILE . 34.7 m -150.69 19.04 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.074 -0.512 . . . . 74.409999999999997 111.164 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -179.46 34.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 73.219999999999999 110.905 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.1 t -160.74 -40.84 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 73.219999999999999 110.851 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.601 ' HB2' ' HB2' ' A' ' 68' ' ' SER . . . -52.3 -54.25 33.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 73.120000000000005 111.111 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.459 ' O ' HD13 ' A' ' 74' ' ' ILE . . . 178.37 85.74 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.815 -0.707 . . . . 75.439999999999998 112.481 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.459 HD13 ' O ' ' A' ' 73' ' ' GLY . 13.9 mm -123.89 67.55 42.17 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.64 0.733 . . . . 72.109999999999999 111.132 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -74.35 -53.86 0.1 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.689 2.259 . . . . 75.010000000000005 112.377 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.3 t70 179.44 -74.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 51.340000000000003 110.855 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -93.04 -169.85 2.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 62.210000000000001 110.918 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.92 114.49 26.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 74.049999999999997 110.882 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -152.64 69.52 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 74.439999999999998 111.12 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.7 p -158.76 161.63 37.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 75.019999999999996 110.851 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.74 163.24 18.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 72.409999999999997 110.834 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -151.16 136.31 17.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 62.119999999999997 110.86 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -88.53 120.21 29.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 74.349999999999994 110.883 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -79.18 102.03 8.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 72.310000000000002 110.896 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 pt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 75.310000000000002 111.101 179.953 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.892 0.377 . . . . 63.340000000000003 110.882 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.73 HG13 ' CH2' ' A' ' 46' ' ' TRP . 96.7 t -115.89 136.37 52.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 71.519999999999996 111.099 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.76 HG23 ' HB3' ' A' ' 40' ' ' LYS . 8.3 tt -131.35 110.66 17.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 74.230000000000004 111.145 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.4 t -127.09 143.13 41.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 73.430000000000007 111.132 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -97.1 140.36 31.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 73.219999999999999 110.925 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -99.24 35.6 1.89 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 61.329999999999998 110.914 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 175.18 -169.73 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 72.340000000000003 110.871 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 13' ' ' ASN . 6.5 t -63.64 159.52 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 61.310000000000002 111.112 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.441 ' N ' HG12 ' A' ' 12' ' ' VAL . 39.5 p30 -85.78 54.19 3.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 62.020000000000003 110.902 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.441 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.1 28.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 75.329999999999998 110.881 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.22 50.28 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.726 -0.749 . . . . 65.129999999999995 112.505 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.1 171.51 24.53 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.761 -0.733 . . . . 64.340000000000003 112.529 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.21 126.06 42.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.764 0.316 . . . . 72.530000000000001 110.906 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.7 p -118.29 156.5 28.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.27 -0.423 . . . . 72.299999999999997 110.824 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -111.03 107.97 17.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 73.420000000000002 110.877 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.6 t70 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 72.230000000000004 110.884 179.96 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.429 ' O ' HG23 ' A' ' 36' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.728 0.299 . . . . 71.209999999999994 110.921 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.71 ' HB ' HG12 ' A' ' 69' ' ' VAL . 4.6 pt -155.23 128.92 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 61.350000000000001 111.103 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 84.8 p -167.34 -168.19 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 74.109999999999999 110.897 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.483 ' O ' HD12 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -125.13 152.72 44.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 75.129999999999995 110.871 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.483 HD12 ' O ' ' A' ' 38' ' ' SER . 1.3 mp -120.91 132.64 69.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 73.150000000000006 111.114 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.76 ' HB3' HG23 ' A' ' 7' ' ' ILE . 2.9 tttt -130.6 131.94 45.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 73.430000000000007 110.899 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.614 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 4.9 p -136.45 139.24 45.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 71.140000000000001 111.098 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.6 mmpp? -143.62 45.98 1.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 71.25 110.864 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.44 124.42 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 71.549999999999997 110.831 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.01 -150.0 8.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.748 -0.739 . . . . 61.299999999999997 112.487 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.6 p -147.57 144.74 28.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.797 0.332 . . . . 70.329999999999998 111.09 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.73 ' CH2' HG13 ' A' ' 6' ' ' VAL . 2.0 m0 -115.87 173.07 6.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 73.129999999999995 110.915 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -119.11 120.76 38.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.425 . . . . 71.409999999999997 110.84 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -109.63 125.73 52.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 60.039999999999999 110.838 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.83 143.91 37.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.074 -0.512 . . . . 74.239999999999995 110.879 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -107.93 88.5 2.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.077 -0.51 . . . . 45.109999999999999 110.918 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.414 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 171.78 -166.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 65.340000000000003 110.933 -179.829 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.609 HG22 ' H ' ' A' ' 53' ' ' ASN . 3.3 mm -78.79 171.52 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 73.040000000000006 111.091 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.609 ' H ' HG22 ' A' ' 52' ' ' ILE . 4.6 t-20 -74.66 57.83 0.77 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 64.140000000000001 110.878 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -151.01 -34.95 0.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 73.340000000000003 110.907 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -158.74 -141.91 3.26 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.731 -0.747 . . . . 50.25 112.489 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.414 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 106.53 -179.97 22.88 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.709 -0.757 . . . . 53.450000000000003 112.461 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.69 105.9 6.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.813 0.339 . . . . 65.209999999999994 110.89 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -76.73 106.99 8.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 63.119999999999997 110.913 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -138.29 106.98 5.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.113 -0.494 . . . . 74.519999999999996 110.897 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -90.32 141.35 28.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 74.319999999999993 110.881 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.561 HD21 ' CE3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -99.32 153.41 18.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 74.310000000000002 110.907 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -132.44 -168.4 12.01 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.729 -0.748 . . . . 52.530000000000001 112.487 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -46.48 101.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.645 2.23 . . . . 74.150000000000006 112.354 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.43 163.76 12.68 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.746 . . . . 70.409999999999997 112.516 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -127.52 138.43 52.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.91 0.386 . . . . 71.310000000000002 110.847 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -135.92 151.95 50.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 73.120000000000005 110.891 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 97.4 p -133.45 81.8 1.95 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 71.239999999999995 110.857 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.6 m -85.97 160.98 19.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 73.420000000000002 110.836 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.71 HG12 ' HB ' ' A' ' 36' ' ' ILE . 6.2 m -152.9 20.45 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 65.239999999999995 111.171 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -178.07 53.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 73.209999999999994 110.935 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.65 -35.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 74.310000000000002 110.851 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.97 -64.29 0.86 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 65.319999999999993 111.113 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 179.08 83.55 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.761 -0.733 . . . . 75.439999999999998 112.498 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.59 67.49 24.34 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.604 0.716 . . . . 73.409999999999997 111.171 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -80.3 -50.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.631 2.221 . . . . 74.319999999999993 112.342 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -179.56 -36.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 70.040000000000006 110.888 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -179.36 55.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 61.240000000000002 110.864 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.5 t -97.34 166.55 11.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 72.430000000000007 110.855 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.6 mt -106.16 153.51 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 73.230000000000004 111.167 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.2 p -149.98 155.91 40.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 73.239999999999995 110.835 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.38 158.15 29.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 74.140000000000001 110.839 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -150.48 135.41 17.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 75.5 110.867 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -95.1 130.8 41.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 63.130000000000003 110.833 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.668 ' HG3' HG21 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -97.28 131.64 43.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.464 . . . . 71.439999999999998 110.894 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.9 pt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 71.409999999999997 111.121 179.985 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.93 0.395 . . . . 71.329999999999998 110.86 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.743 HG22 ' CZ2' ' A' ' 46' ' ' TRP . 98.5 t -110.32 116.03 51.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 60.109999999999999 111.169 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.728 HG23 ' HB3' ' A' ' 40' ' ' LYS . 7.9 tt -115.7 110.39 31.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 60.0 111.101 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 72.2 t -128.68 137.1 58.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 64.549999999999997 111.162 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -88.62 138.38 31.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.461 . . . . 75.439999999999998 110.949 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -96.0 47.85 1.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 61.5 110.846 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 173.29 -170.41 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 71.409999999999997 110.874 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 13' ' ' ASN . 4.9 t -64.61 161.51 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 75.400000000000006 111.092 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.461 ' N ' HG12 ' A' ' 12' ' ' VAL . 5.7 p-10 -86.76 53.66 2.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 62.219999999999999 110.896 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.438 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.52 29.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 74.230000000000004 110.883 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.94 49.72 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.754 -0.736 . . . . 41.039999999999999 112.504 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.07 171.59 24.49 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.702 -0.761 . . . . 72.329999999999998 112.445 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.06 162.94 14.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.771 0.319 . . . . 75.040000000000006 110.903 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.0 p -145.1 153.52 41.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 41.299999999999997 110.879 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -142.27 119.82 11.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 72.450000000000003 110.887 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 p30 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 64.430000000000007 110.802 -179.963 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.763 0.316 . . . . 65.209999999999994 110.931 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 69' ' ' VAL . 1.1 pt -153.36 103.91 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 73.439999999999998 111.136 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 78.7 p -167.74 -166.78 0.78 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 65.329999999999998 110.861 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.579 ' C ' HD12 ' A' ' 39' ' ' ILE . 0.7 OUTLIER -111.69 148.46 33.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 73.439999999999998 110.869 -179.826 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.579 HD12 ' C ' ' A' ' 38' ' ' SER . 1.6 mp -120.85 127.77 75.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 52.140000000000001 111.164 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.728 ' HB3' HG23 ' A' ' 7' ' ' ILE . 1.0 OUTLIER -126.82 133.18 50.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 75.019999999999996 110.924 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.541 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 8.4 p -143.55 139.02 26.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 74.109999999999999 111.167 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.6 mmpp? -142.77 40.27 1.53 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 74.010000000000005 110.879 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.49 135.04 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 73.510000000000005 110.89 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.14 -159.49 2.78 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.777 -0.725 . . . . 72.030000000000001 112.465 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.1 p -145.43 151.3 38.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.799 0.333 . . . . 54.350000000000001 111.133 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.743 ' CZ2' HG22 ' A' ' 6' ' ' VAL . 2.0 m0 -124.2 175.36 7.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 64.219999999999999 110.898 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.578 ' HD2' HD11 ' A' ' 85' ' ' ILE . 1.7 mpt_? -121.48 120.54 35.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 74.530000000000001 110.904 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -107.28 126.23 52.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 75.019999999999996 110.857 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.83 142.99 36.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 73.120000000000005 110.915 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.03 88.36 2.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 44.340000000000003 110.883 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.433 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 172.01 -169.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 75.400000000000006 110.921 -179.831 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 30.1 pt -69.82 172.62 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.106 -0.497 . . . . 54.399999999999999 111.127 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -78.05 56.37 1.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 72.319999999999993 110.889 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -150.93 -40.56 0.12 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.475 . . . . 73.219999999999999 110.927 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.43 -143.89 3.88 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.704 -0.76 . . . . 61.219999999999999 112.476 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.433 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 108.11 176.18 22.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.781 -0.723 . . . . 52.450000000000003 112.506 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.03 104.78 3.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.785 0.326 . . . . 71.200000000000003 110.826 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -76.54 107.49 8.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 75.099999999999994 110.888 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -138.13 106.3 5.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 70.239999999999995 110.958 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -88.83 140.52 29.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.261 -0.427 . . . . 61.119999999999997 110.843 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.542 HD21 ' CE3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -99.3 156.82 16.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 64.310000000000002 110.934 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -131.54 -173.17 13.27 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.699 -0.762 . . . . 54.310000000000002 112.509 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -46.21 101.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.691 2.261 . . . . 71.409999999999997 112.307 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 158.74 157.39 8.47 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.713 -0.756 . . . . 62.420000000000002 112.457 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -117.68 148.24 42.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.83 0.348 . . . . 71.540000000000006 110.909 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -160.28 160.06 32.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.161 -0.472 . . . . 61.409999999999997 110.925 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.2 p -115.22 80.27 1.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.092 -0.504 . . . . 63.340000000000003 110.871 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.817 ' HB2' ' HB2' ' A' ' 72' ' ' ALA . 14.7 m -86.26 84.69 7.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 73.049999999999997 110.881 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.493 ' O ' HG22 ' A' ' 36' ' ' ILE . 12.2 m -89.89 -6.3 10.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.492 . . . . 55.219999999999999 111.156 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -162.62 62.53 0.21 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.487 . . . . 64.109999999999999 110.902 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.68 -34.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 53.310000000000002 110.877 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.817 ' HB2' ' HB2' ' A' ' 68' ' ' SER . . . -50.82 -47.85 59.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 62.32 111.107 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.643 ' H ' HD13 ' A' ' 74' ' ' ILE . . . -178.25 40.4 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.668 -0.777 . . . . 71.519999999999996 112.424 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.643 HD13 ' H ' ' A' ' 73' ' ' GLY . 0.0 OUTLIER -133.48 67.66 76.02 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.625 0.726 . . . . 72.329999999999998 111.156 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -81.77 -70.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.682 2.255 . . . . 74.109999999999999 112.329 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.473 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 1.9 t0 -94.17 -0.47 55.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 74.439999999999998 110.901 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 76' ' ' ASP . 5.6 m-20 81.07 89.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 73.340000000000003 110.844 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.9 m -146.04 -169.93 3.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 72.299999999999997 110.866 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.1 mt -76.23 153.31 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 65.329999999999998 111.162 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.6 t -149.05 157.42 43.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 73.129999999999995 110.872 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.37 159.54 25.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 43.039999999999999 110.89 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -150.83 136.12 17.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 60.409999999999997 110.887 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -87.44 121.62 30.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 73.349999999999994 110.926 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -79.7 93.41 5.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 75.439999999999998 110.96 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.578 HD11 ' HD2' ' A' ' 47' ' ' ARG . 1.8 pt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.438 . . . . 75.209999999999994 111.159 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.876 0.37 . . . . 71.439999999999998 110.884 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.4 m -116.28 138.15 47.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 73.299999999999997 111.1 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.815 HG23 ' HB3' ' A' ' 40' ' ' LYS . 3.6 tp -101.18 110.05 27.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 72.530000000000001 111.141 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.6 t -129.89 140.83 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 42.310000000000002 111.133 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -93.43 138.83 31.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 73.319999999999993 110.94 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -93.47 42.39 1.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 73.329999999999998 110.842 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 175.13 -169.5 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 73.030000000000001 110.842 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 13' ' ' ASN . 5.8 t -64.1 160.61 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 75.040000000000006 111.122 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.442 ' N ' HG12 ' A' ' 12' ' ' VAL . 14.1 t30 -86.44 53.89 2.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 61.229999999999997 110.871 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.444 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.23 28.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 64.109999999999999 110.903 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.0 50.34 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.764 -0.731 . . . . 71.049999999999997 112.516 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.15 171.71 23.79 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.772 -0.728 . . . . 53.43 112.54 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.51 149.84 23.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.822 0.344 . . . . 72.549999999999997 110.848 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -131.32 141.62 49.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 62.509999999999998 110.895 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -136.44 152.3 50.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 74.430000000000007 110.861 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 p30 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 71.549999999999997 110.856 179.987 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.777 0.323 . . . . 75.200000000000003 110.879 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.434 ' HB ' HG12 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -147.43 124.12 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 74.129999999999995 111.124 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.6 p -167.48 -168.34 1.02 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 54.219999999999999 110.844 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.515 ' C ' HD12 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -127.44 158.14 38.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 45.310000000000002 110.844 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.515 HD12 ' C ' ' A' ' 38' ' ' SER . 2.5 mp -120.92 140.07 46.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 54.0 111.154 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.815 ' HB3' HG23 ' A' ' 7' ' ' ILE . 15.1 tttt -130.05 119.53 23.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 64.340000000000003 110.83 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.647 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 4.9 p -114.12 139.28 40.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 65.239999999999995 111.104 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.86 39.69 1.82 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 73.219999999999999 110.928 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.2 114.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 64.019999999999996 110.871 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 60.65 -143.06 48.19 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.733 -0.746 . . . . 65.230000000000004 112.51 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.475 HG22 ' HA2' ' A' ' 62' ' ' GLY . 67.9 p -150.1 154.79 38.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.793 0.33 . . . . 55.530000000000001 111.14 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.647 ' CZ2' HG23 ' A' ' 41' ' ' VAL . 1.7 m0 -124.31 176.95 6.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.432 . . . . 74.329999999999998 110.908 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -126.49 130.8 51.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 74.540000000000006 110.84 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -115.33 126.34 54.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 75.329999999999998 110.897 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.9 126.78 20.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 73.120000000000005 110.948 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -102.89 89.56 3.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 71.430000000000007 110.902 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.472 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.1 OUTLIER 171.44 -166.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.191 -0.459 . . . . 63.420000000000002 110.959 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.401 HG13 ' H ' ' A' ' 52' ' ' ILE . 1.0 OUTLIER -52.19 173.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 55.439999999999998 111.112 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -86.32 50.15 1.93 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 74.430000000000007 110.914 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 22.3 p90 176.89 41.14 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.471 . . . . 75.439999999999998 110.946 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 165.1 -155.97 27.68 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.722 -0.752 . . . . 25.440000000000001 112.47 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.472 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 96.13 -171.33 28.26 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.724 -0.75 . . . . 74.129999999999995 112.469 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -80.93 108.68 14.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.869 0.366 . . . . 72.239999999999995 110.878 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -78.19 109.31 12.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 73.439999999999998 110.911 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -138.18 108.1 6.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 73.349999999999994 110.89 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -94.93 152.87 17.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 73.430000000000007 110.884 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.641 HD11 ' CE3' ' A' ' 46' ' ' TRP . 1.5 pt? -116.09 138.48 51.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 75.5 110.934 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.475 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -111.21 -170.14 19.05 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.729 -0.748 . . . . 43.420000000000002 112.461 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -46.99 99.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.628 2.219 . . . . 65.040000000000006 112.357 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.46 169.09 19.49 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.742 . . . . 72.510000000000005 112.544 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -99.5 146.22 26.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 62.210000000000001 110.875 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -130.38 151.57 50.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 73.439999999999998 110.883 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.5 t -119.11 93.23 4.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.087 -0.506 . . . . 55.25 110.846 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.814 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 0.7 OUTLIER -84.95 94.61 8.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.091 -0.504 . . . . 75.129999999999995 110.813 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.434 HG12 ' HB ' ' A' ' 36' ' ' ILE . 35.8 m -150.6 32.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.492 . . . . 71.150000000000006 111.119 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.449 ' HA ' HD11 ' A' ' 74' ' ' ILE . 1.1 pt-20 -171.41 30.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.463 . . . . 72.099999999999994 110.904 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.47 -67.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 71.310000000000002 110.881 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.814 ' HB3' ' HB3' ' A' ' 68' ' ' SER . . . -74.51 -34.85 63.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 72.450000000000003 111.107 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -65.8 -48.0 70.71 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.726 -0.749 . . . . 74.420000000000002 112.448 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.449 HD11 ' HA ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -113.88 74.17 2.49 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.604 0.716 . . . . 73.420000000000002 111.148 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.18 -49.06 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.681 2.254 . . . . 75.329999999999998 112.38 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -175.26 -62.5 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 73.420000000000002 110.859 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -142.09 -95.68 0.13 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 73.430000000000007 110.885 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.85 52.05 1.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 62.409999999999997 110.885 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.69 85.77 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.087 -0.506 . . . . 63.009999999999998 111.14 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 79.2 p -163.19 154.07 16.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.459 . . . . 73.109999999999999 110.868 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.53 160.76 18.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 72.239999999999995 110.832 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -150.16 135.77 18.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 75.310000000000002 110.89 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.436 ' NH1' HD13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -91.1 120.37 32.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 75.409999999999997 110.879 -179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -86.83 98.82 11.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 65.129999999999995 110.927 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.436 HD13 ' NH1' ' A' ' 83' ' ' ARG . 1.1 pt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 75.109999999999999 111.119 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.817 0.342 . . . . 72.420000000000002 110.897 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.8 m -117.16 138.51 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 75.349999999999994 111.114 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.764 HG23 ' HB3' ' A' ' 40' ' ' LYS . 6.8 tt -99.49 110.38 26.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 73.450000000000003 111.121 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 m -122.89 159.73 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 64.010000000000005 111.134 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -111.66 139.94 46.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.162 -0.472 . . . . 71.530000000000001 110.914 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -100.1 28.51 4.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 61.409999999999997 110.895 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 175.87 -169.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 64.310000000000002 110.836 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 13' ' ' ASN . 10.8 t -62.98 157.37 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 54.450000000000003 111.094 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.415 ' N ' HG12 ' A' ' 12' ' ' VAL . 17.8 p30 -83.22 54.88 2.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 72.25 110.905 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.443 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -177.34 27.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 75.200000000000003 110.886 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.24 45.63 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.76 -0.733 . . . . 65.120000000000005 112.493 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.27 173.68 23.67 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.778 -0.725 . . . . 64.310000000000002 112.512 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.62 146.17 26.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.821 0.343 . . . . 51.119999999999997 110.866 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.0 p -117.15 162.89 17.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 70.319999999999993 110.834 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -118.55 135.81 54.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 74.030000000000001 110.901 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.4 p30 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 73.129999999999995 110.876 179.956 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.777 0.322 . . . . 73.420000000000002 110.862 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.408 ' CB ' HG23 ' A' ' 69' ' ' VAL . 3.9 tt -174.14 102.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 72.019999999999996 111.143 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.4 p -169.21 -167.53 0.73 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 74.120000000000005 110.845 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.565 ' C ' HD12 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -127.36 152.0 48.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.102 -0.499 . . . . 55.509999999999998 110.835 -179.815 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.565 HD12 ' C ' ' A' ' 38' ' ' SER . 1.6 mp -120.99 137.93 53.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 75.519999999999996 111.153 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.764 ' HB3' HG23 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -137.35 119.69 15.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.467 . . . . 65.319999999999993 110.909 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.59 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 4.1 p -109.11 139.08 33.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 54.219999999999999 111.168 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.05 39.55 2.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 71.019999999999996 110.859 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.64 110.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.435 . . . . 55.219999999999999 110.859 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 56.99 -142.13 42.32 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.689 -0.767 . . . . 74.430000000000007 112.47 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.765 HG22 ' HA2' ' A' ' 62' ' ' GLY . 49.5 p -144.86 160.21 41.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.764 0.316 . . . . 54.409999999999997 111.14 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.712 ' CE3' HD11 ' A' ' 61' ' ' LEU . 1.7 m0 -123.22 -179.99 4.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 75.140000000000001 110.866 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.26 115.84 16.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 74.030000000000001 110.899 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -100.68 127.89 46.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 75.319999999999993 110.896 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.14 126.28 19.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 71.010000000000005 110.93 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -103.05 89.62 3.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 70.430000000000007 110.85 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.445 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 173.81 -171.82 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 72.209999999999994 110.904 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.6 tp -57.6 160.64 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 73.329999999999998 111.123 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -74.95 55.5 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 75.349999999999994 110.88 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -153.93 -38.27 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 74.140000000000001 110.892 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -146.61 -140.4 3.44 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 74.129999999999995 112.491 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.445 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 106.93 -175.33 20.61 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.764 -0.731 . . . . 62.439999999999998 112.51 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.7 106.48 7.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 71.510000000000005 110.873 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -79.52 109.23 13.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 73.219999999999999 110.937 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -138.07 108.32 6.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.084 -0.507 . . . . 72.219999999999999 110.951 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.66 157.37 16.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.286 -0.415 . . . . 71.299999999999997 110.87 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.712 HD11 ' CE3' ' A' ' 46' ' ' TRP . 1.6 pt? -121.36 153.98 37.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 74.200000000000003 110.916 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.765 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -121.12 179.32 16.32 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.751 -0.737 . . . . 62.210000000000001 112.496 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -43.97 104.82 0.06 OUTLIER 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.674 2.249 . . . . 72.540000000000006 112.35 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.52 162.59 11.43 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.731 -0.747 . . . . 72.519999999999996 112.488 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -81.11 174.0 12.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.843 0.354 . . . . 72.439999999999998 110.894 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -160.89 99.65 1.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 74.239999999999995 110.895 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.1 p -97.46 65.65 1.95 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.08 -0.509 . . . . 62.310000000000002 110.865 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.6 p -86.93 152.19 22.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 65.219999999999999 110.859 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.429 ' O ' HG22 ' A' ' 69' ' ' VAL . 6.1 p -163.61 23.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.113 -0.494 . . . . 62.229999999999997 111.114 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 177.25 35.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 50.329999999999998 110.908 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.95 -40.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 62.310000000000002 110.863 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.29 -50.1 70.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.1 -0.5 . . . . 75.409999999999997 111.091 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.443 ' C ' ' HD3' ' A' ' 75' ' ' PRO . . . 165.95 101.26 0.15 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 44.329999999999998 112.492 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.1 mm -113.29 74.83 2.11 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.604 0.716 . . . . 64.519999999999996 111.144 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.443 ' HD3' ' C ' ' A' ' 73' ' ' GLY . 70.1 Cg_endo -79.48 -165.62 0.35 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.665 2.243 . . . . 63.420000000000002 112.311 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -145.23 40.58 1.23 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.436 . . . . 72.209999999999994 110.853 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -175.9 -171.63 0.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 64.230000000000004 110.866 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 61.8 p -97.24 81.55 3.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 70.040000000000006 110.863 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -152.07 66.98 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 71.420000000000002 111.122 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 91.5 p -166.28 145.66 5.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 72.420000000000002 110.848 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -163.93 165.62 22.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 74.430000000000007 110.804 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -150.6 143.03 24.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 61.509999999999998 110.871 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -79.91 171.98 14.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 75.329999999999998 110.87 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -148.04 105.94 3.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 65.349999999999994 110.907 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.6 pt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 74.150000000000006 111.147 179.947 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.901 0.381 . . . . 75.349999999999994 110.853 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.791 HG13 ' CH2' ' A' ' 46' ' ' TRP . 61.1 t -112.06 119.8 60.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 72.510000000000005 111.135 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.762 HG23 ' HB3' ' A' ' 40' ' ' LYS . 7.9 tt -123.76 110.19 25.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 51.530000000000001 111.111 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.0 m -126.82 142.25 43.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 75.319999999999993 111.102 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -92.26 141.6 28.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.177 -0.465 . . . . 71.109999999999999 110.923 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -96.42 44.37 1.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 74.230000000000004 110.91 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 172.95 -170.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 70.099999999999994 110.829 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 13' ' ' ASN . 5.1 t -64.47 161.27 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 73.5 111.129 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.46 ' N ' HG12 ' A' ' 12' ' ' VAL . 8.4 p-10 -86.75 53.74 2.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 60.420000000000002 110.919 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.445 ' CG ' ' O ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.41 28.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 74.099999999999994 110.879 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.88 47.11 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.762 -0.732 . . . . 54.329999999999998 112.492 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.08 171.61 24.48 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.711 -0.757 . . . . 63.420000000000002 112.506 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 ptpt -92.64 164.11 13.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.794 0.33 . . . . 72.120000000000005 110.91 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.0 p -138.98 160.33 40.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 55.340000000000003 110.833 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -121.1 110.11 15.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 72.200000000000003 110.86 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 61.340000000000003 110.838 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.749 0.309 . . . . 64.319999999999993 110.884 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.495 ' HA ' HG12 ' A' ' 69' ' ' VAL . 1.1 pt -152.46 118.08 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 74.409999999999997 111.091 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.8 p -167.54 -164.46 0.58 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 63.119999999999997 110.859 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.591 ' O ' HD12 ' A' ' 39' ' ' ILE . 0.7 OUTLIER -118.13 150.32 39.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 73.530000000000001 110.882 -179.836 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.591 HD12 ' O ' ' A' ' 38' ' ' SER . 1.5 mp -121.57 117.0 51.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 70.099999999999994 111.142 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.762 ' HB3' HG23 ' A' ' 7' ' ' ILE . 4.2 tttp -113.75 127.81 56.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 74.450000000000003 110.913 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.785 HG13 ' CZ2' ' A' ' 46' ' ' TRP . 6.2 t -122.33 139.31 49.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 74.109999999999999 111.134 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -151.99 39.76 0.62 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 74.140000000000001 110.893 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.5 t 179.48 115.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 71.239999999999995 110.863 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 51.74 -153.84 5.08 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.72 -0.752 . . . . 55.310000000000002 112.497 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.801 HG22 ' HA2' ' A' ' 62' ' ' GLY . 37.7 p -138.07 158.15 44.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.774 0.321 . . . . 62.210000000000001 111.113 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.791 ' CH2' HG13 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -125.12 170.84 10.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 74.109999999999999 110.942 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -115.44 126.42 54.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 73.319999999999993 110.892 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -112.14 127.15 55.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 72.140000000000001 110.88 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.26 137.41 34.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 71.209999999999994 110.937 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -112.25 87.9 2.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 60.039999999999999 110.867 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.417 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 170.45 -171.74 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.18 -0.463 . . . . 71.329999999999998 110.936 -179.862 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.4 pt -55.0 174.35 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 61.119999999999997 111.107 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -87.63 37.84 0.81 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 71.049999999999997 110.878 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -151.86 18.67 0.69 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 72.109999999999999 110.923 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.05 -154.51 23.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 50.100000000000001 112.517 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.417 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 106.9 178.93 22.81 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.746 -0.74 . . . . 61.240000000000002 112.494 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.85 103.75 6.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.35 . . . . 61.039999999999999 110.868 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -76.67 110.37 11.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 70.230000000000004 110.92 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -138.11 105.82 5.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.126 -0.488 . . . . 73.349999999999994 110.925 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -90.46 133.58 34.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 44.240000000000002 110.893 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.616 HD21 ' CE3' ' A' ' 46' ' ' TRP . 0.8 OUTLIER -99.06 165.02 11.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 72.510000000000005 110.885 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.801 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -128.7 -166.46 11.98 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.779 -0.724 . . . . 70.319999999999993 112.518 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.67 118.05 4.88 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.688 2.259 . . . . 55.210000000000001 112.313 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.96 156.31 7.76 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.797 -0.716 . . . . 61.32 112.53 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -117.99 139.17 51.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 73.409999999999997 110.892 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.597 ' OH ' HD12 ' A' ' 61' ' ' LEU . 2.9 p90 -160.2 160.12 32.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.115 -0.493 . . . . 64.530000000000001 110.896 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.5 m -112.43 81.7 1.52 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.053 -0.521 . . . . 65.420000000000002 110.844 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.2 m -84.98 149.03 25.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 65.329999999999998 110.874 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.495 HG12 ' HA ' ' A' ' 36' ' ' ILE . 6.0 m -152.99 22.55 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 62.149999999999999 111.129 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.435 ' HA ' HD11 ' A' ' 74' ' ' ILE . 0.9 OUTLIER -165.45 60.31 0.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 62.350000000000001 110.871 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.56 -33.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 73.200000000000003 110.89 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.3 -63.81 1.0 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 62.140000000000001 111.092 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.7 79.89 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 72.430000000000007 112.486 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.435 HD11 ' HA ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -140.69 67.23 29.16 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.62 0.724 . . . . 72.349999999999994 111.136 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -80.31 -35.3 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.655 2.237 . . . . 74.299999999999997 112.343 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -179.2 -34.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 63.009999999999998 110.877 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -140.67 164.83 29.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 74.019999999999996 110.864 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.557 ' O ' HD13 ' A' ' 79' ' ' ILE . 12.2 t -68.3 87.38 0.29 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 72.120000000000005 110.855 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.557 HD13 ' O ' ' A' ' 78' ' ' SER . 26.1 mm -139.03 68.51 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 71.25 111.145 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.8 p -146.83 165.17 30.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 61.340000000000003 110.837 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.6 157.73 14.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 65.510000000000005 110.849 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -150.8 136.57 18.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.126 -0.488 . . . . 64.140000000000001 110.901 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.69 120.09 32.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 63.350000000000001 110.815 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.73 ' HG2' HG11 ' A' ' 6' ' ' VAL . 4.4 mt-30 -79.4 97.67 6.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 73.540000000000006 110.936 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 pt . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 72.010000000000005 111.101 179.995 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.904 0.383 . . . . 62.109999999999999 110.86 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.798 HG11 ' HG2' ' A' ' 84' ' ' GLN . 84.2 t -109.02 120.04 59.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 75.109999999999999 111.15 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.441 HG23 ' O ' ' A' ' 7' ' ' ILE . 9.0 tt -128.84 111.54 23.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 65.310000000000002 111.107 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 m -131.21 161.56 40.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 73.319999999999993 111.12 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -114.21 148.29 37.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 64.230000000000004 110.937 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -102.24 40.68 1.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 72.420000000000002 110.897 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 172.79 -171.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 73.129999999999995 110.893 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.446 HG12 ' N ' ' A' ' 13' ' ' ASN . 6.1 t -63.97 160.15 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.429 . . . . 73.439999999999998 111.134 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.446 ' N ' HG12 ' A' ' 12' ' ' VAL . 7.7 t30 -85.79 53.96 2.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 74.129999999999995 110.903 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.419 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.25 28.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 71.530000000000001 110.878 -179.935 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.02 44.38 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.772 -0.728 . . . . 63.130000000000003 112.477 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.02 172.04 24.28 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.765 -0.731 . . . . 33.130000000000003 112.484 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.33 160.33 14.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.793 0.33 . . . . 72.25 110.87 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.1 p -136.37 164.56 27.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 73.040000000000006 110.838 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -123.14 113.91 19.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 63.030000000000001 110.871 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 74.439999999999998 110.866 179.972 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.771 0.32 . . . . 74.420000000000002 110.861 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.486 HG13 HG12 ' A' ' 69' ' ' VAL . 1.5 tt -176.77 107.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 72.530000000000001 111.151 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 83.3 p -167.88 -166.14 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 74.120000000000005 110.909 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.656 ' O ' HD12 ' A' ' 39' ' ' ILE . 0.8 OUTLIER -114.57 141.49 47.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 71.329999999999998 110.885 -179.872 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.656 HD12 ' O ' ' A' ' 38' ' ' SER . 1.6 mp -124.71 118.16 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 42.329999999999998 111.092 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -123.61 135.02 53.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 73.140000000000001 110.888 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.775 HG13 ' CZ2' ' A' ' 46' ' ' TRP . 4.7 t -129.17 139.57 51.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 72.329999999999998 111.143 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.99 39.35 1.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 70.209999999999994 110.907 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.8 t 177.84 120.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 70.310000000000002 110.851 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.14 -152.94 6.21 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.747 -0.74 . . . . 72.450000000000003 112.446 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.6 HG22 ' HA2' ' A' ' 62' ' ' GLY . 42.6 p -142.4 159.37 42.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.345 . . . . 53.530000000000001 111.139 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.775 ' CZ2' HG13 ' A' ' 41' ' ' VAL . 1.5 m0 -123.78 176.55 6.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 71.299999999999997 110.916 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -123.84 122.03 36.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 61.229999999999997 110.86 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -107.55 125.87 51.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 75.25 110.857 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.28 126.91 20.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 73.230000000000004 110.888 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -100.69 89.91 4.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 65.519999999999996 110.864 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.472 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.1 OUTLIER 170.76 -167.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 75.510000000000005 110.921 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -52.26 173.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.478 . . . . 74.420000000000002 111.15 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -86.56 50.28 1.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 65.200000000000003 110.874 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 22.2 p90 176.98 40.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 65.439999999999998 110.903 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.92 -157.71 30.26 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.747 -0.74 . . . . 63.340000000000003 112.533 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.472 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 95.42 -171.59 29.5 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.742 -0.742 . . . . 72.099999999999994 112.488 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.51 106.77 11.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.816 0.341 . . . . 72.129999999999995 110.896 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -77.72 109.47 11.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 70.129999999999995 110.883 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.9 t90 -138.04 105.38 5.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.115 -0.493 . . . . 71.540000000000006 110.892 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -89.41 135.61 33.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 64.329999999999998 110.91 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.592 HD21 ' CE3' ' A' ' 46' ' ' TRP . 0.8 OUTLIER -98.99 164.71 12.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.222 -0.445 . . . . 64.340000000000003 110.955 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.6 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -130.54 -174.92 13.82 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.745 -0.741 . . . . 62.409999999999997 112.52 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.54 117.04 3.26 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.708 2.272 . . . . 64.519999999999996 112.287 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.84 155.48 7.47 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.742 -0.742 . . . . 61.420000000000002 112.477 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -113.63 134.93 54.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 64.439999999999998 110.871 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.474 ' OH ' HD12 ' A' ' 61' ' ' LEU . 5.3 p90 -159.48 159.98 34.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 72.299999999999997 110.922 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 m -108.26 101.41 10.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 75.510000000000005 110.916 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.93 135.21 34.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 74.5 110.822 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.486 HG12 HG13 ' A' ' 36' ' ' ILE . 22.9 m -149.81 24.26 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 73.219999999999999 111.146 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.433 ' HG2' HG23 ' A' ' 69' ' ' VAL . 0.1 OUTLIER 173.21 -16.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 71.209999999999994 110.861 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.9 t -80.76 -23.95 39.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 74.010000000000005 110.827 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -83.62 -63.62 1.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 50.020000000000003 111.108 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.582 ' C ' HD13 ' A' ' 74' ' ' ILE . . . 166.95 124.14 0.7 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.74 -0.743 . . . . 64.409999999999997 112.488 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.582 HD13 ' C ' ' A' ' 73' ' ' GLY . 4.1 mm -122.33 69.8 31.96 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.625 0.726 . . . . 73.120000000000005 111.13 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -78.72 -166.34 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.702 2.268 . . . . 72.349999999999994 112.362 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.62 -29.84 27.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 73.519999999999996 110.847 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -143.65 162.62 35.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 72.340000000000003 110.863 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.59 119.19 10.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 62.32 110.844 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.2 pt -153.36 24.61 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 70.519999999999996 111.158 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.8 t -110.76 164.57 12.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 72.349999999999994 110.869 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.2 m -165.46 157.33 14.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 65.420000000000002 110.881 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -150.67 135.88 17.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 74.549999999999997 110.846 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.0 mmt85 -90.7 120.8 32.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 74.439999999999998 110.846 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.798 ' HG2' HG11 ' A' ' 6' ' ' VAL . 23.2 mt-30 -79.55 94.38 5.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 74.310000000000002 110.875 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 75.010000000000005 111.111 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.899 0.38 . . . . 63.130000000000003 110.88 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.758 HG13 ' CZ2' ' A' ' 46' ' ' TRP . 76.2 t -116.11 127.02 73.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 63.340000000000003 111.13 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.437 HG23 ' O ' ' A' ' 7' ' ' ILE . 7.8 tt -123.14 110.89 27.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 74.219999999999999 111.138 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.1 t -124.54 140.39 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 74.349999999999994 111.103 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -90.7 139.97 30.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 75.120000000000005 110.932 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.33 35.42 1.78 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 60.100000000000001 110.917 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 177.21 -169.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.127 -0.488 . . . . 71.439999999999998 110.871 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.446 HG12 ' N ' ' A' ' 13' ' ' ASN . 5.3 t -63.77 160.28 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.211 -0.449 . . . . 73.129999999999995 111.111 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.446 ' N ' HG12 ' A' ' 12' ' ' VAL . 44.8 t30 -86.31 54.26 3.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 64.540000000000006 110.897 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.441 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.24 28.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 74.409999999999997 110.928 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.86 52.46 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.744 -0.741 . . . . 33.140000000000001 112.516 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.2 171.72 24.49 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.788 -0.72 . . . . 44.030000000000001 112.518 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.62 126.48 42.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.813 0.339 . . . . 74.129999999999995 110.883 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 82.1 p -118.0 151.98 36.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 75.200000000000003 110.907 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -109.11 133.64 52.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 70.329999999999998 110.911 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 p30 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 53.310000000000002 110.862 -179.993 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.742 0.306 . . . . 73.299999999999997 110.911 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.449 ' O ' HG23 ' A' ' 36' ' ' ILE . 7.4 tt -152.29 102.0 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 75.25 111.135 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.9 p -171.81 -165.63 0.38 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 62.399999999999999 110.835 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.556 ' O ' HD12 ' A' ' 39' ' ' ILE . 31.3 t -128.91 156.03 44.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 72.450000000000003 110.879 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.556 HD12 ' O ' ' A' ' 38' ' ' SER . 1.5 mp -121.04 140.54 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 71.409999999999997 111.12 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -141.59 119.39 11.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 64.219999999999999 110.879 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.485 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 13.9 p -119.97 139.64 46.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 72.409999999999997 111.115 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.76 38.23 1.65 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 72.030000000000001 110.922 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 172.86 110.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.234 -0.439 . . . . 63.520000000000003 110.831 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.17 -158.22 39.87 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.729 -0.748 . . . . 71.019999999999996 112.491 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.9 p -150.68 127.58 11.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.74 0.305 . . . . 72.510000000000005 111.177 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.758 ' CZ2' HG13 ' A' ' 6' ' ' VAL . 0.5 OUTLIER -94.15 164.78 12.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 65.420000000000002 110.947 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -119.86 117.18 27.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.302 -0.408 . . . . 74.019999999999996 110.903 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -105.41 125.69 51.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 64.310000000000002 110.878 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -141.08 125.83 17.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 74.540000000000006 110.87 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.23 88.57 3.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 75.329999999999998 110.92 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 175.92 174.33 0.31 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.135 -0.484 . . . . 71.109999999999999 110.9 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.056 HG22 HD12 ' A' ' 79' ' ' ILE . 26.6 pt -52.39 172.88 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 75.5 111.111 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -76.75 56.47 1.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 64.439999999999998 110.902 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -149.92 -69.94 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 63.530000000000001 110.918 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.82 -135.97 5.83 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.738 -0.744 . . . . 70.019999999999996 112.523 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.7 176.61 23.11 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.806 -0.711 . . . . 72.219999999999999 112.472 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.36 103.32 8.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.848 0.356 . . . . 71.140000000000001 110.89 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -77.55 106.53 9.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 74.420000000000002 110.914 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -134.79 106.7 7.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.085 -0.507 . . . . 73.310000000000002 110.941 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -92.19 136.63 33.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 72.150000000000006 110.851 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.721 HD21 ' CE3' ' A' ' 46' ' ' TRP . 1.2 pp -100.26 140.91 33.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 71.319999999999993 110.936 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -122.45 -165.24 12.4 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.735 -0.745 . . . . 52.109999999999999 112.495 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -40.43 104.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.632 2.221 . . . . 73.150000000000006 112.354 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.88 164.35 13.16 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.788 -0.72 . . . . 64.239999999999995 112.539 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.08 148.49 50.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.898 0.38 . . . . 74.519999999999996 110.88 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -153.57 139.1 17.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 64.129999999999995 110.879 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.7 m -122.73 71.67 1.04 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 63.119999999999997 110.894 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 44.7 m -89.61 171.95 9.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 64.340000000000003 110.878 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.455 ' O ' HG13 ' A' ' 69' ' ' VAL . 4.2 p -162.4 23.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 61.119999999999997 111.107 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.424 ' HA ' HD11 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -174.88 35.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 71.230000000000004 110.87 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.9 t -157.81 -40.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 44.520000000000003 110.873 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.27 -61.74 1.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 72.349999999999994 111.135 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.02 94.44 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.718 -0.753 . . . . 74.120000000000005 112.483 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.424 HD11 ' HA ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -147.17 64.28 8.73 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.584 0.707 . . . . 61.530000000000001 111.152 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -80.86 -47.32 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.716 2.277 . . . . 53.520000000000003 112.316 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -174.0 -168.4 0.41 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 71.420000000000002 110.852 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -84.62 53.06 2.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 64.040000000000006 110.891 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.7 m -99.01 -169.63 1.8 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 72.049999999999997 110.831 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 1.056 HD12 HG22 ' A' ' 52' ' ' ILE . 4.8 mt -82.18 137.39 21.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 74.219999999999999 111.111 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.13 143.12 18.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 74.219999999999999 110.881 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.18 168.27 22.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 72.239999999999995 110.828 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -150.82 135.6 17.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 73.129999999999995 110.879 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.0 130.62 34.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 65.099999999999994 110.884 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.748 ' HG2' HG21 ' A' ' 6' ' ' VAL . 5.8 mt-30 -79.94 108.69 13.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 75.230000000000004 110.923 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.3 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 51.140000000000001 111.118 179.94 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.909 0.385 . . . . 63.409999999999997 110.908 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.73 HG13 ' CH2' ' A' ' 46' ' ' TRP . 87.5 t -116.77 128.46 74.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 73.409999999999997 111.142 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.716 HG23 ' HB3' ' A' ' 40' ' ' LYS . 8.9 tt -128.86 110.72 21.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 62.340000000000003 111.129 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 83.0 t -129.79 144.37 38.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 70.329999999999998 111.183 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -103.11 133.86 47.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 71.319999999999993 110.937 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -94.26 48.02 1.22 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.489 . . . . 75.400000000000006 110.86 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 174.26 -169.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 74.150000000000006 110.841 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.454 HG12 ' N ' ' A' ' 13' ' ' ASN . 4.8 t -64.83 161.23 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 73.109999999999999 111.13 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.454 ' N ' HG12 ' A' ' 12' ' ' VAL . 19.4 p-10 -87.93 54.11 2.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 75.319999999999993 110.87 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.432 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -176.96 28.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 62.130000000000003 110.837 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.41 50.67 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.749 -0.739 . . . . 60.450000000000003 112.477 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.08 171.62 24.48 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.707 -0.759 . . . . 54.409999999999997 112.455 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.38 163.46 14.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.767 0.318 . . . . 72.430000000000007 110.919 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.2 p -149.63 157.63 43.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 65.040000000000006 110.865 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -109.58 106.32 15.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 63.520000000000003 110.874 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.115 -0.493 . . . . 60.5 110.855 -179.993 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.779 0.323 . . . . 72.049999999999997 110.89 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.451 HG13 HG12 ' A' ' 69' ' ' VAL . 7.3 tt 179.1 102.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 75.109999999999999 111.142 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 52.2 p -168.35 -168.5 0.94 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 75.329999999999998 110.845 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.522 ' O ' HD12 ' A' ' 39' ' ' ILE . 0.6 OUTLIER -120.9 145.07 48.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.478 . . . . 74.019999999999996 110.867 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.601 HG21 HD22 ' A' ' 61' ' ' LEU . 1.4 mp -121.26 123.07 69.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 65.420000000000002 111.154 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.716 ' HB3' HG23 ' A' ' 7' ' ' ILE . 3.9 tttt -117.06 129.18 55.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 72.409999999999997 110.906 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.455 HG11 ' HG ' ' A' ' 61' ' ' LEU . 4.7 p -144.98 139.81 22.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 71.129999999999995 111.124 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.52 39.93 1.72 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 75.439999999999998 110.952 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 179.78 139.04 0.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 72.450000000000003 110.815 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 53.31 -165.35 1.88 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.77 -0.729 . . . . 71.120000000000005 112.485 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.466 HG22 ' HA2' ' A' ' 62' ' ' GLY . 68.5 p -144.98 144.71 31.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.79 0.329 . . . . 62.530000000000001 111.151 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.73 ' CH2' HG13 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -124.2 136.25 54.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.439 . . . . 64.209999999999994 110.953 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -79.96 125.56 29.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 52.009999999999998 110.857 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -113.21 124.89 53.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 75.420000000000002 110.841 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.87 126.73 20.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 74.409999999999997 110.963 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -95.4 88.8 5.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 73.319999999999993 110.874 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.443 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 172.14 -169.72 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.155 -0.475 . . . . 73.200000000000003 110.91 -179.872 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.0 pt -69.74 172.7 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.09 -0.505 . . . . 54.520000000000003 111.144 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -78.8 56.21 1.85 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 55.130000000000003 110.876 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -151.4 -40.6 0.12 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 75.439999999999998 110.868 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.51 -144.81 4.03 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.698 -0.763 . . . . 73.409999999999997 112.437 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.443 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 108.39 175.38 21.88 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.715 -0.755 . . . . 73.430000000000007 112.488 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -66.93 106.45 1.92 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.844 0.355 . . . . 74.319999999999993 110.857 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -77.96 103.17 7.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 71.310000000000002 110.92 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.0 t90 -137.6 109.28 7.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.156 -0.475 . . . . 63.240000000000002 110.949 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -84.69 144.92 28.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 73.530000000000001 110.837 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.601 HD22 HG21 ' A' ' 39' ' ' ILE . 11.5 tp -99.53 137.34 38.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.229 -0.441 . . . . 74.010000000000005 110.939 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.466 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -115.16 -162.32 13.58 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.739 . . . . 52.340000000000003 112.449 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -64.03 100.89 0.32 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.678 2.252 . . . . 71.120000000000005 112.335 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 158.48 157.44 8.48 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.753 -0.737 . . . . 51.350000000000001 112.485 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.05 136.67 54.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.893 0.377 . . . . 73.140000000000001 110.905 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -135.79 138.34 42.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 74.049999999999997 110.902 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 m -114.25 75.32 0.92 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 65.219999999999999 110.846 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 40.7 t -86.21 152.41 22.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 73.420000000000002 110.829 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.451 HG12 HG13 ' A' ' 36' ' ' ILE . 16.7 m -149.64 23.59 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 63.329999999999998 111.093 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 178.06 -16.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.477 . . . . 65.230000000000004 110.873 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.11 -32.18 64.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 64.109999999999999 110.851 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.52 -65.71 0.79 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 71.040000000000006 111.112 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.735 ' O ' HD13 ' A' ' 74' ' ' ILE . . . 166.49 114.03 0.29 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.745 -0.74 . . . . 72.209999999999994 112.485 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.735 HD13 ' O ' ' A' ' 73' ' ' GLY . 7.0 mm -130.54 67.23 80.04 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.671 0.748 . . . . 70.519999999999996 111.173 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -81.72 -74.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.721 2.28 . . . . 71.25 112.327 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.498 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 4.9 t70 177.44 87.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 75.219999999999999 110.861 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 76' ' ' ASP . 9.0 t-20 83.67 131.11 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 73.310000000000002 110.927 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -179.6 151.75 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 62.350000000000001 110.88 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.6 mt -108.55 153.44 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 51.409999999999997 111.084 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.6 p -154.88 158.87 39.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 73.010000000000005 110.871 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.59 157.32 27.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.495 . . . . 63.140000000000001 110.856 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -150.72 135.78 17.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 75.430000000000007 110.884 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.6 mmm-85 -93.49 126.56 38.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 72.109999999999999 110.878 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.553 ' CG ' HG21 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -91.23 131.48 36.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 60.100000000000001 110.958 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.9 pt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 74.420000000000002 111.115 179.976 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.877 0.37 . . . . 73.109999999999999 110.871 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.762 HG13 ' CH2' ' A' ' 46' ' ' TRP . 99.4 t -106.84 121.77 60.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.485 . . . . 75.150000000000006 111.12 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.445 HG23 ' O ' ' A' ' 7' ' ' ILE . 9.0 tt -123.38 112.17 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 74.0 111.123 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.402 HG13 HG13 ' A' ' 39' ' ' ILE . 17.1 t -128.71 136.88 58.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 74.299999999999997 111.093 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -89.06 140.91 28.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 74.420000000000002 110.908 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -97.09 38.43 1.24 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 72.299999999999997 110.909 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 175.08 -169.53 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.482 . . . . 72.230000000000004 110.891 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.449 HG12 ' N ' ' A' ' 13' ' ' ASN . 4.8 t -63.9 161.39 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 42.229999999999997 111.143 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.449 ' N ' HG12 ' A' ' 12' ' ' VAL . 2.8 t-20 -87.35 54.19 3.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 73.450000000000003 110.905 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.439 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.2 28.56 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 71.239999999999995 110.898 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.6 47.8 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.766 -0.731 . . . . 52.219999999999999 112.497 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.92 171.98 24.27 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.748 -0.739 . . . . 53.439999999999998 112.49 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.56 160.95 17.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.818 0.342 . . . . 73.150000000000006 110.865 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 78.4 p -138.24 155.76 48.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 74.450000000000003 110.874 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -117.24 104.65 11.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 64.549999999999997 110.854 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 74.239999999999995 110.868 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.737 0.304 . . . . 73.230000000000004 110.863 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.403 HG22 ' CB ' ' A' ' 69' ' ' VAL . 1.1 pt -148.89 103.96 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 61.25 111.118 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 79.3 p -167.7 -165.76 0.68 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 70.310000000000002 110.847 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.558 ' C ' HD12 ' A' ' 39' ' ' ILE . 0.9 OUTLIER -123.61 148.48 46.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 52.009999999999998 110.874 -179.819 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.558 HD12 ' C ' ' A' ' 38' ' ' SER . 1.6 mp -121.02 139.07 49.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 54.100000000000001 111.141 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -141.97 134.3 27.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 75.040000000000006 110.881 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.48 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 11.0 p -135.57 138.95 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 74.219999999999999 111.13 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.14 39.48 2.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 63.420000000000002 110.874 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.431 ' H ' HG22 ' A' ' 41' ' ' VAL . 0.3 OUTLIER 178.57 110.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 74.430000000000007 110.865 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.89 -157.41 53.51 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.739 -0.743 . . . . 65.519999999999996 112.428 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.487 HG22 ' HA2' ' A' ' 62' ' ' GLY . 72.7 p -150.24 135.96 18.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.757 0.313 . . . . 70.319999999999993 111.161 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.762 ' CH2' HG13 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -99.63 168.75 9.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 63.119999999999997 110.911 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -115.05 123.29 48.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 75.209999999999994 110.9 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.412 ' HD2' HD23 ' A' ' 61' ' ' LEU . 1.6 m-85 -110.15 123.58 50.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 72.409999999999997 110.89 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.87 126.61 20.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 73.530000000000001 110.902 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -102.62 89.86 3.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 64.5 110.89 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.535 ' HA ' HG22 ' A' ' 79' ' ' ILE . 0.1 OUTLIER 172.05 -166.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.477 . . . . 71.310000000000002 110.937 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.479 HG22 ' N ' ' A' ' 53' ' ' ASN . 5.8 mm -54.98 164.57 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 75.409999999999997 111.131 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.479 ' N ' HG22 ' A' ' 52' ' ' ILE . 59.4 m-20 -80.17 51.9 1.47 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 73.030000000000001 110.886 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.433 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 1.9 p90 -179.47 27.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.482 . . . . 73.230000000000004 110.931 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.33 -164.86 37.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.745 -0.74 . . . . 72.040000000000006 112.457 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.452 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 107.55 -169.68 14.87 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.757 -0.735 . . . . 65.420000000000002 112.488 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.17 105.02 12.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.356 . . . . 71.400000000000006 110.891 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -78.06 108.4 11.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 75.239999999999995 110.945 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -138.11 106.17 5.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.149 -0.478 . . . . 72.439999999999998 110.923 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -93.41 138.41 31.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.436 . . . . 75.230000000000004 110.878 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.64 HD21 ' CE3' ' A' ' 46' ' ' TRP . 1.2 pp -103.13 142.71 33.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 61.219999999999999 110.925 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.487 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -122.77 -162.85 11.65 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.753 -0.737 . . . . 50.310000000000002 112.52 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -45.5 101.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.655 2.237 . . . . 62.439999999999998 112.39 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 163.62 171.53 29.98 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.736 . . . . 72.209999999999994 112.524 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -133.84 143.92 48.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.847 0.356 . . . . 61.229999999999997 110.867 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -151.89 140.12 20.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.484 . . . . 72.409999999999997 110.942 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.8 p -124.29 72.6 1.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 73.299999999999997 110.841 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.8 t -86.06 168.97 13.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 64.030000000000001 110.891 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.403 ' CB ' HG22 ' A' ' 36' ' ' ILE . 12.9 m -152.28 23.53 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 44.25 111.132 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.568 ' HA ' HD13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -176.08 57.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 61.509999999999998 110.879 -179.952 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 t -175.99 -43.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 65.109999999999999 110.872 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.71 -66.09 0.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 75.540000000000006 111.124 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -176.89 93.32 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.716 -0.754 . . . . 71.200000000000003 112.462 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.568 HD13 ' HA ' ' A' ' 70' ' ' GLU . 3.3 mp -128.35 67.91 76.31 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.657 0.741 . . . . 73.329999999999998 111.109 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -76.98 -166.12 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.684 2.256 . . . . 71.519999999999996 112.37 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -91.4 -24.23 19.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 64.329999999999998 110.892 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -141.78 172.45 12.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 75.030000000000001 110.91 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.645 ' O ' HD13 ' A' ' 79' ' ' ILE . 1.0 OUTLIER -67.74 88.14 0.24 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 53.039999999999999 110.868 -179.878 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.645 HD13 ' O ' ' A' ' 78' ' ' SER . 23.9 mm -134.91 61.81 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 74.219999999999999 111.177 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.8 t -163.02 156.17 19.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 64.329999999999998 110.892 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -165.54 159.32 16.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 72.010000000000005 110.917 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -150.4 135.77 17.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 71.140000000000001 110.877 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -94.27 118.35 31.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 71.439999999999998 110.92 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.586 ' HB3' HG21 ' A' ' 6' ' ' VAL . 39.8 mt-30 -79.66 93.0 5.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.458 . . . . 70.150000000000006 110.899 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 pt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 61.200000000000003 111.115 179.965 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.849 0.357 . . . . 64.430000000000007 110.875 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.9 m -112.13 138.64 40.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 74.409999999999997 111.166 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.82 HG23 ' HB3' ' A' ' 40' ' ' LYS . 2.7 tp -105.34 110.97 32.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 64.129999999999995 111.135 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.604 HG12 HD13 ' A' ' 39' ' ' ILE . 3.0 m -131.25 165.0 32.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 75.310000000000002 111.067 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -117.3 142.7 46.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 73.239999999999995 110.916 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -101.45 37.72 1.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.495 . . . . 72.540000000000006 110.889 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 174.02 -170.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.483 . . . . 74.120000000000005 110.816 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.438 HG12 ' N ' ' A' ' 13' ' ' ASN . 5.1 t -64.12 160.37 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 74.409999999999997 111.103 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.438 ' N ' HG12 ' A' ' 12' ' ' VAL . 11.6 p-10 -87.32 54.5 3.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 70.409999999999997 110.924 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.441 ' CG ' ' O ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -176.91 28.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 64.329999999999998 110.883 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.9 46.16 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.786 -0.721 . . . . 75.430000000000007 112.548 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.19 172.01 24.36 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.718 -0.753 . . . . 33.530000000000001 112.484 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.42 152.26 22.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.782 0.325 . . . . 60.149999999999999 110.93 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.62 148.92 49.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 72.150000000000006 110.868 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -102.29 104.29 14.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 65.140000000000001 110.898 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 72.200000000000003 110.858 179.978 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.594 ' O ' HD12 ' A' ' 74' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.76 0.314 . . . . 71.140000000000001 110.931 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.466 HG13 HG12 ' A' ' 69' ' ' VAL . 7.4 tt -179.59 103.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 72.519999999999996 111.156 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 82.5 p -168.23 -166.92 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 75.319999999999993 110.869 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.9 t -115.35 168.22 10.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 75.209999999999994 110.879 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.617 HG21 HD22 ' A' ' 61' ' ' LEU . 0.4 OUTLIER -145.41 139.21 21.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 74.239999999999995 111.173 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.82 ' HB3' HG23 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -139.9 119.65 13.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 72.010000000000005 110.892 179.885 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.681 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 2.6 p -113.94 139.05 41.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 45.509999999999998 111.134 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -138.04 45.26 2.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 65.310000000000002 110.908 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.72 113.68 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 73.5 110.861 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.23 -135.75 35.8 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.742 -0.742 . . . . 65.319999999999993 112.466 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.459 HG22 ' HA2' ' A' ' 62' ' ' GLY . 67.4 p -150.06 150.13 31.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.732 0.301 . . . . 64.310000000000002 111.166 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.681 ' CZ2' HG23 ' A' ' 41' ' ' VAL . 2.7 m0 -117.74 171.38 8.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.247 -0.433 . . . . 75.409999999999997 110.897 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.7 mpp_? -113.85 119.73 38.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 74.25 110.909 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -108.59 126.71 53.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 61.229999999999997 110.9 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.24 126.29 19.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 65.420000000000002 110.922 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -98.44 89.54 4.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 73.439999999999998 110.88 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.447 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 172.54 -168.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.116 -0.493 . . . . 71.209999999999994 110.934 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.499 HG22 ' H ' ' A' ' 53' ' ' ASN . 5.6 mm -69.82 165.98 2.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 54.530000000000001 111.137 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.499 ' H ' HG22 ' A' ' 52' ' ' ILE . 5.5 m120 -74.83 56.69 0.74 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 70.439999999999998 110.902 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -153.09 -39.15 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 65.150000000000006 110.905 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -147.99 -142.36 3.65 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.757 -0.735 . . . . 72.299999999999997 112.523 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.447 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 106.55 -178.09 22.32 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.789 -0.72 . . . . 71.319999999999993 112.492 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -76.72 108.72 9.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.798 0.332 . . . . 74.549999999999997 110.884 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -78.29 100.26 6.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 74.030000000000001 110.903 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -133.41 107.53 8.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 74.040000000000006 110.923 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.88 148.14 27.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 64.25 110.862 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.617 HD22 HG21 ' A' ' 39' ' ' ILE . 8.7 tp -99.52 136.5 39.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 72.439999999999998 110.913 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.459 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -112.93 176.34 17.45 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.708 -0.758 . . . . 74.239999999999995 112.479 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -46.74 100.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.727 2.284 . . . . 74.329999999999998 112.334 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.46 164.6 14.99 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.746 -0.74 . . . . 70.420000000000002 112.506 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -118.52 146.94 44.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.829 0.347 . . . . 74.310000000000002 110.9 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -146.19 140.15 26.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 74.329999999999998 110.867 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.48 73.88 1.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.095 -0.502 . . . . 71.230000000000004 110.858 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 45.7 t -85.06 156.23 21.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 61.43 110.84 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.466 HG12 HG13 ' A' ' 36' ' ' ILE . 27.9 m -149.96 26.27 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.114 -0.494 . . . . 74.150000000000006 111.096 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 173.15 -16.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 75.349999999999994 110.884 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.02 -23.95 41.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 71.219999999999999 110.85 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.79 -71.0 0.54 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 53.340000000000003 111.114 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.609 ' O ' HD13 ' A' ' 74' ' ' ILE . . . 166.79 124.54 0.72 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.781 -0.724 . . . . 65.319999999999993 112.502 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.609 HD13 ' O ' ' A' ' 73' ' ' GLY . 4.4 mm -123.64 68.08 41.02 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.626 0.727 . . . . 73.109999999999999 111.111 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -79.38 -166.18 0.39 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.724 2.283 . . . . 63.340000000000003 112.332 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.62 14.81 14.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 64.129999999999995 110.874 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -157.36 113.94 2.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 74.230000000000004 110.89 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.7 m -92.28 45.0 1.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 71.5 110.855 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.4 mm -76.51 66.26 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 61.420000000000002 111.091 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.1 168.92 9.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 75.120000000000005 110.82 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.69 155.26 12.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 75.120000000000005 110.908 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -151.13 135.96 17.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 62.109999999999999 110.9 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.5 mmm-85 -95.79 126.18 40.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 73.019999999999996 110.902 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -79.26 97.03 6.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 71.030000000000001 110.909 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 63.140000000000001 111.154 179.981 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.887 0.375 . . . . 73.219999999999999 110.897 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.789 HG13 ' CH2' ' A' ' 46' ' ' TRP . 89.5 t -119.79 133.35 66.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 75.099999999999994 111.159 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.458 HG23 ' HB3' ' A' ' 40' ' ' LYS . 7.0 tt -122.29 109.87 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 63.119999999999997 111.133 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.62 HG12 HD13 ' A' ' 39' ' ' ILE . 4.0 m -132.19 164.77 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.182 -0.463 . . . . 63.340000000000003 111.153 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -113.4 138.73 49.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 73.530000000000001 110.99 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -100.73 38.21 1.57 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 71.450000000000003 110.888 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.433 ' HB3' ' HA3' ' A' ' 16' ' ' GLY . 0.3 OUTLIER 169.26 -173.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 75.299999999999997 110.892 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 13' ' ' ASN . 4.8 t -66.02 160.55 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.254 -0.43 . . . . 62.340000000000003 111.109 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.44 ' N ' HG12 ' A' ' 12' ' ' VAL . 18.9 t30 -88.67 54.77 3.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 73.239999999999995 110.895 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.419 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -176.55 28.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 72.120000000000005 110.917 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.56 43.63 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.73 -0.748 . . . . 41.530000000000001 112.5 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.433 ' HA3' ' HB3' ' A' ' 11' ' ' HIS . . . -142.69 172.14 24.52 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.777 -0.725 . . . . 64.120000000000005 112.509 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.2 123.6 34.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.797 0.332 . . . . 75.209999999999994 110.905 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.3 p -121.24 135.17 55.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 65.310000000000002 110.862 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 19' ' ' PHE . 0.8 OUTLIER -124.85 136.73 54.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.15 -0.477 . . . . 75.109999999999999 110.878 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 71.439999999999998 110.828 179.979 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.759 0.314 . . . . 65.510000000000005 110.91 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.96 111.46 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 62.119999999999997 111.157 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.7 p -167.25 -166.46 0.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 62.329999999999998 110.871 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 t -117.61 159.38 23.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 72.349999999999994 110.882 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.62 HD13 HG12 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -139.53 140.96 36.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 64.230000000000004 111.155 179.917 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.458 ' HB3' HG23 ' A' ' 7' ' ' ILE . 9.4 tttt -151.0 147.75 27.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 72.400000000000006 110.892 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.59 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 3.6 p -136.03 130.98 49.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 61.119999999999997 111.135 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.03 39.51 3.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 74.310000000000002 110.837 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.442 ' H ' HG22 ' A' ' 41' ' ' VAL . 0.4 OUTLIER 178.59 110.63 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 60.109999999999999 110.888 -179.92 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.85 -147.86 48.61 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.739 . . . . 54.020000000000003 112.508 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.5 p -150.35 147.82 28.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.762 0.315 . . . . 71.430000000000007 111.123 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.789 ' CH2' HG13 ' A' ' 6' ' ' VAL . 2.0 m0 -118.08 174.84 5.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 74.040000000000006 110.942 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -124.66 129.13 49.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 64.400000000000006 110.858 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.484 ' HD2' HD22 ' A' ' 61' ' ' LEU . 1.6 m-85 -113.57 128.38 56.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 51.149999999999999 110.862 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.33 126.19 19.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.486 . . . . 71.450000000000003 110.928 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -101.09 88.9 3.63 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.074 -0.512 . . . . 62.439999999999998 110.873 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.448 ' HA ' HG22 ' A' ' 79' ' ' ILE . 0.2 OUTLIER 172.04 -171.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 74.450000000000003 110.918 -179.857 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.7 pt -54.97 174.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.499 . . . . 75.439999999999998 111.11 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -87.9 37.86 0.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 70.120000000000005 110.909 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -151.74 18.63 0.7 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 64.349999999999994 110.926 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.07 -152.34 18.95 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.74 -0.743 . . . . 52.229999999999997 112.487 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.401 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 107.29 176.25 22.66 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.749 -0.739 . . . . 52.450000000000003 112.478 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.49 109.42 6.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.812 0.339 . . . . 75.140000000000001 110.857 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -77.59 108.35 10.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 73.0 110.899 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -138.44 107.17 5.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.06 -0.518 . . . . 74.230000000000004 110.925 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -91.28 157.72 16.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 62.130000000000003 110.859 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.653 HD21 ' HB2' ' A' ' 46' ' ' TRP . 1.8 pt? -119.97 149.61 41.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 64.109999999999999 110.934 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -124.81 -173.97 13.88 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.728 -0.748 . . . . 53.530000000000001 112.525 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -43.97 101.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.731 2.287 . . . . 64.340000000000003 112.329 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 158.92 162.4 11.93 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.749 -0.738 . . . . 52.149999999999999 112.495 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.13 147.5 41.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.899 0.381 . . . . 72.040000000000006 110.882 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -132.64 160.4 36.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 74.200000000000003 110.913 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 95.8 p -140.09 62.82 1.49 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 73.430000000000007 110.889 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 71.0 m -85.8 145.81 27.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.488 . . . . 71.129999999999995 110.836 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.411 HG23 ' HG2' ' A' ' 70' ' ' GLU . 35.9 m -150.6 18.44 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.487 . . . . 64.239999999999995 111.127 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.411 ' HG2' HG23 ' A' ' 69' ' ' VAL . 1.7 pt-20 179.3 38.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 71.230000000000004 110.841 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.53 -46.71 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.471 . . . . 70.120000000000005 110.866 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.32 -45.86 62.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.506 . . . . 21.129999999999999 111.077 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.712 ' O ' HD13 ' A' ' 74' ' ' ILE . . . 166.93 103.68 0.17 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.769 -0.729 . . . . 73.040000000000006 112.473 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.712 HD13 ' O ' ' A' ' 73' ' ' GLY . 15.0 mm -131.52 74.02 78.85 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.626 0.727 . . . . 71.310000000000002 111.095 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -77.59 -158.54 0.09 OUTLIER 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.709 2.272 . . . . 52.100000000000001 112.328 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -75.97 -22.71 55.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 71.120000000000005 110.868 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -158.65 -169.54 2.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 73.109999999999999 110.89 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.0 t -57.82 -95.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 71.120000000000005 110.888 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.448 HG22 ' HA ' ' A' ' 51' ' ' TYR . 2.2 mp 50.91 59.89 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 74.540000000000006 111.092 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 66.1 p -159.41 158.61 32.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 75.409999999999997 110.842 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.73 159.63 16.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 70.409999999999997 110.867 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -150.14 135.8 18.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 75.120000000000005 110.872 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.2 mmt-85 -90.48 117.4 29.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 65.439999999999998 110.904 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -82.28 91.85 6.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 65.200000000000003 110.909 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 74.400000000000006 111.11 179.945 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.86 0.362 . . . . 63.25 110.878 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.738 HG21 ' HB3' ' A' ' 84' ' ' GLN . 54.3 t -102.02 119.43 50.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 72.310000000000002 111.102 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.546 HG23 ' HB3' ' A' ' 40' ' ' LYS . 8.3 tt -120.96 109.51 25.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 65.409999999999997 111.135 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.8 t -126.41 141.37 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 65.319999999999993 111.153 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -96.04 134.6 38.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.179 -0.464 . . . . 63.350000000000001 110.892 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -94.35 44.23 1.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 70.329999999999998 110.916 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 174.79 -170.31 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 73.230000000000004 110.884 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 13' ' ' ASN . 6.4 t -63.99 160.5 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 74.540000000000006 111.16 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.453 ' N ' HG12 ' A' ' 12' ' ' VAL . 53.0 t-20 -85.41 53.61 2.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 73.140000000000001 110.855 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.453 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.59 28.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 65.420000000000002 110.849 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.55 44.33 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.721 -0.752 . . . . 44.409999999999997 112.5 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -134.98 171.41 22.45 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.74 -0.743 . . . . 74.25 112.467 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.5 161.99 13.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.751 0.31 . . . . 72.109999999999999 110.92 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.7 p -151.11 155.34 38.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 53.520000000000003 110.84 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -136.34 136.7 39.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 64.409999999999997 110.858 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 72.349999999999994 110.867 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.588 ' HD2' ' HB3' ' A' ' 72' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.749 0.309 . . . . 53.43 110.891 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 36' ' ' ILE . 1.2 tt -162.01 115.55 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 74.329999999999998 111.13 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.9 p -167.22 -167.55 0.93 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 70.209999999999994 110.906 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.562 ' O ' HD12 ' A' ' 39' ' ' ILE . 32.3 t -123.6 150.08 44.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 62.539999999999999 110.867 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.562 HD12 ' O ' ' A' ' 38' ' ' SER . 1.5 mp -120.91 115.18 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 43.299999999999997 111.117 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.546 ' HB3' HG23 ' A' ' 7' ' ' ILE . 10.6 tttm -109.88 119.26 38.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.465 . . . . 75.299999999999997 110.918 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.775 HG22 ' CZ3' ' A' ' 46' ' ' TRP . 17.2 t -102.89 139.16 24.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 72.019999999999996 111.114 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.71 39.84 0.72 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 74.140000000000001 110.896 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 179.38 111.66 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 71.109999999999999 110.842 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.34 -142.22 24.55 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.674 -0.774 . . . . 52.539999999999999 112.523 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -149.84 124.17 9.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.795 0.331 . . . . 71.420000000000002 111.12 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.775 ' CZ3' HG22 ' A' ' 41' ' ' VAL . 0.5 OUTLIER -87.14 -177.08 5.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 74.530000000000001 110.922 179.961 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.25 119.95 19.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.453 . . . . 72.120000000000005 110.83 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -101.64 133.59 46.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 73.439999999999998 110.855 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.72 126.47 20.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.104 -0.498 . . . . 75.510000000000005 110.898 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -105.49 88.85 2.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.079 -0.51 . . . . 72.299999999999997 110.917 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.482 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 171.63 -168.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 71.109999999999999 110.938 -179.838 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.471 HG22 ' N ' ' A' ' 53' ' ' ASN . 18.9 mm -54.97 158.63 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 53.409999999999997 111.138 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.471 ' N ' HG22 ' A' ' 52' ' ' ILE . 47.4 p-10 -76.38 58.2 1.28 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 74.030000000000001 110.945 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -167.19 -31.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.163 -0.471 . . . . 52.520000000000003 110.928 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -142.26 -152.56 5.72 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.737 -0.744 . . . . 72.310000000000002 112.467 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.482 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 108.98 -174.5 18.45 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.773 -0.727 . . . . 70.319999999999993 112.471 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.89 127.04 31.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.8 0.333 . . . . 74.5 110.901 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -96.66 108.12 20.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.236 -0.438 . . . . 54.039999999999999 110.904 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -138.08 106.74 5.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.093 -0.503 . . . . 74.400000000000006 110.914 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -95.47 157.34 15.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 63.509999999999998 110.867 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.494 HD23 ' H ' ' A' ' 61' ' ' LEU . 2.6 pt? -135.96 139.1 42.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 52.439999999999998 110.916 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.52 -165.64 27.38 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.734 -0.746 . . . . 62.130000000000003 112.465 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -56.67 115.85 2.78 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.684 2.256 . . . . 50.219999999999999 112.346 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.7 151.42 5.89 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.733 -0.746 . . . . 73.209999999999994 112.504 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -79.96 155.01 27.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.845 0.355 . . . . 74.140000000000001 110.897 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -160.31 149.5 17.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.126 -0.488 . . . . 72.510000000000005 110.924 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.9 p -108.12 84.26 1.92 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 70.340000000000003 110.872 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.733 ' HB2' ' HB2' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -85.4 117.12 24.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 73.140000000000001 110.873 -179.86 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.7 m -146.34 10.32 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 73.439999999999998 111.117 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -157.52 17.65 0.27 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 73.530000000000001 110.9 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -165.68 21.67 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 75.299999999999997 110.869 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.733 ' HB2' ' HB2' ' A' ' 68' ' ' SER . . . -89.51 -34.67 16.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 35.539999999999999 111.101 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.607 ' H ' HD13 ' A' ' 74' ' ' ILE . . . 165.97 41.31 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.78 -0.724 . . . . 54.210000000000001 112.495 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.607 HD13 ' H ' ' A' ' 73' ' ' GLY . 0.1 OUTLIER -122.45 63.13 17.92 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.62 0.724 . . . . 65.409999999999997 111.102 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.499 ' HD3' ' C ' ' A' ' 73' ' ' GLY . 71.6 Cg_endo -81.41 -47.61 0.07 OUTLIER 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.703 2.268 . . . . 54.119999999999997 112.316 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.472 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 9.3 t70 179.36 87.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 63.43 110.86 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.472 ' CB ' ' O ' ' A' ' 76' ' ' ASP . 5.4 m-20 81.41 -168.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 71.400000000000006 110.907 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.503 ' O ' HD13 ' A' ' 79' ' ' ILE . 0.7 OUTLIER -75.08 71.72 2.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 63.439999999999998 110.869 -179.85 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.503 HD13 ' O ' ' A' ' 78' ' ' SER . 23.4 mm -141.79 69.64 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 72.25 111.184 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -165.99 152.59 9.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 63.520000000000003 110.834 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.71 171.54 12.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 73.109999999999999 110.841 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -152.07 135.9 16.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.134 -0.485 . . . . 75.349999999999994 110.905 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 30.5 mmm180 -98.78 116.37 30.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 72.040000000000006 110.904 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.738 ' HB3' HG21 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -83.63 103.56 13.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 74.430000000000007 110.92 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.1 pt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 75.099999999999994 111.11 179.982 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.921 0.391 . . . . 62.32 110.846 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.501 HG11 ' HG2' ' A' ' 84' ' ' GLN . 4.0 m -115.67 138.56 45.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.501 . . . . 63.229999999999997 111.136 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.823 HG23 ' HB3' ' A' ' 40' ' ' LYS . 1.1 tt -102.32 110.44 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 73.349999999999994 111.101 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.651 HG12 HD13 ' A' ' 39' ' ' ILE . 3.3 m -137.32 159.43 35.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 70.310000000000002 111.123 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -114.0 144.33 43.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 74.019999999999996 110.95 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.31 41.56 1.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 75.549999999999997 110.855 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 172.69 -170.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 64.049999999999997 110.826 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.451 HG12 ' N ' ' A' ' 13' ' ' ASN . 7.3 t -63.61 159.97 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 62.149999999999999 111.076 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.451 ' N ' HG12 ' A' ' 12' ' ' VAL . 58.6 t30 -85.74 53.87 2.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 61.0 110.883 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.438 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.11 28.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 72.310000000000002 110.856 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.57 41.14 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.732 . . . . 53.140000000000001 112.462 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -137.13 171.54 23.06 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.776 -0.726 . . . . 72.430000000000007 112.485 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.35 161.7 16.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.83 0.348 . . . . 72.400000000000006 110.893 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -139.07 166.9 23.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 75.400000000000006 110.86 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -129.44 113.48 14.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 71.239999999999995 110.944 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.4 t0 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 73.5 110.884 -180.0 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.787 0.327 . . . . 53.140000000000001 110.896 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.74 HD12 ' HB ' ' A' ' 69' ' ' VAL . 0.9 OUTLIER -168.98 102.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 73.519999999999996 111.126 179.921 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.4 p -168.11 -167.6 0.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 73.219999999999999 110.879 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.7 t -126.66 157.86 37.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 74.340000000000003 110.866 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.651 HD13 HG12 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -129.69 138.06 55.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 63.450000000000003 111.113 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.823 ' HB3' HG23 ' A' ' 7' ' ' ILE . 12.1 tttt -136.03 124.31 23.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 72.409999999999997 110.853 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.684 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 3.5 p -120.3 139.5 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.436 . . . . 73.310000000000002 111.134 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -142.89 40.37 1.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 70.239999999999995 110.892 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.57 117.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 72.439999999999998 110.842 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 51.76 -151.45 6.84 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.696 -0.764 . . . . 54.130000000000003 112.523 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.7 p -136.62 155.95 49.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.763 0.316 . . . . 61.439999999999998 111.132 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.684 ' CZ2' HG23 ' A' ' 41' ' ' VAL . 2.2 m0 -123.74 175.65 6.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 75.540000000000006 110.916 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.51 ' HD2' HD11 ' A' ' 85' ' ' ILE . 3.7 mpp_? -123.72 122.71 38.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 74.540000000000006 110.888 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -107.52 128.64 54.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 75.530000000000001 110.934 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.13 127.92 21.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 75.040000000000006 110.923 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -99.1 87.05 3.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.505 . . . . 65.010000000000005 110.853 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.411 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 170.23 -170.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.167 -0.47 . . . . 72.310000000000002 110.951 -179.895 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.1 pt -54.68 174.31 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 64.340000000000003 111.139 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -87.41 36.95 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 74.010000000000005 110.945 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -151.85 19.01 0.69 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 65.230000000000004 110.925 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.61 -156.89 27.63 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.788 -0.72 . . . . 75.420000000000002 112.504 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.411 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 107.09 176.29 22.8 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.677 -0.773 . . . . 74.239999999999995 112.496 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -69.81 103.96 2.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.833 0.349 . . . . 73.120000000000005 110.872 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -75.05 108.4 7.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 75.329999999999998 110.957 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -138.1 106.21 5.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.138 -0.483 . . . . 75.530000000000001 110.953 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -88.49 138.41 31.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 71.430000000000007 110.845 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.557 HD21 ' CE3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -99.18 159.44 14.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 65.299999999999997 110.928 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -128.85 175.77 18.62 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.706 -0.759 . . . . 54.340000000000003 112.483 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.412 ' HA ' HG13 ' A' ' 41' ' ' VAL . 78.4 Cg_exo -42.51 107.77 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.657 2.238 . . . . 72.010000000000005 112.382 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.79 159.48 9.39 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.739 . . . . 61.439999999999998 112.489 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -102.6 144.69 30.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.843 0.354 . . . . 73.109999999999999 110.904 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -137.17 145.09 43.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.118 -0.492 . . . . 73.209999999999994 110.917 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.1 m -133.8 67.51 1.52 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 54.310000000000002 110.838 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.63 ' CB ' ' HB2' ' A' ' 72' ' ' ALA . 10.9 m -84.99 145.11 27.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 72.530000000000001 110.866 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.74 ' HB ' HD12 ' A' ' 36' ' ' ILE . 20.6 m -149.97 19.74 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 73.209999999999994 111.118 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -179.5 38.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 62.409999999999997 110.879 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.34 -39.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 71.299999999999997 110.894 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.63 ' HB2' ' CB ' ' A' ' 68' ' ' SER . . . -53.17 -44.47 67.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 50.210000000000001 111.073 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.592 ' O ' HD13 ' A' ' 74' ' ' ILE . . . 167.41 93.79 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.787 -0.721 . . . . 75.209999999999994 112.518 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.592 HD13 ' O ' ' A' ' 73' ' ' GLY . 5.7 mm -123.98 67.27 42.37 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.613 0.72 . . . . 73.430000000000007 111.129 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -80.07 -166.38 0.41 Allowed 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.727 2.285 . . . . 72.109999999999999 112.376 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -57.67 -70.15 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.419 . . . . 64.340000000000003 110.876 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -96.68 -95.54 0.2 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 74.239999999999995 110.846 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.4 p -178.18 -95.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 73.239999999999995 110.836 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.5 mm 56.23 54.92 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 74.049999999999997 111.152 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.6 m -108.07 164.2 12.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 70.349999999999994 110.862 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.3 p -165.54 153.68 11.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 65.319999999999993 110.831 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -151.25 135.47 16.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 71.450000000000003 110.888 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.47 119.69 32.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 75.299999999999997 110.883 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.501 ' HG2' HG11 ' A' ' 6' ' ' VAL . 20.5 mt-30 -79.7 92.01 5.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 61.229999999999997 110.899 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.51 HD11 ' HD2' ' A' ' 47' ' ' ARG . 1.1 pt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 71.439999999999998 111.186 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.806 0.336 . . . . 72.230000000000004 110.9 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -148.11 115.2 6.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 74.230000000000004 110.876 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -155.65 66.45 0.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 53.340000000000003 111.075 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -171.95 103.69 0.18 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 71.400000000000006 111.094 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -90.0 118.76 29.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 73.540000000000006 110.882 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.782 HG13 ' CH2' ' A' ' 46' ' ' TRP . 89.7 t -110.6 111.24 35.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 64.239999999999995 111.116 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.738 HG23 ' HB3' ' A' ' 40' ' ' LYS . 4.0 tp -106.34 110.91 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 52.109999999999999 111.127 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.8 t -131.54 138.8 52.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 65.010000000000005 111.138 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -94.5 137.22 33.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 74.129999999999995 110.863 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -93.98 42.94 1.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 75.150000000000006 110.902 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 174.52 -169.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 63.229999999999997 110.852 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.451 HG12 ' N ' ' A' ' 13' ' ' ASN . 5.0 t -64.68 160.97 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 74.209999999999994 111.17 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.451 ' N ' HG12 ' A' ' 12' ' ' VAL . 51.2 t30 -87.34 53.79 2.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 73.319999999999993 110.923 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.441 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.12 28.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 71.430000000000007 110.911 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.19 52.73 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.726 -0.75 . . . . 74.120000000000005 112.486 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.96 171.52 24.48 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.798 -0.715 . . . . 63.409999999999997 112.513 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.43 134.34 35.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.77 0.319 . . . . 74.340000000000003 110.893 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.48 153.04 34.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 54.340000000000003 110.88 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -148.64 141.35 24.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 64.200000000000003 110.901 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.447 ' HB2' HD13 ' A' ' 7' ' ' ILE . 20.8 t0 -137.8 73.03 1.42 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 71.209999999999994 110.907 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.546 ' HB3' ' HG3' ' A' ' 25' ' ' GLN . . . -80.42 129.61 34.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 74.129999999999995 111.093 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.7 t -93.82 40.08 1.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 61.32 111.116 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.1 m -158.12 54.41 0.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 54.43 110.842 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 63.95 107.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.115 -0.493 . . . . 70.519999999999996 110.855 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.546 ' HG3' ' HB3' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -79.9 162.71 61.36 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.571 0.7 . . . . 63.240000000000002 110.945 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -47.79 -29.42 11.25 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.709 2.273 . . . . 65.010000000000005 112.359 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.81 -166.36 43.5 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.766 -0.731 . . . . 73.120000000000005 112.471 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.696 ' HB3' ' HA ' ' A' ' 81' ' ' SER . . . -89.9 120.8 31.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.798 0.332 . . . . 73.319999999999993 111.098 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.33 -39.71 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.746 -0.74 . . . . 74.140000000000001 112.507 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -97.41 25.19 5.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.817 0.341 . . . . 64.239999999999995 110.866 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -64.31 -178.36 0.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 61.240000000000002 110.891 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.467 HD23 ' H ' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -176.79 -85.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 74.420000000000002 110.89 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.576 ' O ' HG22 ' A' ' 74' ' ' ILE . 2.0 t30 -159.09 -40.25 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 75.129999999999995 110.874 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.467 ' H ' HD23 ' A' ' 32' ' ' LEU . 4.1 t70 -78.95 59.14 2.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 74.430000000000007 110.856 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.96 133.29 49.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 71.109999999999999 110.914 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.542 ' HB ' HG12 ' A' ' 69' ' ' VAL . 1.1 pt -153.11 109.72 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 75.540000000000006 111.127 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.0 p -165.01 -168.35 1.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 64.109999999999999 110.843 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.581 ' O ' HD12 ' A' ' 39' ' ' ILE . 0.6 OUTLIER -124.07 152.05 43.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 63.149999999999999 110.828 -179.825 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.581 HD12 ' O ' ' A' ' 38' ' ' SER . 1.5 mp -120.91 139.33 48.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.51 . . . . 71.140000000000001 111.116 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.738 ' HB3' HG23 ' A' ' 7' ' ' ILE . 7.4 tttt -138.04 125.92 22.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 60.219999999999999 110.915 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.563 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 9.2 p -125.58 139.02 52.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.433 . . . . 63.450000000000003 111.158 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.88 39.39 1.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 74.230000000000004 110.861 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.93 110.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 52.229999999999997 110.855 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.94 -150.21 50.28 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.78 -0.724 . . . . 75.549999999999997 112.451 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.563 HG22 ' HA2' ' A' ' 62' ' ' GLY . 41.9 p -148.4 160.61 42.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.759 0.314 . . . . 55.229999999999997 111.146 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.782 ' CH2' HG13 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -124.53 177.48 5.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 74.129999999999995 110.953 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.411 ' HD2' HD11 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -123.57 111.92 16.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.273 -0.421 . . . . 73.239999999999995 110.864 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -101.01 123.95 45.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 75.150000000000006 110.916 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -139.97 126.63 20.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 74.340000000000003 110.945 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -104.09 89.57 3.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 73.010000000000005 110.871 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.408 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 177.27 -174.34 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 74.239999999999995 110.958 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.0 pt -54.88 174.15 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 65.319999999999993 111.099 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -83.07 10.12 8.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.14 -0.482 . . . . 71.540000000000006 110.881 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.45 67.27 1.26 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 73.519999999999996 110.937 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 116.39 121.08 3.27 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.757 -0.735 . . . . 73.420000000000002 112.503 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.408 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . -177.35 174.48 47.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 32.520000000000003 112.486 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -64.62 95.93 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.844 0.354 . . . . 73.540000000000006 110.918 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -76.38 111.86 12.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 64.230000000000004 110.933 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -138.32 105.86 5.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.144 -0.48 . . . . 73.150000000000006 110.924 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -90.65 137.61 32.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.259 -0.428 . . . . 61.149999999999999 110.916 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.714 HD21 ' CE3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -104.81 142.11 35.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 52.009999999999998 110.879 -179.931 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.563 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -113.79 -168.63 16.63 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.781 -0.723 . . . . 71.349999999999994 112.54 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -46.84 109.89 0.24 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.699 2.266 . . . . 74.340000000000003 112.304 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.93 158.48 8.84 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.732 -0.747 . . . . 52.310000000000002 112.505 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.59 143.86 49.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.861 0.362 . . . . 63.25 110.891 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -148.63 160.12 43.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 72.129999999999995 110.898 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 99.0 p -140.69 78.04 1.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.094 -0.503 . . . . 61.32 110.837 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.4 m -86.64 153.05 22.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 62.530000000000001 110.843 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.542 HG12 ' HB ' ' A' ' 36' ' ' ILE . 5.1 m -153.43 23.92 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 73.030000000000001 111.114 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -179.52 39.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 51.310000000000002 110.9 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.443 ' N ' HD11 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -157.85 -40.2 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 74.25 110.852 -179.772 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.28 -75.79 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.114 -0.493 . . . . 63.329999999999998 111.095 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.85 90.15 0.1 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 64.209999999999994 112.516 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.576 HG22 ' O ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -134.15 67.07 72.89 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.644 0.735 . . . . 74.150000000000006 111.165 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -80.46 -52.21 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.663 2.242 . . . . 52.350000000000001 112.343 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 179.82 -51.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.264 -0.426 . . . . 61.25 110.845 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -173.75 130.14 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 74.439999999999998 110.861 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.17 178.69 2.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 73.420000000000002 110.891 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.4 mm -100.45 155.19 4.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 61.219999999999999 111.111 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.7 p -155.62 155.75 33.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 71.329999999999998 110.851 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.696 ' HA ' ' HB3' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -165.27 158.15 16.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 71.120000000000005 110.838 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -150.55 135.66 17.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 62.509999999999998 110.885 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -89.68 119.71 30.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 74.209999999999994 110.901 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -79.77 99.62 7.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 73.549999999999997 110.906 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.411 HD11 ' HD2' ' A' ' 47' ' ' ARG . 1.1 pt . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 73.349999999999994 111.103 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.1 mtp . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.815 0.341 . . . . 73.140000000000001 110.833 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -90.45 142.32 27.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 44.520000000000003 110.898 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -87.0 98.53 11.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 72.409999999999997 111.117 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -169.1 108.65 0.45 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 72.400000000000006 111.105 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -88.97 97.89 11.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 53.200000000000003 110.898 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.749 HG13 ' CH2' ' A' ' 46' ' ' TRP . 79.5 t -100.85 114.65 40.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.484 . . . . 65.519999999999996 111.141 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.442 HG23 ' O ' ' A' ' 7' ' ' ILE . 8.5 tt -115.41 110.53 32.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 74.120000000000005 111.131 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.5 t -128.79 145.09 36.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 51.5 111.132 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -97.81 136.7 37.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.476 . . . . 73.299999999999997 110.911 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.77 44.68 1.1 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.49 . . . . 71.430000000000007 110.872 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 173.42 -171.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 65.400000000000006 110.824 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 13' ' ' ASN . 5.3 t -64.58 160.57 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 73.239999999999995 111.161 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.444 ' N ' HG12 ' A' ' 12' ' ' VAL . 11.7 t-20 -87.28 53.94 2.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 73.109999999999999 110.883 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.443 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -176.92 28.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 61.200000000000003 110.872 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.4 52.79 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.714 -0.755 . . . . 74.519999999999996 112.438 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.07 171.42 24.55 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.76 -0.733 . . . . 52.420000000000002 112.481 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.04 135.15 34.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.779 0.323 . . . . 73.219999999999999 110.912 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.65 154.35 32.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 74.120000000000005 110.882 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -148.65 151.97 35.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 72.549999999999997 110.878 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -163.18 92.57 0.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 70.439999999999998 110.838 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.99 157.9 16.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 63.439999999999998 111.129 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 m -93.88 40.01 1.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 73.540000000000006 111.141 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.4 m -146.66 -82.47 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 73.150000000000006 110.826 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -163.25 124.06 2.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.106 -0.497 . . . . 73.209999999999994 110.867 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.93 162.26 62.93 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.585 0.707 . . . . 73.209999999999994 110.888 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -72.3 -171.84 0.78 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.646 2.23 . . . . 74.230000000000004 112.357 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.62 139.78 17.53 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.768 -0.729 . . . . 51.039999999999999 112.488 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.05 -168.4 2.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.795 0.331 . . . . 73.010000000000005 111.114 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.29 87.9 1.93 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.725 -0.75 . . . . 43.43 112.485 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.42 -168.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.836 0.351 . . . . 62.420000000000002 110.851 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -63.47 -174.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 74.150000000000006 110.888 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.7 mp -56.31 -87.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 54.439999999999998 110.888 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -93.66 65.98 3.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 70.040000000000006 110.909 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -168.06 42.28 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 72.519999999999996 110.87 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.12 102.01 11.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 71.010000000000005 110.858 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.441 HD12 HG22 ' A' ' 12' ' ' VAL . 1.1 pt -154.49 106.08 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 73.209999999999994 111.14 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 56.6 p -151.08 -168.4 3.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 52.420000000000002 110.848 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.609 ' C ' HD12 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -130.46 152.22 50.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.087 -0.506 . . . . 63.119999999999997 110.847 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.609 HD12 ' C ' ' A' ' 38' ' ' SER . 1.7 mp -122.14 141.52 42.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 73.439999999999998 111.103 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.2 tttt -140.99 135.61 31.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 73.209999999999994 110.841 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.4 p -162.91 139.23 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 72.310000000000002 111.109 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.06 40.65 3.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 75.019999999999996 110.891 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 t 178.94 138.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 74.349999999999994 110.833 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.78 -177.87 1.89 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.705 -0.76 . . . . 63.039999999999999 112.524 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.59 HG22 ' HA2' ' A' ' 62' ' ' GLY . 18.5 p -145.49 147.65 32.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.754 0.311 . . . . 65.099999999999994 111.156 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.779 ' CE3' HD21 ' A' ' 61' ' ' LEU . 0.7 OUTLIER -116.98 175.43 5.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 64.109999999999999 110.953 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -117.69 118.93 33.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.413 . . . . 71.349999999999994 110.906 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.432 ' CD2' HD23 ' A' ' 61' ' ' LEU . 2.6 m-85 -107.63 125.93 51.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 73.219999999999999 110.871 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.18 126.64 20.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.143 -0.48 . . . . 72.430000000000007 110.952 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -99.25 89.13 4.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 73.230000000000004 110.868 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.443 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 170.95 -178.01 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 74.140000000000001 110.961 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.1 tt -54.94 163.34 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 70.439999999999998 111.119 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -76.29 55.84 1.01 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 71.120000000000005 110.886 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -153.5 -37.72 0.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 72.310000000000002 110.938 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -146.27 -144.27 4.04 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.699 -0.762 . . . . 44.100000000000001 112.427 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.443 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 108.18 -170.54 15.17 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.765 -0.731 . . . . 54.130000000000003 112.469 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -83.61 105.36 14.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.841 0.353 . . . . 73.549999999999997 110.852 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -78.16 106.84 10.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 73.430000000000007 110.932 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -138.1 108.35 6.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.48 . . . . 70.329999999999998 110.941 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -92.83 135.07 34.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.436 . . . . 71.510000000000005 110.877 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.779 HD21 ' CE3' ' A' ' 46' ' ' TRP . 1.3 pp -99.22 140.41 33.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 71.25 110.922 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.59 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -107.45 -159.18 20.92 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.773 -0.727 . . . . 34.43 112.475 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.37 88.06 0.13 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.672 2.248 . . . . 60.109999999999999 112.39 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.3 160.52 29.22 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.751 -0.737 . . . . 52.530000000000001 112.504 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -118.61 135.55 54.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 61.420000000000002 110.852 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -143.45 160.09 41.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.129 -0.487 . . . . 71.140000000000001 110.878 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 97.8 p -141.14 78.06 1.63 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.086 -0.506 . . . . 61.130000000000003 110.853 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.471 ' HB2' ' HB2' ' A' ' 72' ' ' ALA . 14.2 m -88.39 148.81 24.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.491 . . . . 72.400000000000006 110.858 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.435 HG12 ' HB ' ' A' ' 36' ' ' ILE . 34.5 m -150.68 24.05 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.495 . . . . 51.350000000000001 111.154 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -179.47 36.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 72.219999999999999 110.858 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.99 -43.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 75.219999999999999 110.831 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.471 ' HB2' ' HB2' ' A' ' 68' ' ' SER . . . -51.59 -42.94 62.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 71.319999999999993 111.104 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.685 ' O ' HD13 ' A' ' 74' ' ' ILE . . . 166.88 91.99 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.766 -0.73 . . . . 43.509999999999998 112.503 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.685 HD13 ' O ' ' A' ' 73' ' ' GLY . 15.0 mm -131.46 69.21 81.74 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.638 0.733 . . . . 71.040000000000006 111.173 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -81.02 -66.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.701 2.267 . . . . 64.409999999999997 112.379 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -179.95 -73.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.266 -0.425 . . . . 75.329999999999998 110.874 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -66.09 -169.8 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 62.399999999999999 110.885 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.93 110.07 6.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 71.310000000000002 110.826 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.6 pt -152.92 22.79 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 73.540000000000006 111.096 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.6 p -79.78 160.54 26.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 61.149999999999999 110.861 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.62 156.69 13.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 65.319999999999993 110.854 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -148.58 138.37 22.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.49 . . . . 63.340000000000003 110.837 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.97 120.59 34.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 75.430000000000007 110.875 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -79.28 111.05 15.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 72.420000000000002 110.925 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.5 pt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.46 . . . . 65.329999999999998 111.132 179.969 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.795 0.331 . . . . 64.129999999999995 110.819 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -160.16 102.19 1.43 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 72.109999999999999 110.885 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -84.75 108.98 17.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 73.420000000000002 111.143 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -163.49 119.88 1.75 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 75.120000000000005 111.067 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.36 96.04 9.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 70.109999999999999 110.88 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.642 HG22 ' CZ2' ' A' ' 46' ' ' TRP . 84.4 t -117.71 118.63 59.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 53.119999999999997 111.119 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.801 HG23 ' HB3' ' A' ' 40' ' ' LYS . 4.4 tp -136.69 116.65 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 50.039999999999999 111.102 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.635 HG12 HD13 ' A' ' 39' ' ' ILE . 2.8 m -133.12 160.33 42.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 73.200000000000003 111.122 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -113.15 141.21 47.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 75.540000000000006 110.952 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -95.46 37.0 1.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 74.200000000000003 110.869 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 175.62 -169.63 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 72.239999999999995 110.868 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 13' ' ' ASN . 6.6 t -63.65 160.28 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 75.409999999999997 111.18 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.45 ' N ' HG12 ' A' ' 12' ' ' VAL . 37.2 t30 -85.87 53.81 2.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 74.129999999999995 110.899 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.44 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.14 28.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 74.209999999999994 110.86 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.54 39.26 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.718 -0.754 . . . . 55.409999999999997 112.47 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -129.16 171.61 19.92 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.725 -0.75 . . . . 33.310000000000002 112.462 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.25 131.01 34.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.773 0.32 . . . . 73.420000000000002 110.921 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.57 145.26 45.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 72.019999999999996 110.855 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -148.77 128.71 13.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 74.209999999999994 110.875 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.697 ' HB3' HD13 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -118.23 71.05 0.82 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 71.010000000000005 110.927 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.712 ' HB3' ' CG ' ' A' ' 25' ' ' GLN . . . -80.83 160.91 24.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 73.329999999999998 111.068 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.5 t -138.77 40.38 2.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 74.340000000000003 111.168 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.4 t -150.35 59.43 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 72.129999999999995 110.843 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 t70 63.26 87.64 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.486 . . . . 65.5 110.854 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.712 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -80.14 162.44 61.74 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.593 0.711 . . . . 62.539999999999999 110.895 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.79 102.64 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.671 2.247 . . . . 72.310000000000002 112.328 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.15 148.96 10.01 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.758 -0.734 . . . . 73.450000000000003 112.438 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.26 106.86 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.839 0.352 . . . . 63.210000000000001 111.088 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.54 38.59 0.51 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.752 -0.737 . . . . 61.439999999999998 112.492 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.39 103.1 0.43 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.809 0.338 . . . . 71.319999999999993 110.881 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -174.08 -169.15 0.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 73.430000000000007 110.932 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.0 tp -142.06 -168.65 2.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 72.319999999999993 110.887 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -53.79 -27.32 28.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 74.129999999999995 110.874 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.413 ' C ' HD13 ' A' ' 36' ' ' ILE . 5.2 m-20 -84.7 54.25 2.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 64.120000000000005 110.891 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.01 102.32 14.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 75.430000000000007 110.906 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.545 ' HB ' HG12 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -147.94 124.68 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 74.010000000000005 111.143 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.0 p -167.86 -166.78 0.77 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 73.319999999999993 110.81 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.8 t -125.54 164.12 21.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.067 -0.515 . . . . 44.240000000000002 110.867 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.635 HD13 HG12 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -130.42 140.33 49.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 75.219999999999999 111.127 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.801 ' HB3' HG23 ' A' ' 7' ' ' ILE . 1.7 tttp -138.58 132.15 30.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 74.409999999999997 110.913 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.665 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 3.6 p -133.0 139.2 50.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.258 -0.428 . . . . 73.409999999999997 111.108 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.62 41.91 1.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.472 . . . . 61.229999999999997 110.927 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -173.44 110.83 0.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 45.130000000000003 110.861 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 56.63 -137.76 47.77 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.729 -0.748 . . . . 41.109999999999999 112.483 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 64.3 p -150.21 141.25 22.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.339 . . . . 63.409999999999997 111.095 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.665 ' CZ2' HG23 ' A' ' 41' ' ' VAL . 2.8 m0 -109.72 168.45 9.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 74.510000000000005 110.891 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -110.2 120.89 43.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 74.230000000000004 110.917 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -110.95 127.72 55.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 72.519999999999996 110.936 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.73 126.15 18.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.471 . . . . 64.150000000000006 110.907 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -99.12 88.69 4.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.076 -0.511 . . . . 73.409999999999997 110.902 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 173.4 -177.85 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 53.539999999999999 110.903 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.0 pt -58.66 172.32 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 72.409999999999997 111.145 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -84.49 51.95 2.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 72.400000000000006 110.866 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -152.74 -47.87 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 74.109999999999999 110.918 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -149.75 125.05 1.89 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.742 . . . . 62.200000000000003 112.515 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.44 173.12 38.67 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.746 -0.74 . . . . 53.039999999999999 112.483 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -61.75 105.94 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.836 0.35 . . . . 74.219999999999999 110.921 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -77.04 103.32 6.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 72.219999999999999 110.922 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.9 t90 -138.19 107.91 6.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.496 . . . . 72.510000000000005 110.925 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -82.31 153.93 25.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 72.340000000000003 110.841 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.628 ' HG ' HG11 ' A' ' 41' ' ' VAL . 7.4 tp -104.79 133.68 49.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 74.299999999999997 110.947 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.454 ' N ' HD12 ' A' ' 61' ' ' LEU . . . -111.08 178.79 19.76 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.733 -0.746 . . . . 52.039999999999999 112.486 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -46.99 100.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.652 2.235 . . . . 65.409999999999997 112.367 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 161.88 164.13 16.18 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.724 -0.751 . . . . 72.140000000000001 112.476 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -124.1 140.27 53.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.89 0.376 . . . . 71.140000000000001 110.868 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -140.77 144.23 35.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 64.430000000000007 110.939 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.1 t -126.18 74.8 1.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 72.019999999999996 110.895 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.6 m -87.27 159.01 18.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 72.540000000000006 110.823 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.545 HG12 ' HB ' ' A' ' 36' ' ' ILE . 30.5 m -151.29 21.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 60.229999999999997 111.166 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -179.37 58.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 73.230000000000004 110.881 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.55 -49.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 54.340000000000003 110.819 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.61 -62.01 1.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 63.310000000000002 111.115 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.62 ' O ' HD13 ' A' ' 74' ' ' ILE . . . -164.74 88.94 0.1 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.722 -0.752 . . . . 63.109999999999999 112.463 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.62 HD13 ' O ' ' A' ' 73' ' ' GLY . 18.8 mm -132.2 67.35 78.89 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.623 0.725 . . . . 70.5 111.14 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -80.25 -51.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.69 2.26 . . . . 74.109999999999999 112.381 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.86 -34.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 72.010000000000005 110.85 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -141.23 -176.77 4.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 71.030000000000001 110.871 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.34 111.68 23.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 73.140000000000001 110.889 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.547 ' H ' HD13 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -141.98 11.1 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 65.230000000000004 111.086 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.4 p -83.37 170.64 14.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 72.219999999999999 110.843 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.64 152.66 10.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 73.010000000000005 110.859 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -150.19 139.9 21.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 62.439999999999998 110.919 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -109.33 130.62 55.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 70.430000000000007 110.86 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.415 ' HB3' HG21 ' A' ' 6' ' ' VAL . 2.1 mp0 -89.38 131.41 35.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 54.109999999999999 110.899 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.6 pt . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 72.010000000000005 111.099 179.975 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.809 0.337 . . . . 60.439999999999998 110.866 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -82.57 176.12 9.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 73.109999999999999 110.865 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -155.47 51.49 0.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 73.5 111.06 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.34 144.76 25.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 74.340000000000003 111.109 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -90.47 116.17 28.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 65.209999999999994 110.879 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.743 HG22 ' CZ2' ' A' ' 46' ' ' TRP . 87.6 t -111.95 111.77 37.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 75.140000000000001 111.117 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.561 HD13 ' HB3' ' A' ' 20' ' ' ASP . 3.3 tp -117.52 110.03 29.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 70.340000000000003 111.118 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 m -130.79 159.9 42.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 72.230000000000004 111.144 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -112.14 146.2 38.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.462 . . . . 75.120000000000005 110.938 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -101.18 38.9 1.48 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.477 . . . . 73.5 110.904 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 175.04 -171.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 74.030000000000001 110.845 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 13' ' ' ASN . 6.7 t -63.33 160.61 2.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 65.200000000000003 111.105 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.452 ' N ' HG12 ' A' ' 12' ' ' VAL . 0.7 OUTLIER -84.19 53.74 2.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 74.409999999999997 110.917 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.446 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -178.06 28.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 73.420000000000002 110.84 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 158.88 38.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.753 -0.737 . . . . 73.319999999999993 112.495 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.3 171.51 20.57 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.756 -0.735 . . . . 74.519999999999996 112.464 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.91 149.79 21.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.798 0.332 . . . . 72.109999999999999 110.915 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.98 149.12 50.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 75.540000000000006 110.831 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -146.39 129.45 16.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 62.329999999999998 110.886 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.561 ' HB3' HD13 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -135.07 94.65 3.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 74.030000000000001 110.896 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -158.09 150.97 22.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 73.549999999999997 111.082 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -93.8 39.93 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 75.299999999999997 111.189 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.42 160.27 0.98 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 71.120000000000005 110.891 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.4 t0 52.0 32.47 10.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 52.32 110.902 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -132.4 138.99 33.41 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.548 0.69 . . . . 72.400000000000006 110.934 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -81.19 -169.05 0.71 Allowed 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.675 2.25 . . . . 62.210000000000001 112.336 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -163.55 -110.97 0.25 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.72 -0.752 . . . . 74.109999999999999 112.508 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.465 ' HB1' ' CB ' ' A' ' 81' ' ' SER . . . -52.24 102.92 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.831 0.348 . . . . 45.32 111.089 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.06 -172.03 42.9 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.721 -0.752 . . . . 75.430000000000007 112.506 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -179.08 175.88 0.93 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.83 0.347 . . . . 72.420000000000002 110.828 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -104.55 -86.7 0.45 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 72.120000000000005 110.884 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 tp -172.47 98.51 0.15 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.218 -0.446 . . . . 63.310000000000002 110.963 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 60.23 19.46 8.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 75.310000000000002 110.878 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -103.66 39.82 1.54 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 63.240000000000002 110.849 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.49 102.96 12.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 71.430000000000007 110.908 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.556 HG13 HG12 ' A' ' 69' ' ' VAL . 2.0 tt -176.76 102.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 73.349999999999994 111.135 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.7 p -168.84 -164.18 0.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 65.519999999999996 110.869 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.548 ' C ' HD12 ' A' ' 39' ' ' ILE . 47.5 t -125.41 149.34 48.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 74.430000000000007 110.883 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.603 HG21 HD13 ' A' ' 61' ' ' LEU . 1.5 mp -120.91 131.26 73.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 42.009999999999998 111.145 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.547 ' HB3' HG23 ' A' ' 7' ' ' ILE . 3.7 tttp -132.51 142.32 49.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 74.129999999999995 110.875 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.607 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 7.2 p -143.74 126.43 12.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 60.310000000000002 111.121 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.67 41.1 3.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 74.420000000000002 110.928 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.9 t -179.1 110.8 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 61.219999999999999 110.878 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.3 -151.24 52.12 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.67 -0.776 . . . . 75.129999999999995 112.508 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.54 HG22 ' HA2' ' A' ' 62' ' ' GLY . 41.1 p -150.07 153.39 36.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.798 0.332 . . . . 74.329999999999998 111.15 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.743 ' CZ2' HG22 ' A' ' 6' ' ' VAL . 1.3 m0 -123.45 179.07 4.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 75.239999999999995 110.935 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -124.44 136.09 53.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.434 . . . . 72.230000000000004 110.823 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.441 ' HD2' HD22 ' A' ' 61' ' ' LEU . 1.7 m-85 -120.12 129.88 54.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 75.430000000000007 110.878 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.71 126.14 20.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.164 -0.471 . . . . 74.409999999999997 110.95 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.78 89.04 3.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 54.399999999999999 110.918 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.569 ' C ' HG22 ' A' ' 79' ' ' ILE . 0.2 OUTLIER 175.38 -169.44 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 74.239999999999995 110.915 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.2 tt -58.6 163.06 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 70.019999999999996 111.113 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -76.24 55.3 0.95 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 75.319999999999993 110.871 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -153.76 -38.02 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 73.510000000000005 110.936 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -145.53 -138.82 3.31 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 72.239999999999995 112.509 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.426 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 108.06 177.37 22.16 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.796 -0.716 . . . . 52.439999999999998 112.5 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.3 109.48 5.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.81 0.338 . . . . 72.409999999999997 110.859 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -77.59 108.71 10.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 75.430000000000007 110.927 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -138.31 106.72 5.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 63.450000000000003 110.88 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -89.13 157.7 18.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 73.409999999999997 110.878 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.635 HD11 ' CE3' ' A' ' 46' ' ' TRP . 1.8 pt? -118.5 149.71 40.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 73.430000000000007 110.944 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.54 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -127.88 -166.6 12.09 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.72 -0.752 . . . . 50.530000000000001 112.493 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -46.41 101.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.7 2.267 . . . . 62.530000000000001 112.317 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.79 165.39 16.63 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.749 -0.738 . . . . 71.420000000000002 112.484 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.44 145.84 47.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.865 0.364 . . . . 74.329999999999998 110.858 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -154.75 156.65 36.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 75.439999999999998 110.924 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 95.8 p -130.4 85.88 2.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 70.209999999999994 110.854 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.1 t -86.01 153.21 22.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 60.310000000000002 110.86 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.556 HG12 HG13 ' A' ' 36' ' ' ILE . 18.7 m -149.65 18.03 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 61.299999999999997 111.163 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -178.7 40.94 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.117 -0.492 . . . . 75.010000000000005 110.863 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 t -158.44 -45.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 74.109999999999999 110.852 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.45 -61.26 2.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.486 . . . . 75.409999999999997 111.097 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 166.62 103.7 0.17 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.717 -0.754 . . . . 55.539999999999999 112.449 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.8 mm -115.76 74.66 4.95 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.666 0.746 . . . . 64.019999999999996 111.14 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.96 -165.54 0.31 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.701 2.267 . . . . 71.129999999999995 112.359 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -51.32 -74.85 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.265 -0.425 . . . . 61.149999999999999 110.834 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -179.41 33.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 74.439999999999998 110.857 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.3 p 178.95 -174.84 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 74.040000000000006 110.859 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.569 HG22 ' C ' ' A' ' 51' ' ' TYR . 14.2 mm 66.8 62.13 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 73.109999999999999 111.151 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.2 p -165.94 137.88 3.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 65.430000000000007 110.895 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.465 ' CB ' ' HB1' ' A' ' 28' ' ' ALA . 0.9 OUTLIER -158.53 166.75 31.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 75.129999999999995 110.864 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -151.12 142.51 23.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 62.450000000000003 110.886 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.86 159.0 26.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 64.430000000000007 110.932 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -128.52 92.53 3.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 63.399999999999999 110.934 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 pt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 65.409999999999997 111.111 179.981 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.4 mtm . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.771 0.32 . . . . 70.310000000000002 110.9 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -162.83 -179.91 7.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 63.299999999999997 110.881 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.0 99.15 1.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 72.409999999999997 111.094 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -146.45 139.16 25.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 74.420000000000002 111.048 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -89.45 93.31 9.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 74.510000000000005 110.878 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.773 HG13 ' CH2' ' A' ' 46' ' ' TRP . 58.3 t -111.92 128.65 68.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 63.240000000000002 111.128 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.454 HG23 ' O ' ' A' ' 7' ' ' ILE . 9.9 tt -126.68 110.56 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 74.430000000000007 111.155 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.4 t -136.54 143.81 34.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 62.420000000000002 111.112 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.85 138.2 40.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 74.319999999999993 110.89 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -93.25 42.67 1.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 75.030000000000001 110.885 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 173.93 -169.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 71.329999999999998 110.858 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.454 HG12 ' N ' ' A' ' 13' ' ' ASN . 6.2 t -63.95 160.3 3.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.218 -0.447 . . . . 64.430000000000007 111.178 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.454 ' N ' HG12 ' A' ' 12' ' ' VAL . 24.4 t30 -86.42 53.97 2.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 74.219999999999999 110.858 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.434 ' CG ' ' O ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.04 28.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 73.239999999999995 110.895 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.36 47.33 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.692 -0.766 . . . . 72.420000000000002 112.424 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.97 171.96 24.3 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.714 -0.755 . . . . 54.009999999999998 112.466 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.2 163.86 15.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.829 0.347 . . . . 72.450000000000003 110.924 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.1 p -144.52 165.44 27.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.434 . . . . 74.120000000000005 110.836 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -124.88 110.89 14.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 75.420000000000002 110.838 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.96 47.24 0.88 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 75.420000000000002 110.862 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.99 -176.08 5.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 73.450000000000003 111.138 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.0 t -138.71 40.02 2.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.443 . . . . 72.219999999999999 111.111 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.1 p -179.33 38.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 64.040000000000006 110.826 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -141.98 24.65 1.99 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.125 -0.489 . . . . 64.329999999999998 110.892 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.8 mp0 -144.18 162.41 40.32 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.583 0.706 . . . . 64.239999999999995 110.938 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -74.58 -50.4 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.699 2.266 . . . . 72.319999999999993 112.346 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 162.57 -88.93 0.11 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.77 -0.729 . . . . 64.349999999999994 112.53 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.625 ' HB2' ' CE1' ' A' ' 82' ' ' PHE . . . -175.42 -169.08 0.35 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.846 0.355 . . . . 72.329999999999998 111.126 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.75 85.77 1.78 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.759 -0.734 . . . . 70.200000000000003 112.496 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -159.77 46.31 0.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.835 0.35 . . . . 73.230000000000004 110.876 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -88.37 53.6 2.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 71.200000000000003 110.886 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.677 HD23 ' HB2' ' A' ' 77' ' ' ASN . 1.8 mp -95.39 -178.88 4.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 71.549999999999997 110.925 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -54.53 -27.03 35.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 70.310000000000002 110.896 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -103.66 41.54 1.27 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 73.219999999999999 110.861 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.489 ' O ' HD12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -96.07 101.86 13.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 63.399999999999999 110.921 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.447 HG23 ' O ' ' A' ' 35' ' ' LYS . 2.4 pt -156.1 119.28 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 74.120000000000005 111.159 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.2 p -161.84 -169.08 2.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 43.310000000000002 110.838 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.657 ' O ' HD12 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -127.85 149.18 50.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 62.140000000000001 110.875 -179.821 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.657 HD12 ' O ' ' A' ' 38' ' ' SER . 1.5 mp -124.35 138.96 52.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 71.409999999999997 111.161 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.4 ' HB3' HG23 ' A' ' 7' ' ' ILE . 1.2 tttt -142.49 138.67 31.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 73.120000000000005 110.945 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.7 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 6.4 p -132.87 139.15 50.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 72.129999999999995 111.095 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.3 39.93 2.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 65.450000000000003 110.89 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.87 120.24 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 71.319999999999993 110.853 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.23 -143.23 21.68 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.725 -0.75 . . . . 74.540000000000006 112.55 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.618 HG22 ' HA2' ' A' ' 62' ' ' GLY . 63.8 p -146.72 156.58 43.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.724 0.297 . . . . 74.150000000000006 111.126 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.773 ' CH2' HG13 ' A' ' 6' ' ' VAL . 2.7 m0 -125.32 169.81 11.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.218 -0.446 . . . . 64.040000000000006 110.919 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -112.11 121.59 45.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 63.32 110.911 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -113.65 120.07 39.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 74.209999999999994 110.901 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -139.88 126.78 20.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.153 -0.476 . . . . 60.100000000000001 110.933 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -100.72 89.98 4.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 73.319999999999993 110.909 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.444 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 170.96 -169.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 74.420000000000002 110.905 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' A' ' 52' ' ' ILE . 7.7 tp -64.87 159.41 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 75.219999999999999 111.104 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 -78.0 45.7 0.54 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 54.030000000000001 110.913 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -152.83 17.06 0.58 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 74.310000000000002 110.93 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 168.32 -118.18 0.77 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.754 -0.736 . . . . 75.140000000000001 112.492 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.444 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 71.56 -179.27 33.9 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.745 -0.74 . . . . 75.329999999999998 112.5 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.02 108.39 14.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.828 0.347 . . . . 64.129999999999995 110.87 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -78.35 106.88 10.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 74.109999999999999 110.897 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -138.15 106.2 5.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.112 -0.494 . . . . 73.239999999999995 110.906 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -84.76 157.41 21.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 74.219999999999999 110.857 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.496 HD22 HG21 ' A' ' 39' ' ' ILE . 9.7 tp -109.75 134.7 51.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 64.209999999999994 110.909 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.618 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -110.32 -178.55 20.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.668 -0.777 . . . . 74.209999999999994 112.493 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -47.88 100.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.747 2.298 . . . . 73.430000000000007 112.314 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.46 165.42 14.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.71 -0.757 . . . . 43.25 112.428 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -93.48 165.08 12.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.86 0.362 . . . . 53.219999999999999 110.941 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -160.24 105.03 1.49 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 74.430000000000007 110.928 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.6 m -96.45 91.13 5.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 71.450000000000003 110.837 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.18 131.81 34.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 75.239999999999995 110.838 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.492 HG23 ' HG2' ' A' ' 70' ' ' GLU . 29.8 m -150.05 18.67 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.119 -0.492 . . . . 53.240000000000002 111.14 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.492 ' HG2' HG23 ' A' ' 69' ' ' VAL . 0.0 OUTLIER 173.45 -17.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 73.299999999999997 110.905 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.34 -49.73 9.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 71.549999999999997 110.867 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.31 -70.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 64.310000000000002 111.064 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.761 ' O ' HD13 ' A' ' 74' ' ' ILE . . . 173.07 119.8 0.54 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.739 -0.743 . . . . 72.140000000000001 112.473 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.761 HD13 ' O ' ' A' ' 73' ' ' GLY . 5.5 mm -129.5 67.14 78.52 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.645 0.736 . . . . 75.530000000000001 111.135 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -81.38 -69.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.704 2.269 . . . . 55.530000000000001 112.335 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.2 t70 179.08 -40.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 71.099999999999994 110.91 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.677 ' HB2' HD23 ' A' ' 32' ' ' LEU . 16.9 t30 -176.71 107.46 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.47 . . . . 72.310000000000002 110.865 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.2 m -140.8 -169.97 2.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 74.239999999999995 110.824 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.9 mp -106.19 150.1 9.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.485 . . . . 74.329999999999998 111.17 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.6 p -165.51 146.8 7.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 62.32 110.861 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.465 ' HA ' ' HB3' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -160.04 158.94 31.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 74.030000000000001 110.863 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.625 ' CE1' ' HB2' ' A' ' 28' ' ' ALA . 4.1 p90 -150.63 135.78 17.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 74.439999999999998 110.862 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -88.59 120.73 30.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 63.210000000000001 110.911 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.662 ' HG2' HG11 ' A' ' 6' ' ' VAL . 28.9 mt-30 -81.36 92.64 6.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 65.340000000000003 110.904 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 74.219999999999999 111.121 179.971 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.762 0.315 . . . . 64.099999999999994 110.895 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -154.11 135.29 14.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 74.25 110.925 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.22 69.27 9.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 72.200000000000003 111.12 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.35 97.4 8.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 71.120000000000005 111.066 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.12 129.58 35.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 74.230000000000004 110.903 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.789 HG13 ' CH2' ' A' ' 46' ' ' TRP . 86.0 t -115.93 127.58 73.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 75.019999999999996 111.095 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.707 HG23 ' HB3' ' A' ' 40' ' ' LYS . 7.8 tt -125.03 110.81 25.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 63.340000000000003 111.134 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.1 t -123.02 143.84 34.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 71.349999999999994 111.113 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -105.12 138.47 41.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 73.150000000000006 110.909 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -94.7 43.34 1.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.085 -0.507 . . . . 75.540000000000006 110.852 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 173.0 -170.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 71.439999999999998 110.852 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.635 HG22 HD12 ' A' ' 36' ' ' ILE . 6.3 t -64.15 159.71 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 72.120000000000005 111.112 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.436 ' N ' HG12 ' A' ' 12' ' ' VAL . 55.5 t30 -86.1 53.9 2.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 73.530000000000001 110.869 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.441 ' CG ' ' O ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.05 28.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 44.219999999999999 110.882 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.35 51.69 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.758 -0.734 . . . . 55.530000000000001 112.484 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.07 171.38 24.57 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.715 -0.755 . . . . 35.130000000000003 112.501 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.54 133.92 35.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.806 0.336 . . . . 54.240000000000002 110.903 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.76 155.08 33.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 72.319999999999993 110.885 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -148.45 117.56 6.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 74.099999999999994 110.936 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -128.71 85.43 2.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 73.549999999999997 110.908 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.45 -169.54 2.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 62.100000000000001 111.117 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.4 t -137.82 39.91 2.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 43.119999999999997 111.131 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.8 p -162.7 41.99 0.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 72.409999999999997 110.832 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 t0 66.22 118.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 70.329999999999998 110.854 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.433 ' HB2' ' HD2' ' A' ' 26' ' ' PRO . 14.1 pt20 -79.78 161.7 65.41 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.625 0.726 . . . . 73.25 110.912 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.433 ' HD2' ' HB2' ' A' ' 25' ' ' GLN . 57.0 Cg_endo -82.02 68.29 7.94 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.649 2.232 . . . . 74.099999999999994 112.336 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 51.44 -166.17 0.82 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.743 -0.742 . . . . 70.439999999999998 112.454 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -152.81 31.39 0.5 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.829 0.347 . . . . 21.449999999999999 111.084 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.81 80.61 0.56 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.752 -0.737 . . . . 61.140000000000001 112.452 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -139.86 23.93 2.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.807 0.337 . . . . 73.530000000000001 110.831 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -74.13 -169.69 0.82 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 64.319999999999993 110.926 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -179.83 -169.15 0.13 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.231 -0.44 . . . . 52.020000000000003 110.957 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -65.45 -24.18 67.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 71.439999999999998 110.887 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -134.46 61.36 1.67 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 55.229999999999997 110.872 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.77 141.06 28.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 74.120000000000005 110.915 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.635 HD12 HG22 ' A' ' 12' ' ' VAL . 1.1 pt -153.41 107.93 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 73.120000000000005 111.143 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 63.7 p -149.86 -172.3 4.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 75.430000000000007 110.892 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.553 ' C ' HD12 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -135.22 149.53 49.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 74.010000000000005 110.859 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.553 HD12 ' C ' ' A' ' 38' ' ' SER . 1.9 mp -120.83 109.89 26.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 74.219999999999999 111.171 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.707 ' HB3' HG23 ' A' ' 7' ' ' ILE . 4.9 tttt -95.04 127.69 41.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 73.430000000000007 110.919 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.445 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 7.1 p -139.68 139.03 38.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 62.43 111.107 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.93 40.55 1.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 64.150000000000006 110.911 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.3 p -179.4 137.67 0.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 65.019999999999996 110.861 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.22 -155.3 4.75 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.753 -0.737 . . . . 70.239999999999995 112.474 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.471 HG22 ' HA2' ' A' ' 62' ' ' GLY . 67.3 p -150.03 150.13 31.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.806 0.336 . . . . 71.140000000000001 111.134 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.789 ' CH2' HG13 ' A' ' 6' ' ' VAL . 2.6 m0 -123.37 169.62 11.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 74.430000000000007 110.923 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -121.5 128.51 52.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 74.340000000000003 110.847 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -114.33 128.53 56.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 71.049999999999997 110.884 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.2 126.47 19.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.136 -0.484 . . . . 73.030000000000001 110.914 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -101.46 89.21 3.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 75.329999999999998 110.855 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.425 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.1 OUTLIER 171.66 -165.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 72.540000000000006 110.926 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -52.01 173.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 64.349999999999994 111.157 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -85.52 49.81 1.83 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 75.109999999999999 110.922 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 22.3 p90 176.86 41.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 63.420000000000002 110.905 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.12 -154.21 24.62 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.718 -0.753 . . . . 51.130000000000003 112.444 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.425 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 94.73 -177.06 35.48 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.767 -0.73 . . . . 74.150000000000006 112.483 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.29 110.8 9.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.826 0.346 . . . . 71.329999999999998 110.893 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -78.03 109.7 12.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 62.100000000000001 110.934 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -138.3 106.26 5.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.11 -0.495 . . . . 74.430000000000007 110.952 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.0 p30 -94.57 153.76 17.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 74.209999999999994 110.817 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.758 HD11 ' CE3' ' A' ' 46' ' ' TRP . 1.3 pt? -117.11 136.08 53.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 61.5 110.931 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.471 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -102.81 -162.68 25.91 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 61.329999999999998 112.484 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.27 105.39 0.29 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.685 2.257 . . . . 54.130000000000003 112.342 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.95 151.92 6.07 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.756 -0.735 . . . . 70.349999999999994 112.509 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.9 144.97 32.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.855 0.36 . . . . 71.109999999999999 110.869 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -124.35 157.28 35.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.095 -0.502 . . . . 60.109999999999999 110.896 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.1 t -160.05 68.31 0.38 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 61.539999999999999 110.866 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.609 ' CB ' ' HB2' ' A' ' 72' ' ' ALA . 0.4 OUTLIER -85.98 146.68 26.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 55.520000000000003 110.89 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.543 ' HB ' HG22 ' A' ' 36' ' ' ILE . 33.9 m -150.58 18.81 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 75.230000000000004 111.141 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -179.05 34.19 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 75.219999999999999 110.888 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 37.8 t -160.9 -40.64 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 74.319999999999993 110.867 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.609 ' HB2' ' CB ' ' A' ' 68' ' ' SER . . . -51.38 -44.18 62.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 61.549999999999997 111.131 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.751 ' O ' HD13 ' A' ' 74' ' ' ILE . . . 166.73 95.0 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.722 -0.752 . . . . 72.310000000000002 112.472 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.751 HD13 ' O ' ' A' ' 73' ' ' GLY . 4.9 mm -129.5 67.14 78.53 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.65 0.738 . . . . 62.25 111.124 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -80.83 -60.79 0.03 OUTLIER 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.667 2.245 . . . . 52.329999999999998 112.362 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 179.23 -33.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 75.349999999999994 110.81 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -141.17 -177.82 5.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 63.530000000000001 110.917 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.1 t -58.54 -96.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 62.43 110.889 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 mp 47.94 54.26 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 74.340000000000003 111.121 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.6 p -155.03 163.0 40.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 75.400000000000006 110.816 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.94 159.82 16.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.074 -0.512 . . . . 63.310000000000002 110.878 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -150.14 135.71 18.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 74.150000000000006 110.847 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -93.21 133.38 36.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 74.140000000000001 110.919 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.498 HE21 HG21 ' A' ' 6' ' ' VAL . 25.2 mt-30 -105.84 131.43 53.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 72.540000000000006 110.967 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.3 pt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 60.310000000000002 111.141 179.993 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.7 ttp . . . . . 0 C--O 1.23 0.037 0 CA-C-O 120.786 0.327 . . . . 35.119999999999997 110.844 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -128.63 147.46 50.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 73.239999999999995 110.913 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.32 98.05 1.68 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 43.210000000000001 111.068 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -81.11 121.28 25.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 53.030000000000001 111.085 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -89.25 104.35 16.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 54.409999999999997 110.897 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.769 HG22 ' CZ2' ' A' ' 46' ' ' TRP . 94.3 t -113.11 105.59 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 73.120000000000005 111.109 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.669 HD13 ' HB3' ' A' ' 20' ' ' ASP . 3.5 tp -117.07 110.3 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 72.239999999999995 111.12 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.2 m -133.15 159.29 43.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 44.509999999999998 111.116 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -112.18 142.3 44.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.127 -0.488 . . . . 74.340000000000003 110.92 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -95.35 31.85 1.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 73.319999999999993 110.924 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 175.52 -169.68 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 74.340000000000003 110.855 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.446 HG12 ' N ' ' A' ' 13' ' ' ASN . 7.9 t -62.75 159.9 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 62.549999999999997 111.149 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.446 ' N ' HG12 ' A' ' 12' ' ' VAL . 4.9 t-20 -84.51 54.07 2.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 74.519999999999996 110.907 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.436 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.66 28.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 74.319999999999993 110.88 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.12 47.61 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.689 -0.767 . . . . 62.009999999999998 112.486 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.8 171.48 24.06 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.709 -0.757 . . . . 75.450000000000003 112.501 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.3 tmmt? -91.01 122.83 34.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.803 0.335 . . . . 75.310000000000002 110.862 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.97 148.54 43.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 74.439999999999998 110.827 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -148.77 139.73 22.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 74.219999999999999 110.894 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.669 ' HB3' HD13 ' A' ' 7' ' ' ILE . 0.7 OUTLIER -125.71 87.14 2.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 60.25 110.873 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.68 179.36 7.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 70.0 111.084 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.7 t -153.57 116.57 4.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 53.530000000000001 111.161 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.0 t -179.36 -82.35 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 72.150000000000006 110.837 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -141.83 38.93 1.65 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 64.400000000000006 110.862 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -80.62 162.22 61.34 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.563 0.696 . . . . 72.5 110.933 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -71.48 -169.73 0.45 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.678 2.252 . . . . 75.400000000000006 112.349 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -162.42 -71.99 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.741 . . . . 54.200000000000003 112.494 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -147.59 179.85 7.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.823 0.344 . . . . 40.119999999999997 111.097 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.27 38.66 2.08 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.77 -0.729 . . . . 74.25 112.447 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -179.3 92.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.839 0.352 . . . . 73.530000000000001 110.897 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -174.25 94.1 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 62.32 110.905 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -88.26 95.36 10.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 71.140000000000001 110.894 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.8 t30 55.85 25.51 8.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 70.129999999999995 110.852 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -133.93 39.9 3.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 60.539999999999999 110.855 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.86 102.06 14.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 74.129999999999995 110.932 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.436 HG22 ' HB ' ' A' ' 69' ' ' VAL . 1.2 pt -153.49 104.13 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 74.349999999999994 111.121 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.9 p -157.16 -166.53 2.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 64.510000000000005 110.819 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.685 ' O ' HD12 ' A' ' 39' ' ' ILE . 21.2 t -127.14 154.46 44.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 71.109999999999999 110.828 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.685 HD12 ' O ' ' A' ' 38' ' ' SER . 1.5 mp -125.52 139.01 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 72.310000000000002 111.128 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.641 ' HB3' HG23 ' A' ' 7' ' ' ILE . 7.9 tttt -145.35 147.83 32.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 74.200000000000003 110.875 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 43' ' ' SER . 11.2 p -161.52 138.82 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 71.439999999999998 111.115 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -134.58 40.92 2.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 65.019999999999996 110.898 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.429 ' H ' HG22 ' A' ' 41' ' ' VAL . 1.8 t -179.62 119.4 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 73.0 110.89 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.08 -163.45 50.82 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.757 -0.735 . . . . 52.210000000000001 112.522 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.65 HG22 ' HA2' ' A' ' 62' ' ' GLY . 41.5 p -149.83 147.7 28.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.796 0.331 . . . . 64.340000000000003 111.166 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.769 ' CZ2' HG22 ' A' ' 6' ' ' VAL . 1.3 m0 -117.37 171.94 7.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 75.219999999999999 110.946 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -112.98 124.26 52.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 64.430000000000007 110.87 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -113.73 125.87 54.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 74.230000000000004 110.925 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.48 126.9 23.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 72.340000000000003 110.91 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -102.09 89.75 3.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 73.129999999999995 110.896 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.501 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.1 OUTLIER 170.72 -166.87 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.161 -0.472 . . . . 75.200000000000003 110.917 -179.873 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.404 ' HB ' ' CE1' ' A' ' 54' ' ' TYR . 1.0 OUTLIER -51.98 172.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 70.409999999999997 111.102 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -86.06 50.08 1.91 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 52.149999999999999 110.897 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.404 ' CE1' ' HB ' ' A' ' 52' ' ' ILE . 2.1 p90 174.88 45.12 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.474 . . . . 62.420000000000002 110.905 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.22 -150.14 18.08 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.724 -0.75 . . . . 54.43 112.465 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.501 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 87.37 -171.51 42.06 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.689 -0.767 . . . . 71.030000000000001 112.497 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.47 112.39 17.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.817 0.342 . . . . 73.120000000000005 110.886 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -79.23 101.04 7.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 74.219999999999999 110.943 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -133.86 107.54 7.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.119 -0.491 . . . . 71.310000000000002 110.914 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -83.85 154.21 23.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 74.340000000000003 110.849 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.549 HD12 ' H ' ' A' ' 62' ' ' GLY . 14.8 tp -99.34 148.34 24.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 44.520000000000003 110.934 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.65 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -129.55 -165.16 11.61 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.723 -0.751 . . . . 61.100000000000001 112.489 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.26 89.73 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.667 2.245 . . . . 64.140000000000001 112.339 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.32 171.18 40.57 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.761 -0.733 . . . . 74.209999999999994 112.513 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.8 143.83 50.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.833 0.349 . . . . 71.340000000000003 110.898 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -152.55 149.03 28.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 74.310000000000002 110.951 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.2 p -130.33 82.44 2.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 41.439999999999998 110.845 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.601 ' HB2' ' HB2' ' A' ' 72' ' ' ALA . 40.4 m -86.66 147.07 26.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 63.140000000000001 110.819 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HB ' HG22 ' A' ' 36' ' ' ILE . 34.7 m -150.69 19.04 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.074 -0.512 . . . . 74.409999999999997 111.164 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -179.46 34.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 73.219999999999999 110.905 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.1 t -160.74 -40.84 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 73.219999999999999 110.851 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.601 ' HB2' ' HB2' ' A' ' 68' ' ' SER . . . -52.3 -54.25 33.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 73.120000000000005 111.111 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.459 ' O ' HD13 ' A' ' 74' ' ' ILE . . . 178.37 85.74 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.815 -0.707 . . . . 75.439999999999998 112.481 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.459 HD13 ' O ' ' A' ' 73' ' ' GLY . 13.9 mm -123.89 67.55 42.17 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.64 0.733 . . . . 72.109999999999999 111.132 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -74.35 -53.86 0.1 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.689 2.259 . . . . 75.010000000000005 112.377 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.3 t70 179.44 -74.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 51.340000000000003 110.855 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -93.04 -169.85 2.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 62.210000000000001 110.918 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.92 114.49 26.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 74.049999999999997 110.882 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -152.64 69.52 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 74.439999999999998 111.12 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.7 p -158.76 161.63 37.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 75.019999999999996 110.851 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.74 163.24 18.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 72.409999999999997 110.834 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -151.16 136.31 17.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 62.119999999999997 110.86 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -88.53 120.21 29.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 74.349999999999994 110.883 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -79.18 102.03 8.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 72.310000000000002 110.896 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 pt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 75.310000000000002 111.101 179.953 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.802 0.334 . . . . 63.149999999999999 110.906 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -81.02 139.0 36.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 72.340000000000003 110.859 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -163.12 88.29 0.59 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 64.319999999999993 111.129 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -84.58 169.53 14.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.425 . . . . 33.32 111.129 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -91.14 109.7 20.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 63.340000000000003 110.882 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.73 HG13 ' CH2' ' A' ' 46' ' ' TRP . 96.7 t -115.89 136.37 52.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 71.519999999999996 111.099 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.76 HG23 ' HB3' ' A' ' 40' ' ' LYS . 8.3 tt -131.35 110.66 17.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 74.230000000000004 111.145 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.4 t -127.09 143.13 41.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 73.430000000000007 111.132 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -97.1 140.36 31.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 73.219999999999999 110.925 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -99.24 35.6 1.89 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 61.329999999999998 110.914 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 175.18 -169.73 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 72.340000000000003 110.871 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 13' ' ' ASN . 6.5 t -63.64 159.52 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 61.310000000000002 111.112 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.441 ' N ' HG12 ' A' ' 12' ' ' VAL . 39.5 p30 -85.78 54.19 3.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 62.020000000000003 110.902 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.441 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.1 28.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 75.329999999999998 110.881 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.22 50.28 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.726 -0.749 . . . . 65.129999999999995 112.505 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.1 171.51 24.53 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.761 -0.733 . . . . 64.340000000000003 112.529 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.21 126.06 42.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.764 0.316 . . . . 72.530000000000001 110.906 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.7 p -118.29 156.5 28.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.27 -0.423 . . . . 72.299999999999997 110.824 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -111.03 107.97 17.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 73.420000000000002 110.877 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -117.69 40.54 3.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 72.230000000000004 110.884 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.02 130.06 16.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 75.439999999999998 111.127 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 22' ' ' THR . 5.1 t -81.59 120.65 25.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.231 -0.441 . . . . 61.25 111.105 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.0 m -152.08 -82.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 73.209999999999994 110.857 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -174.54 72.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 63.229999999999997 110.849 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.16 162.59 53.85 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.572 0.701 . . . . 72.120000000000005 110.914 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.13 -15.71 22.92 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.67 2.247 . . . . 62.340000000000003 112.345 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.46 -80.13 1.03 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.75 -0.738 . . . . 63.539999999999999 112.5 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.548 ' HB2' ' CE1' ' A' ' 82' ' ' PHE . . . -147.65 -174.51 4.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.788 0.327 . . . . 63.149999999999999 111.153 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.97 19.08 9.84 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.708 -0.758 . . . . 72.310000000000002 112.501 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -148.07 68.19 1.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.809 0.338 . . . . 60.009999999999998 110.84 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -129.83 -176.18 3.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 64.209999999999994 110.899 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -175.14 -169.7 0.41 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.162 -0.472 . . . . 72.409999999999997 110.896 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -71.13 -28.18 64.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 63.119999999999997 110.878 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -98.17 39.71 1.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 75.409999999999997 110.885 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.429 ' O ' HG23 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -106.34 133.99 50.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 71.209999999999994 110.921 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.71 ' HB ' HG12 ' A' ' 69' ' ' VAL . 4.6 pt -155.23 128.92 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 61.350000000000001 111.103 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 84.8 p -167.34 -168.19 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 74.109999999999999 110.897 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.483 ' O ' HD12 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -125.13 152.72 44.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 75.129999999999995 110.871 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.483 HD12 ' O ' ' A' ' 38' ' ' SER . 1.3 mp -120.91 132.64 69.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 73.150000000000006 111.114 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.76 ' HB3' HG23 ' A' ' 7' ' ' ILE . 2.9 tttt -130.6 131.94 45.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 73.430000000000007 110.899 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.614 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 4.9 p -136.45 139.24 45.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 71.140000000000001 111.098 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.6 mmpp? -143.62 45.98 1.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 71.25 110.864 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.44 124.42 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 71.549999999999997 110.831 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.01 -150.0 8.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.748 -0.739 . . . . 61.299999999999997 112.487 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.6 p -147.57 144.74 28.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.797 0.332 . . . . 70.329999999999998 111.09 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.73 ' CH2' HG13 ' A' ' 6' ' ' VAL . 2.0 m0 -115.87 173.07 6.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 73.129999999999995 110.915 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -119.11 120.76 38.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.425 . . . . 71.409999999999997 110.84 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -109.63 125.73 52.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 60.039999999999999 110.838 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.83 143.91 37.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.074 -0.512 . . . . 74.239999999999995 110.879 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -107.93 88.5 2.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.077 -0.51 . . . . 45.109999999999999 110.918 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.414 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 171.78 -166.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 65.340000000000003 110.933 -179.829 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.609 HG22 ' H ' ' A' ' 53' ' ' ASN . 3.3 mm -78.79 171.52 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 73.040000000000006 111.091 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.609 ' H ' HG22 ' A' ' 52' ' ' ILE . 4.6 t-20 -74.66 57.83 0.77 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 64.140000000000001 110.878 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -151.01 -34.95 0.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 73.340000000000003 110.907 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -158.74 -141.91 3.26 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.731 -0.747 . . . . 50.25 112.489 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.414 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 106.53 -179.97 22.88 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.709 -0.757 . . . . 53.450000000000003 112.461 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.69 105.9 6.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.813 0.339 . . . . 65.209999999999994 110.89 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -76.73 106.99 8.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 63.119999999999997 110.913 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -138.29 106.98 5.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.113 -0.494 . . . . 74.519999999999996 110.897 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -90.32 141.35 28.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 74.319999999999993 110.881 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.561 HD21 ' CE3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -99.32 153.41 18.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 74.310000000000002 110.907 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -132.44 -168.4 12.01 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.729 -0.748 . . . . 52.530000000000001 112.487 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -46.48 101.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.645 2.23 . . . . 74.150000000000006 112.354 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.43 163.76 12.68 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.746 . . . . 70.409999999999997 112.516 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -127.52 138.43 52.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.91 0.386 . . . . 71.310000000000002 110.847 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -135.92 151.95 50.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 73.120000000000005 110.891 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 97.4 p -133.45 81.8 1.95 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 71.239999999999995 110.857 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.6 m -85.97 160.98 19.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 73.420000000000002 110.836 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.71 HG12 ' HB ' ' A' ' 36' ' ' ILE . 6.2 m -152.9 20.45 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 65.239999999999995 111.171 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -178.07 53.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 73.209999999999994 110.935 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.65 -35.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 74.310000000000002 110.851 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.97 -64.29 0.86 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 65.319999999999993 111.113 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 179.08 83.55 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.761 -0.733 . . . . 75.439999999999998 112.498 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.59 67.49 24.34 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.604 0.716 . . . . 73.409999999999997 111.171 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -80.3 -50.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.631 2.221 . . . . 74.319999999999993 112.342 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -179.56 -36.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 70.040000000000006 110.888 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -179.36 55.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 61.240000000000002 110.864 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.5 t -97.34 166.55 11.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 72.430000000000007 110.855 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.6 mt -106.16 153.51 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 73.230000000000004 111.167 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.2 p -149.98 155.91 40.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 73.239999999999995 110.835 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.38 158.15 29.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 74.140000000000001 110.839 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.548 ' CE1' ' HB2' ' A' ' 28' ' ' ALA . 2.6 p90 -150.48 135.41 17.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 75.5 110.867 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -95.1 130.8 41.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 63.130000000000003 110.833 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.668 ' HG3' HG21 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -97.28 131.64 43.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.464 . . . . 71.439999999999998 110.894 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.9 pt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 71.409999999999997 111.121 179.985 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.063 0 CA-C-O 120.831 0.348 . . . . 73.340000000000003 110.869 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.49 157.21 47.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 62.119999999999997 110.841 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.93 61.54 0.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 70.319999999999993 111.137 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -85.0 170.51 12.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 44.119999999999997 111.046 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.18 105.49 17.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 71.329999999999998 110.86 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.743 HG22 ' CZ2' ' A' ' 46' ' ' TRP . 98.5 t -110.32 116.03 51.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 60.109999999999999 111.169 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.728 HG23 ' HB3' ' A' ' 40' ' ' LYS . 7.9 tt -115.7 110.39 31.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 60.0 111.101 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 72.2 t -128.68 137.1 58.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 64.549999999999997 111.162 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -88.62 138.38 31.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.461 . . . . 75.439999999999998 110.949 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -96.0 47.85 1.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 61.5 110.846 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 173.29 -170.41 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 71.409999999999997 110.874 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 13' ' ' ASN . 4.9 t -64.61 161.51 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 75.400000000000006 111.092 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.461 ' N ' HG12 ' A' ' 12' ' ' VAL . 5.7 p-10 -86.76 53.66 2.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 62.219999999999999 110.896 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.438 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.52 29.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 74.230000000000004 110.883 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.94 49.72 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.754 -0.736 . . . . 41.039999999999999 112.504 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.07 171.59 24.49 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.702 -0.761 . . . . 72.329999999999998 112.445 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.06 162.94 14.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.771 0.319 . . . . 75.040000000000006 110.903 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.0 p -145.1 153.52 41.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 41.299999999999997 110.879 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -142.27 119.82 11.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 72.450000000000003 110.887 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -102.33 41.05 1.26 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 64.430000000000007 110.802 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.43 -168.39 1.69 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 53.329999999999998 111.144 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.48 -169.58 1.97 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 74.010000000000005 111.125 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.3 m -83.51 4.36 28.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 75.439999999999998 110.851 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -84.48 -7.97 59.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 73.540000000000006 110.872 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.8 155.42 75.58 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.589 0.709 . . . . 64.420000000000002 110.893 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.13 75.83 2.73 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.625 2.216 . . . . 72.549999999999997 112.37 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.6 -69.19 1.42 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.746 -0.74 . . . . 44.210000000000001 112.48 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.513 ' HB1' ' OG ' ' A' ' 81' ' ' SER . . . -60.35 -171.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.345 . . . . 74.230000000000004 111.096 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.28 57.69 0.59 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.751 -0.738 . . . . 53.030000000000001 112.509 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -98.15 -169.96 1.89 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.358 . . . . 73.200000000000003 110.837 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -169.45 -170.73 1.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 72.230000000000004 110.834 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.64 106.58 0.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 43.439999999999998 110.922 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 51.91 50.82 17.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 71.450000000000003 110.893 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.87 39.65 3.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 73.409999999999997 110.813 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.17 102.64 4.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 65.209999999999994 110.931 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 69' ' ' VAL . 1.1 pt -153.36 103.91 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 73.439999999999998 111.136 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 78.7 p -167.74 -166.78 0.78 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 65.329999999999998 110.861 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.579 ' C ' HD12 ' A' ' 39' ' ' ILE . 0.7 OUTLIER -111.69 148.46 33.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 73.439999999999998 110.869 -179.826 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.579 HD12 ' C ' ' A' ' 38' ' ' SER . 1.6 mp -120.85 127.77 75.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 52.140000000000001 111.164 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.728 ' HB3' HG23 ' A' ' 7' ' ' ILE . 1.0 OUTLIER -126.82 133.18 50.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 75.019999999999996 110.924 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.541 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 8.4 p -143.55 139.02 26.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 74.109999999999999 111.167 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.6 mmpp? -142.77 40.27 1.53 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 74.010000000000005 110.879 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.49 135.04 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 73.510000000000005 110.89 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.14 -159.49 2.78 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.777 -0.725 . . . . 72.030000000000001 112.465 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.1 p -145.43 151.3 38.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.799 0.333 . . . . 54.350000000000001 111.133 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.743 ' CZ2' HG22 ' A' ' 6' ' ' VAL . 2.0 m0 -124.2 175.36 7.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 64.219999999999999 110.898 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.578 ' HD2' HD11 ' A' ' 85' ' ' ILE . 1.7 mpt_? -121.48 120.54 35.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 74.530000000000001 110.904 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -107.28 126.23 52.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 75.019999999999996 110.857 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.83 142.99 36.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 73.120000000000005 110.915 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.03 88.36 2.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 44.340000000000003 110.883 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.433 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 172.01 -169.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 75.400000000000006 110.921 -179.831 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 30.1 pt -69.82 172.62 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.106 -0.497 . . . . 54.399999999999999 111.127 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -78.05 56.37 1.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 72.319999999999993 110.889 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -150.93 -40.56 0.12 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.475 . . . . 73.219999999999999 110.927 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.43 -143.89 3.88 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.704 -0.76 . . . . 61.219999999999999 112.476 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.433 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 108.11 176.18 22.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.781 -0.723 . . . . 52.450000000000003 112.506 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.03 104.78 3.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.785 0.326 . . . . 71.200000000000003 110.826 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -76.54 107.49 8.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 75.099999999999994 110.888 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -138.13 106.3 5.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 70.239999999999995 110.958 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -88.83 140.52 29.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.261 -0.427 . . . . 61.119999999999997 110.843 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.542 HD21 ' CE3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -99.3 156.82 16.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 64.310000000000002 110.934 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -131.54 -173.17 13.27 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.699 -0.762 . . . . 54.310000000000002 112.509 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -46.21 101.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.691 2.261 . . . . 71.409999999999997 112.307 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 158.74 157.39 8.47 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.713 -0.756 . . . . 62.420000000000002 112.457 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -117.68 148.24 42.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.83 0.348 . . . . 71.540000000000006 110.909 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -160.28 160.06 32.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.161 -0.472 . . . . 61.409999999999997 110.925 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.2 p -115.22 80.27 1.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.092 -0.504 . . . . 63.340000000000003 110.871 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.817 ' HB2' ' HB2' ' A' ' 72' ' ' ALA . 14.7 m -86.26 84.69 7.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 73.049999999999997 110.881 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.493 ' O ' HG22 ' A' ' 36' ' ' ILE . 12.2 m -89.89 -6.3 10.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.492 . . . . 55.219999999999999 111.156 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -162.62 62.53 0.21 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.487 . . . . 64.109999999999999 110.902 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.68 -34.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 53.310000000000002 110.877 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.817 ' HB2' ' HB2' ' A' ' 68' ' ' SER . . . -50.82 -47.85 59.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 62.32 111.107 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.643 ' H ' HD13 ' A' ' 74' ' ' ILE . . . -178.25 40.4 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.668 -0.777 . . . . 71.519999999999996 112.424 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.643 HD13 ' H ' ' A' ' 73' ' ' GLY . 0.0 OUTLIER -133.48 67.66 76.02 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.625 0.726 . . . . 72.329999999999998 111.156 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -81.77 -70.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.682 2.255 . . . . 74.109999999999999 112.329 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.473 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 1.9 t0 -94.17 -0.47 55.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 74.439999999999998 110.901 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 76' ' ' ASP . 5.6 m-20 81.07 89.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 73.340000000000003 110.844 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.9 m -146.04 -169.93 3.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 72.299999999999997 110.866 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.1 mt -76.23 153.31 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 65.329999999999998 111.162 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.6 t -149.05 157.42 43.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 73.129999999999995 110.872 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.513 ' OG ' ' HB1' ' A' ' 28' ' ' ALA . 0.3 OUTLIER -162.37 159.54 25.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 43.039999999999999 110.89 -179.795 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -150.83 136.12 17.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 60.409999999999997 110.887 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -87.44 121.62 30.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 73.349999999999994 110.926 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -79.7 93.41 5.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 75.439999999999998 110.96 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.578 HD11 ' HD2' ' A' ' 47' ' ' ARG . 1.8 pt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.438 . . . . 75.209999999999994 111.159 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 ttm . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.787 0.327 . . . . 71.430000000000007 110.904 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.33 163.01 24.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 62.399999999999999 110.849 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -165.4 66.19 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 41.009999999999998 111.111 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -148.83 94.33 2.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.463 . . . . 62.32 111.075 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.96 121.06 28.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 71.439999999999998 110.884 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.4 m -116.28 138.15 47.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 73.299999999999997 111.1 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.815 HG23 ' HB3' ' A' ' 40' ' ' LYS . 3.6 tp -101.18 110.05 27.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 72.530000000000001 111.141 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.6 t -129.89 140.83 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 42.310000000000002 111.133 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -93.43 138.83 31.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 73.319999999999993 110.94 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -93.47 42.39 1.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 73.329999999999998 110.842 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 175.13 -169.5 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 73.030000000000001 110.842 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 13' ' ' ASN . 5.8 t -64.1 160.61 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 75.040000000000006 111.122 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.442 ' N ' HG12 ' A' ' 12' ' ' VAL . 14.1 t30 -86.44 53.89 2.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 61.229999999999997 110.871 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.444 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.23 28.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 64.109999999999999 110.903 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.0 50.34 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.764 -0.731 . . . . 71.049999999999997 112.516 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.15 171.71 23.79 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.772 -0.728 . . . . 53.43 112.54 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.51 149.84 23.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.822 0.344 . . . . 72.549999999999997 110.848 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -131.32 141.62 49.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 62.509999999999998 110.895 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -136.44 152.3 50.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 74.430000000000007 110.861 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -140.93 77.57 1.6 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 71.549999999999997 110.856 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.43 152.86 28.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 44.009999999999998 111.137 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.5 p -94.3 45.03 1.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 55.200000000000003 111.14 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.55 -172.05 1.36 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 73.25 110.886 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.42 108.38 1.32 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 75.310000000000002 110.869 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.92 162.58 61.79 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.581 0.705 . . . . 65.030000000000001 110.903 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -47.92 105.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.687 2.258 . . . . 71.510000000000005 112.375 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.52 174.75 0.36 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.797 -0.716 . . . . 72.519999999999996 112.502 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.587 ' HB3' ' HA ' ' A' ' 81' ' ' SER . . . -60.07 -172.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.852 0.358 . . . . 44.039999999999999 111.051 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.54 112.01 2.41 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.777 -0.725 . . . . 44.140000000000001 112.493 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.03 -170.06 2.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.772 0.32 . . . . 63.140000000000001 110.885 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.08 179.24 0.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 64.549999999999997 110.923 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.2 mp -81.57 123.19 28.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.169 -0.469 . . . . 74.340000000000003 110.911 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 52.05 64.9 1.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 74.540000000000006 110.864 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -175.32 48.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 74.239999999999995 110.882 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.79 103.1 4.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 75.200000000000003 110.879 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.434 ' HB ' HG12 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -147.43 124.12 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 74.129999999999995 111.124 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.6 p -167.48 -168.34 1.02 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 54.219999999999999 110.844 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.515 ' C ' HD12 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -127.44 158.14 38.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 45.310000000000002 110.844 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.515 HD12 ' C ' ' A' ' 38' ' ' SER . 2.5 mp -120.92 140.07 46.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 54.0 111.154 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.815 ' HB3' HG23 ' A' ' 7' ' ' ILE . 15.1 tttt -130.05 119.53 23.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 64.340000000000003 110.83 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.647 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 4.9 p -114.12 139.28 40.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 65.239999999999995 111.104 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.86 39.69 1.82 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 73.219999999999999 110.928 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.2 114.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 64.019999999999996 110.871 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 60.65 -143.06 48.19 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.733 -0.746 . . . . 65.230000000000004 112.51 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.475 HG22 ' HA2' ' A' ' 62' ' ' GLY . 67.9 p -150.1 154.79 38.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.793 0.33 . . . . 55.530000000000001 111.14 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.647 ' CZ2' HG23 ' A' ' 41' ' ' VAL . 1.7 m0 -124.31 176.95 6.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.432 . . . . 74.329999999999998 110.908 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -126.49 130.8 51.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 74.540000000000006 110.84 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -115.33 126.34 54.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 75.329999999999998 110.897 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.9 126.78 20.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 73.120000000000005 110.948 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -102.89 89.56 3.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 71.430000000000007 110.902 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.472 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.1 OUTLIER 171.44 -166.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.191 -0.459 . . . . 63.420000000000002 110.959 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.401 HG13 ' H ' ' A' ' 52' ' ' ILE . 1.0 OUTLIER -52.19 173.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 55.439999999999998 111.112 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -86.32 50.15 1.93 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 74.430000000000007 110.914 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 22.3 p90 176.89 41.14 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.471 . . . . 75.439999999999998 110.946 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 165.1 -155.97 27.68 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.722 -0.752 . . . . 25.440000000000001 112.47 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.472 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 96.13 -171.33 28.26 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.724 -0.75 . . . . 74.129999999999995 112.469 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -80.93 108.68 14.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.869 0.366 . . . . 72.239999999999995 110.878 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -78.19 109.31 12.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 73.439999999999998 110.911 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -138.18 108.1 6.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 73.349999999999994 110.89 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -94.93 152.87 17.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 73.430000000000007 110.884 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.641 HD11 ' CE3' ' A' ' 46' ' ' TRP . 1.5 pt? -116.09 138.48 51.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 75.5 110.934 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.475 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -111.21 -170.14 19.05 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.729 -0.748 . . . . 43.420000000000002 112.461 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -46.99 99.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.628 2.219 . . . . 65.040000000000006 112.357 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.46 169.09 19.49 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.742 . . . . 72.510000000000005 112.544 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -99.5 146.22 26.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 62.210000000000001 110.875 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -130.38 151.57 50.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 73.439999999999998 110.883 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.5 t -119.11 93.23 4.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.087 -0.506 . . . . 55.25 110.846 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.814 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 0.7 OUTLIER -84.95 94.61 8.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.091 -0.504 . . . . 75.129999999999995 110.813 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.434 HG12 ' HB ' ' A' ' 36' ' ' ILE . 35.8 m -150.6 32.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.492 . . . . 71.150000000000006 111.119 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.449 ' HA ' HD11 ' A' ' 74' ' ' ILE . 1.1 pt-20 -171.41 30.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.463 . . . . 72.099999999999994 110.904 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.47 -67.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 71.310000000000002 110.881 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.814 ' HB3' ' HB3' ' A' ' 68' ' ' SER . . . -74.51 -34.85 63.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 72.450000000000003 111.107 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -65.8 -48.0 70.71 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.726 -0.749 . . . . 74.420000000000002 112.448 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.449 HD11 ' HA ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -113.88 74.17 2.49 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.604 0.716 . . . . 73.420000000000002 111.148 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.18 -49.06 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.681 2.254 . . . . 75.329999999999998 112.38 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -175.26 -62.5 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 73.420000000000002 110.859 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -142.09 -95.68 0.13 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 73.430000000000007 110.885 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.85 52.05 1.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 62.409999999999997 110.885 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.69 85.77 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.087 -0.506 . . . . 63.009999999999998 111.14 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 79.2 p -163.19 154.07 16.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.459 . . . . 73.109999999999999 110.868 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.587 ' HA ' ' HB3' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -165.53 160.76 18.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 72.239999999999995 110.832 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -150.16 135.77 18.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 75.310000000000002 110.89 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.436 ' NH1' HD13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -91.1 120.37 32.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 75.409999999999997 110.879 -179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -86.83 98.82 11.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 65.129999999999995 110.927 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.436 HD13 ' NH1' ' A' ' 83' ' ' ARG . 1.1 pt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 75.109999999999999 111.119 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mtp . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.794 0.331 . . . . 71.219999999999999 110.885 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -111.32 124.63 52.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 64.510000000000005 110.836 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.85 57.04 0.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 71.030000000000001 111.122 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -154.23 44.12 0.55 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 63.219999999999999 111.113 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -87.32 96.28 10.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.226 -0.443 . . . . 72.420000000000002 110.897 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.8 m -117.16 138.51 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 75.349999999999994 111.114 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.764 HG23 ' HB3' ' A' ' 40' ' ' LYS . 6.8 tt -99.49 110.38 26.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 73.450000000000003 111.121 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 m -122.89 159.73 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 64.010000000000005 111.134 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -111.66 139.94 46.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.162 -0.472 . . . . 71.530000000000001 110.914 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -100.1 28.51 4.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 61.409999999999997 110.895 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 175.87 -169.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 64.310000000000002 110.836 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 13' ' ' ASN . 10.8 t -62.98 157.37 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 54.450000000000003 111.094 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.415 ' N ' HG12 ' A' ' 12' ' ' VAL . 17.8 p30 -83.22 54.88 2.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 72.25 110.905 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.443 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -177.34 27.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 75.200000000000003 110.886 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.24 45.63 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.76 -0.733 . . . . 65.120000000000005 112.493 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.27 173.68 23.67 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.778 -0.725 . . . . 64.310000000000002 112.512 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.62 146.17 26.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.821 0.343 . . . . 51.119999999999997 110.866 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.0 p -117.15 162.89 17.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 70.319999999999993 110.834 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -118.55 135.81 54.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 74.030000000000001 110.901 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.4 p30 -147.2 42.13 1.09 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 73.129999999999995 110.876 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.57 158.7 25.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 75.349999999999994 111.111 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.1 m -138.68 70.85 1.38 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.456 . . . . 63.299999999999997 111.105 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.6 m -155.86 -82.6 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 61.450000000000003 110.872 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -179.14 101.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 74.430000000000007 110.881 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -80.16 161.94 63.54 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.598 0.713 . . . . 64.219999999999999 110.912 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.53 -170.54 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.715 2.277 . . . . 61.219999999999999 112.335 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.91 -98.41 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.749 -0.738 . . . . 34.439999999999998 112.44 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.554 ' HB2' ' CE1' ' A' ' 82' ' ' PHE . . . -173.84 154.7 2.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 70.340000000000003 111.063 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 177.3 155.97 14.99 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.729 -0.748 . . . . 60.119999999999997 112.457 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -174.74 -169.78 0.44 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.814 0.34 . . . . 75.030000000000001 110.852 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.0 167.67 6.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 64.439999999999998 110.923 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.694 HD23 ' O ' ' A' ' 76' ' ' ASP . 5.2 mp -65.12 -87.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 61.439999999999998 110.852 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -95.11 70.33 3.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 72.310000000000002 110.88 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -154.13 59.53 0.71 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 54.32 110.856 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.74 119.62 39.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 73.420000000000002 110.862 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.408 ' CB ' HG23 ' A' ' 69' ' ' VAL . 3.9 tt -174.14 102.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 72.019999999999996 111.143 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.4 p -169.21 -167.53 0.73 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 74.120000000000005 110.845 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.565 ' C ' HD12 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -127.36 152.0 48.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.102 -0.499 . . . . 55.509999999999998 110.835 -179.815 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.565 HD12 ' C ' ' A' ' 38' ' ' SER . 1.6 mp -120.99 137.93 53.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 75.519999999999996 111.153 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.764 ' HB3' HG23 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -137.35 119.69 15.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.467 . . . . 65.319999999999993 110.909 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.59 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 4.1 p -109.11 139.08 33.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 54.219999999999999 111.168 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.05 39.55 2.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 71.019999999999996 110.859 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.64 110.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.435 . . . . 55.219999999999999 110.859 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 56.99 -142.13 42.32 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.689 -0.767 . . . . 74.430000000000007 112.47 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.765 HG22 ' HA2' ' A' ' 62' ' ' GLY . 49.5 p -144.86 160.21 41.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.764 0.316 . . . . 54.409999999999997 111.14 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.712 ' CE3' HD11 ' A' ' 61' ' ' LEU . 1.7 m0 -123.22 -179.99 4.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 75.140000000000001 110.866 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.26 115.84 16.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 74.030000000000001 110.899 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -100.68 127.89 46.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 75.319999999999993 110.896 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.14 126.28 19.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 71.010000000000005 110.93 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -103.05 89.62 3.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 70.430000000000007 110.85 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.445 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 173.81 -171.82 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 72.209999999999994 110.904 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.6 tp -57.6 160.64 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 73.329999999999998 111.123 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -74.95 55.5 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 75.349999999999994 110.88 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -153.93 -38.27 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 74.140000000000001 110.892 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -146.61 -140.4 3.44 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 74.129999999999995 112.491 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.445 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 106.93 -175.33 20.61 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.764 -0.731 . . . . 62.439999999999998 112.51 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.7 106.48 7.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 71.510000000000005 110.873 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -79.52 109.23 13.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 73.219999999999999 110.937 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -138.07 108.32 6.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.084 -0.507 . . . . 72.219999999999999 110.951 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.66 157.37 16.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.286 -0.415 . . . . 71.299999999999997 110.87 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.712 HD11 ' CE3' ' A' ' 46' ' ' TRP . 1.6 pt? -121.36 153.98 37.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 74.200000000000003 110.916 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.765 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -121.12 179.32 16.32 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.751 -0.737 . . . . 62.210000000000001 112.496 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -43.97 104.82 0.06 OUTLIER 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.674 2.249 . . . . 72.540000000000006 112.35 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.52 162.59 11.43 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.731 -0.747 . . . . 72.519999999999996 112.488 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -81.11 174.0 12.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.843 0.354 . . . . 72.439999999999998 110.894 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -160.89 99.65 1.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 74.239999999999995 110.895 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.1 p -97.46 65.65 1.95 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.08 -0.509 . . . . 62.310000000000002 110.865 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.6 p -86.93 152.19 22.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 65.219999999999999 110.859 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 69' ' ' VAL . 6.1 p -163.61 23.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.113 -0.494 . . . . 62.229999999999997 111.114 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 177.25 35.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 50.329999999999998 110.908 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.95 -40.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 62.310000000000002 110.863 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.29 -50.1 70.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.1 -0.5 . . . . 75.409999999999997 111.091 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.443 ' C ' ' HD3' ' A' ' 75' ' ' PRO . . . 165.95 101.26 0.15 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 44.329999999999998 112.492 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.1 mm -113.29 74.83 2.11 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.604 0.716 . . . . 64.519999999999996 111.144 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.443 ' HD3' ' C ' ' A' ' 73' ' ' GLY . 70.1 Cg_endo -79.48 -165.62 0.35 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.665 2.243 . . . . 63.420000000000002 112.311 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.694 ' O ' HD23 ' A' ' 32' ' ' LEU . 3.7 m-20 -145.23 40.58 1.23 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.436 . . . . 72.209999999999994 110.853 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -175.9 -171.63 0.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 64.230000000000004 110.866 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 61.8 p -97.24 81.55 3.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 70.040000000000006 110.863 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -152.07 66.98 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 71.420000000000002 111.122 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 91.5 p -166.28 145.66 5.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 72.420000000000002 110.848 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.455 ' HA ' ' HB3' ' A' ' 28' ' ' ALA . 0.7 OUTLIER -163.93 165.62 22.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 74.430000000000007 110.804 -179.816 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.554 ' CE1' ' HB2' ' A' ' 28' ' ' ALA . 4.4 p90 -150.6 143.03 24.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 61.509999999999998 110.871 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -79.91 171.98 14.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 75.329999999999998 110.87 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -148.04 105.94 3.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 65.349999999999994 110.907 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.6 pt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 74.150000000000006 111.147 179.947 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mtt . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.75 0.309 . . . . 71.049999999999997 110.889 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -97.65 135.7 39.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 54.399999999999999 110.942 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.91 95.32 8.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 73.299999999999997 111.115 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -167.5 141.87 3.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 52.210000000000001 111.138 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -88.16 96.26 10.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 75.349999999999994 110.853 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.791 HG13 ' CH2' ' A' ' 46' ' ' TRP . 61.1 t -112.06 119.8 60.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 72.510000000000005 111.135 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.762 HG23 ' HB3' ' A' ' 40' ' ' LYS . 7.9 tt -123.76 110.19 25.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 51.530000000000001 111.111 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.0 m -126.82 142.25 43.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 75.319999999999993 111.102 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -92.26 141.6 28.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.177 -0.465 . . . . 71.109999999999999 110.923 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -96.42 44.37 1.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 74.230000000000004 110.91 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 172.95 -170.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 70.099999999999994 110.829 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 13' ' ' ASN . 5.1 t -64.47 161.27 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 73.5 111.129 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.46 ' N ' HG12 ' A' ' 12' ' ' VAL . 8.4 p-10 -86.75 53.74 2.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 60.420000000000002 110.919 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.445 ' CG ' ' O ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.41 28.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 74.099999999999994 110.879 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.88 47.11 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.762 -0.732 . . . . 54.329999999999998 112.492 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.08 171.61 24.48 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.711 -0.757 . . . . 63.420000000000002 112.506 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 ptpt -92.64 164.11 13.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.794 0.33 . . . . 72.120000000000005 110.91 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.0 p -138.98 160.33 40.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 55.340000000000003 110.833 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -121.1 110.11 15.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 72.200000000000003 110.86 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.92 48.38 0.97 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 61.340000000000003 110.838 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -98.27 149.12 22.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 72.310000000000002 111.119 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.1 m -92.36 43.69 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 63.399999999999999 111.095 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.57 -176.12 5.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 70.140000000000001 110.875 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -73.39 109.72 7.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.142 -0.481 . . . . 71.319999999999993 110.876 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.11 162.6 61.25 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.604 0.716 . . . . 73.340000000000003 110.897 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.23 106.17 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.703 2.269 . . . . 62.310000000000002 112.334 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.43 167.02 1.01 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.704 -0.76 . . . . 70.319999999999993 112.5 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.06 67.9 3.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.804 0.335 . . . . 74.230000000000004 111.094 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.24 -47.01 2.48 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.75 -0.738 . . . . 64.400000000000006 112.493 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.596 ' O ' ' CB ' ' A' ' 31' ' ' ASN . 12.9 m-20 -65.77 -171.36 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.814 0.34 . . . . 74.420000000000002 110.887 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.596 ' CB ' ' O ' ' A' ' 30' ' ' ASP . 2.2 t-20 90.88 175.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 74.439999999999998 110.874 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -153.6 63.7 0.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 70.109999999999999 110.896 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 53.5 t30 62.77 25.44 15.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 73.530000000000001 110.858 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -140.13 46.4 1.84 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 74.439999999999998 110.935 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.81 133.47 34.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 64.319999999999993 110.884 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.495 ' HA ' HG12 ' A' ' 69' ' ' VAL . 1.1 pt -152.46 118.08 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 74.409999999999997 111.091 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.8 p -167.54 -164.46 0.58 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 63.119999999999997 110.859 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.591 ' O ' HD12 ' A' ' 39' ' ' ILE . 0.7 OUTLIER -118.13 150.32 39.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 73.530000000000001 110.882 -179.836 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.591 HD12 ' O ' ' A' ' 38' ' ' SER . 1.5 mp -121.57 117.0 51.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 70.099999999999994 111.142 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.762 ' HB3' HG23 ' A' ' 7' ' ' ILE . 4.2 tttp -113.75 127.81 56.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 74.450000000000003 110.913 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.785 HG13 ' CZ2' ' A' ' 46' ' ' TRP . 6.2 t -122.33 139.31 49.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 74.109999999999999 111.134 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -151.99 39.76 0.62 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 74.140000000000001 110.893 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.5 t 179.48 115.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 71.239999999999995 110.863 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 51.74 -153.84 5.08 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.72 -0.752 . . . . 55.310000000000002 112.497 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.801 HG22 ' HA2' ' A' ' 62' ' ' GLY . 37.7 p -138.07 158.15 44.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.774 0.321 . . . . 62.210000000000001 111.113 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.791 ' CH2' HG13 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -125.12 170.84 10.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 74.109999999999999 110.942 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -115.44 126.42 54.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 73.319999999999993 110.892 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -112.14 127.15 55.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 72.140000000000001 110.88 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.26 137.41 34.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 71.209999999999994 110.937 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -112.25 87.9 2.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 60.039999999999999 110.867 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.417 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 170.45 -171.74 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.18 -0.463 . . . . 71.329999999999998 110.936 -179.862 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.4 pt -55.0 174.35 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 61.119999999999997 111.107 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -87.63 37.84 0.81 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 71.049999999999997 110.878 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -151.86 18.67 0.69 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 72.109999999999999 110.923 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.05 -154.51 23.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 50.100000000000001 112.517 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.417 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 106.9 178.93 22.81 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.746 -0.74 . . . . 61.240000000000002 112.494 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.85 103.75 6.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.35 . . . . 61.039999999999999 110.868 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -76.67 110.37 11.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 70.230000000000004 110.92 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -138.11 105.82 5.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.126 -0.488 . . . . 73.349999999999994 110.925 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -90.46 133.58 34.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 44.240000000000002 110.893 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.616 HD21 ' CE3' ' A' ' 46' ' ' TRP . 0.8 OUTLIER -99.06 165.02 11.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 72.510000000000005 110.885 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.801 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -128.7 -166.46 11.98 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.779 -0.724 . . . . 70.319999999999993 112.518 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.67 118.05 4.88 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.688 2.259 . . . . 55.210000000000001 112.313 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.96 156.31 7.76 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.797 -0.716 . . . . 61.32 112.53 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -117.99 139.17 51.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 73.409999999999997 110.892 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.597 ' OH ' HD12 ' A' ' 61' ' ' LEU . 2.9 p90 -160.2 160.12 32.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.115 -0.493 . . . . 64.530000000000001 110.896 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.5 m -112.43 81.7 1.52 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.053 -0.521 . . . . 65.420000000000002 110.844 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.2 m -84.98 149.03 25.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 65.329999999999998 110.874 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.495 HG12 ' HA ' ' A' ' 36' ' ' ILE . 6.0 m -152.99 22.55 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 62.149999999999999 111.129 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.435 ' HA ' HD11 ' A' ' 74' ' ' ILE . 0.9 OUTLIER -165.45 60.31 0.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 62.350000000000001 110.871 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.56 -33.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 73.200000000000003 110.89 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.3 -63.81 1.0 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 62.140000000000001 111.092 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.7 79.89 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 72.430000000000007 112.486 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.435 HD11 ' HA ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -140.69 67.23 29.16 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.62 0.724 . . . . 72.349999999999994 111.136 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -80.31 -35.3 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.655 2.237 . . . . 74.299999999999997 112.343 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -179.2 -34.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 63.009999999999998 110.877 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -140.67 164.83 29.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 74.019999999999996 110.864 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.557 ' O ' HD13 ' A' ' 79' ' ' ILE . 12.2 t -68.3 87.38 0.29 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 72.120000000000005 110.855 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.557 HD13 ' O ' ' A' ' 78' ' ' SER . 26.1 mm -139.03 68.51 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 71.25 111.145 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.8 p -146.83 165.17 30.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 61.340000000000003 110.837 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.6 157.73 14.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 65.510000000000005 110.849 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -150.8 136.57 18.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.126 -0.488 . . . . 64.140000000000001 110.901 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.69 120.09 32.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 63.350000000000001 110.815 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.73 ' HG2' HG11 ' A' ' 6' ' ' VAL . 4.4 mt-30 -79.4 97.67 6.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 73.540000000000006 110.936 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 pt . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 72.010000000000005 111.101 179.995 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.2 mtm . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.822 0.344 . . . . 75.129999999999995 110.909 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -101.37 155.51 18.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 63.329999999999998 110.893 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -163.67 113.99 1.32 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 64.150000000000006 111.116 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -169.85 119.73 0.64 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 74.420000000000002 111.137 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -84.99 96.45 9.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 62.109999999999999 110.86 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.798 HG11 ' HG2' ' A' ' 84' ' ' GLN . 84.2 t -109.02 120.04 59.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 75.109999999999999 111.15 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.441 HG23 ' O ' ' A' ' 7' ' ' ILE . 9.0 tt -128.84 111.54 23.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 65.310000000000002 111.107 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 m -131.21 161.56 40.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 73.319999999999993 111.12 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -114.21 148.29 37.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 64.230000000000004 110.937 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -102.24 40.68 1.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 72.420000000000002 110.897 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 172.79 -171.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 73.129999999999995 110.893 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.446 HG12 ' N ' ' A' ' 13' ' ' ASN . 6.1 t -63.97 160.15 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.429 . . . . 73.439999999999998 111.134 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.446 ' N ' HG12 ' A' ' 12' ' ' VAL . 7.7 t30 -85.79 53.96 2.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 74.129999999999995 110.903 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.419 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.25 28.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 71.530000000000001 110.878 -179.935 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.02 44.38 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.772 -0.728 . . . . 63.130000000000003 112.477 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.02 172.04 24.28 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.765 -0.731 . . . . 33.130000000000003 112.484 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.33 160.33 14.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.793 0.33 . . . . 72.25 110.87 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.1 p -136.37 164.56 27.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 73.040000000000006 110.838 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -123.14 113.91 19.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 63.030000000000001 110.871 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -127.37 67.38 1.3 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 74.439999999999998 110.866 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.78 150.96 23.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 72.099999999999994 111.096 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.6 p -93.89 40.06 1.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 43.439999999999998 111.153 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.8 m -93.94 20.3 7.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 65.129999999999995 110.855 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.2 t0 59.77 96.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 63.329999999999998 110.88 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 -80.06 162.34 62.32 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.654 0.74 . . . . 73.150000000000006 110.841 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -73.05 -170.91 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.7 2.266 . . . . 64.200000000000003 112.316 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.37 167.85 43.59 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.772 -0.727 . . . . 51.049999999999997 112.465 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.11 107.67 19.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.883 0.373 . . . . 54.229999999999997 111.071 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.41 86.39 1.82 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.771 -0.728 . . . . 74.319999999999993 112.466 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -141.88 30.11 1.66 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.813 0.34 . . . . 74.450000000000003 110.887 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 -130.88 -86.61 0.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 72.120000000000005 110.871 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.71 176.55 10.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 72.349999999999994 110.906 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -63.17 98.8 0.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 74.340000000000003 110.865 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -171.28 59.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 61.119999999999997 110.853 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.13 113.15 19.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 74.420000000000002 110.861 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.486 HG13 HG12 ' A' ' 69' ' ' VAL . 1.5 tt -176.77 107.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 72.530000000000001 111.151 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 83.3 p -167.88 -166.14 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 74.120000000000005 110.909 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.656 ' O ' HD12 ' A' ' 39' ' ' ILE . 0.8 OUTLIER -114.57 141.49 47.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 71.329999999999998 110.885 -179.872 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.656 HD12 ' O ' ' A' ' 38' ' ' SER . 1.6 mp -124.71 118.16 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 42.329999999999998 111.092 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -123.61 135.02 53.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 73.140000000000001 110.888 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.775 HG13 ' CZ2' ' A' ' 46' ' ' TRP . 4.7 t -129.17 139.57 51.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 72.329999999999998 111.143 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.99 39.35 1.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 70.209999999999994 110.907 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.8 t 177.84 120.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 70.310000000000002 110.851 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.14 -152.94 6.21 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.747 -0.74 . . . . 72.450000000000003 112.446 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.6 HG22 ' HA2' ' A' ' 62' ' ' GLY . 42.6 p -142.4 159.37 42.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.345 . . . . 53.530000000000001 111.139 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.775 ' CZ2' HG13 ' A' ' 41' ' ' VAL . 1.5 m0 -123.78 176.55 6.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 71.299999999999997 110.916 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -123.84 122.03 36.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 61.229999999999997 110.86 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -107.55 125.87 51.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 75.25 110.857 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.28 126.91 20.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 73.230000000000004 110.888 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -100.69 89.91 4.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 65.519999999999996 110.864 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.472 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.1 OUTLIER 170.76 -167.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 75.510000000000005 110.921 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -52.26 173.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.478 . . . . 74.420000000000002 111.15 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -86.56 50.28 1.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 65.200000000000003 110.874 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 22.2 p90 176.98 40.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 65.439999999999998 110.903 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.92 -157.71 30.26 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.747 -0.74 . . . . 63.340000000000003 112.533 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.472 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 95.42 -171.59 29.5 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.742 -0.742 . . . . 72.099999999999994 112.488 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.51 106.77 11.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.816 0.341 . . . . 72.129999999999995 110.896 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -77.72 109.47 11.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 70.129999999999995 110.883 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.9 t90 -138.04 105.38 5.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.115 -0.493 . . . . 71.540000000000006 110.892 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -89.41 135.61 33.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 64.329999999999998 110.91 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.592 HD21 ' CE3' ' A' ' 46' ' ' TRP . 0.8 OUTLIER -98.99 164.71 12.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.222 -0.445 . . . . 64.340000000000003 110.955 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.6 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -130.54 -174.92 13.82 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.745 -0.741 . . . . 62.409999999999997 112.52 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.54 117.04 3.26 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.708 2.272 . . . . 64.519999999999996 112.287 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.84 155.48 7.47 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.742 -0.742 . . . . 61.420000000000002 112.477 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -113.63 134.93 54.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 64.439999999999998 110.871 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.474 ' OH ' HD12 ' A' ' 61' ' ' LEU . 5.3 p90 -159.48 159.98 34.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 72.299999999999997 110.922 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 m -108.26 101.41 10.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 75.510000000000005 110.916 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.93 135.21 34.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 74.5 110.822 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.486 HG12 HG13 ' A' ' 36' ' ' ILE . 22.9 m -149.81 24.26 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 73.219999999999999 111.146 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.433 ' HG2' HG23 ' A' ' 69' ' ' VAL . 0.1 OUTLIER 173.21 -16.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 71.209999999999994 110.861 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.9 t -80.76 -23.95 39.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 74.010000000000005 110.827 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -83.62 -63.62 1.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 50.020000000000003 111.108 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.582 ' C ' HD13 ' A' ' 74' ' ' ILE . . . 166.95 124.14 0.7 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.74 -0.743 . . . . 64.409999999999997 112.488 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.582 HD13 ' C ' ' A' ' 73' ' ' GLY . 4.1 mm -122.33 69.8 31.96 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.625 0.726 . . . . 73.120000000000005 111.13 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -78.72 -166.34 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.702 2.268 . . . . 72.349999999999994 112.362 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.62 -29.84 27.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 73.519999999999996 110.847 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -143.65 162.62 35.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 72.340000000000003 110.863 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.59 119.19 10.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 62.32 110.844 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.2 pt -153.36 24.61 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 70.519999999999996 111.158 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.8 t -110.76 164.57 12.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 72.349999999999994 110.869 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.2 m -165.46 157.33 14.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 65.420000000000002 110.881 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -150.67 135.88 17.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 74.549999999999997 110.846 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.0 mmt85 -90.7 120.8 32.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 74.439999999999998 110.846 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.798 ' HG2' HG11 ' A' ' 6' ' ' VAL . 23.2 mt-30 -79.55 94.38 5.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 74.310000000000002 110.875 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 75.010000000000005 111.111 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 ptt? . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.827 0.346 . . . . 62.409999999999997 110.927 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -80.0 120.54 24.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 64.010000000000005 110.848 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.95 76.0 9.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 64.129999999999995 111.076 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.458 ' HB1' ' CD1' ' A' ' 85' ' ' ILE . . . -177.45 39.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 44.450000000000003 111.092 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.54 130.6 38.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 63.130000000000003 110.88 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.758 HG13 ' CZ2' ' A' ' 46' ' ' TRP . 76.2 t -116.11 127.02 73.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 63.340000000000003 111.13 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.437 HG23 ' O ' ' A' ' 7' ' ' ILE . 7.8 tt -123.14 110.89 27.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 74.219999999999999 111.138 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.1 t -124.54 140.39 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 74.349999999999994 111.103 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -90.7 139.97 30.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 75.120000000000005 110.932 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.33 35.42 1.78 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 60.100000000000001 110.917 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 177.21 -169.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.127 -0.488 . . . . 71.439999999999998 110.871 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.446 HG12 ' N ' ' A' ' 13' ' ' ASN . 5.3 t -63.77 160.28 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.211 -0.449 . . . . 73.129999999999995 111.111 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.446 ' N ' HG12 ' A' ' 12' ' ' VAL . 44.8 t30 -86.31 54.26 3.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 64.540000000000006 110.897 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.441 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.24 28.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 74.409999999999997 110.928 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.86 52.46 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.744 -0.741 . . . . 33.140000000000001 112.516 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.2 171.72 24.49 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.788 -0.72 . . . . 44.030000000000001 112.518 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.62 126.48 42.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.813 0.339 . . . . 74.129999999999995 110.883 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 82.1 p -118.0 151.98 36.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 75.200000000000003 110.907 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -109.11 133.64 52.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 70.329999999999998 110.911 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -130.54 41.01 3.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 53.310000000000002 110.862 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.96 151.77 23.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 54.32 111.053 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.2 m -80.14 63.14 4.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.223 -0.444 . . . . 64.400000000000006 111.148 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.2 p -148.7 -82.52 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 64.299999999999997 110.826 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -77.54 60.08 2.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.495 . . . . 64.430000000000007 110.848 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -158.72 68.23 3.43 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.572 0.701 . . . . 73.120000000000005 110.964 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -70.18 -173.1 0.71 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.664 2.243 . . . . 73.099999999999994 112.385 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.28 -176.31 47.49 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.719 -0.753 . . . . 51.109999999999999 112.485 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.667 ' HB3' ' HA ' ' A' ' 81' ' ' SER . . . -90.8 73.38 6.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.85 0.357 . . . . 75.019999999999996 111.122 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.52 -99.7 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.686 -0.769 . . . . 74.519999999999996 112.493 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -78.33 65.01 3.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.861 0.363 . . . . 74.230000000000004 110.845 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -64.1 179.37 0.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 55.409999999999997 110.899 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -164.52 -177.49 4.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 74.25 110.907 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -92.07 10.62 28.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 61.439999999999998 110.909 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -106.24 40.06 1.68 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 74.439999999999998 110.86 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.06 136.47 33.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 73.299999999999997 110.911 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.449 ' O ' HG23 ' A' ' 36' ' ' ILE . 7.4 tt -152.29 102.0 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 75.25 111.135 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.9 p -171.81 -165.63 0.38 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 62.399999999999999 110.835 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.556 ' O ' HD12 ' A' ' 39' ' ' ILE . 31.3 t -128.91 156.03 44.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 72.450000000000003 110.879 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.556 HD12 ' O ' ' A' ' 38' ' ' SER . 1.5 mp -121.04 140.54 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 71.409999999999997 111.12 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -141.59 119.39 11.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 64.219999999999999 110.879 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.485 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 13.9 p -119.97 139.64 46.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 72.409999999999997 111.115 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.76 38.23 1.65 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 72.030000000000001 110.922 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 172.86 110.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.234 -0.439 . . . . 63.520000000000003 110.831 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.17 -158.22 39.87 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.729 -0.748 . . . . 71.019999999999996 112.491 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.9 p -150.68 127.58 11.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.74 0.305 . . . . 72.510000000000005 111.177 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.758 ' CZ2' HG13 ' A' ' 6' ' ' VAL . 0.5 OUTLIER -94.15 164.78 12.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 65.420000000000002 110.947 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -119.86 117.18 27.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.302 -0.408 . . . . 74.019999999999996 110.903 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -105.41 125.69 51.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 64.310000000000002 110.878 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -141.08 125.83 17.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 74.540000000000006 110.87 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.23 88.57 3.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 75.329999999999998 110.92 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 175.92 174.33 0.31 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.135 -0.484 . . . . 71.109999999999999 110.9 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.056 HG22 HD12 ' A' ' 79' ' ' ILE . 26.6 pt -52.39 172.88 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 75.5 111.111 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -76.75 56.47 1.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 64.439999999999998 110.902 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -149.92 -69.94 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 63.530000000000001 110.918 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.82 -135.97 5.83 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.738 -0.744 . . . . 70.019999999999996 112.523 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.7 176.61 23.11 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.806 -0.711 . . . . 72.219999999999999 112.472 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.36 103.32 8.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.848 0.356 . . . . 71.140000000000001 110.89 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -77.55 106.53 9.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 74.420000000000002 110.914 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -134.79 106.7 7.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.085 -0.507 . . . . 73.310000000000002 110.941 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -92.19 136.63 33.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 72.150000000000006 110.851 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.721 HD21 ' CE3' ' A' ' 46' ' ' TRP . 1.2 pp -100.26 140.91 33.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 71.319999999999993 110.936 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -122.45 -165.24 12.4 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.735 -0.745 . . . . 52.109999999999999 112.495 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -40.43 104.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.632 2.221 . . . . 73.150000000000006 112.354 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.88 164.35 13.16 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.788 -0.72 . . . . 64.239999999999995 112.539 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.08 148.49 50.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.898 0.38 . . . . 74.519999999999996 110.88 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -153.57 139.1 17.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 64.129999999999995 110.879 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.7 m -122.73 71.67 1.04 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 63.119999999999997 110.894 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 44.7 m -89.61 171.95 9.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 64.340000000000003 110.878 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.455 ' O ' HG13 ' A' ' 69' ' ' VAL . 4.2 p -162.4 23.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 61.119999999999997 111.107 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.424 ' HA ' HD11 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -174.88 35.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 71.230000000000004 110.87 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.9 t -157.81 -40.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 44.520000000000003 110.873 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.27 -61.74 1.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 72.349999999999994 111.135 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.02 94.44 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.718 -0.753 . . . . 74.120000000000005 112.483 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.424 HD11 ' HA ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -147.17 64.28 8.73 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.584 0.707 . . . . 61.530000000000001 111.152 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -80.86 -47.32 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.716 2.277 . . . . 53.520000000000003 112.316 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -174.0 -168.4 0.41 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 71.420000000000002 110.852 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -84.62 53.06 2.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 64.040000000000006 110.891 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.7 m -99.01 -169.63 1.8 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 72.049999999999997 110.831 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 1.056 HD12 HG22 ' A' ' 52' ' ' ILE . 4.8 mt -82.18 137.39 21.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 74.219999999999999 111.111 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.13 143.12 18.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 74.219999999999999 110.881 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.667 ' HA ' ' HB3' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -162.18 168.27 22.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 72.239999999999995 110.828 -179.801 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -150.82 135.6 17.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 73.129999999999995 110.879 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.0 130.62 34.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 65.099999999999994 110.884 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.748 ' HG2' HG21 ' A' ' 6' ' ' VAL . 5.8 mt-30 -79.94 108.69 13.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 75.230000000000004 110.923 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.458 ' CD1' ' HB1' ' A' ' 4' ' ' ALA . 13.3 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 51.140000000000001 111.118 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.762 0.315 . . . . 70.519999999999996 110.871 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -91.97 177.74 6.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 63.439999999999998 110.878 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -165.34 77.6 0.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 64.040000000000006 111.072 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 24' ' ' ASP . . . -167.32 108.39 0.62 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 64.319999999999993 111.137 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -89.49 104.88 17.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 63.409999999999997 110.908 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.73 HG13 ' CH2' ' A' ' 46' ' ' TRP . 87.5 t -116.77 128.46 74.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 73.409999999999997 111.142 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.716 HG23 ' HB3' ' A' ' 40' ' ' LYS . 8.9 tt -128.86 110.72 21.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 62.340000000000003 111.129 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 83.0 t -129.79 144.37 38.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 70.329999999999998 111.183 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -103.11 133.86 47.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 71.319999999999993 110.937 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -94.26 48.02 1.22 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.489 . . . . 75.400000000000006 110.86 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 174.26 -169.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 74.150000000000006 110.841 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.454 HG12 ' N ' ' A' ' 13' ' ' ASN . 4.8 t -64.83 161.23 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 73.109999999999999 111.13 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.454 ' N ' HG12 ' A' ' 12' ' ' VAL . 19.4 p-10 -87.93 54.11 2.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 75.319999999999993 110.87 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.432 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -176.96 28.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 62.130000000000003 110.837 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.41 50.67 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.749 -0.739 . . . . 60.450000000000003 112.477 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.08 171.62 24.48 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.707 -0.759 . . . . 54.409999999999997 112.455 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.38 163.46 14.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.767 0.318 . . . . 72.430000000000007 110.919 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.2 p -149.63 157.63 43.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 65.040000000000006 110.865 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -109.58 106.32 15.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 63.520000000000003 110.874 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -124.45 69.73 1.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.115 -0.493 . . . . 60.5 110.855 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -120.67 160.23 23.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 64.299999999999997 111.086 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.9 t -93.56 40.82 1.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 62.240000000000002 111.168 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.2 m -145.49 25.04 1.37 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 74.340000000000003 110.89 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.488 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 24.3 m-20 54.91 -174.22 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.1 -0.5 . . . . 73.319999999999993 110.825 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.98 159.23 73.51 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.62 0.724 . . . . 72.420000000000002 110.916 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -80.65 -169.12 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.729 2.286 . . . . 62.549999999999997 112.365 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.52 108.64 2.55 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.755 -0.736 . . . . 72.219999999999999 112.471 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.85 -86.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.865 0.365 . . . . 73.450000000000003 111.089 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.54 98.66 0.28 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 60.140000000000001 112.533 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -60.74 -171.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.833 0.349 . . . . 71.340000000000003 110.83 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.85 -172.3 2.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 71.099999999999994 110.934 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.9 mp -61.86 102.25 0.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 71.030000000000001 110.907 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 63.74 20.92 12.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 72.120000000000005 110.863 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -99.78 39.66 1.3 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 75.340000000000003 110.843 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.86 102.39 11.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 72.049999999999997 110.89 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.451 HG13 HG12 ' A' ' 69' ' ' VAL . 7.3 tt 179.1 102.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 75.109999999999999 111.142 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 52.2 p -168.35 -168.5 0.94 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 75.329999999999998 110.845 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.522 ' O ' HD12 ' A' ' 39' ' ' ILE . 0.6 OUTLIER -120.9 145.07 48.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.478 . . . . 74.019999999999996 110.867 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.601 HG21 HD22 ' A' ' 61' ' ' LEU . 1.4 mp -121.26 123.07 69.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 65.420000000000002 111.154 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.716 ' HB3' HG23 ' A' ' 7' ' ' ILE . 3.9 tttt -117.06 129.18 55.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 72.409999999999997 110.906 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.455 HG11 ' HG ' ' A' ' 61' ' ' LEU . 4.7 p -144.98 139.81 22.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 71.129999999999995 111.124 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.52 39.93 1.72 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 75.439999999999998 110.952 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 179.78 139.04 0.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 72.450000000000003 110.815 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 53.31 -165.35 1.88 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.77 -0.729 . . . . 71.120000000000005 112.485 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.466 HG22 ' HA2' ' A' ' 62' ' ' GLY . 68.5 p -144.98 144.71 31.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.79 0.329 . . . . 62.530000000000001 111.151 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.73 ' CH2' HG13 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -124.2 136.25 54.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.439 . . . . 64.209999999999994 110.953 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -79.96 125.56 29.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 52.009999999999998 110.857 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -113.21 124.89 53.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 75.420000000000002 110.841 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.87 126.73 20.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 74.409999999999997 110.963 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -95.4 88.8 5.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 73.319999999999993 110.874 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.443 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 172.14 -169.72 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.155 -0.475 . . . . 73.200000000000003 110.91 -179.872 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.0 pt -69.74 172.7 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.09 -0.505 . . . . 54.520000000000003 111.144 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -78.8 56.21 1.85 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 55.130000000000003 110.876 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -151.4 -40.6 0.12 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 75.439999999999998 110.868 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.51 -144.81 4.03 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.698 -0.763 . . . . 73.409999999999997 112.437 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.443 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 108.39 175.38 21.88 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.715 -0.755 . . . . 73.430000000000007 112.488 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -66.93 106.45 1.92 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.844 0.355 . . . . 74.319999999999993 110.857 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -77.96 103.17 7.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 71.310000000000002 110.92 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.0 t90 -137.6 109.28 7.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.156 -0.475 . . . . 63.240000000000002 110.949 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -84.69 144.92 28.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 73.530000000000001 110.837 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.601 HD22 HG21 ' A' ' 39' ' ' ILE . 11.5 tp -99.53 137.34 38.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.229 -0.441 . . . . 74.010000000000005 110.939 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.466 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -115.16 -162.32 13.58 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.739 . . . . 52.340000000000003 112.449 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -64.03 100.89 0.32 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.678 2.252 . . . . 71.120000000000005 112.335 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 158.48 157.44 8.48 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.753 -0.737 . . . . 51.350000000000001 112.485 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.05 136.67 54.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.893 0.377 . . . . 73.140000000000001 110.905 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -135.79 138.34 42.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 74.049999999999997 110.902 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 m -114.25 75.32 0.92 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 65.219999999999999 110.846 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 40.7 t -86.21 152.41 22.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 73.420000000000002 110.829 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.451 HG12 HG13 ' A' ' 36' ' ' ILE . 16.7 m -149.64 23.59 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 63.329999999999998 111.093 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 178.06 -16.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.477 . . . . 65.230000000000004 110.873 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.11 -32.18 64.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 64.109999999999999 110.851 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.52 -65.71 0.79 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 71.040000000000006 111.112 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.735 ' O ' HD13 ' A' ' 74' ' ' ILE . . . 166.49 114.03 0.29 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.745 -0.74 . . . . 72.209999999999994 112.485 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.735 HD13 ' O ' ' A' ' 73' ' ' GLY . 7.0 mm -130.54 67.23 80.04 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.671 0.748 . . . . 70.519999999999996 111.173 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -81.72 -74.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.721 2.28 . . . . 71.25 112.327 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.498 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 4.9 t70 177.44 87.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 75.219999999999999 110.861 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 76' ' ' ASP . 9.0 t-20 83.67 131.11 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 73.310000000000002 110.927 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -179.6 151.75 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 62.350000000000001 110.88 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.6 mt -108.55 153.44 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 51.409999999999997 111.084 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.6 p -154.88 158.87 39.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 73.010000000000005 110.871 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.59 157.32 27.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.495 . . . . 63.140000000000001 110.856 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -150.72 135.78 17.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 75.430000000000007 110.884 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.6 mmm-85 -93.49 126.56 38.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 72.109999999999999 110.878 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.553 ' CG ' HG21 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -91.23 131.48 36.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 60.100000000000001 110.958 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.9 pt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 74.420000000000002 111.115 179.976 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.806 0.336 . . . . 72.530000000000001 110.827 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -161.69 -169.13 2.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 72.439999999999998 110.889 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.19 -146.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 53.25 111.107 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.15 133.72 36.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 71.349999999999994 111.088 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -87.36 99.95 12.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 73.109999999999999 110.871 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.762 HG13 ' CH2' ' A' ' 46' ' ' TRP . 99.4 t -106.84 121.77 60.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.485 . . . . 75.150000000000006 111.12 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.445 HG23 ' O ' ' A' ' 7' ' ' ILE . 9.0 tt -123.38 112.17 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 74.0 111.123 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.402 HG13 HG13 ' A' ' 39' ' ' ILE . 17.1 t -128.71 136.88 58.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 74.299999999999997 111.093 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -89.06 140.91 28.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 74.420000000000002 110.908 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -97.09 38.43 1.24 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 72.299999999999997 110.909 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 175.08 -169.53 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.482 . . . . 72.230000000000004 110.891 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.449 HG12 ' N ' ' A' ' 13' ' ' ASN . 4.8 t -63.9 161.39 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 42.229999999999997 111.143 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.449 ' N ' HG12 ' A' ' 12' ' ' VAL . 2.8 t-20 -87.35 54.19 3.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 73.450000000000003 110.905 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.439 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.2 28.56 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 71.239999999999995 110.898 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.6 47.8 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.766 -0.731 . . . . 52.219999999999999 112.497 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.92 171.98 24.27 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.748 -0.739 . . . . 53.439999999999998 112.49 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.56 160.95 17.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.818 0.342 . . . . 73.150000000000006 110.865 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 78.4 p -138.24 155.76 48.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 74.450000000000003 110.874 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -117.24 104.65 11.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 64.549999999999997 110.854 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -105.34 40.01 1.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 74.239999999999995 110.868 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -127.98 -166.2 1.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 45.149999999999999 111.081 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.5 t -78.79 -170.76 2.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 62.240000000000002 111.136 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.4 m -77.16 59.38 1.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 42.530000000000001 110.9 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.1 -37.11 9.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.491 . . . . 73.219999999999999 110.893 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.97 162.96 60.27 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.565 0.697 . . . . 73.140000000000001 110.893 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -47.49 100.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.34 0.111 0 C-N-CA 122.669 2.246 . . . . 64.329999999999998 112.342 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.91 -97.64 1.02 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.744 -0.741 . . . . 64.349999999999994 112.488 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.513 ' HB1' ' OG ' ' A' ' 81' ' ' SER . . . -83.44 60.85 5.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.778 0.323 . . . . 70.209999999999994 111.089 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 177.39 67.5 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.722 -0.751 . . . . 53.32 112.472 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -176.98 92.16 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.79 0.328 . . . . 63.409999999999997 110.871 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -174.08 176.43 2.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 64.439999999999998 110.873 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.407 HD23 ' N ' ' A' ' 33' ' ' ASN . 0.4 OUTLIER -176.65 -85.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 70.019999999999996 110.941 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.436 ' OD1' HG22 ' A' ' 74' ' ' ILE . 55.8 t30 -146.68 22.27 1.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 43.100000000000001 110.882 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -133.46 39.81 3.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 73.230000000000004 110.887 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.86 102.81 11.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 73.230000000000004 110.863 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.403 HG22 ' CB ' ' A' ' 69' ' ' VAL . 1.1 pt -148.89 103.96 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 61.25 111.118 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 79.3 p -167.7 -165.76 0.68 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 70.310000000000002 110.847 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.558 ' C ' HD12 ' A' ' 39' ' ' ILE . 0.9 OUTLIER -123.61 148.48 46.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 52.009999999999998 110.874 -179.819 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.558 HD12 ' C ' ' A' ' 38' ' ' SER . 1.6 mp -121.02 139.07 49.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 54.100000000000001 111.141 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -141.97 134.3 27.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 75.040000000000006 110.881 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.48 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 11.0 p -135.57 138.95 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 74.219999999999999 111.13 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.14 39.48 2.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 63.420000000000002 110.874 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.431 ' H ' HG22 ' A' ' 41' ' ' VAL . 0.3 OUTLIER 178.57 110.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 74.430000000000007 110.865 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.89 -157.41 53.51 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.739 -0.743 . . . . 65.519999999999996 112.428 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.487 HG22 ' HA2' ' A' ' 62' ' ' GLY . 72.7 p -150.24 135.96 18.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.757 0.313 . . . . 70.319999999999993 111.161 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.762 ' CH2' HG13 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -99.63 168.75 9.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 63.119999999999997 110.911 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -115.05 123.29 48.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 75.209999999999994 110.9 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.412 ' HD2' HD23 ' A' ' 61' ' ' LEU . 1.6 m-85 -110.15 123.58 50.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 72.409999999999997 110.89 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.87 126.61 20.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 73.530000000000001 110.902 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -102.62 89.86 3.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 64.5 110.89 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.535 ' HA ' HG22 ' A' ' 79' ' ' ILE . 0.1 OUTLIER 172.05 -166.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.477 . . . . 71.310000000000002 110.937 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.479 HG22 ' N ' ' A' ' 53' ' ' ASN . 5.8 mm -54.98 164.57 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 75.409999999999997 111.131 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.479 ' N ' HG22 ' A' ' 52' ' ' ILE . 59.4 m-20 -80.17 51.9 1.47 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 73.030000000000001 110.886 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.433 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 1.9 p90 -179.47 27.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.482 . . . . 73.230000000000004 110.931 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.33 -164.86 37.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.745 -0.74 . . . . 72.040000000000006 112.457 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.452 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 107.55 -169.68 14.87 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.757 -0.735 . . . . 65.420000000000002 112.488 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.17 105.02 12.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.356 . . . . 71.400000000000006 110.891 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -78.06 108.4 11.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 75.239999999999995 110.945 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -138.11 106.17 5.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.149 -0.478 . . . . 72.439999999999998 110.923 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -93.41 138.41 31.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.436 . . . . 75.230000000000004 110.878 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.64 HD21 ' CE3' ' A' ' 46' ' ' TRP . 1.2 pp -103.13 142.71 33.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 61.219999999999999 110.925 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.487 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -122.77 -162.85 11.65 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.753 -0.737 . . . . 50.310000000000002 112.52 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -45.5 101.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.655 2.237 . . . . 62.439999999999998 112.39 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 163.62 171.53 29.98 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.736 . . . . 72.209999999999994 112.524 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -133.84 143.92 48.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.847 0.356 . . . . 61.229999999999997 110.867 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -151.89 140.12 20.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.484 . . . . 72.409999999999997 110.942 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.8 p -124.29 72.6 1.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 73.299999999999997 110.841 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.8 t -86.06 168.97 13.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 64.030000000000001 110.891 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.403 ' CB ' HG22 ' A' ' 36' ' ' ILE . 12.9 m -152.28 23.53 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 44.25 111.132 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.568 ' HA ' HD13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -176.08 57.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 61.509999999999998 110.879 -179.952 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 t -175.99 -43.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 65.109999999999999 110.872 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.71 -66.09 0.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 75.540000000000006 111.124 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -176.89 93.32 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.716 -0.754 . . . . 71.200000000000003 112.462 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.568 HD13 ' HA ' ' A' ' 70' ' ' GLU . 3.3 mp -128.35 67.91 76.31 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.657 0.741 . . . . 73.329999999999998 111.109 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -76.98 -166.12 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.684 2.256 . . . . 71.519999999999996 112.37 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -91.4 -24.23 19.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 64.329999999999998 110.892 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -141.78 172.45 12.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 75.030000000000001 110.91 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.645 ' O ' HD13 ' A' ' 79' ' ' ILE . 1.0 OUTLIER -67.74 88.14 0.24 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 53.039999999999999 110.868 -179.878 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.645 HD13 ' O ' ' A' ' 78' ' ' SER . 23.9 mm -134.91 61.81 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 74.219999999999999 111.177 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.8 t -163.02 156.17 19.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 64.329999999999998 110.892 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.513 ' OG ' ' HB1' ' A' ' 28' ' ' ALA . 0.6 OUTLIER -165.54 159.32 16.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 72.010000000000005 110.917 -179.803 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -150.4 135.77 17.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 71.140000000000001 110.877 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -94.27 118.35 31.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 71.439999999999998 110.92 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.586 ' HB3' HG21 ' A' ' 6' ' ' VAL . 39.8 mt-30 -79.66 93.0 5.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.458 . . . . 70.150000000000006 110.899 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 pt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 61.200000000000003 111.115 179.965 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.811 0.338 . . . . 73.099999999999994 110.899 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -148.39 170.45 17.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 54.329999999999998 110.917 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -160.68 106.11 1.44 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 61.530000000000001 111.112 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -161.89 132.61 5.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 45.329999999999998 111.092 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.576 ' HB3' HG23 ' A' ' 22' ' ' THR . 0.0 OUTLIER -88.62 115.4 26.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 64.430000000000007 110.875 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.9 m -112.13 138.64 40.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 74.409999999999997 111.166 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.82 HG23 ' HB3' ' A' ' 40' ' ' LYS . 2.7 tp -105.34 110.97 32.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 64.129999999999995 111.135 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.604 HG12 HD13 ' A' ' 39' ' ' ILE . 3.0 m -131.25 165.0 32.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 75.310000000000002 111.067 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -117.3 142.7 46.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 73.239999999999995 110.916 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -101.45 37.72 1.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.495 . . . . 72.540000000000006 110.889 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 174.02 -170.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.483 . . . . 74.120000000000005 110.816 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.438 HG12 ' N ' ' A' ' 13' ' ' ASN . 5.1 t -64.12 160.37 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 74.409999999999997 111.103 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.438 ' N ' HG12 ' A' ' 12' ' ' VAL . 11.6 p-10 -87.32 54.5 3.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 70.409999999999997 110.924 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.441 ' CG ' ' O ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -176.91 28.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 64.329999999999998 110.883 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.9 46.16 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.786 -0.721 . . . . 75.430000000000007 112.548 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.19 172.01 24.36 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.718 -0.753 . . . . 33.530000000000001 112.484 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.42 152.26 22.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.782 0.325 . . . . 60.149999999999999 110.93 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.62 148.92 49.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 72.150000000000006 110.868 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -102.29 104.29 14.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 65.140000000000001 110.898 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -122.72 53.29 1.28 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 72.200000000000003 110.858 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -139.49 140.56 37.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 62.140000000000001 111.078 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.576 HG23 ' HB3' ' A' ' 5' ' ' GLU . 3.0 m -80.44 69.33 6.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 74.349999999999994 111.093 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.6 t -145.51 -170.05 3.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 74.409999999999997 110.812 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -90.02 77.23 6.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.124 -0.489 . . . . 65.120000000000005 110.866 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -80.07 162.32 62.38 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.582 0.706 . . . . 65.140000000000001 110.926 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -57.18 95.97 0.07 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.67 2.246 . . . . 70.549999999999997 112.314 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.34 -101.72 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.745 -0.74 . . . . 74.450000000000003 112.45 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.404 ' HB1' ' HA ' ' A' ' 81' ' ' SER . . . -91.06 -175.08 4.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.881 0.372 . . . . 52.130000000000003 111.085 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.67 83.87 1.76 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.746 -0.74 . . . . 53.420000000000002 112.5 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -98.12 179.82 4.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.768 0.318 . . . . 73.0 110.892 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -108.19 165.76 11.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 62.509999999999998 110.902 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.1 mp -56.21 124.48 18.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 71.120000000000005 110.938 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 51.91 46.24 26.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.457 . . . . 73.349999999999994 110.893 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.53 39.93 3.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 62.420000000000002 110.882 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.594 ' O ' HD12 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -102.94 102.84 12.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 71.140000000000001 110.931 179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.466 HG13 HG12 ' A' ' 69' ' ' VAL . 7.4 tt -179.59 103.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 72.519999999999996 111.156 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 82.5 p -168.23 -166.92 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 75.319999999999993 110.869 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.9 t -115.35 168.22 10.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 75.209999999999994 110.879 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.617 HG21 HD22 ' A' ' 61' ' ' LEU . 0.4 OUTLIER -145.41 139.21 21.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 74.239999999999995 111.173 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.82 ' HB3' HG23 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -139.9 119.65 13.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 72.010000000000005 110.892 179.885 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.681 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 2.6 p -113.94 139.05 41.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 45.509999999999998 111.134 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -138.04 45.26 2.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 65.310000000000002 110.908 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.72 113.68 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 73.5 110.861 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.23 -135.75 35.8 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.742 -0.742 . . . . 65.319999999999993 112.466 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.459 HG22 ' HA2' ' A' ' 62' ' ' GLY . 67.4 p -150.06 150.13 31.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.732 0.301 . . . . 64.310000000000002 111.166 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.681 ' CZ2' HG23 ' A' ' 41' ' ' VAL . 2.7 m0 -117.74 171.38 8.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.247 -0.433 . . . . 75.409999999999997 110.897 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.7 mpp_? -113.85 119.73 38.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 74.25 110.909 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -108.59 126.71 53.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 61.229999999999997 110.9 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.24 126.29 19.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 65.420000000000002 110.922 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -98.44 89.54 4.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 73.439999999999998 110.88 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.447 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 172.54 -168.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.116 -0.493 . . . . 71.209999999999994 110.934 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.499 HG22 ' H ' ' A' ' 53' ' ' ASN . 5.6 mm -69.82 165.98 2.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 54.530000000000001 111.137 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.499 ' H ' HG22 ' A' ' 52' ' ' ILE . 5.5 m120 -74.83 56.69 0.74 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 70.439999999999998 110.902 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -153.09 -39.15 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 65.150000000000006 110.905 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -147.99 -142.36 3.65 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.757 -0.735 . . . . 72.299999999999997 112.523 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.447 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 106.55 -178.09 22.32 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.789 -0.72 . . . . 71.319999999999993 112.492 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -76.72 108.72 9.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.798 0.332 . . . . 74.549999999999997 110.884 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -78.29 100.26 6.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 74.030000000000001 110.903 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -133.41 107.53 8.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 74.040000000000006 110.923 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.88 148.14 27.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 64.25 110.862 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.617 HD22 HG21 ' A' ' 39' ' ' ILE . 8.7 tp -99.52 136.5 39.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 72.439999999999998 110.913 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.459 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -112.93 176.34 17.45 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.708 -0.758 . . . . 74.239999999999995 112.479 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -46.74 100.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.727 2.284 . . . . 74.329999999999998 112.334 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.46 164.6 14.99 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.746 -0.74 . . . . 70.420000000000002 112.506 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -118.52 146.94 44.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.829 0.347 . . . . 74.310000000000002 110.9 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -146.19 140.15 26.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 74.329999999999998 110.867 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.48 73.88 1.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.095 -0.502 . . . . 71.230000000000004 110.858 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 45.7 t -85.06 156.23 21.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 61.43 110.84 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.466 HG12 HG13 ' A' ' 36' ' ' ILE . 27.9 m -149.96 26.27 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.114 -0.494 . . . . 74.150000000000006 111.096 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 173.15 -16.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 75.349999999999994 110.884 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.02 -23.95 41.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 71.219999999999999 110.85 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.79 -71.0 0.54 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 53.340000000000003 111.114 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.609 ' O ' HD13 ' A' ' 74' ' ' ILE . . . 166.79 124.54 0.72 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.781 -0.724 . . . . 65.319999999999993 112.502 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.609 HD13 ' O ' ' A' ' 73' ' ' GLY . 4.4 mm -123.64 68.08 41.02 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.626 0.727 . . . . 73.109999999999999 111.111 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -79.38 -166.18 0.39 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.724 2.283 . . . . 63.340000000000003 112.332 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.62 14.81 14.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 64.129999999999995 110.874 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -157.36 113.94 2.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 74.230000000000004 110.89 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.7 m -92.28 45.0 1.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 71.5 110.855 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.4 mm -76.51 66.26 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 61.420000000000002 111.091 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.1 168.92 9.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 75.120000000000005 110.82 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.404 ' HA ' ' HB1' ' A' ' 28' ' ' ALA . 0.3 OUTLIER -165.69 155.26 12.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 75.120000000000005 110.908 -179.802 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -151.13 135.96 17.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 62.109999999999999 110.9 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.5 mmm-85 -95.79 126.18 40.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 73.019999999999996 110.902 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -79.26 97.03 6.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 71.030000000000001 110.909 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 63.140000000000001 111.154 179.981 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.752 0.31 . . . . 71.340000000000003 110.896 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -115.68 171.71 7.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 54.409999999999997 110.886 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.87 79.4 0.78 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 32.049999999999997 111.14 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.25 168.38 27.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 63.229999999999997 111.091 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.704 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 14.7 mt-10 -90.2 92.96 9.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 73.219999999999999 110.897 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.789 HG13 ' CH2' ' A' ' 46' ' ' TRP . 89.5 t -119.79 133.35 66.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 75.099999999999994 111.159 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.458 HG23 ' HB3' ' A' ' 40' ' ' LYS . 7.0 tt -122.29 109.87 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 63.119999999999997 111.133 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.62 HG12 HD13 ' A' ' 39' ' ' ILE . 4.0 m -132.19 164.77 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.182 -0.463 . . . . 63.340000000000003 111.153 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -113.4 138.73 49.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 73.530000000000001 110.99 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -100.73 38.21 1.57 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 71.450000000000003 110.888 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.433 ' HB3' ' HA3' ' A' ' 16' ' ' GLY . 0.3 OUTLIER 169.26 -173.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 75.299999999999997 110.892 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 13' ' ' ASN . 4.8 t -66.02 160.55 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.254 -0.43 . . . . 62.340000000000003 111.109 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.44 ' N ' HG12 ' A' ' 12' ' ' VAL . 18.9 t30 -88.67 54.77 3.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 73.239999999999995 110.895 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.419 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -176.55 28.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 72.120000000000005 110.917 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.56 43.63 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.73 -0.748 . . . . 41.530000000000001 112.5 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.433 ' HA3' ' HB3' ' A' ' 11' ' ' HIS . . . -142.69 172.14 24.52 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.777 -0.725 . . . . 64.120000000000005 112.509 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.2 123.6 34.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.797 0.332 . . . . 75.209999999999994 110.905 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.3 p -121.24 135.17 55.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 65.310000000000002 110.862 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 19' ' ' PHE . 0.8 OUTLIER -124.85 136.73 54.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.15 -0.477 . . . . 75.109999999999999 110.878 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.94 -163.08 0.38 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 71.439999999999998 110.828 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.704 ' HB1' ' HA ' ' A' ' 5' ' ' GLU . . . -78.56 98.69 6.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 74.430000000000007 111.055 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -178.81 179.22 0.72 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 51.130000000000003 111.103 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.6 m -65.13 91.72 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 65.129999999999995 110.859 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.17 -78.54 0.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 65.400000000000006 110.843 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -153.36 67.53 6.22 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.582 0.706 . . . . 74.140000000000001 110.904 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -85.85 70.09 4.81 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.669 2.246 . . . . 72.329999999999998 112.341 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 163.01 111.56 0.26 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.759 -0.734 . . . . 65.209999999999994 112.498 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.38 124.31 35.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.84 0.352 . . . . 72.25 111.142 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.37 -58.18 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.777 -0.725 . . . . 74.5 112.491 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -71.91 80.53 0.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.825 0.345 . . . . 63.140000000000001 110.877 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -129.81 -169.95 2.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 71.219999999999999 110.911 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -168.33 -169.01 1.01 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 53.329999999999998 110.929 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -54.07 -27.55 33.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 72.25 110.877 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.413 ' C ' HD13 ' A' ' 36' ' ' ILE . 5.2 m-20 -82.73 58.74 4.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 75.319999999999993 110.844 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.52 102.22 14.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 65.510000000000005 110.91 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.413 HD13 ' C ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -147.96 111.46 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 62.119999999999997 111.157 179.905 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.7 p -167.25 -166.46 0.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 62.329999999999998 110.871 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 t -117.61 159.38 23.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 72.349999999999994 110.882 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.62 HD13 HG12 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -139.53 140.96 36.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 64.230000000000004 111.155 179.917 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.458 ' HB3' HG23 ' A' ' 7' ' ' ILE . 9.4 tttt -151.0 147.75 27.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 72.400000000000006 110.892 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.59 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 3.6 p -136.03 130.98 49.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 61.119999999999997 111.135 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.03 39.51 3.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 74.310000000000002 110.837 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.442 ' H ' HG22 ' A' ' 41' ' ' VAL . 0.4 OUTLIER 178.59 110.63 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 60.109999999999999 110.888 -179.92 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.85 -147.86 48.61 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.739 . . . . 54.020000000000003 112.508 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.5 p -150.35 147.82 28.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.762 0.315 . . . . 71.430000000000007 111.123 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.789 ' CH2' HG13 ' A' ' 6' ' ' VAL . 2.0 m0 -118.08 174.84 5.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 74.040000000000006 110.942 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -124.66 129.13 49.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 64.400000000000006 110.858 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.484 ' HD2' HD22 ' A' ' 61' ' ' LEU . 1.6 m-85 -113.57 128.38 56.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 51.149999999999999 110.862 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.33 126.19 19.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.486 . . . . 71.450000000000003 110.928 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -101.09 88.9 3.63 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.074 -0.512 . . . . 62.439999999999998 110.873 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.448 ' HA ' HG22 ' A' ' 79' ' ' ILE . 0.2 OUTLIER 172.04 -171.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 74.450000000000003 110.918 -179.857 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.7 pt -54.97 174.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.499 . . . . 75.439999999999998 111.11 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -87.9 37.86 0.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 70.120000000000005 110.909 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -151.74 18.63 0.7 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 64.349999999999994 110.926 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.07 -152.34 18.95 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.74 -0.743 . . . . 52.229999999999997 112.487 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.401 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 107.29 176.25 22.66 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.749 -0.739 . . . . 52.450000000000003 112.478 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.49 109.42 6.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.812 0.339 . . . . 75.140000000000001 110.857 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -77.59 108.35 10.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 73.0 110.899 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -138.44 107.17 5.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.06 -0.518 . . . . 74.230000000000004 110.925 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -91.28 157.72 16.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 62.130000000000003 110.859 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.653 HD21 ' HB2' ' A' ' 46' ' ' TRP . 1.8 pt? -119.97 149.61 41.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 64.109999999999999 110.934 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -124.81 -173.97 13.88 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.728 -0.748 . . . . 53.530000000000001 112.525 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -43.97 101.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.731 2.287 . . . . 64.340000000000003 112.329 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 158.92 162.4 11.93 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.749 -0.738 . . . . 52.149999999999999 112.495 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.13 147.5 41.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.899 0.381 . . . . 72.040000000000006 110.882 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -132.64 160.4 36.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 74.200000000000003 110.913 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 95.8 p -140.09 62.82 1.49 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 73.430000000000007 110.889 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 71.0 m -85.8 145.81 27.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.488 . . . . 71.129999999999995 110.836 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.411 HG23 ' HG2' ' A' ' 70' ' ' GLU . 35.9 m -150.6 18.44 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.487 . . . . 64.239999999999995 111.127 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.411 ' HG2' HG23 ' A' ' 69' ' ' VAL . 1.7 pt-20 179.3 38.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 71.230000000000004 110.841 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.53 -46.71 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.471 . . . . 70.120000000000005 110.866 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.32 -45.86 62.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.506 . . . . 21.129999999999999 111.077 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.712 ' O ' HD13 ' A' ' 74' ' ' ILE . . . 166.93 103.68 0.17 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.769 -0.729 . . . . 73.040000000000006 112.473 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.712 HD13 ' O ' ' A' ' 73' ' ' GLY . 15.0 mm -131.52 74.02 78.85 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.626 0.727 . . . . 71.310000000000002 111.095 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -77.59 -158.54 0.09 OUTLIER 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.709 2.272 . . . . 52.100000000000001 112.328 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -75.97 -22.71 55.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 71.120000000000005 110.868 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -158.65 -169.54 2.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 73.109999999999999 110.89 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.0 t -57.82 -95.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 71.120000000000005 110.888 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.448 HG22 ' HA ' ' A' ' 51' ' ' TYR . 2.2 mp 50.91 59.89 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 74.540000000000006 111.092 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 66.1 p -159.41 158.61 32.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 75.409999999999997 110.842 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.73 159.63 16.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 70.409999999999997 110.867 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -150.14 135.8 18.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 75.120000000000005 110.872 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.2 mmt-85 -90.48 117.4 29.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 65.439999999999998 110.904 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.28 91.85 6.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 65.200000000000003 110.909 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 74.400000000000006 111.11 179.945 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.043 0 CA-C-O 120.854 0.359 . . . . 75.340000000000003 110.896 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -133.82 178.55 6.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 70.540000000000006 110.854 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.82 85.51 0.9 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 43.030000000000001 111.114 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -167.0 122.19 1.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 71.129999999999995 111.105 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.85 98.11 11.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.239 -0.437 . . . . 63.25 110.878 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.738 HG21 ' HB3' ' A' ' 84' ' ' GLN . 54.3 t -102.02 119.43 50.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 72.310000000000002 111.102 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.546 HG23 ' HB3' ' A' ' 40' ' ' LYS . 8.3 tt -120.96 109.51 25.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 65.409999999999997 111.135 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.8 t -126.41 141.37 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 65.319999999999993 111.153 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -96.04 134.6 38.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.179 -0.464 . . . . 63.350000000000001 110.892 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -94.35 44.23 1.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 70.329999999999998 110.916 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 174.79 -170.31 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 73.230000000000004 110.884 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 13' ' ' ASN . 6.4 t -63.99 160.5 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 74.540000000000006 111.16 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.453 ' N ' HG12 ' A' ' 12' ' ' VAL . 53.0 t-20 -85.41 53.61 2.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 73.140000000000001 110.855 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.453 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.59 28.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 65.420000000000002 110.849 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.55 44.33 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.721 -0.752 . . . . 44.409999999999997 112.5 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -134.98 171.41 22.45 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.74 -0.743 . . . . 74.25 112.467 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.5 161.99 13.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.751 0.31 . . . . 72.109999999999999 110.92 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.7 p -151.11 155.34 38.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 53.520000000000003 110.84 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -136.34 136.7 39.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 64.409999999999997 110.858 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.7 68.03 0.66 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 72.349999999999994 110.867 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -151.72 167.21 28.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 34.100000000000001 111.093 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 m -144.97 40.73 1.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 62.030000000000001 111.134 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.1 t -172.31 36.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 41.43 110.879 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -155.72 -44.19 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.48 . . . . 53.229999999999997 110.879 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -83.05 162.24 55.25 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.625 0.726 . . . . 74.310000000000002 110.917 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.25 -173.18 1.2 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.694 2.263 . . . . 74.239999999999995 112.369 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.74 -104.57 0.71 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.695 -0.764 . . . . 64.239999999999995 112.528 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.654 ' HB2' ' CE1' ' A' ' 82' ' ' PHE . . . -150.91 158.2 43.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.82 0.343 . . . . 60.149999999999999 111.107 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.58 126.65 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.776 -0.726 . . . . 72.450000000000003 112.498 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -152.21 25.03 0.63 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.832 0.349 . . . . 63.140000000000001 110.903 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -174.18 -169.89 0.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 73.319999999999993 110.875 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.14 166.14 0.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 73.219999999999999 110.91 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -68.02 87.62 0.26 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.467 . . . . 73.319999999999993 110.906 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -176.02 88.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 74.299999999999997 110.827 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.588 ' HD2' ' HB3' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -130.69 168.11 17.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 53.43 110.891 179.966 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 36' ' ' ILE . 1.2 tt -162.01 115.55 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 74.329999999999998 111.13 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.9 p -167.22 -167.55 0.93 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 70.209999999999994 110.906 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.562 ' O ' HD12 ' A' ' 39' ' ' ILE . 32.3 t -123.6 150.08 44.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 62.539999999999999 110.867 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.562 HD12 ' O ' ' A' ' 38' ' ' SER . 1.5 mp -120.91 115.18 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 43.299999999999997 111.117 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.546 ' HB3' HG23 ' A' ' 7' ' ' ILE . 10.6 tttm -109.88 119.26 38.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.465 . . . . 75.299999999999997 110.918 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.775 HG22 ' CZ3' ' A' ' 46' ' ' TRP . 17.2 t -102.89 139.16 24.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 72.019999999999996 111.114 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.71 39.84 0.72 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 74.140000000000001 110.896 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 179.38 111.66 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 71.109999999999999 110.842 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.34 -142.22 24.55 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.674 -0.774 . . . . 52.539999999999999 112.523 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -149.84 124.17 9.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.795 0.331 . . . . 71.420000000000002 111.12 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.775 ' CZ3' HG22 ' A' ' 41' ' ' VAL . 0.5 OUTLIER -87.14 -177.08 5.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 74.530000000000001 110.922 179.961 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.25 119.95 19.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.453 . . . . 72.120000000000005 110.83 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -101.64 133.59 46.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 73.439999999999998 110.855 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.72 126.47 20.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.104 -0.498 . . . . 75.510000000000005 110.898 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -105.49 88.85 2.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.079 -0.51 . . . . 72.299999999999997 110.917 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.482 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 171.63 -168.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 71.109999999999999 110.938 -179.838 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.471 HG22 ' N ' ' A' ' 53' ' ' ASN . 18.9 mm -54.97 158.63 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 53.409999999999997 111.138 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.471 ' N ' HG22 ' A' ' 52' ' ' ILE . 47.4 p-10 -76.38 58.2 1.28 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 74.030000000000001 110.945 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -167.19 -31.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.163 -0.471 . . . . 52.520000000000003 110.928 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -142.26 -152.56 5.72 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.737 -0.744 . . . . 72.310000000000002 112.467 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.482 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 108.98 -174.5 18.45 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.773 -0.727 . . . . 70.319999999999993 112.471 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.89 127.04 31.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.8 0.333 . . . . 74.5 110.901 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -96.66 108.12 20.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.236 -0.438 . . . . 54.039999999999999 110.904 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -138.08 106.74 5.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.093 -0.503 . . . . 74.400000000000006 110.914 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -95.47 157.34 15.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 63.509999999999998 110.867 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.494 HD23 ' H ' ' A' ' 61' ' ' LEU . 2.6 pt? -135.96 139.1 42.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 52.439999999999998 110.916 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.52 -165.64 27.38 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.734 -0.746 . . . . 62.130000000000003 112.465 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -56.67 115.85 2.78 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.684 2.256 . . . . 50.219999999999999 112.346 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.7 151.42 5.89 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.733 -0.746 . . . . 73.209999999999994 112.504 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -79.96 155.01 27.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.845 0.355 . . . . 74.140000000000001 110.897 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -160.31 149.5 17.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.126 -0.488 . . . . 72.510000000000005 110.924 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.9 p -108.12 84.26 1.92 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 70.340000000000003 110.872 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.733 ' HB2' ' HB2' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -85.4 117.12 24.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 73.140000000000001 110.873 -179.86 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.7 m -146.34 10.32 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 73.439999999999998 111.117 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -157.52 17.65 0.27 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 73.530000000000001 110.9 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -165.68 21.67 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 75.299999999999997 110.869 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.733 ' HB2' ' HB2' ' A' ' 68' ' ' SER . . . -89.51 -34.67 16.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 35.539999999999999 111.101 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.607 ' H ' HD13 ' A' ' 74' ' ' ILE . . . 165.97 41.31 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.78 -0.724 . . . . 54.210000000000001 112.495 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.607 HD13 ' H ' ' A' ' 73' ' ' GLY . 0.1 OUTLIER -122.45 63.13 17.92 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.62 0.724 . . . . 65.409999999999997 111.102 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.499 ' HD3' ' C ' ' A' ' 73' ' ' GLY . 71.6 Cg_endo -81.41 -47.61 0.07 OUTLIER 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.703 2.268 . . . . 54.119999999999997 112.316 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.472 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 9.3 t70 179.36 87.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 63.43 110.86 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.472 ' CB ' ' O ' ' A' ' 76' ' ' ASP . 5.4 m-20 81.41 -168.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 71.400000000000006 110.907 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.503 ' O ' HD13 ' A' ' 79' ' ' ILE . 0.7 OUTLIER -75.08 71.72 2.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 63.439999999999998 110.869 -179.85 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.503 HD13 ' O ' ' A' ' 78' ' ' SER . 23.4 mm -141.79 69.64 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 72.25 111.184 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -165.99 152.59 9.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 63.520000000000003 110.834 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.71 171.54 12.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 73.109999999999999 110.841 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.654 ' CE1' ' HB2' ' A' ' 28' ' ' ALA . 2.9 p90 -152.07 135.9 16.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.134 -0.485 . . . . 75.349999999999994 110.905 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 30.5 mmm180 -98.78 116.37 30.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 72.040000000000006 110.904 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.738 ' HB3' HG21 ' A' ' 6' ' ' VAL . 1.2 mp0 -83.63 103.56 13.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 74.430000000000007 110.92 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.1 pt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 75.099999999999994 111.11 179.982 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.815 0.341 . . . . 64.439999999999998 110.93 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -93.68 160.91 14.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 71.400000000000006 110.884 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -160.77 84.75 0.69 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 75.340000000000003 111.086 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.61 134.68 34.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 70.150000000000006 111.08 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -91.65 98.99 11.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 62.32 110.846 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.501 HG11 ' HG2' ' A' ' 84' ' ' GLN . 4.0 m -115.67 138.56 45.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.501 . . . . 63.229999999999997 111.136 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.823 HG23 ' HB3' ' A' ' 40' ' ' LYS . 1.1 tt -102.32 110.44 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 73.349999999999994 111.101 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.651 HG12 HD13 ' A' ' 39' ' ' ILE . 3.3 m -137.32 159.43 35.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 70.310000000000002 111.123 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -114.0 144.33 43.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 74.019999999999996 110.95 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.31 41.56 1.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 75.549999999999997 110.855 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 172.69 -170.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 64.049999999999997 110.826 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.451 HG12 ' N ' ' A' ' 13' ' ' ASN . 7.3 t -63.61 159.97 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 62.149999999999999 111.076 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.451 ' N ' HG12 ' A' ' 12' ' ' VAL . 58.6 t30 -85.74 53.87 2.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 61.0 110.883 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.438 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.11 28.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 72.310000000000002 110.856 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.57 41.14 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.732 . . . . 53.140000000000001 112.462 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -137.13 171.54 23.06 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.776 -0.726 . . . . 72.430000000000007 112.485 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.35 161.7 16.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.83 0.348 . . . . 72.400000000000006 110.893 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -139.07 166.9 23.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 75.400000000000006 110.86 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -129.44 113.48 14.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 71.239999999999995 110.944 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -121.04 50.01 1.42 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 73.5 110.884 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -125.25 143.76 50.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 73.040000000000006 111.114 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.8 t -100.18 39.92 1.3 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 65.420000000000002 111.13 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.2 t -92.98 -82.66 0.33 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.45 . . . . 72.310000000000002 110.888 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.79 88.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.141 -0.482 . . . . 63.450000000000003 110.873 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -80.18 162.17 62.65 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.604 0.716 . . . . 63.32 110.91 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -74.16 -173.36 1.41 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.749 2.299 . . . . 74.349999999999994 112.366 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.7 177.63 49.88 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.763 -0.732 . . . . 74.209999999999994 112.515 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.98 122.89 34.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.812 0.339 . . . . 71.019999999999996 111.096 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.47 119.1 3.83 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.765 -0.731 . . . . 71.319999999999993 112.494 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -159.58 44.11 0.23 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.87 0.367 . . . . 74.450000000000003 110.872 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -174.2 173.58 3.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 51.020000000000003 110.914 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.2 tp -60.98 -167.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 65.420000000000002 110.882 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -52.58 102.75 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 74.519999999999996 110.911 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -167.3 39.73 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 62.350000000000001 110.839 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.85 108.97 15.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 53.140000000000001 110.896 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.74 HD12 ' HB ' ' A' ' 69' ' ' VAL . 0.9 OUTLIER -168.98 102.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 73.519999999999996 111.126 179.921 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.4 p -168.11 -167.6 0.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 73.219999999999999 110.879 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.7 t -126.66 157.86 37.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 74.340000000000003 110.866 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.651 HD13 HG12 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -129.69 138.06 55.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 63.450000000000003 111.113 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.823 ' HB3' HG23 ' A' ' 7' ' ' ILE . 12.1 tttt -136.03 124.31 23.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 72.409999999999997 110.853 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.684 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 3.5 p -120.3 139.5 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.436 . . . . 73.310000000000002 111.134 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -142.89 40.37 1.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 70.239999999999995 110.892 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.57 117.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 72.439999999999998 110.842 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 51.76 -151.45 6.84 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.696 -0.764 . . . . 54.130000000000003 112.523 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.7 p -136.62 155.95 49.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.763 0.316 . . . . 61.439999999999998 111.132 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.684 ' CZ2' HG23 ' A' ' 41' ' ' VAL . 2.2 m0 -123.74 175.65 6.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 75.540000000000006 110.916 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.51 ' HD2' HD11 ' A' ' 85' ' ' ILE . 3.7 mpp_? -123.72 122.71 38.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 74.540000000000006 110.888 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -107.52 128.64 54.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 75.530000000000001 110.934 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.13 127.92 21.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 75.040000000000006 110.923 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -99.1 87.05 3.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.505 . . . . 65.010000000000005 110.853 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.411 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 170.23 -170.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.167 -0.47 . . . . 72.310000000000002 110.951 -179.895 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.1 pt -54.68 174.31 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 64.340000000000003 111.139 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -87.41 36.95 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 74.010000000000005 110.945 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -151.85 19.01 0.69 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 65.230000000000004 110.925 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.61 -156.89 27.63 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.788 -0.72 . . . . 75.420000000000002 112.504 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.411 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 107.09 176.29 22.8 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.677 -0.773 . . . . 74.239999999999995 112.496 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -69.81 103.96 2.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.833 0.349 . . . . 73.120000000000005 110.872 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -75.05 108.4 7.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 75.329999999999998 110.957 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -138.1 106.21 5.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.138 -0.483 . . . . 75.530000000000001 110.953 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -88.49 138.41 31.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 71.430000000000007 110.845 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.557 HD21 ' CE3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -99.18 159.44 14.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 65.299999999999997 110.928 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -128.85 175.77 18.62 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.706 -0.759 . . . . 54.340000000000003 112.483 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.412 ' HA ' HG13 ' A' ' 41' ' ' VAL . 78.4 Cg_exo -42.51 107.77 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.657 2.238 . . . . 72.010000000000005 112.382 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.79 159.48 9.39 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.739 . . . . 61.439999999999998 112.489 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -102.6 144.69 30.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.843 0.354 . . . . 73.109999999999999 110.904 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -137.17 145.09 43.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.118 -0.492 . . . . 73.209999999999994 110.917 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.1 m -133.8 67.51 1.52 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 54.310000000000002 110.838 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.63 ' CB ' ' HB2' ' A' ' 72' ' ' ALA . 10.9 m -84.99 145.11 27.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 72.530000000000001 110.866 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.74 ' HB ' HD12 ' A' ' 36' ' ' ILE . 20.6 m -149.97 19.74 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 73.209999999999994 111.118 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -179.5 38.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 62.409999999999997 110.879 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.34 -39.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 71.299999999999997 110.894 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.63 ' HB2' ' CB ' ' A' ' 68' ' ' SER . . . -53.17 -44.47 67.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 50.210000000000001 111.073 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.592 ' O ' HD13 ' A' ' 74' ' ' ILE . . . 167.41 93.79 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.787 -0.721 . . . . 75.209999999999994 112.518 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.592 HD13 ' O ' ' A' ' 73' ' ' GLY . 5.7 mm -123.98 67.27 42.37 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.613 0.72 . . . . 73.430000000000007 111.129 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -80.07 -166.38 0.41 Allowed 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.727 2.285 . . . . 72.109999999999999 112.376 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -57.67 -70.15 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.419 . . . . 64.340000000000003 110.876 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -96.68 -95.54 0.2 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 74.239999999999995 110.846 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.4 p -178.18 -95.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 73.239999999999995 110.836 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.5 mm 56.23 54.92 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 74.049999999999997 111.152 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.6 m -108.07 164.2 12.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 70.349999999999994 110.862 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.3 p -165.54 153.68 11.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 65.319999999999993 110.831 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -151.25 135.47 16.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 71.450000000000003 110.888 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.47 119.69 32.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 75.299999999999997 110.883 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.501 ' HG2' HG11 ' A' ' 6' ' ' VAL . 20.5 mt-30 -79.7 92.01 5.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 61.229999999999997 110.899 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.51 HD11 ' HD2' ' A' ' 47' ' ' ARG . 1.1 pt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 71.439999999999998 111.186 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.931 0.396 . . . . 73.540000000000006 110.882 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.782 HG13 ' CH2' ' A' ' 46' ' ' TRP . 89.7 t -110.6 111.24 35.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 64.239999999999995 111.116 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.738 HG23 ' HB3' ' A' ' 40' ' ' LYS . 4.0 tp -106.34 110.91 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 52.109999999999999 111.127 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.8 t -131.54 138.8 52.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 65.010000000000005 111.138 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -94.5 137.22 33.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 74.129999999999995 110.863 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -93.98 42.94 1.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 75.150000000000006 110.902 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 174.52 -169.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 63.229999999999997 110.852 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.451 HG12 ' N ' ' A' ' 13' ' ' ASN . 5.0 t -64.68 160.97 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 74.209999999999994 111.17 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.451 ' N ' HG12 ' A' ' 12' ' ' VAL . 51.2 t30 -87.34 53.79 2.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 73.319999999999993 110.923 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.441 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.12 28.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 71.430000000000007 110.911 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.19 52.73 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.726 -0.75 . . . . 74.120000000000005 112.486 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.96 171.52 24.48 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.798 -0.715 . . . . 63.409999999999997 112.513 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.43 134.34 35.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.77 0.319 . . . . 74.340000000000003 110.893 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.48 153.04 34.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 54.340000000000003 110.88 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -148.64 141.35 24.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 64.200000000000003 110.901 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.447 ' HB2' HD13 ' A' ' 7' ' ' ILE . 20.8 t0 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 71.209999999999994 110.907 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.784 0.325 . . . . 71.109999999999999 110.914 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.542 ' HB ' HG12 ' A' ' 69' ' ' VAL . 1.1 pt -153.11 109.72 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 75.540000000000006 111.127 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.0 p -165.01 -168.35 1.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 64.109999999999999 110.843 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.581 ' O ' HD12 ' A' ' 39' ' ' ILE . 0.6 OUTLIER -124.07 152.05 43.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 63.149999999999999 110.828 -179.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.581 HD12 ' O ' ' A' ' 38' ' ' SER . 1.5 mp -120.91 139.33 48.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.51 . . . . 71.140000000000001 111.116 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.738 ' HB3' HG23 ' A' ' 7' ' ' ILE . 7.4 tttt -138.04 125.92 22.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 60.219999999999999 110.915 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.563 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 9.2 p -125.58 139.02 52.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.433 . . . . 63.450000000000003 111.158 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.88 39.39 1.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 74.230000000000004 110.861 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.93 110.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 52.229999999999997 110.855 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.94 -150.21 50.28 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.78 -0.724 . . . . 75.549999999999997 112.451 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.563 HG22 ' HA2' ' A' ' 62' ' ' GLY . 41.9 p -148.4 160.61 42.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.759 0.314 . . . . 55.229999999999997 111.146 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.782 ' CH2' HG13 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -124.53 177.48 5.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 74.129999999999995 110.953 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.411 ' HD2' HD11 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -123.57 111.92 16.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.273 -0.421 . . . . 73.239999999999995 110.864 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -101.01 123.95 45.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 75.150000000000006 110.916 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -139.97 126.63 20.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 74.340000000000003 110.945 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -104.09 89.57 3.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 73.010000000000005 110.871 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.408 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 177.27 -174.34 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 74.239999999999995 110.958 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.0 pt -54.88 174.15 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 65.319999999999993 111.099 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -83.07 10.12 8.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.14 -0.482 . . . . 71.540000000000006 110.881 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.45 67.27 1.26 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 73.519999999999996 110.937 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 116.39 121.08 3.27 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.757 -0.735 . . . . 73.420000000000002 112.503 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.408 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . -177.35 174.48 47.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 32.520000000000003 112.486 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -64.62 95.93 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.844 0.354 . . . . 73.540000000000006 110.918 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -76.38 111.86 12.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 64.230000000000004 110.933 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -138.32 105.86 5.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.144 -0.48 . . . . 73.150000000000006 110.924 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -90.65 137.61 32.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.259 -0.428 . . . . 61.149999999999999 110.916 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.714 HD21 ' CE3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -104.81 142.11 35.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 52.009999999999998 110.879 -179.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.563 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -113.79 -168.63 16.63 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.781 -0.723 . . . . 71.349999999999994 112.54 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -46.84 109.89 0.24 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.699 2.266 . . . . 74.340000000000003 112.304 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.93 158.48 8.84 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.732 -0.747 . . . . 52.310000000000002 112.505 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.59 143.86 49.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.861 0.362 . . . . 63.25 110.891 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -148.63 160.12 43.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 72.129999999999995 110.898 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 99.0 p -140.69 78.04 1.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.094 -0.503 . . . . 61.32 110.837 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.4 m -86.64 153.05 22.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 62.530000000000001 110.843 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.542 HG12 ' HB ' ' A' ' 36' ' ' ILE . 5.1 m -153.43 23.92 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 73.030000000000001 111.114 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -179.52 39.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 51.310000000000002 110.9 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.443 ' N ' HD11 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -157.85 -40.2 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 74.25 110.852 -179.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.28 -75.79 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.114 -0.493 . . . . 63.329999999999998 111.095 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.85 90.15 0.1 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 64.209999999999994 112.516 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.443 HD11 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -134.15 67.07 72.89 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.644 0.735 . . . . 74.150000000000006 111.165 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -80.46 -52.21 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.663 2.242 . . . . 52.350000000000001 112.343 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 179.82 -51.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.264 -0.426 . . . . 61.25 110.845 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -173.75 130.14 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 74.439999999999998 110.861 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.17 178.69 2.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 73.420000000000002 110.891 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.4 mm -100.45 155.19 4.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 61.219999999999999 111.111 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.7 p -155.62 155.75 33.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 71.329999999999998 110.851 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -165.27 158.15 16.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 71.120000000000005 110.838 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -150.55 135.66 17.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 62.509999999999998 110.885 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -89.68 119.71 30.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 74.209999999999994 110.901 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -79.77 99.62 7.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 73.549999999999997 110.906 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.411 HD11 ' HD2' ' A' ' 47' ' ' ARG . 1.1 pt . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 73.349999999999994 111.103 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.865 0.364 . . . . 53.200000000000003 110.898 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.749 HG13 ' CH2' ' A' ' 46' ' ' TRP . 79.5 t -100.85 114.65 40.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.484 . . . . 65.519999999999996 111.141 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.442 HG23 ' O ' ' A' ' 7' ' ' ILE . 8.5 tt -115.41 110.53 32.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 74.120000000000005 111.131 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.5 t -128.79 145.09 36.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 51.5 111.132 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -97.81 136.7 37.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.476 . . . . 73.299999999999997 110.911 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.77 44.68 1.1 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.49 . . . . 71.430000000000007 110.872 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 173.42 -171.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 65.400000000000006 110.824 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 13' ' ' ASN . 5.3 t -64.58 160.57 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 73.239999999999995 111.161 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.444 ' N ' HG12 ' A' ' 12' ' ' VAL . 11.7 t-20 -87.28 53.94 2.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 73.109999999999999 110.883 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.443 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -176.92 28.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 61.200000000000003 110.872 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.4 52.79 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.714 -0.755 . . . . 74.519999999999996 112.438 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.07 171.42 24.55 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.76 -0.733 . . . . 52.420000000000002 112.481 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.04 135.15 34.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.779 0.323 . . . . 73.219999999999999 110.912 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.65 154.35 32.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 74.120000000000005 110.882 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -148.65 151.97 35.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 72.549999999999997 110.878 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.0 t0 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 70.439999999999998 110.838 179.927 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.796 0.331 . . . . 71.010000000000005 110.858 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.441 HD12 HG22 ' A' ' 12' ' ' VAL . 1.1 pt -154.49 106.08 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 73.209999999999994 111.14 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 56.6 p -151.08 -168.4 3.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 52.420000000000002 110.848 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.609 ' C ' HD12 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -130.46 152.22 50.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.087 -0.506 . . . . 63.119999999999997 110.847 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.609 HD12 ' C ' ' A' ' 38' ' ' SER . 1.7 mp -122.14 141.52 42.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 73.439999999999998 111.103 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.2 tttt -140.99 135.61 31.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 73.209999999999994 110.841 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.4 p -162.91 139.23 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 72.310000000000002 111.109 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.06 40.65 3.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 75.019999999999996 110.891 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 t 178.94 138.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 74.349999999999994 110.833 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.78 -177.87 1.89 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.705 -0.76 . . . . 63.039999999999999 112.524 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.59 HG22 ' HA2' ' A' ' 62' ' ' GLY . 18.5 p -145.49 147.65 32.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.754 0.311 . . . . 65.099999999999994 111.156 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.779 ' CE3' HD21 ' A' ' 61' ' ' LEU . 0.7 OUTLIER -116.98 175.43 5.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 64.109999999999999 110.953 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -117.69 118.93 33.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.413 . . . . 71.349999999999994 110.906 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.432 ' CD2' HD23 ' A' ' 61' ' ' LEU . 2.6 m-85 -107.63 125.93 51.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 73.219999999999999 110.871 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.18 126.64 20.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.143 -0.48 . . . . 72.430000000000007 110.952 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -99.25 89.13 4.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 73.230000000000004 110.868 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.443 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 170.95 -178.01 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 74.140000000000001 110.961 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.1 tt -54.94 163.34 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 70.439999999999998 111.119 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -76.29 55.84 1.01 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 71.120000000000005 110.886 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -153.5 -37.72 0.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 72.310000000000002 110.938 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -146.27 -144.27 4.04 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.699 -0.762 . . . . 44.100000000000001 112.427 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.443 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 108.18 -170.54 15.17 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.765 -0.731 . . . . 54.130000000000003 112.469 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -83.61 105.36 14.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.841 0.353 . . . . 73.549999999999997 110.852 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -78.16 106.84 10.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 73.430000000000007 110.932 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -138.1 108.35 6.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.48 . . . . 70.329999999999998 110.941 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -92.83 135.07 34.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.436 . . . . 71.510000000000005 110.877 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.779 HD21 ' CE3' ' A' ' 46' ' ' TRP . 1.3 pp -99.22 140.41 33.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 71.25 110.922 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.59 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -107.45 -159.18 20.92 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.773 -0.727 . . . . 34.43 112.475 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.37 88.06 0.13 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.672 2.248 . . . . 60.109999999999999 112.39 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.3 160.52 29.22 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.751 -0.737 . . . . 52.530000000000001 112.504 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -118.61 135.55 54.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 61.420000000000002 110.852 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -143.45 160.09 41.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.129 -0.487 . . . . 71.140000000000001 110.878 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 97.8 p -141.14 78.06 1.63 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.086 -0.506 . . . . 61.130000000000003 110.853 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.471 ' HB2' ' HB2' ' A' ' 72' ' ' ALA . 14.2 m -88.39 148.81 24.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.491 . . . . 72.400000000000006 110.858 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.435 HG12 ' HB ' ' A' ' 36' ' ' ILE . 34.5 m -150.68 24.05 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.495 . . . . 51.350000000000001 111.154 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -179.47 36.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 72.219999999999999 110.858 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.99 -43.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 75.219999999999999 110.831 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.471 ' HB2' ' HB2' ' A' ' 68' ' ' SER . . . -51.59 -42.94 62.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 71.319999999999993 111.104 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.685 ' O ' HD13 ' A' ' 74' ' ' ILE . . . 166.88 91.99 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.766 -0.73 . . . . 43.509999999999998 112.503 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.685 HD13 ' O ' ' A' ' 73' ' ' GLY . 15.0 mm -131.46 69.21 81.74 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.638 0.733 . . . . 71.040000000000006 111.173 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -81.02 -66.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.701 2.267 . . . . 64.409999999999997 112.379 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -179.95 -73.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.266 -0.425 . . . . 75.329999999999998 110.874 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -66.09 -169.8 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 62.399999999999999 110.885 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.93 110.07 6.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 71.310000000000002 110.826 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.6 pt -152.92 22.79 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 73.540000000000006 111.096 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.6 p -79.78 160.54 26.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 61.149999999999999 110.861 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.62 156.69 13.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 65.319999999999993 110.854 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -148.58 138.37 22.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.49 . . . . 63.340000000000003 110.837 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.97 120.59 34.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 75.430000000000007 110.875 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -79.28 111.05 15.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 72.420000000000002 110.925 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.5 pt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.46 . . . . 65.329999999999998 111.132 179.969 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.888 0.375 . . . . 70.109999999999999 110.88 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.642 HG22 ' CZ2' ' A' ' 46' ' ' TRP . 84.4 t -117.71 118.63 59.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 53.119999999999997 111.119 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.801 HG23 ' HB3' ' A' ' 40' ' ' LYS . 4.4 tp -136.69 116.65 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 50.039999999999999 111.102 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.635 HG12 HD13 ' A' ' 39' ' ' ILE . 2.8 m -133.12 160.33 42.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 73.200000000000003 111.122 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -113.15 141.21 47.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 75.540000000000006 110.952 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -95.46 37.0 1.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 74.200000000000003 110.869 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 175.62 -169.63 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 72.239999999999995 110.868 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 13' ' ' ASN . 6.6 t -63.65 160.28 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 75.409999999999997 111.18 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.45 ' N ' HG12 ' A' ' 12' ' ' VAL . 37.2 t30 -85.87 53.81 2.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 74.129999999999995 110.899 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.44 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.14 28.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 74.209999999999994 110.86 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.54 39.26 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.718 -0.754 . . . . 55.409999999999997 112.47 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -129.16 171.61 19.92 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.725 -0.75 . . . . 33.310000000000002 112.462 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.25 131.01 34.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.773 0.32 . . . . 73.420000000000002 110.921 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.57 145.26 45.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 72.019999999999996 110.855 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -148.77 128.71 13.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 74.209999999999994 110.875 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.697 ' HB3' HD13 ' A' ' 7' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 71.010000000000005 110.927 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.75 0.31 . . . . 75.430000000000007 110.906 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.545 ' HB ' HG12 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -147.94 124.68 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 74.010000000000005 111.143 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.0 p -167.86 -166.78 0.77 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 73.319999999999993 110.81 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.8 t -125.54 164.12 21.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.067 -0.515 . . . . 44.240000000000002 110.867 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.635 HD13 HG12 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -130.42 140.33 49.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 75.219999999999999 111.127 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.801 ' HB3' HG23 ' A' ' 7' ' ' ILE . 1.7 tttp -138.58 132.15 30.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 74.409999999999997 110.913 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.665 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 3.6 p -133.0 139.2 50.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.258 -0.428 . . . . 73.409999999999997 111.108 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.62 41.91 1.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.472 . . . . 61.229999999999997 110.927 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -173.44 110.83 0.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 45.130000000000003 110.861 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 56.63 -137.76 47.77 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.729 -0.748 . . . . 41.109999999999999 112.483 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 64.3 p -150.21 141.25 22.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.339 . . . . 63.409999999999997 111.095 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.665 ' CZ2' HG23 ' A' ' 41' ' ' VAL . 2.8 m0 -109.72 168.45 9.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 74.510000000000005 110.891 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -110.2 120.89 43.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 74.230000000000004 110.917 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -110.95 127.72 55.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 72.519999999999996 110.936 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.73 126.15 18.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.471 . . . . 64.150000000000006 110.907 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -99.12 88.69 4.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.076 -0.511 . . . . 73.409999999999997 110.902 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 173.4 -177.85 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 53.539999999999999 110.903 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.0 pt -58.66 172.32 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 72.409999999999997 111.145 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -84.49 51.95 2.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 72.400000000000006 110.866 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -152.74 -47.87 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 74.109999999999999 110.918 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -149.75 125.05 1.89 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.742 . . . . 62.200000000000003 112.515 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.44 173.12 38.67 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.746 -0.74 . . . . 53.039999999999999 112.483 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -61.75 105.94 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.836 0.35 . . . . 74.219999999999999 110.921 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -77.04 103.32 6.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 72.219999999999999 110.922 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.9 t90 -138.19 107.91 6.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.496 . . . . 72.510000000000005 110.925 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -82.31 153.93 25.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 72.340000000000003 110.841 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.628 ' HG ' HG11 ' A' ' 41' ' ' VAL . 7.4 tp -104.79 133.68 49.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 74.299999999999997 110.947 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.454 ' N ' HD12 ' A' ' 61' ' ' LEU . . . -111.08 178.79 19.76 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.733 -0.746 . . . . 52.039999999999999 112.486 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -46.99 100.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.652 2.235 . . . . 65.409999999999997 112.367 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 161.88 164.13 16.18 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.724 -0.751 . . . . 72.140000000000001 112.476 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -124.1 140.27 53.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.89 0.376 . . . . 71.140000000000001 110.868 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -140.77 144.23 35.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 64.430000000000007 110.939 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.1 t -126.18 74.8 1.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 72.019999999999996 110.895 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.6 m -87.27 159.01 18.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 72.540000000000006 110.823 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.545 HG12 ' HB ' ' A' ' 36' ' ' ILE . 30.5 m -151.29 21.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 60.229999999999997 111.166 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -179.37 58.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 73.230000000000004 110.881 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.55 -49.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 54.340000000000003 110.819 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.61 -62.01 1.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 63.310000000000002 111.115 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.62 ' O ' HD13 ' A' ' 74' ' ' ILE . . . -164.74 88.94 0.1 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.722 -0.752 . . . . 63.109999999999999 112.463 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.62 HD13 ' O ' ' A' ' 73' ' ' GLY . 18.8 mm -132.2 67.35 78.89 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.623 0.725 . . . . 70.5 111.14 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -80.25 -51.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.69 2.26 . . . . 74.109999999999999 112.381 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.86 -34.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 72.010000000000005 110.85 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -141.23 -176.77 4.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 71.030000000000001 110.871 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.34 111.68 23.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 73.140000000000001 110.889 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.547 HD13 ' H ' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -141.98 11.1 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 65.230000000000004 111.086 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.4 p -83.37 170.64 14.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 72.219999999999999 110.843 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.64 152.66 10.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 73.010000000000005 110.859 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -150.19 139.9 21.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 62.439999999999998 110.919 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -109.33 130.62 55.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 70.430000000000007 110.86 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.415 ' HB3' HG21 ' A' ' 6' ' ' VAL . 2.1 mp0 -89.38 131.41 35.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 54.109999999999999 110.899 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.6 pt . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 72.010000000000005 111.099 179.975 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.929 0.395 . . . . 65.209999999999994 110.879 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.743 HG22 ' CZ2' ' A' ' 46' ' ' TRP . 87.6 t -111.95 111.77 37.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 75.140000000000001 111.117 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.561 HD13 ' HB3' ' A' ' 20' ' ' ASP . 3.3 tp -117.52 110.03 29.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 70.340000000000003 111.118 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 m -130.79 159.9 42.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 72.230000000000004 111.144 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -112.14 146.2 38.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.462 . . . . 75.120000000000005 110.938 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -101.18 38.9 1.48 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.477 . . . . 73.5 110.904 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 175.04 -171.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 74.030000000000001 110.845 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 13' ' ' ASN . 6.7 t -63.33 160.61 2.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 65.200000000000003 111.105 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.452 ' N ' HG12 ' A' ' 12' ' ' VAL . 12.0 t-20 -84.19 53.74 2.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 74.409999999999997 110.917 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.446 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -178.06 28.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 73.420000000000002 110.84 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 158.88 38.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.753 -0.737 . . . . 73.319999999999993 112.495 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.3 171.51 20.57 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.756 -0.735 . . . . 74.519999999999996 112.464 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.91 149.79 21.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.798 0.332 . . . . 72.109999999999999 110.915 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.98 149.12 50.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 75.540000000000006 110.831 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -146.39 129.45 16.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 62.329999999999998 110.886 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.561 ' HB3' HD13 ' A' ' 7' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 74.030000000000001 110.896 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.762 0.315 . . . . 71.430000000000007 110.908 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.556 HG13 HG12 ' A' ' 69' ' ' VAL . 2.0 tt -176.76 102.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 73.349999999999994 111.135 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.7 p -168.84 -164.18 0.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 65.519999999999996 110.869 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.548 ' C ' HD12 ' A' ' 39' ' ' ILE . 47.5 t -125.41 149.34 48.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 74.430000000000007 110.883 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.603 HG21 HD13 ' A' ' 61' ' ' LEU . 1.5 mp -120.91 131.26 73.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 42.009999999999998 111.145 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.547 ' HB3' HG23 ' A' ' 7' ' ' ILE . 3.7 tttp -132.51 142.32 49.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 74.129999999999995 110.875 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.607 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 7.2 p -143.74 126.43 12.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 60.310000000000002 111.121 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.67 41.1 3.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 74.420000000000002 110.928 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.9 t -179.1 110.8 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 61.219999999999999 110.878 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.3 -151.24 52.12 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.67 -0.776 . . . . 75.129999999999995 112.508 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.54 HG22 ' HA2' ' A' ' 62' ' ' GLY . 41.1 p -150.07 153.39 36.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.798 0.332 . . . . 74.329999999999998 111.15 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.743 ' CZ2' HG22 ' A' ' 6' ' ' VAL . 1.3 m0 -123.45 179.07 4.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 75.239999999999995 110.935 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -124.44 136.09 53.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.434 . . . . 72.230000000000004 110.823 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.441 ' HD2' HD22 ' A' ' 61' ' ' LEU . 1.7 m-85 -120.12 129.88 54.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 75.430000000000007 110.878 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.71 126.14 20.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.164 -0.471 . . . . 74.409999999999997 110.95 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.78 89.04 3.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 54.399999999999999 110.918 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.569 ' C ' HG22 ' A' ' 79' ' ' ILE . 0.2 OUTLIER 175.38 -169.44 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 74.239999999999995 110.915 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.2 tt -58.6 163.06 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 70.019999999999996 111.113 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -76.24 55.3 0.95 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 75.319999999999993 110.871 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -153.76 -38.02 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 73.510000000000005 110.936 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -145.53 -138.82 3.31 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 72.239999999999995 112.509 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.426 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 108.06 177.37 22.16 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.796 -0.716 . . . . 52.439999999999998 112.5 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.3 109.48 5.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.81 0.338 . . . . 72.409999999999997 110.859 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -77.59 108.71 10.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 75.430000000000007 110.927 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -138.31 106.72 5.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 63.450000000000003 110.88 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -89.13 157.7 18.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 73.409999999999997 110.878 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.635 HD11 ' CE3' ' A' ' 46' ' ' TRP . 1.8 pt? -118.5 149.71 40.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 73.430000000000007 110.944 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.54 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -127.88 -166.6 12.09 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.72 -0.752 . . . . 50.530000000000001 112.493 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -46.41 101.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.7 2.267 . . . . 62.530000000000001 112.317 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.79 165.39 16.63 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.749 -0.738 . . . . 71.420000000000002 112.484 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.44 145.84 47.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.865 0.364 . . . . 74.329999999999998 110.858 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -154.75 156.65 36.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 75.439999999999998 110.924 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 95.8 p -130.4 85.88 2.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 70.209999999999994 110.854 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.1 t -86.01 153.21 22.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 60.310000000000002 110.86 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.556 HG12 HG13 ' A' ' 36' ' ' ILE . 18.7 m -149.65 18.03 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 61.299999999999997 111.163 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -178.7 40.94 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.117 -0.492 . . . . 75.010000000000005 110.863 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 t -158.44 -45.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 74.109999999999999 110.852 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.45 -61.26 2.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.486 . . . . 75.409999999999997 111.097 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 166.62 103.7 0.17 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.717 -0.754 . . . . 55.539999999999999 112.449 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.8 mm -115.76 74.66 4.95 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.666 0.746 . . . . 64.019999999999996 111.14 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.96 -165.54 0.31 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.701 2.267 . . . . 71.129999999999995 112.359 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -51.32 -74.85 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.265 -0.425 . . . . 61.149999999999999 110.834 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -179.41 33.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 74.439999999999998 110.857 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.3 p 178.95 -174.84 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 74.040000000000006 110.859 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.569 HG22 ' C ' ' A' ' 51' ' ' TYR . 14.2 mm 66.8 62.13 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 73.109999999999999 111.151 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.2 p -165.94 137.88 3.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 65.430000000000007 110.895 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -158.53 166.75 31.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 75.129999999999995 110.864 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -151.12 142.51 23.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 62.450000000000003 110.886 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.86 159.0 26.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 64.430000000000007 110.932 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -128.52 92.53 3.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 63.399999999999999 110.934 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 pt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 65.409999999999997 111.111 179.981 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.919 0.39 . . . . 74.510000000000005 110.878 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.773 HG13 ' CH2' ' A' ' 46' ' ' TRP . 58.3 t -111.92 128.65 68.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 63.240000000000002 111.128 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.454 HG23 ' O ' ' A' ' 7' ' ' ILE . 9.9 tt -126.68 110.56 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 74.430000000000007 111.155 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.4 t -136.54 143.81 34.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 62.420000000000002 111.112 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.85 138.2 40.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 74.319999999999993 110.89 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -93.25 42.67 1.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 75.030000000000001 110.885 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 173.93 -169.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 71.329999999999998 110.858 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.454 HG12 ' N ' ' A' ' 13' ' ' ASN . 6.2 t -63.95 160.3 3.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.218 -0.447 . . . . 64.430000000000007 111.178 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.454 ' N ' HG12 ' A' ' 12' ' ' VAL . 24.4 t30 -86.42 53.97 2.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 74.219999999999999 110.858 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.434 ' CG ' ' O ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.04 28.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 73.239999999999995 110.895 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.36 47.33 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.692 -0.766 . . . . 72.420000000000002 112.424 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.97 171.96 24.3 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.714 -0.755 . . . . 54.009999999999998 112.466 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.2 163.86 15.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.829 0.347 . . . . 72.450000000000003 110.924 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.1 p -144.52 165.44 27.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.434 . . . . 74.120000000000005 110.836 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -124.88 110.89 14.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 75.420000000000002 110.838 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 75.420000000000002 110.862 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.489 ' O ' HD12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.753 0.311 . . . . 63.399999999999999 110.921 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.447 HG23 ' O ' ' A' ' 35' ' ' LYS . 2.4 pt -156.1 119.28 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 74.120000000000005 111.159 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.2 p -161.84 -169.08 2.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 43.310000000000002 110.838 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.657 ' O ' HD12 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -127.85 149.18 50.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 62.140000000000001 110.875 -179.821 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.657 HD12 ' O ' ' A' ' 38' ' ' SER . 1.5 mp -124.35 138.96 52.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 71.409999999999997 111.161 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.4 ' HB3' HG23 ' A' ' 7' ' ' ILE . 1.2 tttt -142.49 138.67 31.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 73.120000000000005 110.945 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.7 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 6.4 p -132.87 139.15 50.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 72.129999999999995 111.095 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.3 39.93 2.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 65.450000000000003 110.89 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.87 120.24 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 71.319999999999993 110.853 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.23 -143.23 21.68 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.725 -0.75 . . . . 74.540000000000006 112.55 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.618 HG22 ' HA2' ' A' ' 62' ' ' GLY . 63.8 p -146.72 156.58 43.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.724 0.297 . . . . 74.150000000000006 111.126 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.773 ' CH2' HG13 ' A' ' 6' ' ' VAL . 2.7 m0 -125.32 169.81 11.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.218 -0.446 . . . . 64.040000000000006 110.919 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -112.11 121.59 45.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 63.32 110.911 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -113.65 120.07 39.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 74.209999999999994 110.901 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -139.88 126.78 20.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.153 -0.476 . . . . 60.100000000000001 110.933 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -100.72 89.98 4.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 73.319999999999993 110.909 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.444 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 170.96 -169.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 74.420000000000002 110.905 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' A' ' 52' ' ' ILE . 7.7 tp -64.87 159.41 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 75.219999999999999 111.104 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 -78.0 45.7 0.54 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 54.030000000000001 110.913 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -152.83 17.06 0.58 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 74.310000000000002 110.93 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 168.32 -118.18 0.77 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.754 -0.736 . . . . 75.140000000000001 112.492 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.444 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 71.56 -179.27 33.9 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.745 -0.74 . . . . 75.329999999999998 112.5 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.02 108.39 14.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.828 0.347 . . . . 64.129999999999995 110.87 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -78.35 106.88 10.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 74.109999999999999 110.897 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -138.15 106.2 5.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.112 -0.494 . . . . 73.239999999999995 110.906 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -84.76 157.41 21.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 74.219999999999999 110.857 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.496 HD22 HG21 ' A' ' 39' ' ' ILE . 9.7 tp -109.75 134.7 51.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 64.209999999999994 110.909 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.618 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -110.32 -178.55 20.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.668 -0.777 . . . . 74.209999999999994 112.493 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -47.88 100.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.747 2.298 . . . . 73.430000000000007 112.314 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.46 165.42 14.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.71 -0.757 . . . . 43.25 112.428 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -93.48 165.08 12.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.86 0.362 . . . . 53.219999999999999 110.941 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -160.24 105.03 1.49 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 74.430000000000007 110.928 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.6 m -96.45 91.13 5.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 71.450000000000003 110.837 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.18 131.81 34.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 75.239999999999995 110.838 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.492 HG23 ' HG2' ' A' ' 70' ' ' GLU . 29.8 m -150.05 18.67 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.119 -0.492 . . . . 53.240000000000002 111.14 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.492 ' HG2' HG23 ' A' ' 69' ' ' VAL . 0.0 OUTLIER 173.45 -17.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 73.299999999999997 110.905 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.34 -49.73 9.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 71.549999999999997 110.867 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.31 -70.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 64.310000000000002 111.064 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.761 ' O ' HD13 ' A' ' 74' ' ' ILE . . . 173.07 119.8 0.54 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.739 -0.743 . . . . 72.140000000000001 112.473 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.761 HD13 ' O ' ' A' ' 73' ' ' GLY . 5.5 mm -129.5 67.14 78.52 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.645 0.736 . . . . 75.530000000000001 111.135 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -81.38 -69.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.704 2.269 . . . . 55.530000000000001 112.335 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.2 t70 179.08 -40.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 71.099999999999994 110.91 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -176.71 107.46 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.47 . . . . 72.310000000000002 110.865 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.2 m -140.8 -169.97 2.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 74.239999999999995 110.824 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.9 mp -106.19 150.1 9.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.485 . . . . 74.329999999999998 111.17 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.6 p -165.51 146.8 7.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 62.32 110.861 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.04 158.94 31.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 74.030000000000001 110.863 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -150.63 135.78 17.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 74.439999999999998 110.862 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -88.59 120.73 30.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 63.210000000000001 110.911 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.662 ' HG2' HG11 ' A' ' 6' ' ' VAL . 28.9 mt-30 -81.36 92.64 6.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 65.340000000000003 110.904 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 74.219999999999999 111.121 179.971 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.891 0.377 . . . . 74.230000000000004 110.903 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.789 HG13 ' CH2' ' A' ' 46' ' ' TRP . 86.0 t -115.93 127.58 73.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 75.019999999999996 111.095 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.707 HG23 ' HB3' ' A' ' 40' ' ' LYS . 7.8 tt -125.03 110.81 25.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 63.340000000000003 111.134 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.1 t -123.02 143.84 34.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 71.349999999999994 111.113 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -105.12 138.47 41.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 73.150000000000006 110.909 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -94.7 43.34 1.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.085 -0.507 . . . . 75.540000000000006 110.852 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 173.0 -170.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 71.439999999999998 110.852 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.635 HG22 HD12 ' A' ' 36' ' ' ILE . 6.3 t -64.15 159.71 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 72.120000000000005 111.112 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.436 ' N ' HG12 ' A' ' 12' ' ' VAL . 55.5 t30 -86.1 53.9 2.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 73.530000000000001 110.869 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.441 ' CG ' ' O ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.05 28.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 44.219999999999999 110.882 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.35 51.69 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.758 -0.734 . . . . 55.530000000000001 112.484 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.07 171.38 24.57 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.715 -0.755 . . . . 35.130000000000003 112.501 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.54 133.92 35.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.806 0.336 . . . . 54.240000000000002 110.903 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.76 155.08 33.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 72.319999999999993 110.885 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -148.45 117.56 6.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 74.099999999999994 110.936 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 73.549999999999997 110.908 179.978 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.754 0.311 . . . . 74.120000000000005 110.915 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.635 HD12 HG22 ' A' ' 12' ' ' VAL . 1.1 pt -153.41 107.93 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 73.120000000000005 111.143 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 63.7 p -149.86 -172.3 4.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 75.430000000000007 110.892 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.553 ' C ' HD12 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -135.22 149.53 49.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 74.010000000000005 110.859 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.553 HD12 ' C ' ' A' ' 38' ' ' SER . 1.9 mp -120.83 109.89 26.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 74.219999999999999 111.171 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.707 ' HB3' HG23 ' A' ' 7' ' ' ILE . 4.9 tttt -95.04 127.69 41.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 73.430000000000007 110.919 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.445 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 7.1 p -139.68 139.03 38.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 62.43 111.107 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.93 40.55 1.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 64.150000000000006 110.911 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.3 p -179.4 137.67 0.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 65.019999999999996 110.861 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.22 -155.3 4.75 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.753 -0.737 . . . . 70.239999999999995 112.474 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.471 HG22 ' HA2' ' A' ' 62' ' ' GLY . 67.3 p -150.03 150.13 31.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.806 0.336 . . . . 71.140000000000001 111.134 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.789 ' CH2' HG13 ' A' ' 6' ' ' VAL . 2.6 m0 -123.37 169.62 11.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 74.430000000000007 110.923 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -121.5 128.51 52.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 74.340000000000003 110.847 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -114.33 128.53 56.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 71.049999999999997 110.884 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.2 126.47 19.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.136 -0.484 . . . . 73.030000000000001 110.914 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -101.46 89.21 3.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 75.329999999999998 110.855 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.425 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.1 OUTLIER 171.66 -165.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 72.540000000000006 110.926 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -52.01 173.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 64.349999999999994 111.157 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -85.52 49.81 1.83 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 75.109999999999999 110.922 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 22.3 p90 176.86 41.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 63.420000000000002 110.905 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.12 -154.21 24.62 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.718 -0.753 . . . . 51.130000000000003 112.444 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.425 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 94.73 -177.06 35.48 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.767 -0.73 . . . . 74.150000000000006 112.483 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.29 110.8 9.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.826 0.346 . . . . 71.329999999999998 110.893 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -78.03 109.7 12.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 62.100000000000001 110.934 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -138.3 106.26 5.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.11 -0.495 . . . . 74.430000000000007 110.952 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.0 p30 -94.57 153.76 17.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 74.209999999999994 110.817 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.758 HD11 ' CE3' ' A' ' 46' ' ' TRP . 1.3 pt? -117.11 136.08 53.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 61.5 110.931 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.471 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -102.81 -162.68 25.91 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 61.329999999999998 112.484 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.27 105.39 0.29 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.685 2.257 . . . . 54.130000000000003 112.342 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.95 151.92 6.07 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.756 -0.735 . . . . 70.349999999999994 112.509 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.9 144.97 32.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.855 0.36 . . . . 71.109999999999999 110.869 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -124.35 157.28 35.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.095 -0.502 . . . . 60.109999999999999 110.896 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.1 t -160.05 68.31 0.38 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 61.539999999999999 110.866 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.609 ' CB ' ' HB2' ' A' ' 72' ' ' ALA . 0.4 OUTLIER -85.98 146.68 26.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 55.520000000000003 110.89 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.543 ' HB ' HG22 ' A' ' 36' ' ' ILE . 33.9 m -150.58 18.81 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 75.230000000000004 111.141 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -179.05 34.19 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 75.219999999999999 110.888 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 37.8 t -160.9 -40.64 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 74.319999999999993 110.867 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.609 ' HB2' ' CB ' ' A' ' 68' ' ' SER . . . -51.38 -44.18 62.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 61.549999999999997 111.131 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.751 ' O ' HD13 ' A' ' 74' ' ' ILE . . . 166.73 95.0 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.722 -0.752 . . . . 72.310000000000002 112.472 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.751 HD13 ' O ' ' A' ' 73' ' ' GLY . 4.9 mm -129.5 67.14 78.53 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.65 0.738 . . . . 62.25 111.124 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -80.83 -60.79 0.03 OUTLIER 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.667 2.245 . . . . 52.329999999999998 112.362 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 179.23 -33.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 75.349999999999994 110.81 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -141.17 -177.82 5.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 63.530000000000001 110.917 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.1 t -58.54 -96.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 62.43 110.889 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 mp 47.94 54.26 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 74.340000000000003 111.121 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.6 p -155.03 163.0 40.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 75.400000000000006 110.816 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.94 159.82 16.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.074 -0.512 . . . . 63.310000000000002 110.878 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -150.14 135.71 18.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 74.150000000000006 110.847 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -93.21 133.38 36.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 74.140000000000001 110.919 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.498 HE21 HG21 ' A' ' 6' ' ' VAL . 25.2 mt-30 -105.84 131.43 53.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 72.540000000000006 110.967 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.3 pt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 60.310000000000002 111.141 179.993 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.875 0.369 . . . . 54.409999999999997 110.897 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.769 HG22 ' CZ2' ' A' ' 46' ' ' TRP . 94.3 t -113.11 105.59 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 73.120000000000005 111.109 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.669 HD13 ' HB3' ' A' ' 20' ' ' ASP . 3.5 tp -117.07 110.3 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 72.239999999999995 111.12 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.2 m -133.15 159.29 43.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 44.509999999999998 111.116 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -112.18 142.3 44.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.127 -0.488 . . . . 74.340000000000003 110.92 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -95.35 31.85 1.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 73.319999999999993 110.924 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 175.52 -169.68 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 74.340000000000003 110.855 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.446 HG12 ' N ' ' A' ' 13' ' ' ASN . 7.9 t -62.75 159.9 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 62.549999999999997 111.149 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.446 ' N ' HG12 ' A' ' 12' ' ' VAL . 4.9 t-20 -84.51 54.07 2.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 74.519999999999996 110.907 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.436 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.66 28.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 74.319999999999993 110.88 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.12 47.61 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.689 -0.767 . . . . 62.009999999999998 112.486 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.8 171.48 24.06 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.709 -0.757 . . . . 75.450000000000003 112.501 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.3 tmmt? -91.01 122.83 34.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.803 0.335 . . . . 75.310000000000002 110.862 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.97 148.54 43.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 74.439999999999998 110.827 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -148.77 139.73 22.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 74.219999999999999 110.894 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.669 ' HB3' HD13 ' A' ' 7' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 60.25 110.873 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.724 0.297 . . . . 74.129999999999995 110.932 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.436 HG22 ' HB ' ' A' ' 69' ' ' VAL . 1.2 pt -153.49 104.13 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 74.349999999999994 111.121 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.9 p -157.16 -166.53 2.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 64.510000000000005 110.819 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.685 ' O ' HD12 ' A' ' 39' ' ' ILE . 21.2 t -127.14 154.46 44.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 71.109999999999999 110.828 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.685 HD12 ' O ' ' A' ' 38' ' ' SER . 1.5 mp -125.52 139.01 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 72.310000000000002 111.128 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.641 ' HB3' HG23 ' A' ' 7' ' ' ILE . 7.9 tttt -145.35 147.83 32.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 74.200000000000003 110.875 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 43' ' ' SER . 11.2 p -161.52 138.82 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 71.439999999999998 111.115 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -134.58 40.92 2.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 65.019999999999996 110.898 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.429 ' H ' HG22 ' A' ' 41' ' ' VAL . 1.8 t -179.62 119.4 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 73.0 110.89 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.08 -163.45 50.82 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.757 -0.735 . . . . 52.210000000000001 112.522 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.65 HG22 ' HA2' ' A' ' 62' ' ' GLY . 41.5 p -149.83 147.7 28.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.796 0.331 . . . . 64.340000000000003 111.166 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.769 ' CZ2' HG22 ' A' ' 6' ' ' VAL . 1.3 m0 -117.37 171.94 7.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 75.219999999999999 110.946 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -112.98 124.26 52.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 64.430000000000007 110.87 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -113.73 125.87 54.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 74.230000000000004 110.925 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.48 126.9 23.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 72.340000000000003 110.91 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -102.09 89.75 3.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 73.129999999999995 110.896 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.501 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.1 OUTLIER 170.72 -166.87 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.161 -0.472 . . . . 75.200000000000003 110.917 -179.873 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.404 ' HB ' ' CE1' ' A' ' 54' ' ' TYR . 1.0 OUTLIER -51.98 172.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 70.409999999999997 111.102 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -86.06 50.08 1.91 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 52.149999999999999 110.897 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.404 ' CE1' ' HB ' ' A' ' 52' ' ' ILE . 2.1 p90 174.88 45.12 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.474 . . . . 62.420000000000002 110.905 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.22 -150.14 18.08 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.724 -0.75 . . . . 54.43 112.465 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.501 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 87.37 -171.51 42.06 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.689 -0.767 . . . . 71.030000000000001 112.497 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.47 112.39 17.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.817 0.342 . . . . 73.120000000000005 110.886 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -79.23 101.04 7.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 74.219999999999999 110.943 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -133.86 107.54 7.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.119 -0.491 . . . . 71.310000000000002 110.914 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -83.85 154.21 23.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 74.340000000000003 110.849 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.549 HD12 ' H ' ' A' ' 62' ' ' GLY . 14.8 tp -99.34 148.34 24.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 44.520000000000003 110.934 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.65 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -129.55 -165.16 11.61 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.723 -0.751 . . . . 61.100000000000001 112.489 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.26 89.73 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.667 2.245 . . . . 64.140000000000001 112.339 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.32 171.18 40.57 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.761 -0.733 . . . . 74.209999999999994 112.513 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.8 143.83 50.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.833 0.349 . . . . 71.340000000000003 110.898 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -152.55 149.03 28.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 74.310000000000002 110.951 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.2 p -130.33 82.44 2.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 41.439999999999998 110.845 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.601 ' HB2' ' HB2' ' A' ' 72' ' ' ALA . 40.4 m -86.66 147.07 26.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 63.140000000000001 110.819 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HB ' HG22 ' A' ' 36' ' ' ILE . 34.7 m -150.69 19.04 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.074 -0.512 . . . . 74.409999999999997 111.164 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -179.46 34.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 73.219999999999999 110.905 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.1 t -160.74 -40.84 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 73.219999999999999 110.851 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.601 ' HB2' ' HB2' ' A' ' 68' ' ' SER . . . -52.3 -54.25 33.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 73.120000000000005 111.111 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.459 ' O ' HD13 ' A' ' 74' ' ' ILE . . . 178.37 85.74 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.815 -0.707 . . . . 75.439999999999998 112.481 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.459 HD13 ' O ' ' A' ' 73' ' ' GLY . 13.9 mm -123.89 67.55 42.17 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.64 0.733 . . . . 72.109999999999999 111.132 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -74.35 -53.86 0.1 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.689 2.259 . . . . 75.010000000000005 112.377 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.3 t70 179.44 -74.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 51.340000000000003 110.855 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -93.04 -169.85 2.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 62.210000000000001 110.918 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.92 114.49 26.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 74.049999999999997 110.882 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -152.64 69.52 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 74.439999999999998 111.12 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.7 p -158.76 161.63 37.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 75.019999999999996 110.851 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.74 163.24 18.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 72.409999999999997 110.834 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -151.16 136.31 17.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 62.119999999999997 110.86 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -88.53 120.21 29.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 74.349999999999994 110.883 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -79.18 102.03 8.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 72.310000000000002 110.896 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 pt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 75.310000000000002 111.101 179.953 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.892 0.377 . . . . 63.340000000000003 110.882 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.73 HG13 ' CH2' ' A' ' 46' ' ' TRP . 96.7 t -115.89 136.37 52.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 71.519999999999996 111.099 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.76 HG23 ' HB3' ' A' ' 40' ' ' LYS . 8.3 tt -131.35 110.66 17.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 74.230000000000004 111.145 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.4 t -127.09 143.13 41.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 73.430000000000007 111.132 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -97.1 140.36 31.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 73.219999999999999 110.925 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -99.24 35.6 1.89 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 61.329999999999998 110.914 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 175.18 -169.73 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 72.340000000000003 110.871 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 13' ' ' ASN . 6.5 t -63.64 159.52 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 61.310000000000002 111.112 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.441 ' N ' HG12 ' A' ' 12' ' ' VAL . 39.5 p30 -85.78 54.19 3.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 62.020000000000003 110.902 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.441 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.1 28.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 75.329999999999998 110.881 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.22 50.28 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.726 -0.749 . . . . 65.129999999999995 112.505 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.1 171.51 24.53 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.761 -0.733 . . . . 64.340000000000003 112.529 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.21 126.06 42.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.764 0.316 . . . . 72.530000000000001 110.906 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.7 p -118.29 156.5 28.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.27 -0.423 . . . . 72.299999999999997 110.824 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -111.03 107.97 17.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 73.420000000000002 110.877 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.6 t70 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 72.230000000000004 110.884 179.96 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.429 ' O ' HG23 ' A' ' 36' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.728 0.299 . . . . 71.209999999999994 110.921 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.71 ' HB ' HG12 ' A' ' 69' ' ' VAL . 4.6 pt -155.23 128.92 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 61.350000000000001 111.103 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 84.8 p -167.34 -168.19 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 74.109999999999999 110.897 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.483 ' O ' HD12 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -125.13 152.72 44.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 75.129999999999995 110.871 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.483 HD12 ' O ' ' A' ' 38' ' ' SER . 1.3 mp -120.91 132.64 69.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 73.150000000000006 111.114 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.76 ' HB3' HG23 ' A' ' 7' ' ' ILE . 2.9 tttt -130.6 131.94 45.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 73.430000000000007 110.899 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.614 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 4.9 p -136.45 139.24 45.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 71.140000000000001 111.098 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.6 mmpp? -143.62 45.98 1.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 71.25 110.864 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.44 124.42 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 71.549999999999997 110.831 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.01 -150.0 8.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.748 -0.739 . . . . 61.299999999999997 112.487 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.6 p -147.57 144.74 28.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.797 0.332 . . . . 70.329999999999998 111.09 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.73 ' CH2' HG13 ' A' ' 6' ' ' VAL . 2.0 m0 -115.87 173.07 6.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 73.129999999999995 110.915 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -119.11 120.76 38.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.425 . . . . 71.409999999999997 110.84 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -109.63 125.73 52.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 60.039999999999999 110.838 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.83 143.91 37.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.074 -0.512 . . . . 74.239999999999995 110.879 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -107.93 88.5 2.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.077 -0.51 . . . . 45.109999999999999 110.918 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.414 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 171.78 -166.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 65.340000000000003 110.933 -179.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.609 HG22 ' H ' ' A' ' 53' ' ' ASN . 3.3 mm -78.79 171.52 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 73.040000000000006 111.091 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.609 ' H ' HG22 ' A' ' 52' ' ' ILE . 4.6 t-20 -74.66 57.83 0.77 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 64.140000000000001 110.878 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -151.01 -34.95 0.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 73.340000000000003 110.907 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -158.74 -141.91 3.26 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.731 -0.747 . . . . 50.25 112.489 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.414 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 106.53 -179.97 22.88 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.709 -0.757 . . . . 53.450000000000003 112.461 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.69 105.9 6.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.813 0.339 . . . . 65.209999999999994 110.89 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -76.73 106.99 8.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 63.119999999999997 110.913 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -138.29 106.98 5.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.113 -0.494 . . . . 74.519999999999996 110.897 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -90.32 141.35 28.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 74.319999999999993 110.881 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.561 HD21 ' CE3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -99.32 153.41 18.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 74.310000000000002 110.907 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -132.44 -168.4 12.01 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.729 -0.748 . . . . 52.530000000000001 112.487 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -46.48 101.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.645 2.23 . . . . 74.150000000000006 112.354 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.43 163.76 12.68 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.746 . . . . 70.409999999999997 112.516 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -127.52 138.43 52.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.91 0.386 . . . . 71.310000000000002 110.847 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -135.92 151.95 50.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 73.120000000000005 110.891 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 97.4 p -133.45 81.8 1.95 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 71.239999999999995 110.857 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.6 m -85.97 160.98 19.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 73.420000000000002 110.836 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.71 HG12 ' HB ' ' A' ' 36' ' ' ILE . 6.2 m -152.9 20.45 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 65.239999999999995 111.171 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -178.07 53.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 73.209999999999994 110.935 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.65 -35.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 74.310000000000002 110.851 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.97 -64.29 0.86 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 65.319999999999993 111.113 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 179.08 83.55 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.761 -0.733 . . . . 75.439999999999998 112.498 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.59 67.49 24.34 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.604 0.716 . . . . 73.409999999999997 111.171 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -80.3 -50.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.631 2.221 . . . . 74.319999999999993 112.342 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -179.56 -36.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 70.040000000000006 110.888 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -179.36 55.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 61.240000000000002 110.864 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.5 t -97.34 166.55 11.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 72.430000000000007 110.855 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.6 mt -106.16 153.51 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 73.230000000000004 111.167 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.2 p -149.98 155.91 40.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 73.239999999999995 110.835 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.38 158.15 29.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 74.140000000000001 110.839 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -150.48 135.41 17.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 75.5 110.867 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -95.1 130.8 41.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 63.130000000000003 110.833 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.668 ' HG3' HG21 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -97.28 131.64 43.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.464 . . . . 71.439999999999998 110.894 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.9 pt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 71.409999999999997 111.121 179.985 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.93 0.395 . . . . 71.329999999999998 110.86 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.743 HG22 ' CZ2' ' A' ' 46' ' ' TRP . 98.5 t -110.32 116.03 51.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 60.109999999999999 111.169 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.728 HG23 ' HB3' ' A' ' 40' ' ' LYS . 7.9 tt -115.7 110.39 31.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 60.0 111.101 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 72.2 t -128.68 137.1 58.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 64.549999999999997 111.162 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -88.62 138.38 31.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.461 . . . . 75.439999999999998 110.949 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -96.0 47.85 1.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 61.5 110.846 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 173.29 -170.41 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 71.409999999999997 110.874 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 13' ' ' ASN . 4.9 t -64.61 161.51 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 75.400000000000006 111.092 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.461 ' N ' HG12 ' A' ' 12' ' ' VAL . 5.8 p30 -86.76 53.66 2.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 62.219999999999999 110.896 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.438 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.52 29.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 74.230000000000004 110.883 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.94 49.72 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.754 -0.736 . . . . 41.039999999999999 112.504 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.07 171.59 24.49 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.702 -0.761 . . . . 72.329999999999998 112.445 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.06 162.94 14.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.771 0.319 . . . . 75.040000000000006 110.903 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.0 p -145.1 153.52 41.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 41.299999999999997 110.879 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -142.27 119.82 11.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 72.450000000000003 110.887 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 p30 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 64.430000000000007 110.802 -179.963 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.763 0.316 . . . . 65.209999999999994 110.931 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 69' ' ' VAL . 1.1 pt -153.36 103.91 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 73.439999999999998 111.136 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 78.7 p -167.74 -166.78 0.78 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 65.329999999999998 110.861 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.579 ' C ' HD12 ' A' ' 39' ' ' ILE . 0.7 OUTLIER -111.69 148.46 33.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 73.439999999999998 110.869 -179.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.579 HD12 ' C ' ' A' ' 38' ' ' SER . 1.6 mp -120.85 127.77 75.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 52.140000000000001 111.164 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.728 ' HB3' HG23 ' A' ' 7' ' ' ILE . 1.0 OUTLIER -126.82 133.18 50.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 75.019999999999996 110.924 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.541 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 8.4 p -143.55 139.02 26.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 74.109999999999999 111.167 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.6 mmpp? -142.77 40.27 1.53 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 74.010000000000005 110.879 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.49 135.04 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 73.510000000000005 110.89 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.14 -159.49 2.78 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.777 -0.725 . . . . 72.030000000000001 112.465 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.1 p -145.43 151.3 38.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.799 0.333 . . . . 54.350000000000001 111.133 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.743 ' CZ2' HG22 ' A' ' 6' ' ' VAL . 2.0 m0 -124.2 175.36 7.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 64.219999999999999 110.898 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.578 ' HD2' HD11 ' A' ' 85' ' ' ILE . 1.7 mpt_? -121.48 120.54 35.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 74.530000000000001 110.904 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -107.28 126.23 52.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 75.019999999999996 110.857 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.83 142.99 36.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 73.120000000000005 110.915 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.03 88.36 2.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 44.340000000000003 110.883 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.433 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 172.01 -169.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 75.400000000000006 110.921 -179.831 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 30.1 pt -69.82 172.62 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.106 -0.497 . . . . 54.399999999999999 111.127 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -78.05 56.37 1.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 72.319999999999993 110.889 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -150.93 -40.56 0.12 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.475 . . . . 73.219999999999999 110.927 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.43 -143.89 3.88 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.704 -0.76 . . . . 61.219999999999999 112.476 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.433 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 108.11 176.18 22.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.781 -0.723 . . . . 52.450000000000003 112.506 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.03 104.78 3.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.785 0.326 . . . . 71.200000000000003 110.826 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -76.54 107.49 8.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 75.099999999999994 110.888 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -138.13 106.3 5.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 70.239999999999995 110.958 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -88.83 140.52 29.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.261 -0.427 . . . . 61.119999999999997 110.843 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.542 HD21 ' CE3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -99.3 156.82 16.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 64.310000000000002 110.934 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -131.54 -173.17 13.27 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.699 -0.762 . . . . 54.310000000000002 112.509 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -46.21 101.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.691 2.261 . . . . 71.409999999999997 112.307 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 158.74 157.39 8.47 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.713 -0.756 . . . . 62.420000000000002 112.457 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -117.68 148.24 42.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.83 0.348 . . . . 71.540000000000006 110.909 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -160.28 160.06 32.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.161 -0.472 . . . . 61.409999999999997 110.925 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.2 p -115.22 80.27 1.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.092 -0.504 . . . . 63.340000000000003 110.871 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.817 ' HB2' ' HB2' ' A' ' 72' ' ' ALA . 14.7 m -86.26 84.69 7.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 73.049999999999997 110.881 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.493 ' O ' HG22 ' A' ' 36' ' ' ILE . 12.2 m -89.89 -6.3 10.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.492 . . . . 55.219999999999999 111.156 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -162.62 62.53 0.21 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.487 . . . . 64.109999999999999 110.902 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.68 -34.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 53.310000000000002 110.877 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.817 ' HB2' ' HB2' ' A' ' 68' ' ' SER . . . -50.82 -47.85 59.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 62.32 111.107 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.643 ' H ' HD13 ' A' ' 74' ' ' ILE . . . -178.25 40.4 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.668 -0.777 . . . . 71.519999999999996 112.424 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.643 HD13 ' H ' ' A' ' 73' ' ' GLY . 0.0 OUTLIER -133.48 67.66 76.02 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.625 0.726 . . . . 72.329999999999998 111.156 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -81.77 -70.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.682 2.255 . . . . 74.109999999999999 112.329 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.473 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 1.9 t0 -94.17 -0.47 55.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 74.439999999999998 110.901 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 76' ' ' ASP . 5.6 m-20 81.07 89.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 73.340000000000003 110.844 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.9 m -146.04 -169.93 3.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 72.299999999999997 110.866 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.1 mt -76.23 153.31 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 65.329999999999998 111.162 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.6 t -149.05 157.42 43.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 73.129999999999995 110.872 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.37 159.54 25.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 43.039999999999999 110.89 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -150.83 136.12 17.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 60.409999999999997 110.887 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -87.44 121.62 30.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 73.349999999999994 110.926 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -79.7 93.41 5.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 75.439999999999998 110.96 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.578 HD11 ' HD2' ' A' ' 47' ' ' ARG . 1.8 pt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.438 . . . . 75.209999999999994 111.159 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.876 0.37 . . . . 71.439999999999998 110.884 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.4 m -116.28 138.15 47.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 73.299999999999997 111.1 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.815 HG23 ' HB3' ' A' ' 40' ' ' LYS . 3.6 tp -101.18 110.05 27.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 72.530000000000001 111.141 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.6 t -129.89 140.83 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 42.310000000000002 111.133 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -93.43 138.83 31.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 73.319999999999993 110.94 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -93.47 42.39 1.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 73.329999999999998 110.842 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 175.13 -169.5 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 73.030000000000001 110.842 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 13' ' ' ASN . 5.8 t -64.1 160.61 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 75.040000000000006 111.122 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.442 ' N ' HG12 ' A' ' 12' ' ' VAL . 14.1 t30 -86.44 53.89 2.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 61.229999999999997 110.871 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.444 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.23 28.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 64.109999999999999 110.903 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.0 50.34 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.764 -0.731 . . . . 71.049999999999997 112.516 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.15 171.71 23.79 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.772 -0.728 . . . . 53.43 112.54 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.51 149.84 23.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.822 0.344 . . . . 72.549999999999997 110.848 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -131.32 141.62 49.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 62.509999999999998 110.895 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -136.44 152.3 50.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 74.430000000000007 110.861 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 p30 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 71.549999999999997 110.856 179.987 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.777 0.323 . . . . 75.200000000000003 110.879 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.434 ' HB ' HG12 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -147.43 124.12 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 74.129999999999995 111.124 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.6 p -167.48 -168.34 1.02 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 54.219999999999999 110.844 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.515 ' C ' HD12 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -127.44 158.14 38.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 45.310000000000002 110.844 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.515 HD12 ' C ' ' A' ' 38' ' ' SER . 2.5 mp -120.92 140.07 46.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 54.0 111.154 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.815 ' HB3' HG23 ' A' ' 7' ' ' ILE . 15.1 tttt -130.05 119.53 23.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 64.340000000000003 110.83 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.647 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 4.9 p -114.12 139.28 40.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 65.239999999999995 111.104 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.86 39.69 1.82 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 73.219999999999999 110.928 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.2 114.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 64.019999999999996 110.871 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 60.65 -143.06 48.19 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.733 -0.746 . . . . 65.230000000000004 112.51 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.475 HG22 ' HA2' ' A' ' 62' ' ' GLY . 67.9 p -150.1 154.79 38.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.793 0.33 . . . . 55.530000000000001 111.14 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.647 ' CZ2' HG23 ' A' ' 41' ' ' VAL . 1.7 m0 -124.31 176.95 6.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.432 . . . . 74.329999999999998 110.908 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -126.49 130.8 51.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 74.540000000000006 110.84 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -115.33 126.34 54.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 75.329999999999998 110.897 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.9 126.78 20.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 73.120000000000005 110.948 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -102.89 89.56 3.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 71.430000000000007 110.902 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.472 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.1 OUTLIER 171.44 -166.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.191 -0.459 . . . . 63.420000000000002 110.959 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.401 HG13 ' H ' ' A' ' 52' ' ' ILE . 1.0 OUTLIER -52.19 173.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 55.439999999999998 111.112 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -86.32 50.15 1.93 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 74.430000000000007 110.914 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 22.3 p90 176.89 41.14 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.471 . . . . 75.439999999999998 110.946 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 165.1 -155.97 27.68 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.722 -0.752 . . . . 25.440000000000001 112.47 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.472 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 96.13 -171.33 28.26 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.724 -0.75 . . . . 74.129999999999995 112.469 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -80.93 108.68 14.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.869 0.366 . . . . 72.239999999999995 110.878 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -78.19 109.31 12.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 73.439999999999998 110.911 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -138.18 108.1 6.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 73.349999999999994 110.89 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -94.93 152.87 17.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 73.430000000000007 110.884 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.641 HD11 ' CE3' ' A' ' 46' ' ' TRP . 1.5 pt? -116.09 138.48 51.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 75.5 110.934 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.475 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -111.21 -170.14 19.05 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.729 -0.748 . . . . 43.420000000000002 112.461 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -46.99 99.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.628 2.219 . . . . 65.040000000000006 112.357 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.46 169.09 19.49 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.742 . . . . 72.510000000000005 112.544 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -99.5 146.22 26.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 62.210000000000001 110.875 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -130.38 151.57 50.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 73.439999999999998 110.883 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.5 t -119.11 93.23 4.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.087 -0.506 . . . . 55.25 110.846 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.814 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 0.7 OUTLIER -84.95 94.61 8.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.091 -0.504 . . . . 75.129999999999995 110.813 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.434 HG12 ' HB ' ' A' ' 36' ' ' ILE . 35.8 m -150.6 32.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.492 . . . . 71.150000000000006 111.119 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.449 ' HA ' HD11 ' A' ' 74' ' ' ILE . 1.1 pt-20 -171.41 30.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.463 . . . . 72.099999999999994 110.904 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.47 -67.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 71.310000000000002 110.881 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.814 ' HB3' ' HB3' ' A' ' 68' ' ' SER . . . -74.51 -34.85 63.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 72.450000000000003 111.107 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -65.8 -48.0 70.71 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.726 -0.749 . . . . 74.420000000000002 112.448 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.449 HD11 ' HA ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -113.88 74.17 2.49 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.604 0.716 . . . . 73.420000000000002 111.148 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.18 -49.06 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.681 2.254 . . . . 75.329999999999998 112.38 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -175.26 -62.5 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 73.420000000000002 110.859 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -142.09 -95.68 0.13 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 73.430000000000007 110.885 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.85 52.05 1.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 62.409999999999997 110.885 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.69 85.77 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.087 -0.506 . . . . 63.009999999999998 111.14 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 79.2 p -163.19 154.07 16.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.459 . . . . 73.109999999999999 110.868 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.53 160.76 18.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 72.239999999999995 110.832 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -150.16 135.77 18.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 75.310000000000002 110.89 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.436 ' NH1' HD13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -91.1 120.37 32.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 75.409999999999997 110.879 -179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -86.83 98.82 11.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 65.129999999999995 110.927 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.436 HD13 ' NH1' ' A' ' 83' ' ' ARG . 1.1 pt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 75.109999999999999 111.119 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.817 0.342 . . . . 72.420000000000002 110.897 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.8 m -117.16 138.51 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 75.349999999999994 111.114 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.764 HG23 ' HB3' ' A' ' 40' ' ' LYS . 6.8 tt -99.49 110.38 26.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 73.450000000000003 111.121 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 m -122.89 159.73 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 64.010000000000005 111.134 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -111.66 139.94 46.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.162 -0.472 . . . . 71.530000000000001 110.914 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -100.1 28.51 4.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 61.409999999999997 110.895 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 175.87 -169.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 64.310000000000002 110.836 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 13' ' ' ASN . 10.8 t -62.98 157.37 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 54.450000000000003 111.094 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.415 ' N ' HG12 ' A' ' 12' ' ' VAL . 17.8 p30 -83.22 54.88 2.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 72.25 110.905 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.443 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -177.34 27.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 75.200000000000003 110.886 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.24 45.63 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.76 -0.733 . . . . 65.120000000000005 112.493 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.27 173.68 23.67 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.778 -0.725 . . . . 64.310000000000002 112.512 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.62 146.17 26.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.821 0.343 . . . . 51.119999999999997 110.866 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.0 p -117.15 162.89 17.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 70.319999999999993 110.834 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -118.55 135.81 54.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 74.030000000000001 110.901 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.4 p30 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 73.129999999999995 110.876 179.956 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.777 0.322 . . . . 73.420000000000002 110.862 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.408 ' CB ' HG23 ' A' ' 69' ' ' VAL . 3.9 tt -174.14 102.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 72.019999999999996 111.143 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.4 p -169.21 -167.53 0.73 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 74.120000000000005 110.845 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.565 ' C ' HD12 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -127.36 152.0 48.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.102 -0.499 . . . . 55.509999999999998 110.835 -179.815 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.565 HD12 ' C ' ' A' ' 38' ' ' SER . 1.6 mp -120.99 137.93 53.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 75.519999999999996 111.153 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.764 ' HB3' HG23 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -137.35 119.69 15.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.467 . . . . 65.319999999999993 110.909 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.59 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 4.1 p -109.11 139.08 33.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 54.219999999999999 111.168 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.05 39.55 2.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 71.019999999999996 110.859 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.64 110.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.435 . . . . 55.219999999999999 110.859 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 56.99 -142.13 42.32 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.689 -0.767 . . . . 74.430000000000007 112.47 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.765 HG22 ' HA2' ' A' ' 62' ' ' GLY . 49.5 p -144.86 160.21 41.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.764 0.316 . . . . 54.409999999999997 111.14 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.712 ' CE3' HD11 ' A' ' 61' ' ' LEU . 1.7 m0 -123.22 -179.99 4.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 75.140000000000001 110.866 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.26 115.84 16.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 74.030000000000001 110.899 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -100.68 127.89 46.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 75.319999999999993 110.896 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.14 126.28 19.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 71.010000000000005 110.93 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -103.05 89.62 3.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 70.430000000000007 110.85 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.445 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 173.81 -171.82 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 72.209999999999994 110.904 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.6 tp -57.6 160.64 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 73.329999999999998 111.123 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -74.95 55.5 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 75.349999999999994 110.88 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -153.93 -38.27 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 74.140000000000001 110.892 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -146.61 -140.4 3.44 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 74.129999999999995 112.491 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.445 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 106.93 -175.33 20.61 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.764 -0.731 . . . . 62.439999999999998 112.51 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.7 106.48 7.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 71.510000000000005 110.873 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -79.52 109.23 13.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 73.219999999999999 110.937 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -138.07 108.32 6.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.084 -0.507 . . . . 72.219999999999999 110.951 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.66 157.37 16.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.286 -0.415 . . . . 71.299999999999997 110.87 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.712 HD11 ' CE3' ' A' ' 46' ' ' TRP . 1.6 pt? -121.36 153.98 37.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 74.200000000000003 110.916 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.765 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -121.12 179.32 16.32 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.751 -0.737 . . . . 62.210000000000001 112.496 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -43.97 104.82 0.06 OUTLIER 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.674 2.249 . . . . 72.540000000000006 112.35 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.52 162.59 11.43 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.731 -0.747 . . . . 72.519999999999996 112.488 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -81.11 174.0 12.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.843 0.354 . . . . 72.439999999999998 110.894 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -160.89 99.65 1.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 74.239999999999995 110.895 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.1 p -97.46 65.65 1.95 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.08 -0.509 . . . . 62.310000000000002 110.865 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.6 p -86.93 152.19 22.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 65.219999999999999 110.859 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.429 ' O ' HG22 ' A' ' 69' ' ' VAL . 6.1 p -163.61 23.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.113 -0.494 . . . . 62.229999999999997 111.114 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 177.25 35.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 50.329999999999998 110.908 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.95 -40.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 62.310000000000002 110.863 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.29 -50.1 70.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.1 -0.5 . . . . 75.409999999999997 111.091 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.443 ' C ' ' HD3' ' A' ' 75' ' ' PRO . . . 165.95 101.26 0.15 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 44.329999999999998 112.492 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.1 mm -113.29 74.83 2.11 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.604 0.716 . . . . 64.519999999999996 111.144 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.443 ' HD3' ' C ' ' A' ' 73' ' ' GLY . 70.1 Cg_endo -79.48 -165.62 0.35 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.665 2.243 . . . . 63.420000000000002 112.311 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -145.23 40.58 1.23 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.436 . . . . 72.209999999999994 110.853 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -175.9 -171.63 0.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 64.230000000000004 110.866 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 61.8 p -97.24 81.55 3.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 70.040000000000006 110.863 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -152.07 66.98 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 71.420000000000002 111.122 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 91.5 p -166.28 145.66 5.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 72.420000000000002 110.848 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -163.93 165.62 22.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 74.430000000000007 110.804 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -150.6 143.03 24.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 61.509999999999998 110.871 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -79.91 171.98 14.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 75.329999999999998 110.87 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -148.04 105.94 3.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 65.349999999999994 110.907 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.6 pt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 74.150000000000006 111.147 179.947 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.901 0.381 . . . . 75.349999999999994 110.853 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.791 HG13 ' CH2' ' A' ' 46' ' ' TRP . 61.1 t -112.06 119.8 60.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 72.510000000000005 111.135 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.762 HG23 ' HB3' ' A' ' 40' ' ' LYS . 7.9 tt -123.76 110.19 25.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 51.530000000000001 111.111 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.0 m -126.82 142.25 43.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 75.319999999999993 111.102 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -92.26 141.6 28.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.177 -0.465 . . . . 71.109999999999999 110.923 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -96.42 44.37 1.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 74.230000000000004 110.91 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 172.95 -170.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 70.099999999999994 110.829 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 13' ' ' ASN . 5.1 t -64.47 161.27 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 73.5 111.129 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.46 ' N ' HG12 ' A' ' 12' ' ' VAL . 8.4 p-10 -86.75 53.74 2.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 60.420000000000002 110.919 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.445 ' CG ' ' O ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.41 28.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 74.099999999999994 110.879 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.88 47.11 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.762 -0.732 . . . . 54.329999999999998 112.492 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.08 171.61 24.48 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.711 -0.757 . . . . 63.420000000000002 112.506 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 ptpt -92.64 164.11 13.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.794 0.33 . . . . 72.120000000000005 110.91 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.0 p -138.98 160.33 40.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 55.340000000000003 110.833 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -121.1 110.11 15.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 72.200000000000003 110.86 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 61.340000000000003 110.838 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.749 0.309 . . . . 64.319999999999993 110.884 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.495 ' HA ' HG12 ' A' ' 69' ' ' VAL . 1.1 pt -152.46 118.08 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 74.409999999999997 111.091 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.8 p -167.54 -164.46 0.58 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 63.119999999999997 110.859 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.591 ' O ' HD12 ' A' ' 39' ' ' ILE . 0.7 OUTLIER -118.13 150.32 39.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 73.530000000000001 110.882 -179.836 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.591 HD12 ' O ' ' A' ' 38' ' ' SER . 1.5 mp -121.57 117.0 51.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 70.099999999999994 111.142 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.762 ' HB3' HG23 ' A' ' 7' ' ' ILE . 4.2 tttp -113.75 127.81 56.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 74.450000000000003 110.913 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.785 HG13 ' CZ2' ' A' ' 46' ' ' TRP . 6.2 t -122.33 139.31 49.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 74.109999999999999 111.134 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -151.99 39.76 0.62 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 74.140000000000001 110.893 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.5 t 179.48 115.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 71.239999999999995 110.863 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 51.74 -153.84 5.08 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.72 -0.752 . . . . 55.310000000000002 112.497 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.801 HG22 ' HA2' ' A' ' 62' ' ' GLY . 37.7 p -138.07 158.15 44.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.774 0.321 . . . . 62.210000000000001 111.113 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.791 ' CH2' HG13 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -125.12 170.84 10.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 74.109999999999999 110.942 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -115.44 126.42 54.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 73.319999999999993 110.892 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -112.14 127.15 55.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 72.140000000000001 110.88 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.26 137.41 34.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 71.209999999999994 110.937 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -112.25 87.9 2.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 60.039999999999999 110.867 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.417 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 170.45 -171.74 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.18 -0.463 . . . . 71.329999999999998 110.936 -179.862 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.4 pt -55.0 174.35 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 61.119999999999997 111.107 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -87.63 37.84 0.81 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 71.049999999999997 110.878 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -151.86 18.67 0.69 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 72.109999999999999 110.923 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.05 -154.51 23.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 50.100000000000001 112.517 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.417 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 106.9 178.93 22.81 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.746 -0.74 . . . . 61.240000000000002 112.494 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.85 103.75 6.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.35 . . . . 61.039999999999999 110.868 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -76.67 110.37 11.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 70.230000000000004 110.92 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -138.11 105.82 5.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.126 -0.488 . . . . 73.349999999999994 110.925 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -90.46 133.58 34.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 44.240000000000002 110.893 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.616 HD21 ' CE3' ' A' ' 46' ' ' TRP . 0.8 OUTLIER -99.06 165.02 11.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 72.510000000000005 110.885 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.801 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -128.7 -166.46 11.98 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.779 -0.724 . . . . 70.319999999999993 112.518 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.67 118.05 4.88 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.688 2.259 . . . . 55.210000000000001 112.313 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.96 156.31 7.76 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.797 -0.716 . . . . 61.32 112.53 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -117.99 139.17 51.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 73.409999999999997 110.892 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.597 ' OH ' HD12 ' A' ' 61' ' ' LEU . 2.9 p90 -160.2 160.12 32.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.115 -0.493 . . . . 64.530000000000001 110.896 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.5 m -112.43 81.7 1.52 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.053 -0.521 . . . . 65.420000000000002 110.844 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.2 m -84.98 149.03 25.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 65.329999999999998 110.874 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.495 HG12 ' HA ' ' A' ' 36' ' ' ILE . 6.0 m -152.99 22.55 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 62.149999999999999 111.129 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.435 ' HA ' HD11 ' A' ' 74' ' ' ILE . 0.9 OUTLIER -165.45 60.31 0.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 62.350000000000001 110.871 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.56 -33.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 73.200000000000003 110.89 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.3 -63.81 1.0 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 62.140000000000001 111.092 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.7 79.89 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 72.430000000000007 112.486 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.435 HD11 ' HA ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -140.69 67.23 29.16 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.62 0.724 . . . . 72.349999999999994 111.136 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -80.31 -35.3 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.655 2.237 . . . . 74.299999999999997 112.343 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -179.2 -34.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 63.009999999999998 110.877 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -140.67 164.83 29.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 74.019999999999996 110.864 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.557 ' O ' HD13 ' A' ' 79' ' ' ILE . 12.2 t -68.3 87.38 0.29 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 72.120000000000005 110.855 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.557 HD13 ' O ' ' A' ' 78' ' ' SER . 26.1 mm -139.03 68.51 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 71.25 111.145 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.8 p -146.83 165.17 30.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 61.340000000000003 110.837 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.6 157.73 14.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 65.510000000000005 110.849 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -150.8 136.57 18.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.126 -0.488 . . . . 64.140000000000001 110.901 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.69 120.09 32.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 63.350000000000001 110.815 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.73 ' HG2' HG11 ' A' ' 6' ' ' VAL . 4.4 mt-30 -79.4 97.67 6.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 73.540000000000006 110.936 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 pt . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 72.010000000000005 111.101 179.995 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.904 0.383 . . . . 62.109999999999999 110.86 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.798 HG11 ' HG2' ' A' ' 84' ' ' GLN . 84.2 t -109.02 120.04 59.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 75.109999999999999 111.15 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.441 HG23 ' O ' ' A' ' 7' ' ' ILE . 9.0 tt -128.84 111.54 23.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 65.310000000000002 111.107 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 m -131.21 161.56 40.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 73.319999999999993 111.12 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -114.21 148.29 37.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 64.230000000000004 110.937 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -102.24 40.68 1.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 72.420000000000002 110.897 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 172.79 -171.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 73.129999999999995 110.893 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.446 HG12 ' N ' ' A' ' 13' ' ' ASN . 6.1 t -63.97 160.15 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.429 . . . . 73.439999999999998 111.134 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.446 ' N ' HG12 ' A' ' 12' ' ' VAL . 7.7 t30 -85.79 53.96 2.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 74.129999999999995 110.903 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.419 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.25 28.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 71.530000000000001 110.878 -179.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.02 44.38 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.772 -0.728 . . . . 63.130000000000003 112.477 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.02 172.04 24.28 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.765 -0.731 . . . . 33.130000000000003 112.484 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.33 160.33 14.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.793 0.33 . . . . 72.25 110.87 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.1 p -136.37 164.56 27.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 73.040000000000006 110.838 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -123.14 113.91 19.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 63.030000000000001 110.871 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 74.439999999999998 110.866 179.972 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.771 0.32 . . . . 74.420000000000002 110.861 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.486 HG13 HG12 ' A' ' 69' ' ' VAL . 1.5 tt -176.77 107.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 72.530000000000001 111.151 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 83.3 p -167.88 -166.14 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 74.120000000000005 110.909 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.656 ' O ' HD12 ' A' ' 39' ' ' ILE . 0.8 OUTLIER -114.57 141.49 47.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 71.329999999999998 110.885 -179.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.656 HD12 ' O ' ' A' ' 38' ' ' SER . 1.6 mp -124.71 118.16 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 42.329999999999998 111.092 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -123.61 135.02 53.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 73.140000000000001 110.888 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.775 HG13 ' CZ2' ' A' ' 46' ' ' TRP . 4.7 t -129.17 139.57 51.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 72.329999999999998 111.143 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.99 39.35 1.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 70.209999999999994 110.907 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.8 t 177.84 120.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 70.310000000000002 110.851 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.14 -152.94 6.21 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.747 -0.74 . . . . 72.450000000000003 112.446 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.6 HG22 ' HA2' ' A' ' 62' ' ' GLY . 42.6 p -142.4 159.37 42.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.345 . . . . 53.530000000000001 111.139 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.775 ' CZ2' HG13 ' A' ' 41' ' ' VAL . 1.5 m0 -123.78 176.55 6.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 71.299999999999997 110.916 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -123.84 122.03 36.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 61.229999999999997 110.86 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -107.55 125.87 51.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 75.25 110.857 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.28 126.91 20.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 73.230000000000004 110.888 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -100.69 89.91 4.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 65.519999999999996 110.864 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.472 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.1 OUTLIER 170.76 -167.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 75.510000000000005 110.921 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -52.26 173.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.478 . . . . 74.420000000000002 111.15 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -86.56 50.28 1.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 65.200000000000003 110.874 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 22.2 p90 176.98 40.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 65.439999999999998 110.903 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.92 -157.71 30.26 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.747 -0.74 . . . . 63.340000000000003 112.533 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.472 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 95.42 -171.59 29.5 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.742 -0.742 . . . . 72.099999999999994 112.488 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.51 106.77 11.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.816 0.341 . . . . 72.129999999999995 110.896 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -77.72 109.47 11.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 70.129999999999995 110.883 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.9 t90 -138.04 105.38 5.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.115 -0.493 . . . . 71.540000000000006 110.892 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -89.41 135.61 33.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 64.329999999999998 110.91 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.592 HD21 ' CE3' ' A' ' 46' ' ' TRP . 0.8 OUTLIER -98.99 164.71 12.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.222 -0.445 . . . . 64.340000000000003 110.955 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.6 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -130.54 -174.92 13.82 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.745 -0.741 . . . . 62.409999999999997 112.52 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.54 117.04 3.26 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.708 2.272 . . . . 64.519999999999996 112.287 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.84 155.48 7.47 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.742 -0.742 . . . . 61.420000000000002 112.477 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -113.63 134.93 54.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 64.439999999999998 110.871 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.474 ' OH ' HD12 ' A' ' 61' ' ' LEU . 5.3 p90 -159.48 159.98 34.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 72.299999999999997 110.922 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 m -108.26 101.41 10.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 75.510000000000005 110.916 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.93 135.21 34.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 74.5 110.822 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.486 HG12 HG13 ' A' ' 36' ' ' ILE . 22.9 m -149.81 24.26 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 73.219999999999999 111.146 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.433 ' HG2' HG23 ' A' ' 69' ' ' VAL . 0.1 OUTLIER 173.21 -16.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 71.209999999999994 110.861 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.9 t -80.76 -23.95 39.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 74.010000000000005 110.827 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -83.62 -63.62 1.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 50.020000000000003 111.108 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.582 ' C ' HD13 ' A' ' 74' ' ' ILE . . . 166.95 124.14 0.7 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.74 -0.743 . . . . 64.409999999999997 112.488 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.582 HD13 ' C ' ' A' ' 73' ' ' GLY . 4.1 mm -122.33 69.8 31.96 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.625 0.726 . . . . 73.120000000000005 111.13 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -78.72 -166.34 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.702 2.268 . . . . 72.349999999999994 112.362 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.62 -29.84 27.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 73.519999999999996 110.847 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -143.65 162.62 35.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 72.340000000000003 110.863 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.59 119.19 10.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 62.32 110.844 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.2 pt -153.36 24.61 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 70.519999999999996 111.158 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.8 t -110.76 164.57 12.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 72.349999999999994 110.869 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.2 m -165.46 157.33 14.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 65.420000000000002 110.881 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -150.67 135.88 17.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 74.549999999999997 110.846 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.0 mmt85 -90.7 120.8 32.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 74.439999999999998 110.846 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.798 ' HG2' HG11 ' A' ' 6' ' ' VAL . 23.2 mt-30 -79.55 94.38 5.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 74.310000000000002 110.875 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 75.010000000000005 111.111 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.899 0.38 . . . . 63.130000000000003 110.88 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.758 HG13 ' CZ2' ' A' ' 46' ' ' TRP . 76.2 t -116.11 127.02 73.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 63.340000000000003 111.13 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.437 HG23 ' O ' ' A' ' 7' ' ' ILE . 7.8 tt -123.14 110.89 27.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 74.219999999999999 111.138 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.1 t -124.54 140.39 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 74.349999999999994 111.103 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -90.7 139.97 30.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 75.120000000000005 110.932 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.33 35.42 1.78 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 60.100000000000001 110.917 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 177.21 -169.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.127 -0.488 . . . . 71.439999999999998 110.871 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.446 HG12 ' N ' ' A' ' 13' ' ' ASN . 5.3 t -63.77 160.28 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.211 -0.449 . . . . 73.129999999999995 111.111 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.446 ' N ' HG12 ' A' ' 12' ' ' VAL . 44.8 t30 -86.31 54.26 3.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 64.540000000000006 110.897 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.441 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.24 28.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 74.409999999999997 110.928 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.86 52.46 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.744 -0.741 . . . . 33.140000000000001 112.516 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.2 171.72 24.49 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.788 -0.72 . . . . 44.030000000000001 112.518 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.62 126.48 42.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.813 0.339 . . . . 74.129999999999995 110.883 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 82.1 p -118.0 151.98 36.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 75.200000000000003 110.907 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -109.11 133.64 52.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 70.329999999999998 110.911 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 p30 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 53.310000000000002 110.862 -179.993 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.742 0.306 . . . . 73.299999999999997 110.911 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.449 ' O ' HG23 ' A' ' 36' ' ' ILE . 7.4 tt -152.29 102.0 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 75.25 111.135 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.9 p -171.81 -165.63 0.38 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 62.399999999999999 110.835 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.556 ' O ' HD12 ' A' ' 39' ' ' ILE . 31.3 t -128.91 156.03 44.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 72.450000000000003 110.879 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.556 HD12 ' O ' ' A' ' 38' ' ' SER . 1.5 mp -121.04 140.54 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 71.409999999999997 111.12 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -141.59 119.39 11.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 64.219999999999999 110.879 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.485 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 13.9 p -119.97 139.64 46.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 72.409999999999997 111.115 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.76 38.23 1.65 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 72.030000000000001 110.922 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 172.86 110.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.234 -0.439 . . . . 63.520000000000003 110.831 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.17 -158.22 39.87 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.729 -0.748 . . . . 71.019999999999996 112.491 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.9 p -150.68 127.58 11.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.74 0.305 . . . . 72.510000000000005 111.177 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.758 ' CZ2' HG13 ' A' ' 6' ' ' VAL . 0.5 OUTLIER -94.15 164.78 12.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 65.420000000000002 110.947 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -119.86 117.18 27.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.302 -0.408 . . . . 74.019999999999996 110.903 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -105.41 125.69 51.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 64.310000000000002 110.878 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -141.08 125.83 17.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 74.540000000000006 110.87 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.23 88.57 3.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 75.329999999999998 110.92 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 175.92 174.33 0.31 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.135 -0.484 . . . . 71.109999999999999 110.9 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.056 HG22 HD12 ' A' ' 79' ' ' ILE . 26.6 pt -52.39 172.88 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 75.5 111.111 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -76.75 56.47 1.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 64.439999999999998 110.902 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -149.92 -69.94 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 63.530000000000001 110.918 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.82 -135.97 5.83 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.738 -0.744 . . . . 70.019999999999996 112.523 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.7 176.61 23.11 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.806 -0.711 . . . . 72.219999999999999 112.472 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.36 103.32 8.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.848 0.356 . . . . 71.140000000000001 110.89 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -77.55 106.53 9.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 74.420000000000002 110.914 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -134.79 106.7 7.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.085 -0.507 . . . . 73.310000000000002 110.941 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -92.19 136.63 33.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 72.150000000000006 110.851 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.721 HD21 ' CE3' ' A' ' 46' ' ' TRP . 1.2 pp -100.26 140.91 33.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 71.319999999999993 110.936 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -122.45 -165.24 12.4 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.735 -0.745 . . . . 52.109999999999999 112.495 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -40.43 104.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.632 2.221 . . . . 73.150000000000006 112.354 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.88 164.35 13.16 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.788 -0.72 . . . . 64.239999999999995 112.539 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.08 148.49 50.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.898 0.38 . . . . 74.519999999999996 110.88 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -153.57 139.1 17.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 64.129999999999995 110.879 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.7 m -122.73 71.67 1.04 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 63.119999999999997 110.894 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 44.7 m -89.61 171.95 9.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 64.340000000000003 110.878 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.455 ' O ' HG13 ' A' ' 69' ' ' VAL . 4.2 p -162.4 23.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 61.119999999999997 111.107 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.424 ' HA ' HD11 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -174.88 35.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 71.230000000000004 110.87 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.9 t -157.81 -40.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 44.520000000000003 110.873 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.27 -61.74 1.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 72.349999999999994 111.135 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.02 94.44 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.718 -0.753 . . . . 74.120000000000005 112.483 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.424 HD11 ' HA ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -147.17 64.28 8.73 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.584 0.707 . . . . 61.530000000000001 111.152 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -80.86 -47.32 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.716 2.277 . . . . 53.520000000000003 112.316 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -174.0 -168.4 0.41 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 71.420000000000002 110.852 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -84.62 53.06 2.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 64.040000000000006 110.891 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.7 m -99.01 -169.63 1.8 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 72.049999999999997 110.831 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 1.056 HD12 HG22 ' A' ' 52' ' ' ILE . 4.8 mt -82.18 137.39 21.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 74.219999999999999 111.111 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.13 143.12 18.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 74.219999999999999 110.881 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.18 168.27 22.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 72.239999999999995 110.828 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -150.82 135.6 17.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 73.129999999999995 110.879 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.0 130.62 34.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 65.099999999999994 110.884 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.748 ' HG2' HG21 ' A' ' 6' ' ' VAL . 5.8 mt-30 -79.94 108.69 13.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 75.230000000000004 110.923 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.3 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 51.140000000000001 111.118 179.94 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.909 0.385 . . . . 63.409999999999997 110.908 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.73 HG13 ' CH2' ' A' ' 46' ' ' TRP . 87.5 t -116.77 128.46 74.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 73.409999999999997 111.142 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.716 HG23 ' HB3' ' A' ' 40' ' ' LYS . 8.9 tt -128.86 110.72 21.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 62.340000000000003 111.129 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 83.0 t -129.79 144.37 38.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 70.329999999999998 111.183 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -103.11 133.86 47.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 71.319999999999993 110.937 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -94.26 48.02 1.22 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.489 . . . . 75.400000000000006 110.86 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 174.26 -169.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 74.150000000000006 110.841 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.454 HG12 ' N ' ' A' ' 13' ' ' ASN . 4.8 t -64.83 161.23 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 73.109999999999999 111.13 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.454 ' N ' HG12 ' A' ' 12' ' ' VAL . 19.4 p-10 -87.93 54.11 2.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 75.319999999999993 110.87 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.432 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -176.96 28.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 62.130000000000003 110.837 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.41 50.67 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.749 -0.739 . . . . 60.450000000000003 112.477 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.08 171.62 24.48 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.707 -0.759 . . . . 54.409999999999997 112.455 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.38 163.46 14.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.767 0.318 . . . . 72.430000000000007 110.919 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.2 p -149.63 157.63 43.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 65.040000000000006 110.865 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -109.58 106.32 15.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 63.520000000000003 110.874 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.115 -0.493 . . . . 60.5 110.855 -179.993 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.779 0.323 . . . . 72.049999999999997 110.89 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.451 HG13 HG12 ' A' ' 69' ' ' VAL . 7.3 tt 179.1 102.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 75.109999999999999 111.142 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 52.2 p -168.35 -168.5 0.94 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 75.329999999999998 110.845 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.522 ' O ' HD12 ' A' ' 39' ' ' ILE . 0.6 OUTLIER -120.9 145.07 48.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.478 . . . . 74.019999999999996 110.867 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.601 HG21 HD22 ' A' ' 61' ' ' LEU . 1.4 mp -121.26 123.07 69.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 65.420000000000002 111.154 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.716 ' HB3' HG23 ' A' ' 7' ' ' ILE . 3.9 tttt -117.06 129.18 55.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 72.409999999999997 110.906 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.455 HG11 ' HG ' ' A' ' 61' ' ' LEU . 4.7 p -144.98 139.81 22.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 71.129999999999995 111.124 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.52 39.93 1.72 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 75.439999999999998 110.952 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 179.78 139.04 0.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 72.450000000000003 110.815 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 53.31 -165.35 1.88 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.77 -0.729 . . . . 71.120000000000005 112.485 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.466 HG22 ' HA2' ' A' ' 62' ' ' GLY . 68.5 p -144.98 144.71 31.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.79 0.329 . . . . 62.530000000000001 111.151 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.73 ' CH2' HG13 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -124.2 136.25 54.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.439 . . . . 64.209999999999994 110.953 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -79.96 125.56 29.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 52.009999999999998 110.857 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -113.21 124.89 53.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 75.420000000000002 110.841 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.87 126.73 20.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 74.409999999999997 110.963 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -95.4 88.8 5.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 73.319999999999993 110.874 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.443 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 172.14 -169.72 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.155 -0.475 . . . . 73.200000000000003 110.91 -179.872 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.0 pt -69.74 172.7 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.09 -0.505 . . . . 54.520000000000003 111.144 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -78.8 56.21 1.85 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 55.130000000000003 110.876 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -151.4 -40.6 0.12 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 75.439999999999998 110.868 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.51 -144.81 4.03 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.698 -0.763 . . . . 73.409999999999997 112.437 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.443 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 108.39 175.38 21.88 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.715 -0.755 . . . . 73.430000000000007 112.488 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -66.93 106.45 1.92 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.844 0.355 . . . . 74.319999999999993 110.857 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -77.96 103.17 7.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 71.310000000000002 110.92 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.0 t90 -137.6 109.28 7.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.156 -0.475 . . . . 63.240000000000002 110.949 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -84.69 144.92 28.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 73.530000000000001 110.837 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.601 HD22 HG21 ' A' ' 39' ' ' ILE . 11.5 tp -99.53 137.34 38.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.229 -0.441 . . . . 74.010000000000005 110.939 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.466 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -115.16 -162.32 13.58 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.739 . . . . 52.340000000000003 112.449 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -64.03 100.89 0.32 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.678 2.252 . . . . 71.120000000000005 112.335 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 158.48 157.44 8.48 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.753 -0.737 . . . . 51.350000000000001 112.485 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.05 136.67 54.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.893 0.377 . . . . 73.140000000000001 110.905 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -135.79 138.34 42.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 74.049999999999997 110.902 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 m -114.25 75.32 0.92 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 65.219999999999999 110.846 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 40.7 t -86.21 152.41 22.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 73.420000000000002 110.829 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.451 HG12 HG13 ' A' ' 36' ' ' ILE . 16.7 m -149.64 23.59 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 63.329999999999998 111.093 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 178.06 -16.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.477 . . . . 65.230000000000004 110.873 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.11 -32.18 64.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 64.109999999999999 110.851 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.52 -65.71 0.79 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 71.040000000000006 111.112 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.735 ' O ' HD13 ' A' ' 74' ' ' ILE . . . 166.49 114.03 0.29 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.745 -0.74 . . . . 72.209999999999994 112.485 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.735 HD13 ' O ' ' A' ' 73' ' ' GLY . 7.0 mm -130.54 67.23 80.04 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.671 0.748 . . . . 70.519999999999996 111.173 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -81.72 -74.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.721 2.28 . . . . 71.25 112.327 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.498 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 4.9 t70 177.44 87.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 75.219999999999999 110.861 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 76' ' ' ASP . 9.0 t-20 83.67 131.11 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 73.310000000000002 110.927 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -179.6 151.75 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 62.350000000000001 110.88 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.6 mt -108.55 153.44 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 51.409999999999997 111.084 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.6 p -154.88 158.87 39.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 73.010000000000005 110.871 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.59 157.32 27.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.495 . . . . 63.140000000000001 110.856 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -150.72 135.78 17.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 75.430000000000007 110.884 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.6 mmm-85 -93.49 126.56 38.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 72.109999999999999 110.878 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.553 ' CG ' HG21 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -91.23 131.48 36.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 60.100000000000001 110.958 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.9 pt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 74.420000000000002 111.115 179.976 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.877 0.37 . . . . 73.109999999999999 110.871 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.762 HG13 ' CH2' ' A' ' 46' ' ' TRP . 99.4 t -106.84 121.77 60.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.485 . . . . 75.150000000000006 111.12 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.445 HG23 ' O ' ' A' ' 7' ' ' ILE . 9.0 tt -123.38 112.17 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 74.0 111.123 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.402 HG13 HG13 ' A' ' 39' ' ' ILE . 17.1 t -128.71 136.88 58.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 74.299999999999997 111.093 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -89.06 140.91 28.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 74.420000000000002 110.908 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -97.09 38.43 1.24 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 72.299999999999997 110.909 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 175.08 -169.53 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.482 . . . . 72.230000000000004 110.891 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.449 HG12 ' N ' ' A' ' 13' ' ' ASN . 4.8 t -63.9 161.39 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 42.229999999999997 111.143 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.449 ' N ' HG12 ' A' ' 12' ' ' VAL . 2.8 t-20 -87.35 54.19 3.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 73.450000000000003 110.905 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.439 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.2 28.56 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 71.239999999999995 110.898 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.6 47.8 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.766 -0.731 . . . . 52.219999999999999 112.497 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.92 171.98 24.27 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.748 -0.739 . . . . 53.439999999999998 112.49 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.56 160.95 17.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.818 0.342 . . . . 73.150000000000006 110.865 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 78.4 p -138.24 155.76 48.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 74.450000000000003 110.874 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -117.24 104.65 11.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 64.549999999999997 110.854 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 74.239999999999995 110.868 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.737 0.304 . . . . 73.230000000000004 110.863 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.403 HG22 ' CB ' ' A' ' 69' ' ' VAL . 1.1 pt -148.89 103.96 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 61.25 111.118 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 79.3 p -167.7 -165.76 0.68 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 70.310000000000002 110.847 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.558 ' C ' HD12 ' A' ' 39' ' ' ILE . 0.9 OUTLIER -123.61 148.48 46.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 52.009999999999998 110.874 -179.819 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.558 HD12 ' C ' ' A' ' 38' ' ' SER . 1.6 mp -121.02 139.07 49.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 54.100000000000001 111.141 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -141.97 134.3 27.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 75.040000000000006 110.881 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.48 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 11.0 p -135.57 138.95 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 74.219999999999999 111.13 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.14 39.48 2.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 63.420000000000002 110.874 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.431 ' H ' HG22 ' A' ' 41' ' ' VAL . 0.3 OUTLIER 178.57 110.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 74.430000000000007 110.865 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.89 -157.41 53.51 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.739 -0.743 . . . . 65.519999999999996 112.428 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.487 HG22 ' HA2' ' A' ' 62' ' ' GLY . 72.7 p -150.24 135.96 18.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.757 0.313 . . . . 70.319999999999993 111.161 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.762 ' CH2' HG13 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -99.63 168.75 9.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 63.119999999999997 110.911 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -115.05 123.29 48.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 75.209999999999994 110.9 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.412 ' HD2' HD23 ' A' ' 61' ' ' LEU . 1.6 m-85 -110.15 123.58 50.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 72.409999999999997 110.89 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.87 126.61 20.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 73.530000000000001 110.902 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -102.62 89.86 3.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 64.5 110.89 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.535 ' HA ' HG22 ' A' ' 79' ' ' ILE . 0.1 OUTLIER 172.05 -166.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.477 . . . . 71.310000000000002 110.937 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.479 HG22 ' N ' ' A' ' 53' ' ' ASN . 5.8 mm -54.98 164.57 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 75.409999999999997 111.131 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.479 ' N ' HG22 ' A' ' 52' ' ' ILE . 59.4 m-20 -80.17 51.9 1.47 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 73.030000000000001 110.886 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.433 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 1.9 p90 -179.47 27.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.482 . . . . 73.230000000000004 110.931 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.33 -164.86 37.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.745 -0.74 . . . . 72.040000000000006 112.457 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.452 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 107.55 -169.68 14.87 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.757 -0.735 . . . . 65.420000000000002 112.488 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.17 105.02 12.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.356 . . . . 71.400000000000006 110.891 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -78.06 108.4 11.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 75.239999999999995 110.945 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -138.11 106.17 5.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.149 -0.478 . . . . 72.439999999999998 110.923 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -93.41 138.41 31.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.436 . . . . 75.230000000000004 110.878 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.64 HD21 ' CE3' ' A' ' 46' ' ' TRP . 1.2 pp -103.13 142.71 33.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 61.219999999999999 110.925 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.487 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -122.77 -162.85 11.65 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.753 -0.737 . . . . 50.310000000000002 112.52 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -45.5 101.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.655 2.237 . . . . 62.439999999999998 112.39 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 163.62 171.53 29.98 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.736 . . . . 72.209999999999994 112.524 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -133.84 143.92 48.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.847 0.356 . . . . 61.229999999999997 110.867 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -151.89 140.12 20.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.484 . . . . 72.409999999999997 110.942 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.8 p -124.29 72.6 1.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 73.299999999999997 110.841 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.8 t -86.06 168.97 13.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 64.030000000000001 110.891 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.403 ' CB ' HG22 ' A' ' 36' ' ' ILE . 12.9 m -152.28 23.53 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 44.25 111.132 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.568 ' HA ' HD13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -176.08 57.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 61.509999999999998 110.879 -179.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 t -175.99 -43.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 65.109999999999999 110.872 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.71 -66.09 0.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 75.540000000000006 111.124 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -176.89 93.32 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.716 -0.754 . . . . 71.200000000000003 112.462 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.568 HD13 ' HA ' ' A' ' 70' ' ' GLU . 3.3 mp -128.35 67.91 76.31 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.657 0.741 . . . . 73.329999999999998 111.109 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -76.98 -166.12 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.684 2.256 . . . . 71.519999999999996 112.37 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -91.4 -24.23 19.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 64.329999999999998 110.892 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -141.78 172.45 12.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 75.030000000000001 110.91 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.645 ' O ' HD13 ' A' ' 79' ' ' ILE . 1.0 OUTLIER -67.74 88.14 0.24 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 53.039999999999999 110.868 -179.878 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.645 HD13 ' O ' ' A' ' 78' ' ' SER . 23.9 mm -134.91 61.81 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 74.219999999999999 111.177 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.8 t -163.02 156.17 19.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 64.329999999999998 110.892 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -165.54 159.32 16.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 72.010000000000005 110.917 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -150.4 135.77 17.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 71.140000000000001 110.877 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -94.27 118.35 31.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 71.439999999999998 110.92 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.586 ' HB3' HG21 ' A' ' 6' ' ' VAL . 39.8 mt-30 -79.66 93.0 5.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.458 . . . . 70.150000000000006 110.899 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 pt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 61.200000000000003 111.115 179.965 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.849 0.357 . . . . 64.430000000000007 110.875 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.9 m -112.13 138.64 40.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 74.409999999999997 111.166 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.82 HG23 ' HB3' ' A' ' 40' ' ' LYS . 2.7 tp -105.34 110.97 32.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 64.129999999999995 111.135 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.604 HG12 HD13 ' A' ' 39' ' ' ILE . 3.0 m -131.25 165.0 32.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 75.310000000000002 111.067 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -117.3 142.7 46.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 73.239999999999995 110.916 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -101.45 37.72 1.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.495 . . . . 72.540000000000006 110.889 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 174.02 -170.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.483 . . . . 74.120000000000005 110.816 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.438 HG12 ' N ' ' A' ' 13' ' ' ASN . 5.1 t -64.12 160.37 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 74.409999999999997 111.103 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.438 ' N ' HG12 ' A' ' 12' ' ' VAL . 11.6 p-10 -87.32 54.5 3.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 70.409999999999997 110.924 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.441 ' CG ' ' O ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -176.91 28.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 64.329999999999998 110.883 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.9 46.16 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.786 -0.721 . . . . 75.430000000000007 112.548 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.19 172.01 24.36 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.718 -0.753 . . . . 33.530000000000001 112.484 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.42 152.26 22.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.782 0.325 . . . . 60.149999999999999 110.93 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.62 148.92 49.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 72.150000000000006 110.868 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -102.29 104.29 14.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 65.140000000000001 110.898 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 72.200000000000003 110.858 179.978 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.594 ' O ' HD12 ' A' ' 74' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.76 0.314 . . . . 71.140000000000001 110.931 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.466 HG13 HG12 ' A' ' 69' ' ' VAL . 7.4 tt -179.59 103.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 72.519999999999996 111.156 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 82.5 p -168.23 -166.92 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 75.319999999999993 110.869 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.9 t -115.35 168.22 10.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 75.209999999999994 110.879 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.617 HG21 HD22 ' A' ' 61' ' ' LEU . 0.4 OUTLIER -145.41 139.21 21.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 74.239999999999995 111.173 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.82 ' HB3' HG23 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -139.9 119.65 13.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 72.010000000000005 110.892 179.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.681 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 2.6 p -113.94 139.05 41.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 45.509999999999998 111.134 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -138.04 45.26 2.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 65.310000000000002 110.908 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.72 113.68 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 73.5 110.861 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.23 -135.75 35.8 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.742 -0.742 . . . . 65.319999999999993 112.466 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.459 HG22 ' HA2' ' A' ' 62' ' ' GLY . 67.4 p -150.06 150.13 31.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.732 0.301 . . . . 64.310000000000002 111.166 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.681 ' CZ2' HG23 ' A' ' 41' ' ' VAL . 2.7 m0 -117.74 171.38 8.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.247 -0.433 . . . . 75.409999999999997 110.897 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.7 mpp_? -113.85 119.73 38.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 74.25 110.909 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -108.59 126.71 53.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 61.229999999999997 110.9 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.24 126.29 19.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 65.420000000000002 110.922 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -98.44 89.54 4.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 73.439999999999998 110.88 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.447 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 172.54 -168.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.116 -0.493 . . . . 71.209999999999994 110.934 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.499 HG22 ' H ' ' A' ' 53' ' ' ASN . 5.6 mm -69.82 165.98 2.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 54.530000000000001 111.137 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.499 ' H ' HG22 ' A' ' 52' ' ' ILE . 2.8 m-80 -74.83 56.69 0.74 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 70.439999999999998 110.902 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -153.09 -39.15 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 65.150000000000006 110.905 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -147.99 -142.36 3.65 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.757 -0.735 . . . . 72.299999999999997 112.523 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.447 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 106.55 -178.09 22.32 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.789 -0.72 . . . . 71.319999999999993 112.492 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -76.72 108.72 9.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.798 0.332 . . . . 74.549999999999997 110.884 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -78.29 100.26 6.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 74.030000000000001 110.903 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -133.41 107.53 8.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 74.040000000000006 110.923 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.88 148.14 27.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 64.25 110.862 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.617 HD22 HG21 ' A' ' 39' ' ' ILE . 8.7 tp -99.52 136.5 39.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 72.439999999999998 110.913 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.459 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -112.93 176.34 17.45 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.708 -0.758 . . . . 74.239999999999995 112.479 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -46.74 100.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.727 2.284 . . . . 74.329999999999998 112.334 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.46 164.6 14.99 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.746 -0.74 . . . . 70.420000000000002 112.506 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -118.52 146.94 44.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.829 0.347 . . . . 74.310000000000002 110.9 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -146.19 140.15 26.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 74.329999999999998 110.867 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.48 73.88 1.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.095 -0.502 . . . . 71.230000000000004 110.858 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 45.7 t -85.06 156.23 21.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 61.43 110.84 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.466 HG12 HG13 ' A' ' 36' ' ' ILE . 27.9 m -149.96 26.27 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.114 -0.494 . . . . 74.150000000000006 111.096 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 173.15 -16.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 75.349999999999994 110.884 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.02 -23.95 41.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 71.219999999999999 110.85 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.79 -71.0 0.54 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 53.340000000000003 111.114 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.609 ' O ' HD13 ' A' ' 74' ' ' ILE . . . 166.79 124.54 0.72 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.781 -0.724 . . . . 65.319999999999993 112.502 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.609 HD13 ' O ' ' A' ' 73' ' ' GLY . 4.4 mm -123.64 68.08 41.02 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.626 0.727 . . . . 73.109999999999999 111.111 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -79.38 -166.18 0.39 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.724 2.283 . . . . 63.340000000000003 112.332 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.62 14.81 14.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 64.129999999999995 110.874 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -157.36 113.94 2.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 74.230000000000004 110.89 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.7 m -92.28 45.0 1.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 71.5 110.855 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.4 mm -76.51 66.26 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 61.420000000000002 111.091 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.1 168.92 9.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 75.120000000000005 110.82 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.69 155.26 12.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 75.120000000000005 110.908 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -151.13 135.96 17.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 62.109999999999999 110.9 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.5 mmm-85 -95.79 126.18 40.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 73.019999999999996 110.902 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -79.26 97.03 6.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 71.030000000000001 110.909 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 63.140000000000001 111.154 179.981 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.887 0.375 . . . . 73.219999999999999 110.897 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.789 HG13 ' CH2' ' A' ' 46' ' ' TRP . 89.5 t -119.79 133.35 66.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 75.099999999999994 111.159 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.458 HG23 ' HB3' ' A' ' 40' ' ' LYS . 7.0 tt -122.29 109.87 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 63.119999999999997 111.133 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.62 HG12 HD13 ' A' ' 39' ' ' ILE . 4.0 m -132.19 164.77 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.182 -0.463 . . . . 63.340000000000003 111.153 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -113.4 138.73 49.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 73.530000000000001 110.99 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -100.73 38.21 1.57 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 71.450000000000003 110.888 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.433 ' HB3' ' HA3' ' A' ' 16' ' ' GLY . 0.3 OUTLIER 169.26 -173.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 75.299999999999997 110.892 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 13' ' ' ASN . 4.8 t -66.02 160.55 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.254 -0.43 . . . . 62.340000000000003 111.109 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.44 ' N ' HG12 ' A' ' 12' ' ' VAL . 18.9 t30 -88.67 54.77 3.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 73.239999999999995 110.895 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.419 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -176.55 28.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 72.120000000000005 110.917 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.56 43.63 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.73 -0.748 . . . . 41.530000000000001 112.5 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.433 ' HA3' ' HB3' ' A' ' 11' ' ' HIS . . . -142.69 172.14 24.52 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.777 -0.725 . . . . 64.120000000000005 112.509 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.2 123.6 34.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.797 0.332 . . . . 75.209999999999994 110.905 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.3 p -121.24 135.17 55.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 65.310000000000002 110.862 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 19' ' ' PHE . 0.8 OUTLIER -124.85 136.73 54.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.15 -0.477 . . . . 75.109999999999999 110.878 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 71.439999999999998 110.828 179.979 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.759 0.314 . . . . 65.510000000000005 110.91 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.96 111.46 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 62.119999999999997 111.157 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.7 p -167.25 -166.46 0.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 62.329999999999998 110.871 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 t -117.61 159.38 23.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 72.349999999999994 110.882 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.62 HD13 HG12 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -139.53 140.96 36.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 64.230000000000004 111.155 179.917 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.458 ' HB3' HG23 ' A' ' 7' ' ' ILE . 9.4 tttt -151.0 147.75 27.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 72.400000000000006 110.892 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.59 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 3.6 p -136.03 130.98 49.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 61.119999999999997 111.135 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.03 39.51 3.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 74.310000000000002 110.837 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.442 ' H ' HG22 ' A' ' 41' ' ' VAL . 0.4 OUTLIER 178.59 110.63 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 60.109999999999999 110.888 -179.92 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.85 -147.86 48.61 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.739 . . . . 54.020000000000003 112.508 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.5 p -150.35 147.82 28.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.762 0.315 . . . . 71.430000000000007 111.123 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.789 ' CH2' HG13 ' A' ' 6' ' ' VAL . 2.0 m0 -118.08 174.84 5.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 74.040000000000006 110.942 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -124.66 129.13 49.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 64.400000000000006 110.858 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.484 ' HD2' HD22 ' A' ' 61' ' ' LEU . 1.6 m-85 -113.57 128.38 56.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 51.149999999999999 110.862 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.33 126.19 19.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.486 . . . . 71.450000000000003 110.928 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -101.09 88.9 3.63 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.074 -0.512 . . . . 62.439999999999998 110.873 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.448 ' HA ' HG22 ' A' ' 79' ' ' ILE . 0.2 OUTLIER 172.04 -171.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 74.450000000000003 110.918 -179.857 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.7 pt -54.97 174.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.499 . . . . 75.439999999999998 111.11 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -87.9 37.86 0.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 70.120000000000005 110.909 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -151.74 18.63 0.7 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 64.349999999999994 110.926 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.07 -152.34 18.95 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.74 -0.743 . . . . 52.229999999999997 112.487 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.401 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 107.29 176.25 22.66 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.749 -0.739 . . . . 52.450000000000003 112.478 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.49 109.42 6.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.812 0.339 . . . . 75.140000000000001 110.857 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -77.59 108.35 10.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 73.0 110.899 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -138.44 107.17 5.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.06 -0.518 . . . . 74.230000000000004 110.925 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -91.28 157.72 16.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 62.130000000000003 110.859 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.653 HD21 ' HB2' ' A' ' 46' ' ' TRP . 1.8 pt? -119.97 149.61 41.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 64.109999999999999 110.934 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -124.81 -173.97 13.88 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.728 -0.748 . . . . 53.530000000000001 112.525 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -43.97 101.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.731 2.287 . . . . 64.340000000000003 112.329 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 158.92 162.4 11.93 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.749 -0.738 . . . . 52.149999999999999 112.495 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.13 147.5 41.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.899 0.381 . . . . 72.040000000000006 110.882 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -132.64 160.4 36.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 74.200000000000003 110.913 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 95.8 p -140.09 62.82 1.49 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 73.430000000000007 110.889 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 71.0 m -85.8 145.81 27.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.488 . . . . 71.129999999999995 110.836 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.411 HG23 ' HG2' ' A' ' 70' ' ' GLU . 35.9 m -150.6 18.44 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.487 . . . . 64.239999999999995 111.127 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.411 ' HG2' HG23 ' A' ' 69' ' ' VAL . 1.7 pt-20 179.3 38.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 71.230000000000004 110.841 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.53 -46.71 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.471 . . . . 70.120000000000005 110.866 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.32 -45.86 62.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.506 . . . . 21.129999999999999 111.077 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.712 ' O ' HD13 ' A' ' 74' ' ' ILE . . . 166.93 103.68 0.17 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.769 -0.729 . . . . 73.040000000000006 112.473 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.712 HD13 ' O ' ' A' ' 73' ' ' GLY . 15.0 mm -131.52 74.02 78.85 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.626 0.727 . . . . 71.310000000000002 111.095 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -77.59 -158.54 0.09 OUTLIER 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.709 2.272 . . . . 52.100000000000001 112.328 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -75.97 -22.71 55.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 71.120000000000005 110.868 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -158.65 -169.54 2.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 73.109999999999999 110.89 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.0 t -57.82 -95.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 71.120000000000005 110.888 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.448 HG22 ' HA ' ' A' ' 51' ' ' TYR . 2.2 mp 50.91 59.89 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 74.540000000000006 111.092 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 66.1 p -159.41 158.61 32.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 75.409999999999997 110.842 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.73 159.63 16.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 70.409999999999997 110.867 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -150.14 135.8 18.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 75.120000000000005 110.872 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.2 mmt-85 -90.48 117.4 29.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 65.439999999999998 110.904 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -82.28 91.85 6.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 65.200000000000003 110.909 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 74.400000000000006 111.11 179.945 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.86 0.362 . . . . 63.25 110.878 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.738 HG21 ' HB3' ' A' ' 84' ' ' GLN . 54.3 t -102.02 119.43 50.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 72.310000000000002 111.102 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.546 HG23 ' HB3' ' A' ' 40' ' ' LYS . 8.3 tt -120.96 109.51 25.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 65.409999999999997 111.135 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.8 t -126.41 141.37 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 65.319999999999993 111.153 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -96.04 134.6 38.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.179 -0.464 . . . . 63.350000000000001 110.892 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -94.35 44.23 1.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 70.329999999999998 110.916 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 174.79 -170.31 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 73.230000000000004 110.884 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 13' ' ' ASN . 6.4 t -63.99 160.5 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 74.540000000000006 111.16 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.453 ' N ' HG12 ' A' ' 12' ' ' VAL . 53.0 t-20 -85.41 53.61 2.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 73.140000000000001 110.855 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.453 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.59 28.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 65.420000000000002 110.849 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.55 44.33 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.721 -0.752 . . . . 44.409999999999997 112.5 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -134.98 171.41 22.45 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.74 -0.743 . . . . 74.25 112.467 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.5 161.99 13.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.751 0.31 . . . . 72.109999999999999 110.92 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.7 p -151.11 155.34 38.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 53.520000000000003 110.84 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -136.34 136.7 39.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 64.409999999999997 110.858 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 72.349999999999994 110.867 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.588 ' HD2' ' HB3' ' A' ' 72' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.749 0.309 . . . . 53.43 110.891 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 36' ' ' ILE . 1.2 tt -162.01 115.55 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 74.329999999999998 111.13 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.9 p -167.22 -167.55 0.93 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 70.209999999999994 110.906 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.562 ' O ' HD12 ' A' ' 39' ' ' ILE . 32.3 t -123.6 150.08 44.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 62.539999999999999 110.867 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.562 HD12 ' O ' ' A' ' 38' ' ' SER . 1.5 mp -120.91 115.18 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 43.299999999999997 111.117 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.546 ' HB3' HG23 ' A' ' 7' ' ' ILE . 10.6 tttm -109.88 119.26 38.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.465 . . . . 75.299999999999997 110.918 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.775 HG22 ' CZ3' ' A' ' 46' ' ' TRP . 17.2 t -102.89 139.16 24.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 72.019999999999996 111.114 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.71 39.84 0.72 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 74.140000000000001 110.896 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 179.38 111.66 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 71.109999999999999 110.842 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.34 -142.22 24.55 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.674 -0.774 . . . . 52.539999999999999 112.523 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -149.84 124.17 9.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.795 0.331 . . . . 71.420000000000002 111.12 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.775 ' CZ3' HG22 ' A' ' 41' ' ' VAL . 0.5 OUTLIER -87.14 -177.08 5.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 74.530000000000001 110.922 179.961 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.25 119.95 19.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.453 . . . . 72.120000000000005 110.83 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -101.64 133.59 46.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 73.439999999999998 110.855 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.72 126.47 20.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.104 -0.498 . . . . 75.510000000000005 110.898 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -105.49 88.85 2.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.079 -0.51 . . . . 72.299999999999997 110.917 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.482 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 171.63 -168.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 71.109999999999999 110.938 -179.838 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.471 HG22 ' N ' ' A' ' 53' ' ' ASN . 18.9 mm -54.97 158.63 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 53.409999999999997 111.138 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.471 ' N ' HG22 ' A' ' 52' ' ' ILE . 47.4 p-10 -76.38 58.2 1.28 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 74.030000000000001 110.945 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -167.19 -31.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.163 -0.471 . . . . 52.520000000000003 110.928 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -142.26 -152.56 5.72 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.737 -0.744 . . . . 72.310000000000002 112.467 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.482 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 108.98 -174.5 18.45 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.773 -0.727 . . . . 70.319999999999993 112.471 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.89 127.04 31.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.8 0.333 . . . . 74.5 110.901 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -96.66 108.12 20.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.236 -0.438 . . . . 54.039999999999999 110.904 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -138.08 106.74 5.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.093 -0.503 . . . . 74.400000000000006 110.914 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -95.47 157.34 15.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 63.509999999999998 110.867 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.494 HD23 ' H ' ' A' ' 61' ' ' LEU . 2.6 pt? -135.96 139.1 42.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 52.439999999999998 110.916 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.52 -165.64 27.38 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.734 -0.746 . . . . 62.130000000000003 112.465 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -56.67 115.85 2.78 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.684 2.256 . . . . 50.219999999999999 112.346 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.7 151.42 5.89 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.733 -0.746 . . . . 73.209999999999994 112.504 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -79.96 155.01 27.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.845 0.355 . . . . 74.140000000000001 110.897 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -160.31 149.5 17.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.126 -0.488 . . . . 72.510000000000005 110.924 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.9 p -108.12 84.26 1.92 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 70.340000000000003 110.872 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.733 ' HB2' ' HB2' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -85.4 117.12 24.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 73.140000000000001 110.873 -179.86 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.7 m -146.34 10.32 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 73.439999999999998 111.117 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -157.52 17.65 0.27 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 73.530000000000001 110.9 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -165.68 21.67 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 75.299999999999997 110.869 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.733 ' HB2' ' HB2' ' A' ' 68' ' ' SER . . . -89.51 -34.67 16.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 35.539999999999999 111.101 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.607 ' H ' HD13 ' A' ' 74' ' ' ILE . . . 165.97 41.31 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.78 -0.724 . . . . 54.210000000000001 112.495 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.607 HD13 ' H ' ' A' ' 73' ' ' GLY . 0.1 OUTLIER -122.45 63.13 17.92 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.62 0.724 . . . . 65.409999999999997 111.102 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.499 ' HD3' ' C ' ' A' ' 73' ' ' GLY . 71.6 Cg_endo -81.41 -47.61 0.07 OUTLIER 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.703 2.268 . . . . 54.119999999999997 112.316 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.472 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 9.3 t70 179.36 87.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 63.43 110.86 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.472 ' CB ' ' O ' ' A' ' 76' ' ' ASP . 5.4 m-20 81.41 -168.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 71.400000000000006 110.907 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.503 ' O ' HD13 ' A' ' 79' ' ' ILE . 0.7 OUTLIER -75.08 71.72 2.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 63.439999999999998 110.869 -179.85 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.503 HD13 ' O ' ' A' ' 78' ' ' SER . 23.4 mm -141.79 69.64 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 72.25 111.184 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -165.99 152.59 9.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 63.520000000000003 110.834 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.71 171.54 12.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 73.109999999999999 110.841 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -152.07 135.9 16.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.134 -0.485 . . . . 75.349999999999994 110.905 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 30.5 mmm180 -98.78 116.37 30.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 72.040000000000006 110.904 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.738 ' HB3' HG21 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -83.63 103.56 13.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 74.430000000000007 110.92 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.1 pt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 75.099999999999994 111.11 179.982 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.921 0.391 . . . . 62.32 110.846 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.501 HG11 ' HG2' ' A' ' 84' ' ' GLN . 4.0 m -115.67 138.56 45.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.501 . . . . 63.229999999999997 111.136 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.823 HG23 ' HB3' ' A' ' 40' ' ' LYS . 1.1 tt -102.32 110.44 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 73.349999999999994 111.101 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.651 HG12 HD13 ' A' ' 39' ' ' ILE . 3.3 m -137.32 159.43 35.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 70.310000000000002 111.123 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -114.0 144.33 43.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 74.019999999999996 110.95 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.31 41.56 1.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 75.549999999999997 110.855 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 172.69 -170.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 64.049999999999997 110.826 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.451 HG12 ' N ' ' A' ' 13' ' ' ASN . 7.3 t -63.61 159.97 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 62.149999999999999 111.076 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.451 ' N ' HG12 ' A' ' 12' ' ' VAL . 58.6 t30 -85.74 53.87 2.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 61.0 110.883 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.438 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.11 28.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 72.310000000000002 110.856 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.57 41.14 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.732 . . . . 53.140000000000001 112.462 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -137.13 171.54 23.06 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.776 -0.726 . . . . 72.430000000000007 112.485 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.35 161.7 16.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.83 0.348 . . . . 72.400000000000006 110.893 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -139.07 166.9 23.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 75.400000000000006 110.86 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -129.44 113.48 14.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 71.239999999999995 110.944 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.4 t0 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 73.5 110.884 -180.0 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.787 0.327 . . . . 53.140000000000001 110.896 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.74 HD12 ' HB ' ' A' ' 69' ' ' VAL . 0.9 OUTLIER -168.98 102.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 73.519999999999996 111.126 179.921 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.4 p -168.11 -167.6 0.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 73.219999999999999 110.879 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.7 t -126.66 157.86 37.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 74.340000000000003 110.866 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.651 HD13 HG12 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -129.69 138.06 55.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 63.450000000000003 111.113 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.823 ' HB3' HG23 ' A' ' 7' ' ' ILE . 12.1 tttt -136.03 124.31 23.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 72.409999999999997 110.853 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.684 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 3.5 p -120.3 139.5 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.436 . . . . 73.310000000000002 111.134 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -142.89 40.37 1.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 70.239999999999995 110.892 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.57 117.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 72.439999999999998 110.842 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 51.76 -151.45 6.84 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.696 -0.764 . . . . 54.130000000000003 112.523 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.7 p -136.62 155.95 49.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.763 0.316 . . . . 61.439999999999998 111.132 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.684 ' CZ2' HG23 ' A' ' 41' ' ' VAL . 2.2 m0 -123.74 175.65 6.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 75.540000000000006 110.916 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.51 ' HD2' HD11 ' A' ' 85' ' ' ILE . 3.7 mpp_? -123.72 122.71 38.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 74.540000000000006 110.888 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -107.52 128.64 54.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 75.530000000000001 110.934 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.13 127.92 21.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 75.040000000000006 110.923 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -99.1 87.05 3.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.505 . . . . 65.010000000000005 110.853 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.411 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 170.23 -170.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.167 -0.47 . . . . 72.310000000000002 110.951 -179.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.1 pt -54.68 174.31 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 64.340000000000003 111.139 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -87.41 36.95 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 74.010000000000005 110.945 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -151.85 19.01 0.69 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 65.230000000000004 110.925 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.61 -156.89 27.63 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.788 -0.72 . . . . 75.420000000000002 112.504 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.411 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 107.09 176.29 22.8 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.677 -0.773 . . . . 74.239999999999995 112.496 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -69.81 103.96 2.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.833 0.349 . . . . 73.120000000000005 110.872 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -75.05 108.4 7.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 75.329999999999998 110.957 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -138.1 106.21 5.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.138 -0.483 . . . . 75.530000000000001 110.953 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -88.49 138.41 31.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 71.430000000000007 110.845 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.557 HD21 ' CE3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -99.18 159.44 14.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 65.299999999999997 110.928 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -128.85 175.77 18.62 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.706 -0.759 . . . . 54.340000000000003 112.483 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.412 ' HA ' HG13 ' A' ' 41' ' ' VAL . 78.4 Cg_exo -42.51 107.77 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.657 2.238 . . . . 72.010000000000005 112.382 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.79 159.48 9.39 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.739 . . . . 61.439999999999998 112.489 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -102.6 144.69 30.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.843 0.354 . . . . 73.109999999999999 110.904 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -137.17 145.09 43.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.118 -0.492 . . . . 73.209999999999994 110.917 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.1 m -133.8 67.51 1.52 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 54.310000000000002 110.838 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.63 ' CB ' ' HB2' ' A' ' 72' ' ' ALA . 10.9 m -84.99 145.11 27.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 72.530000000000001 110.866 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.74 ' HB ' HD12 ' A' ' 36' ' ' ILE . 20.6 m -149.97 19.74 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 73.209999999999994 111.118 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -179.5 38.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 62.409999999999997 110.879 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.34 -39.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 71.299999999999997 110.894 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.63 ' HB2' ' CB ' ' A' ' 68' ' ' SER . . . -53.17 -44.47 67.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 50.210000000000001 111.073 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.592 ' O ' HD13 ' A' ' 74' ' ' ILE . . . 167.41 93.79 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.787 -0.721 . . . . 75.209999999999994 112.518 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.592 HD13 ' O ' ' A' ' 73' ' ' GLY . 5.7 mm -123.98 67.27 42.37 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.613 0.72 . . . . 73.430000000000007 111.129 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -80.07 -166.38 0.41 Allowed 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.727 2.285 . . . . 72.109999999999999 112.376 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -57.67 -70.15 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.419 . . . . 64.340000000000003 110.876 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -96.68 -95.54 0.2 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 74.239999999999995 110.846 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.4 p -178.18 -95.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 73.239999999999995 110.836 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.5 mm 56.23 54.92 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 74.049999999999997 111.152 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.6 m -108.07 164.2 12.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 70.349999999999994 110.862 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.3 p -165.54 153.68 11.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 65.319999999999993 110.831 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -151.25 135.47 16.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 71.450000000000003 110.888 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.47 119.69 32.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 75.299999999999997 110.883 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.501 ' HG2' HG11 ' A' ' 6' ' ' VAL . 20.5 mt-30 -79.7 92.01 5.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 61.229999999999997 110.899 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.51 HD11 ' HD2' ' A' ' 47' ' ' ARG . 1.1 pt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 71.439999999999998 111.186 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.806 0.336 . . . . 72.230000000000004 110.9 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -148.11 115.2 6.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 74.230000000000004 110.876 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -155.65 66.45 0.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 53.340000000000003 111.075 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -171.95 103.69 0.18 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 71.400000000000006 111.094 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -90.0 118.76 29.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 73.540000000000006 110.882 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.782 HG13 ' CH2' ' A' ' 46' ' ' TRP . 89.7 t -110.6 111.24 35.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 64.239999999999995 111.116 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.738 HG23 ' HB3' ' A' ' 40' ' ' LYS . 4.0 tp -106.34 110.91 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 52.109999999999999 111.127 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.8 t -131.54 138.8 52.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 65.010000000000005 111.138 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -94.5 137.22 33.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 74.129999999999995 110.863 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -93.98 42.94 1.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 75.150000000000006 110.902 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 174.52 -169.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 63.229999999999997 110.852 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.451 HG12 ' N ' ' A' ' 13' ' ' ASN . 5.0 t -64.68 160.97 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 74.209999999999994 111.17 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.451 ' N ' HG12 ' A' ' 12' ' ' VAL . 51.2 t30 -87.34 53.79 2.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 73.319999999999993 110.923 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.441 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.12 28.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 71.430000000000007 110.911 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.19 52.73 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.726 -0.75 . . . . 74.120000000000005 112.486 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.96 171.52 24.48 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.798 -0.715 . . . . 63.409999999999997 112.513 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.43 134.34 35.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.77 0.319 . . . . 74.340000000000003 110.893 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.48 153.04 34.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 54.340000000000003 110.88 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -148.64 141.35 24.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 64.200000000000003 110.901 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.447 ' HB2' HD13 ' A' ' 7' ' ' ILE . 20.8 t0 -137.8 73.03 1.42 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 71.209999999999994 110.907 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.546 ' HB3' ' HG3' ' A' ' 25' ' ' GLN . . . -80.42 129.61 34.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 74.129999999999995 111.093 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.7 t -93.82 40.08 1.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 61.32 111.116 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.1 m -158.12 54.41 0.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 54.43 110.842 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 63.95 107.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.115 -0.493 . . . . 70.519999999999996 110.855 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.546 ' HG3' ' HB3' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -79.9 162.71 61.36 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.571 0.7 . . . . 63.240000000000002 110.945 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -47.79 -29.42 11.25 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.709 2.273 . . . . 65.010000000000005 112.359 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.81 -166.36 43.5 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.766 -0.731 . . . . 73.120000000000005 112.471 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.696 ' HB3' ' HA ' ' A' ' 81' ' ' SER . . . -89.9 120.8 31.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.798 0.332 . . . . 73.319999999999993 111.098 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.33 -39.71 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.746 -0.74 . . . . 74.140000000000001 112.507 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -97.41 25.19 5.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.817 0.341 . . . . 64.239999999999995 110.866 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.497 ' ND2' ' HB1' ' A' ' 28' ' ' ALA . 1.8 m-80 -64.31 -178.36 0.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 61.240000000000002 110.891 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.467 HD23 ' H ' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -176.79 -85.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 74.420000000000002 110.89 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.576 ' O ' HG22 ' A' ' 74' ' ' ILE . 2.0 t30 -159.09 -40.25 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 75.129999999999995 110.874 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.467 ' H ' HD23 ' A' ' 32' ' ' LEU . 4.1 t70 -78.95 59.14 2.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 74.430000000000007 110.856 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.96 133.29 49.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 71.109999999999999 110.914 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.542 ' HB ' HG12 ' A' ' 69' ' ' VAL . 1.1 pt -153.11 109.72 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 75.540000000000006 111.127 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.0 p -165.01 -168.35 1.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 64.109999999999999 110.843 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.581 ' O ' HD12 ' A' ' 39' ' ' ILE . 0.6 OUTLIER -124.07 152.05 43.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 63.149999999999999 110.828 -179.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.581 HD12 ' O ' ' A' ' 38' ' ' SER . 1.5 mp -120.91 139.33 48.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.51 . . . . 71.140000000000001 111.116 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.738 ' HB3' HG23 ' A' ' 7' ' ' ILE . 7.4 tttt -138.04 125.92 22.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 60.219999999999999 110.915 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.563 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 9.2 p -125.58 139.02 52.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.433 . . . . 63.450000000000003 111.158 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.88 39.39 1.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 74.230000000000004 110.861 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.93 110.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 52.229999999999997 110.855 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.94 -150.21 50.28 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.78 -0.724 . . . . 75.549999999999997 112.451 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.563 HG22 ' HA2' ' A' ' 62' ' ' GLY . 41.9 p -148.4 160.61 42.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.759 0.314 . . . . 55.229999999999997 111.146 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.782 ' CH2' HG13 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -124.53 177.48 5.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 74.129999999999995 110.953 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.411 ' HD2' HD11 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -123.57 111.92 16.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.273 -0.421 . . . . 73.239999999999995 110.864 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -101.01 123.95 45.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 75.150000000000006 110.916 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -139.97 126.63 20.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 74.340000000000003 110.945 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -104.09 89.57 3.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 73.010000000000005 110.871 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.408 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 177.27 -174.34 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 74.239999999999995 110.958 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.0 pt -54.88 174.15 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 65.319999999999993 111.099 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -83.07 10.12 8.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.14 -0.482 . . . . 71.540000000000006 110.881 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.45 67.27 1.26 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 73.519999999999996 110.937 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 116.39 121.08 3.27 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.757 -0.735 . . . . 73.420000000000002 112.503 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.408 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . -177.35 174.48 47.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 32.520000000000003 112.486 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -64.62 95.93 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.844 0.354 . . . . 73.540000000000006 110.918 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -76.38 111.86 12.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 64.230000000000004 110.933 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -138.32 105.86 5.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.144 -0.48 . . . . 73.150000000000006 110.924 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -90.65 137.61 32.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.259 -0.428 . . . . 61.149999999999999 110.916 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.714 HD21 ' CE3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -104.81 142.11 35.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 52.009999999999998 110.879 -179.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.563 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -113.79 -168.63 16.63 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.781 -0.723 . . . . 71.349999999999994 112.54 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -46.84 109.89 0.24 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.699 2.266 . . . . 74.340000000000003 112.304 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.93 158.48 8.84 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.732 -0.747 . . . . 52.310000000000002 112.505 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.59 143.86 49.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.861 0.362 . . . . 63.25 110.891 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -148.63 160.12 43.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 72.129999999999995 110.898 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 99.0 p -140.69 78.04 1.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.094 -0.503 . . . . 61.32 110.837 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.4 m -86.64 153.05 22.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 62.530000000000001 110.843 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.542 HG12 ' HB ' ' A' ' 36' ' ' ILE . 5.1 m -153.43 23.92 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 73.030000000000001 111.114 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -179.52 39.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 51.310000000000002 110.9 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.443 ' N ' HD11 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -157.85 -40.2 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 74.25 110.852 -179.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.28 -75.79 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.114 -0.493 . . . . 63.329999999999998 111.095 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.85 90.15 0.1 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 64.209999999999994 112.516 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.576 HG22 ' O ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -134.15 67.07 72.89 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.644 0.735 . . . . 74.150000000000006 111.165 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -80.46 -52.21 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.663 2.242 . . . . 52.350000000000001 112.343 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 179.82 -51.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.264 -0.426 . . . . 61.25 110.845 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -173.75 130.14 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 74.439999999999998 110.861 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.17 178.69 2.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 73.420000000000002 110.891 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.4 mm -100.45 155.19 4.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 61.219999999999999 111.111 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.7 p -155.62 155.75 33.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 71.329999999999998 110.851 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.696 ' HA ' ' HB3' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -165.27 158.15 16.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 71.120000000000005 110.838 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -150.55 135.66 17.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 62.509999999999998 110.885 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -89.68 119.71 30.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 74.209999999999994 110.901 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -79.77 99.62 7.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 73.549999999999997 110.906 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.411 HD11 ' HD2' ' A' ' 47' ' ' ARG . 1.1 pt . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 73.349999999999994 111.103 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.1 mtp . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.815 0.341 . . . . 73.140000000000001 110.833 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -90.45 142.32 27.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 44.520000000000003 110.898 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -87.0 98.53 11.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 72.409999999999997 111.117 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -169.1 108.65 0.45 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 72.400000000000006 111.105 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -88.97 97.89 11.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 53.200000000000003 110.898 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.749 HG13 ' CH2' ' A' ' 46' ' ' TRP . 79.5 t -100.85 114.65 40.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.484 . . . . 65.519999999999996 111.141 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.442 HG23 ' O ' ' A' ' 7' ' ' ILE . 8.5 tt -115.41 110.53 32.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 74.120000000000005 111.131 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.5 t -128.79 145.09 36.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 51.5 111.132 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -97.81 136.7 37.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.476 . . . . 73.299999999999997 110.911 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.77 44.68 1.1 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.49 . . . . 71.430000000000007 110.872 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 173.42 -171.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 65.400000000000006 110.824 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 13' ' ' ASN . 5.3 t -64.58 160.57 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 73.239999999999995 111.161 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.444 ' N ' HG12 ' A' ' 12' ' ' VAL . 11.7 t-20 -87.28 53.94 2.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 73.109999999999999 110.883 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.443 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -176.92 28.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 61.200000000000003 110.872 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.4 52.79 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.714 -0.755 . . . . 74.519999999999996 112.438 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.07 171.42 24.55 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.76 -0.733 . . . . 52.420000000000002 112.481 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.04 135.15 34.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.779 0.323 . . . . 73.219999999999999 110.912 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.65 154.35 32.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 74.120000000000005 110.882 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -148.65 151.97 35.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 72.549999999999997 110.878 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -163.18 92.57 0.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 70.439999999999998 110.838 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.99 157.9 16.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 63.439999999999998 111.129 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 m -93.88 40.01 1.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 73.540000000000006 111.141 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.4 m -146.66 -82.47 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 73.150000000000006 110.826 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -163.25 124.06 2.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.106 -0.497 . . . . 73.209999999999994 110.867 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.93 162.26 62.93 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.585 0.707 . . . . 73.209999999999994 110.888 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -72.3 -171.84 0.78 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.646 2.23 . . . . 74.230000000000004 112.357 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.62 139.78 17.53 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.768 -0.729 . . . . 51.039999999999999 112.488 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.05 -168.4 2.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.795 0.331 . . . . 73.010000000000005 111.114 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.29 87.9 1.93 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.725 -0.75 . . . . 43.43 112.485 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.42 -168.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.836 0.351 . . . . 62.420000000000002 110.851 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -63.47 -174.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 74.150000000000006 110.888 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.7 mp -56.31 -87.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 54.439999999999998 110.888 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -93.66 65.98 3.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 70.040000000000006 110.909 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -168.06 42.28 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 72.519999999999996 110.87 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.12 102.01 11.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 71.010000000000005 110.858 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.441 HD12 HG22 ' A' ' 12' ' ' VAL . 1.1 pt -154.49 106.08 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 73.209999999999994 111.14 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 56.6 p -151.08 -168.4 3.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 52.420000000000002 110.848 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.609 ' C ' HD12 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -130.46 152.22 50.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.087 -0.506 . . . . 63.119999999999997 110.847 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.609 HD12 ' C ' ' A' ' 38' ' ' SER . 1.7 mp -122.14 141.52 42.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 73.439999999999998 111.103 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.2 tttt -140.99 135.61 31.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 73.209999999999994 110.841 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.4 p -162.91 139.23 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 72.310000000000002 111.109 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.06 40.65 3.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 75.019999999999996 110.891 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 t 178.94 138.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 74.349999999999994 110.833 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.78 -177.87 1.89 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.705 -0.76 . . . . 63.039999999999999 112.524 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.59 HG22 ' HA2' ' A' ' 62' ' ' GLY . 18.5 p -145.49 147.65 32.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.754 0.311 . . . . 65.099999999999994 111.156 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.779 ' CE3' HD21 ' A' ' 61' ' ' LEU . 0.7 OUTLIER -116.98 175.43 5.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 64.109999999999999 110.953 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -117.69 118.93 33.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.413 . . . . 71.349999999999994 110.906 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.432 ' CD2' HD23 ' A' ' 61' ' ' LEU . 2.6 m-85 -107.63 125.93 51.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 73.219999999999999 110.871 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.18 126.64 20.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.143 -0.48 . . . . 72.430000000000007 110.952 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -99.25 89.13 4.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 73.230000000000004 110.868 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.443 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 170.95 -178.01 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 74.140000000000001 110.961 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.1 tt -54.94 163.34 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 70.439999999999998 111.119 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -76.29 55.84 1.01 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 71.120000000000005 110.886 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -153.5 -37.72 0.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 72.310000000000002 110.938 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -146.27 -144.27 4.04 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.699 -0.762 . . . . 44.100000000000001 112.427 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.443 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 108.18 -170.54 15.17 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.765 -0.731 . . . . 54.130000000000003 112.469 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -83.61 105.36 14.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.841 0.353 . . . . 73.549999999999997 110.852 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -78.16 106.84 10.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 73.430000000000007 110.932 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -138.1 108.35 6.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.48 . . . . 70.329999999999998 110.941 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -92.83 135.07 34.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.436 . . . . 71.510000000000005 110.877 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.779 HD21 ' CE3' ' A' ' 46' ' ' TRP . 1.3 pp -99.22 140.41 33.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 71.25 110.922 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.59 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -107.45 -159.18 20.92 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.773 -0.727 . . . . 34.43 112.475 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.37 88.06 0.13 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.672 2.248 . . . . 60.109999999999999 112.39 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.3 160.52 29.22 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.751 -0.737 . . . . 52.530000000000001 112.504 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -118.61 135.55 54.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 61.420000000000002 110.852 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -143.45 160.09 41.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.129 -0.487 . . . . 71.140000000000001 110.878 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 97.8 p -141.14 78.06 1.63 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.086 -0.506 . . . . 61.130000000000003 110.853 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.471 ' HB2' ' HB2' ' A' ' 72' ' ' ALA . 14.2 m -88.39 148.81 24.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.491 . . . . 72.400000000000006 110.858 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.435 HG12 ' HB ' ' A' ' 36' ' ' ILE . 34.5 m -150.68 24.05 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.495 . . . . 51.350000000000001 111.154 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -179.47 36.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 72.219999999999999 110.858 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.99 -43.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 75.219999999999999 110.831 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.471 ' HB2' ' HB2' ' A' ' 68' ' ' SER . . . -51.59 -42.94 62.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 71.319999999999993 111.104 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.685 ' O ' HD13 ' A' ' 74' ' ' ILE . . . 166.88 91.99 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.766 -0.73 . . . . 43.509999999999998 112.503 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.685 HD13 ' O ' ' A' ' 73' ' ' GLY . 15.0 mm -131.46 69.21 81.74 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.638 0.733 . . . . 71.040000000000006 111.173 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -81.02 -66.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.701 2.267 . . . . 64.409999999999997 112.379 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -179.95 -73.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.266 -0.425 . . . . 75.329999999999998 110.874 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -66.09 -169.8 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 62.399999999999999 110.885 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.93 110.07 6.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 71.310000000000002 110.826 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.6 pt -152.92 22.79 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 73.540000000000006 111.096 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.6 p -79.78 160.54 26.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 61.149999999999999 110.861 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.62 156.69 13.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 65.319999999999993 110.854 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -148.58 138.37 22.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.49 . . . . 63.340000000000003 110.837 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.97 120.59 34.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 75.430000000000007 110.875 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -79.28 111.05 15.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 72.420000000000002 110.925 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.5 pt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.46 . . . . 65.329999999999998 111.132 179.969 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.795 0.331 . . . . 64.129999999999995 110.819 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -160.16 102.19 1.43 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 72.109999999999999 110.885 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -84.75 108.98 17.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 73.420000000000002 111.143 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -163.49 119.88 1.75 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 75.120000000000005 111.067 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.36 96.04 9.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 70.109999999999999 110.88 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.642 HG22 ' CZ2' ' A' ' 46' ' ' TRP . 84.4 t -117.71 118.63 59.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 53.119999999999997 111.119 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.801 HG23 ' HB3' ' A' ' 40' ' ' LYS . 4.4 tp -136.69 116.65 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 50.039999999999999 111.102 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.635 HG12 HD13 ' A' ' 39' ' ' ILE . 2.8 m -133.12 160.33 42.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 73.200000000000003 111.122 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -113.15 141.21 47.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 75.540000000000006 110.952 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -95.46 37.0 1.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 74.200000000000003 110.869 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 175.62 -169.63 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 72.239999999999995 110.868 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 13' ' ' ASN . 6.6 t -63.65 160.28 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 75.409999999999997 111.18 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.45 ' N ' HG12 ' A' ' 12' ' ' VAL . 37.2 t30 -85.87 53.81 2.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 74.129999999999995 110.899 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.44 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.14 28.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 74.209999999999994 110.86 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.54 39.26 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.718 -0.754 . . . . 55.409999999999997 112.47 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -129.16 171.61 19.92 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.725 -0.75 . . . . 33.310000000000002 112.462 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.25 131.01 34.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.773 0.32 . . . . 73.420000000000002 110.921 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.57 145.26 45.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 72.019999999999996 110.855 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -148.77 128.71 13.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 74.209999999999994 110.875 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.697 ' HB3' HD13 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -118.23 71.05 0.82 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 71.010000000000005 110.927 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.712 ' HB3' ' CG ' ' A' ' 25' ' ' GLN . . . -80.83 160.91 24.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 73.329999999999998 111.068 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.5 t -138.77 40.38 2.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 74.340000000000003 111.168 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.4 t -150.35 59.43 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 72.129999999999995 110.843 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 t70 63.26 87.64 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.486 . . . . 65.5 110.854 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.712 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -80.14 162.44 61.74 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.593 0.711 . . . . 62.539999999999999 110.895 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.79 102.64 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.671 2.247 . . . . 72.310000000000002 112.328 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.15 148.96 10.01 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.758 -0.734 . . . . 73.450000000000003 112.438 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.26 106.86 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.839 0.352 . . . . 63.210000000000001 111.088 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.54 38.59 0.51 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.752 -0.737 . . . . 61.439999999999998 112.492 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.39 103.1 0.43 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.809 0.338 . . . . 71.319999999999993 110.881 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -174.08 -169.15 0.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 73.430000000000007 110.932 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.0 tp -142.06 -168.65 2.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 72.319999999999993 110.887 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -53.79 -27.32 28.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 74.129999999999995 110.874 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.413 ' C ' HD13 ' A' ' 36' ' ' ILE . 5.2 m-20 -84.7 54.25 2.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 64.120000000000005 110.891 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.01 102.32 14.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 75.430000000000007 110.906 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.545 ' HB ' HG12 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -147.94 124.68 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 74.010000000000005 111.143 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.0 p -167.86 -166.78 0.77 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 73.319999999999993 110.81 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.8 t -125.54 164.12 21.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.067 -0.515 . . . . 44.240000000000002 110.867 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.635 HD13 HG12 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -130.42 140.33 49.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 75.219999999999999 111.127 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.801 ' HB3' HG23 ' A' ' 7' ' ' ILE . 1.7 tttp -138.58 132.15 30.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 74.409999999999997 110.913 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.665 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 3.6 p -133.0 139.2 50.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.258 -0.428 . . . . 73.409999999999997 111.108 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.62 41.91 1.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.472 . . . . 61.229999999999997 110.927 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -173.44 110.83 0.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 45.130000000000003 110.861 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 56.63 -137.76 47.77 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.729 -0.748 . . . . 41.109999999999999 112.483 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 64.3 p -150.21 141.25 22.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.339 . . . . 63.409999999999997 111.095 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.665 ' CZ2' HG23 ' A' ' 41' ' ' VAL . 2.8 m0 -109.72 168.45 9.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 74.510000000000005 110.891 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -110.2 120.89 43.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 74.230000000000004 110.917 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -110.95 127.72 55.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 72.519999999999996 110.936 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.73 126.15 18.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.471 . . . . 64.150000000000006 110.907 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -99.12 88.69 4.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.076 -0.511 . . . . 73.409999999999997 110.902 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 173.4 -177.85 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 53.539999999999999 110.903 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.0 pt -58.66 172.32 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 72.409999999999997 111.145 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -84.49 51.95 2.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 72.400000000000006 110.866 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -152.74 -47.87 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 74.109999999999999 110.918 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -149.75 125.05 1.89 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.742 . . . . 62.200000000000003 112.515 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.44 173.12 38.67 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.746 -0.74 . . . . 53.039999999999999 112.483 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -61.75 105.94 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.836 0.35 . . . . 74.219999999999999 110.921 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -77.04 103.32 6.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 72.219999999999999 110.922 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.9 t90 -138.19 107.91 6.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.496 . . . . 72.510000000000005 110.925 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -82.31 153.93 25.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 72.340000000000003 110.841 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.628 ' HG ' HG11 ' A' ' 41' ' ' VAL . 7.4 tp -104.79 133.68 49.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 74.299999999999997 110.947 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.454 ' N ' HD12 ' A' ' 61' ' ' LEU . . . -111.08 178.79 19.76 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.733 -0.746 . . . . 52.039999999999999 112.486 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -46.99 100.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.652 2.235 . . . . 65.409999999999997 112.367 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 161.88 164.13 16.18 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.724 -0.751 . . . . 72.140000000000001 112.476 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -124.1 140.27 53.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.89 0.376 . . . . 71.140000000000001 110.868 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -140.77 144.23 35.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 64.430000000000007 110.939 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.1 t -126.18 74.8 1.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 72.019999999999996 110.895 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.6 m -87.27 159.01 18.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 72.540000000000006 110.823 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.545 HG12 ' HB ' ' A' ' 36' ' ' ILE . 30.5 m -151.29 21.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 60.229999999999997 111.166 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -179.37 58.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 73.230000000000004 110.881 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.55 -49.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 54.340000000000003 110.819 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.61 -62.01 1.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 63.310000000000002 111.115 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.62 ' O ' HD13 ' A' ' 74' ' ' ILE . . . -164.74 88.94 0.1 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.722 -0.752 . . . . 63.109999999999999 112.463 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.62 HD13 ' O ' ' A' ' 73' ' ' GLY . 18.8 mm -132.2 67.35 78.89 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.623 0.725 . . . . 70.5 111.14 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -80.25 -51.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.69 2.26 . . . . 74.109999999999999 112.381 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.86 -34.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 72.010000000000005 110.85 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -141.23 -176.77 4.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 71.030000000000001 110.871 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.34 111.68 23.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 73.140000000000001 110.889 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.547 ' H ' HD13 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -141.98 11.1 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 65.230000000000004 111.086 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.4 p -83.37 170.64 14.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 72.219999999999999 110.843 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.64 152.66 10.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 73.010000000000005 110.859 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -150.19 139.9 21.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 62.439999999999998 110.919 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -109.33 130.62 55.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 70.430000000000007 110.86 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.415 ' HB3' HG21 ' A' ' 6' ' ' VAL . 2.1 mp0 -89.38 131.41 35.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 54.109999999999999 110.899 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.6 pt . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 72.010000000000005 111.099 179.975 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.809 0.337 . . . . 60.439999999999998 110.866 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -82.57 176.12 9.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 73.109999999999999 110.865 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -155.47 51.49 0.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 73.5 111.06 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.34 144.76 25.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 74.340000000000003 111.109 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -90.47 116.17 28.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 65.209999999999994 110.879 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.743 HG22 ' CZ2' ' A' ' 46' ' ' TRP . 87.6 t -111.95 111.77 37.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 75.140000000000001 111.117 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.561 HD13 ' HB3' ' A' ' 20' ' ' ASP . 3.3 tp -117.52 110.03 29.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 70.340000000000003 111.118 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 m -130.79 159.9 42.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 72.230000000000004 111.144 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -112.14 146.2 38.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.462 . . . . 75.120000000000005 110.938 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -101.18 38.9 1.48 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.477 . . . . 73.5 110.904 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 175.04 -171.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 74.030000000000001 110.845 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 13' ' ' ASN . 6.7 t -63.33 160.61 2.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 65.200000000000003 111.105 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.452 ' N ' HG12 ' A' ' 12' ' ' VAL . 12.0 t-20 -84.19 53.74 2.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 74.409999999999997 110.917 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.446 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -178.06 28.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 73.420000000000002 110.84 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 158.88 38.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.753 -0.737 . . . . 73.319999999999993 112.495 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.3 171.51 20.57 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.756 -0.735 . . . . 74.519999999999996 112.464 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.91 149.79 21.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.798 0.332 . . . . 72.109999999999999 110.915 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.98 149.12 50.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 75.540000000000006 110.831 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -146.39 129.45 16.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 62.329999999999998 110.886 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.561 ' HB3' HD13 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -135.07 94.65 3.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 74.030000000000001 110.896 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -158.09 150.97 22.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 73.549999999999997 111.082 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -93.8 39.93 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 75.299999999999997 111.189 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.42 160.27 0.98 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 71.120000000000005 110.891 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.4 t0 52.0 32.47 10.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 52.32 110.902 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -132.4 138.99 33.41 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.548 0.69 . . . . 72.400000000000006 110.934 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -81.19 -169.05 0.71 Allowed 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.675 2.25 . . . . 62.210000000000001 112.336 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -163.55 -110.97 0.25 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.72 -0.752 . . . . 74.109999999999999 112.508 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.465 ' HB1' ' CB ' ' A' ' 81' ' ' SER . . . -52.24 102.92 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.831 0.348 . . . . 45.32 111.089 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.06 -172.03 42.9 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.721 -0.752 . . . . 75.430000000000007 112.506 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -179.08 175.88 0.93 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.83 0.347 . . . . 72.420000000000002 110.828 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -104.55 -86.7 0.45 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 72.120000000000005 110.884 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 tp -172.47 98.51 0.15 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.218 -0.446 . . . . 63.310000000000002 110.963 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 60.23 19.46 8.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 75.310000000000002 110.878 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -103.66 39.82 1.54 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 63.240000000000002 110.849 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.49 102.96 12.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 71.430000000000007 110.908 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.556 HG13 HG12 ' A' ' 69' ' ' VAL . 2.0 tt -176.76 102.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 73.349999999999994 111.135 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.7 p -168.84 -164.18 0.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 65.519999999999996 110.869 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.548 ' C ' HD12 ' A' ' 39' ' ' ILE . 47.5 t -125.41 149.34 48.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 74.430000000000007 110.883 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.603 HG21 HD13 ' A' ' 61' ' ' LEU . 1.5 mp -120.91 131.26 73.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 42.009999999999998 111.145 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.547 ' HB3' HG23 ' A' ' 7' ' ' ILE . 3.7 tttp -132.51 142.32 49.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 74.129999999999995 110.875 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.607 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 7.2 p -143.74 126.43 12.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 60.310000000000002 111.121 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.67 41.1 3.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 74.420000000000002 110.928 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.9 t -179.1 110.8 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 61.219999999999999 110.878 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.3 -151.24 52.12 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.67 -0.776 . . . . 75.129999999999995 112.508 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.54 HG22 ' HA2' ' A' ' 62' ' ' GLY . 41.1 p -150.07 153.39 36.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.798 0.332 . . . . 74.329999999999998 111.15 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.743 ' CZ2' HG22 ' A' ' 6' ' ' VAL . 1.3 m0 -123.45 179.07 4.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 75.239999999999995 110.935 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -124.44 136.09 53.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.434 . . . . 72.230000000000004 110.823 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.441 ' HD2' HD22 ' A' ' 61' ' ' LEU . 1.7 m-85 -120.12 129.88 54.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 75.430000000000007 110.878 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.71 126.14 20.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.164 -0.471 . . . . 74.409999999999997 110.95 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.78 89.04 3.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 54.399999999999999 110.918 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.569 ' C ' HG22 ' A' ' 79' ' ' ILE . 0.2 OUTLIER 175.38 -169.44 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 74.239999999999995 110.915 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.2 tt -58.6 163.06 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 70.019999999999996 111.113 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -76.24 55.3 0.95 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 75.319999999999993 110.871 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -153.76 -38.02 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 73.510000000000005 110.936 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -145.53 -138.82 3.31 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 72.239999999999995 112.509 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.426 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 108.06 177.37 22.16 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.796 -0.716 . . . . 52.439999999999998 112.5 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.3 109.48 5.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.81 0.338 . . . . 72.409999999999997 110.859 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -77.59 108.71 10.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 75.430000000000007 110.927 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -138.31 106.72 5.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 63.450000000000003 110.88 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -89.13 157.7 18.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 73.409999999999997 110.878 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.635 HD11 ' CE3' ' A' ' 46' ' ' TRP . 1.8 pt? -118.5 149.71 40.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 73.430000000000007 110.944 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.54 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -127.88 -166.6 12.09 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.72 -0.752 . . . . 50.530000000000001 112.493 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -46.41 101.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.7 2.267 . . . . 62.530000000000001 112.317 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.79 165.39 16.63 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.749 -0.738 . . . . 71.420000000000002 112.484 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.44 145.84 47.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.865 0.364 . . . . 74.329999999999998 110.858 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -154.75 156.65 36.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 75.439999999999998 110.924 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 95.8 p -130.4 85.88 2.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 70.209999999999994 110.854 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.1 t -86.01 153.21 22.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 60.310000000000002 110.86 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.556 HG12 HG13 ' A' ' 36' ' ' ILE . 18.7 m -149.65 18.03 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 61.299999999999997 111.163 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -178.7 40.94 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.117 -0.492 . . . . 75.010000000000005 110.863 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 t -158.44 -45.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 74.109999999999999 110.852 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.45 -61.26 2.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.486 . . . . 75.409999999999997 111.097 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 166.62 103.7 0.17 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.717 -0.754 . . . . 55.539999999999999 112.449 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.8 mm -115.76 74.66 4.95 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.666 0.746 . . . . 64.019999999999996 111.14 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.96 -165.54 0.31 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.701 2.267 . . . . 71.129999999999995 112.359 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -51.32 -74.85 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.265 -0.425 . . . . 61.149999999999999 110.834 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -179.41 33.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 74.439999999999998 110.857 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.3 p 178.95 -174.84 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 74.040000000000006 110.859 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.569 HG22 ' C ' ' A' ' 51' ' ' TYR . 14.2 mm 66.8 62.13 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 73.109999999999999 111.151 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.2 p -165.94 137.88 3.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 65.430000000000007 110.895 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.465 ' CB ' ' HB1' ' A' ' 28' ' ' ALA . 0.9 OUTLIER -158.53 166.75 31.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 75.129999999999995 110.864 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -151.12 142.51 23.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 62.450000000000003 110.886 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.86 159.0 26.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 64.430000000000007 110.932 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -128.52 92.53 3.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 63.399999999999999 110.934 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 pt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 65.409999999999997 111.111 179.981 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.4 mtm . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.771 0.32 . . . . 70.310000000000002 110.9 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -162.83 -179.91 7.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 63.299999999999997 110.881 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.0 99.15 1.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 72.409999999999997 111.094 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -146.45 139.16 25.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 74.420000000000002 111.048 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -89.45 93.31 9.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 74.510000000000005 110.878 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.773 HG13 ' CH2' ' A' ' 46' ' ' TRP . 58.3 t -111.92 128.65 68.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 63.240000000000002 111.128 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.454 HG23 ' O ' ' A' ' 7' ' ' ILE . 9.9 tt -126.68 110.56 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 74.430000000000007 111.155 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.4 t -136.54 143.81 34.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 62.420000000000002 111.112 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.85 138.2 40.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 74.319999999999993 110.89 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -93.25 42.67 1.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 75.030000000000001 110.885 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 173.93 -169.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 71.329999999999998 110.858 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.454 HG12 ' N ' ' A' ' 13' ' ' ASN . 6.2 t -63.95 160.3 3.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.218 -0.447 . . . . 64.430000000000007 111.178 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.454 ' N ' HG12 ' A' ' 12' ' ' VAL . 24.4 t30 -86.42 53.97 2.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 74.219999999999999 110.858 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.434 ' CG ' ' O ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.04 28.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 73.239999999999995 110.895 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.36 47.33 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.692 -0.766 . . . . 72.420000000000002 112.424 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.97 171.96 24.3 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.714 -0.755 . . . . 54.009999999999998 112.466 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.2 163.86 15.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.829 0.347 . . . . 72.450000000000003 110.924 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.1 p -144.52 165.44 27.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.434 . . . . 74.120000000000005 110.836 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -124.88 110.89 14.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 75.420000000000002 110.838 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.96 47.24 0.88 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 75.420000000000002 110.862 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.99 -176.08 5.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 73.450000000000003 111.138 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.0 t -138.71 40.02 2.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.443 . . . . 72.219999999999999 111.111 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.1 p -179.33 38.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 64.040000000000006 110.826 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -141.98 24.65 1.99 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.125 -0.489 . . . . 64.329999999999998 110.892 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.8 mp0 -144.18 162.41 40.32 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.583 0.706 . . . . 64.239999999999995 110.938 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -74.58 -50.4 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.699 2.266 . . . . 72.319999999999993 112.346 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 162.57 -88.93 0.11 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.77 -0.729 . . . . 64.349999999999994 112.53 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.625 ' HB2' ' CE1' ' A' ' 82' ' ' PHE . . . -175.42 -169.08 0.35 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.846 0.355 . . . . 72.329999999999998 111.126 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.75 85.77 1.78 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.759 -0.734 . . . . 70.200000000000003 112.496 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -159.77 46.31 0.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.835 0.35 . . . . 73.230000000000004 110.876 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -88.37 53.6 2.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 71.200000000000003 110.886 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.677 HD23 ' HB2' ' A' ' 77' ' ' ASN . 1.8 mp -95.39 -178.88 4.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 71.549999999999997 110.925 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -54.53 -27.03 35.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 70.310000000000002 110.896 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -103.66 41.54 1.27 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 73.219999999999999 110.861 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.489 ' O ' HD12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -96.07 101.86 13.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 63.399999999999999 110.921 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.447 HG23 ' O ' ' A' ' 35' ' ' LYS . 2.4 pt -156.1 119.28 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 74.120000000000005 111.159 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.2 p -161.84 -169.08 2.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 43.310000000000002 110.838 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.657 ' O ' HD12 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -127.85 149.18 50.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 62.140000000000001 110.875 -179.821 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.657 HD12 ' O ' ' A' ' 38' ' ' SER . 1.5 mp -124.35 138.96 52.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 71.409999999999997 111.161 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.4 ' HB3' HG23 ' A' ' 7' ' ' ILE . 1.2 tttt -142.49 138.67 31.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 73.120000000000005 110.945 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.7 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 6.4 p -132.87 139.15 50.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 72.129999999999995 111.095 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.3 39.93 2.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 65.450000000000003 110.89 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.87 120.24 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 71.319999999999993 110.853 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.23 -143.23 21.68 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.725 -0.75 . . . . 74.540000000000006 112.55 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.618 HG22 ' HA2' ' A' ' 62' ' ' GLY . 63.8 p -146.72 156.58 43.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.724 0.297 . . . . 74.150000000000006 111.126 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.773 ' CH2' HG13 ' A' ' 6' ' ' VAL . 2.7 m0 -125.32 169.81 11.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.218 -0.446 . . . . 64.040000000000006 110.919 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -112.11 121.59 45.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 63.32 110.911 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -113.65 120.07 39.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 74.209999999999994 110.901 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -139.88 126.78 20.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.153 -0.476 . . . . 60.100000000000001 110.933 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -100.72 89.98 4.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 73.319999999999993 110.909 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.444 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 170.96 -169.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 74.420000000000002 110.905 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' A' ' 52' ' ' ILE . 7.7 tp -64.87 159.41 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 75.219999999999999 111.104 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 -78.0 45.7 0.54 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 54.030000000000001 110.913 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -152.83 17.06 0.58 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 74.310000000000002 110.93 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 168.32 -118.18 0.77 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.754 -0.736 . . . . 75.140000000000001 112.492 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.444 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 71.56 -179.27 33.9 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.745 -0.74 . . . . 75.329999999999998 112.5 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.02 108.39 14.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.828 0.347 . . . . 64.129999999999995 110.87 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -78.35 106.88 10.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 74.109999999999999 110.897 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -138.15 106.2 5.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.112 -0.494 . . . . 73.239999999999995 110.906 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -84.76 157.41 21.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 74.219999999999999 110.857 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.496 HD22 HG21 ' A' ' 39' ' ' ILE . 9.7 tp -109.75 134.7 51.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 64.209999999999994 110.909 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.618 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -110.32 -178.55 20.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.668 -0.777 . . . . 74.209999999999994 112.493 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -47.88 100.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.747 2.298 . . . . 73.430000000000007 112.314 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.46 165.42 14.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.71 -0.757 . . . . 43.25 112.428 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -93.48 165.08 12.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.86 0.362 . . . . 53.219999999999999 110.941 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -160.24 105.03 1.49 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 74.430000000000007 110.928 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.6 m -96.45 91.13 5.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 71.450000000000003 110.837 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.18 131.81 34.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 75.239999999999995 110.838 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.492 HG23 ' HG2' ' A' ' 70' ' ' GLU . 29.8 m -150.05 18.67 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.119 -0.492 . . . . 53.240000000000002 111.14 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.492 ' HG2' HG23 ' A' ' 69' ' ' VAL . 0.0 OUTLIER 173.45 -17.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 73.299999999999997 110.905 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.34 -49.73 9.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 71.549999999999997 110.867 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.31 -70.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 64.310000000000002 111.064 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.761 ' O ' HD13 ' A' ' 74' ' ' ILE . . . 173.07 119.8 0.54 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.739 -0.743 . . . . 72.140000000000001 112.473 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.761 HD13 ' O ' ' A' ' 73' ' ' GLY . 5.5 mm -129.5 67.14 78.52 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.645 0.736 . . . . 75.530000000000001 111.135 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -81.38 -69.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.704 2.269 . . . . 55.530000000000001 112.335 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.2 t70 179.08 -40.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 71.099999999999994 110.91 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.677 ' HB2' HD23 ' A' ' 32' ' ' LEU . 16.9 t30 -176.71 107.46 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.47 . . . . 72.310000000000002 110.865 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.2 m -140.8 -169.97 2.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 74.239999999999995 110.824 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.9 mp -106.19 150.1 9.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.485 . . . . 74.329999999999998 111.17 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.6 p -165.51 146.8 7.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 62.32 110.861 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.465 ' HA ' ' HB3' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -160.04 158.94 31.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 74.030000000000001 110.863 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.625 ' CE1' ' HB2' ' A' ' 28' ' ' ALA . 4.1 p90 -150.63 135.78 17.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 74.439999999999998 110.862 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -88.59 120.73 30.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 63.210000000000001 110.911 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.662 ' HG2' HG11 ' A' ' 6' ' ' VAL . 28.9 mt-30 -81.36 92.64 6.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 65.340000000000003 110.904 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 74.219999999999999 111.121 179.971 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.762 0.315 . . . . 64.099999999999994 110.895 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -154.11 135.29 14.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 74.25 110.925 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.22 69.27 9.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 72.200000000000003 111.12 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.35 97.4 8.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 71.120000000000005 111.066 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.12 129.58 35.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 74.230000000000004 110.903 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.789 HG13 ' CH2' ' A' ' 46' ' ' TRP . 86.0 t -115.93 127.58 73.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 75.019999999999996 111.095 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.707 HG23 ' HB3' ' A' ' 40' ' ' LYS . 7.8 tt -125.03 110.81 25.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 63.340000000000003 111.134 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.1 t -123.02 143.84 34.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 71.349999999999994 111.113 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -105.12 138.47 41.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 73.150000000000006 110.909 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -94.7 43.34 1.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.085 -0.507 . . . . 75.540000000000006 110.852 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 173.0 -170.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 71.439999999999998 110.852 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.635 HG22 HD12 ' A' ' 36' ' ' ILE . 6.3 t -64.15 159.71 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 72.120000000000005 111.112 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.436 ' N ' HG12 ' A' ' 12' ' ' VAL . 55.5 t30 -86.1 53.9 2.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 73.530000000000001 110.869 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.441 ' CG ' ' O ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.05 28.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 44.219999999999999 110.882 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.35 51.69 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.758 -0.734 . . . . 55.530000000000001 112.484 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.07 171.38 24.57 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.715 -0.755 . . . . 35.130000000000003 112.501 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.54 133.92 35.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.806 0.336 . . . . 54.240000000000002 110.903 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.76 155.08 33.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 72.319999999999993 110.885 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -148.45 117.56 6.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 74.099999999999994 110.936 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -128.71 85.43 2.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 73.549999999999997 110.908 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.45 -169.54 2.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 62.100000000000001 111.117 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.4 t -137.82 39.91 2.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 43.119999999999997 111.131 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.8 p -162.7 41.99 0.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 72.409999999999997 110.832 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 t0 66.22 118.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 70.329999999999998 110.854 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.433 ' HB2' ' HD2' ' A' ' 26' ' ' PRO . 14.1 pt20 -79.78 161.7 65.41 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.625 0.726 . . . . 73.25 110.912 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.433 ' HD2' ' HB2' ' A' ' 25' ' ' GLN . 57.0 Cg_endo -82.02 68.29 7.94 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.649 2.232 . . . . 74.099999999999994 112.336 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 51.44 -166.17 0.82 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.743 -0.742 . . . . 70.439999999999998 112.454 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -152.81 31.39 0.5 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.829 0.347 . . . . 21.449999999999999 111.084 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.81 80.61 0.56 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.752 -0.737 . . . . 61.140000000000001 112.452 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -139.86 23.93 2.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.807 0.337 . . . . 73.530000000000001 110.831 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -74.13 -169.69 0.82 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 64.319999999999993 110.926 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -179.83 -169.15 0.13 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.231 -0.44 . . . . 52.020000000000003 110.957 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -65.45 -24.18 67.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 71.439999999999998 110.887 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -134.46 61.36 1.67 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 55.229999999999997 110.872 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.77 141.06 28.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 74.120000000000005 110.915 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.635 HD12 HG22 ' A' ' 12' ' ' VAL . 1.1 pt -153.41 107.93 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 73.120000000000005 111.143 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 63.7 p -149.86 -172.3 4.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 75.430000000000007 110.892 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.553 ' C ' HD12 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -135.22 149.53 49.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 74.010000000000005 110.859 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.553 HD12 ' C ' ' A' ' 38' ' ' SER . 1.9 mp -120.83 109.89 26.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 74.219999999999999 111.171 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.707 ' HB3' HG23 ' A' ' 7' ' ' ILE . 4.9 tttt -95.04 127.69 41.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 73.430000000000007 110.919 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.445 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 7.1 p -139.68 139.03 38.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 62.43 111.107 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.93 40.55 1.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 64.150000000000006 110.911 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.3 p -179.4 137.67 0.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 65.019999999999996 110.861 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.22 -155.3 4.75 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.753 -0.737 . . . . 70.239999999999995 112.474 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.471 HG22 ' HA2' ' A' ' 62' ' ' GLY . 67.3 p -150.03 150.13 31.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.806 0.336 . . . . 71.140000000000001 111.134 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.789 ' CH2' HG13 ' A' ' 6' ' ' VAL . 2.6 m0 -123.37 169.62 11.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 74.430000000000007 110.923 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -121.5 128.51 52.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 74.340000000000003 110.847 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -114.33 128.53 56.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 71.049999999999997 110.884 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.2 126.47 19.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.136 -0.484 . . . . 73.030000000000001 110.914 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -101.46 89.21 3.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 75.329999999999998 110.855 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.425 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.1 OUTLIER 171.66 -165.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 72.540000000000006 110.926 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -52.01 173.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 64.349999999999994 111.157 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -85.52 49.81 1.83 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 75.109999999999999 110.922 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 22.3 p90 176.86 41.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 63.420000000000002 110.905 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.12 -154.21 24.62 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.718 -0.753 . . . . 51.130000000000003 112.444 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.425 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 94.73 -177.06 35.48 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.767 -0.73 . . . . 74.150000000000006 112.483 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.29 110.8 9.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.826 0.346 . . . . 71.329999999999998 110.893 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -78.03 109.7 12.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 62.100000000000001 110.934 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -138.3 106.26 5.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.11 -0.495 . . . . 74.430000000000007 110.952 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.0 p30 -94.57 153.76 17.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 74.209999999999994 110.817 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.758 HD11 ' CE3' ' A' ' 46' ' ' TRP . 1.3 pt? -117.11 136.08 53.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 61.5 110.931 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.471 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -102.81 -162.68 25.91 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 61.329999999999998 112.484 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.27 105.39 0.29 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.685 2.257 . . . . 54.130000000000003 112.342 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.95 151.92 6.07 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.756 -0.735 . . . . 70.349999999999994 112.509 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.9 144.97 32.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.855 0.36 . . . . 71.109999999999999 110.869 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -124.35 157.28 35.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.095 -0.502 . . . . 60.109999999999999 110.896 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.1 t -160.05 68.31 0.38 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 61.539999999999999 110.866 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.609 ' CB ' ' HB2' ' A' ' 72' ' ' ALA . 0.4 OUTLIER -85.98 146.68 26.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 55.520000000000003 110.89 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.543 ' HB ' HG22 ' A' ' 36' ' ' ILE . 33.9 m -150.58 18.81 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 75.230000000000004 111.141 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -179.05 34.19 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 75.219999999999999 110.888 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 37.8 t -160.9 -40.64 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 74.319999999999993 110.867 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.609 ' HB2' ' CB ' ' A' ' 68' ' ' SER . . . -51.38 -44.18 62.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 61.549999999999997 111.131 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.751 ' O ' HD13 ' A' ' 74' ' ' ILE . . . 166.73 95.0 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.722 -0.752 . . . . 72.310000000000002 112.472 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.751 HD13 ' O ' ' A' ' 73' ' ' GLY . 4.9 mm -129.5 67.14 78.53 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.65 0.738 . . . . 62.25 111.124 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -80.83 -60.79 0.03 OUTLIER 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.667 2.245 . . . . 52.329999999999998 112.362 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 179.23 -33.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 75.349999999999994 110.81 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -141.17 -177.82 5.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 63.530000000000001 110.917 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.1 t -58.54 -96.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 62.43 110.889 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 mp 47.94 54.26 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 74.340000000000003 111.121 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.6 p -155.03 163.0 40.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 75.400000000000006 110.816 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.94 159.82 16.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.074 -0.512 . . . . 63.310000000000002 110.878 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -150.14 135.71 18.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 74.150000000000006 110.847 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -93.21 133.38 36.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 74.140000000000001 110.919 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.498 HE21 HG21 ' A' ' 6' ' ' VAL . 25.2 mt-30 -105.84 131.43 53.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 72.540000000000006 110.967 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.3 pt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 60.310000000000002 111.141 179.993 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.7 ttp . . . . . 0 C--O 1.23 0.037 0 CA-C-O 120.786 0.327 . . . . 35.119999999999997 110.844 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -128.63 147.46 50.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 73.239999999999995 110.913 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.32 98.05 1.68 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 43.210000000000001 111.068 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -81.11 121.28 25.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 53.030000000000001 111.085 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -89.25 104.35 16.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 54.409999999999997 110.897 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.769 HG22 ' CZ2' ' A' ' 46' ' ' TRP . 94.3 t -113.11 105.59 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 73.120000000000005 111.109 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.669 HD13 ' HB3' ' A' ' 20' ' ' ASP . 3.5 tp -117.07 110.3 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 72.239999999999995 111.12 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.2 m -133.15 159.29 43.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 44.509999999999998 111.116 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -112.18 142.3 44.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.127 -0.488 . . . . 74.340000000000003 110.92 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -95.35 31.85 1.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 73.319999999999993 110.924 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 175.52 -169.68 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 74.340000000000003 110.855 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.446 HG12 ' N ' ' A' ' 13' ' ' ASN . 7.9 t -62.75 159.9 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 62.549999999999997 111.149 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.446 ' N ' HG12 ' A' ' 12' ' ' VAL . 4.9 t-20 -84.51 54.07 2.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 74.519999999999996 110.907 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.436 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.66 28.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 74.319999999999993 110.88 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.12 47.61 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.689 -0.767 . . . . 62.009999999999998 112.486 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.8 171.48 24.06 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.709 -0.757 . . . . 75.450000000000003 112.501 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.3 tmmt? -91.01 122.83 34.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.803 0.335 . . . . 75.310000000000002 110.862 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.97 148.54 43.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 74.439999999999998 110.827 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -148.77 139.73 22.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 74.219999999999999 110.894 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.669 ' HB3' HD13 ' A' ' 7' ' ' ILE . 0.7 OUTLIER -125.71 87.14 2.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 60.25 110.873 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.68 179.36 7.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 70.0 111.084 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.7 t -153.57 116.57 4.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 53.530000000000001 111.161 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.0 t -179.36 -82.35 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 72.150000000000006 110.837 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -141.83 38.93 1.65 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 64.400000000000006 110.862 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -80.62 162.22 61.34 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.563 0.696 . . . . 72.5 110.933 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -71.48 -169.73 0.45 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.678 2.252 . . . . 75.400000000000006 112.349 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -162.42 -71.99 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.741 . . . . 54.200000000000003 112.494 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -147.59 179.85 7.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.823 0.344 . . . . 40.119999999999997 111.097 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.27 38.66 2.08 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.77 -0.729 . . . . 74.25 112.447 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -179.3 92.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.839 0.352 . . . . 73.530000000000001 110.897 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -174.25 94.1 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 62.32 110.905 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -88.26 95.36 10.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 71.140000000000001 110.894 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.8 t30 55.85 25.51 8.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 70.129999999999995 110.852 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -133.93 39.9 3.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 60.539999999999999 110.855 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.86 102.06 14.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 74.129999999999995 110.932 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.436 HG22 ' HB ' ' A' ' 69' ' ' VAL . 1.2 pt -153.49 104.13 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 74.349999999999994 111.121 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.9 p -157.16 -166.53 2.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 64.510000000000005 110.819 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.685 ' O ' HD12 ' A' ' 39' ' ' ILE . 21.2 t -127.14 154.46 44.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 71.109999999999999 110.828 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.685 HD12 ' O ' ' A' ' 38' ' ' SER . 1.5 mp -125.52 139.01 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 72.310000000000002 111.128 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.641 ' HB3' HG23 ' A' ' 7' ' ' ILE . 7.9 tttt -145.35 147.83 32.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 74.200000000000003 110.875 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 43' ' ' SER . 11.2 p -161.52 138.82 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 71.439999999999998 111.115 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -134.58 40.92 2.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 65.019999999999996 110.898 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.429 ' H ' HG22 ' A' ' 41' ' ' VAL . 1.8 t -179.62 119.4 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 73.0 110.89 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.08 -163.45 50.82 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.757 -0.735 . . . . 52.210000000000001 112.522 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.65 HG22 ' HA2' ' A' ' 62' ' ' GLY . 41.5 p -149.83 147.7 28.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.796 0.331 . . . . 64.340000000000003 111.166 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.769 ' CZ2' HG22 ' A' ' 6' ' ' VAL . 1.3 m0 -117.37 171.94 7.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 75.219999999999999 110.946 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -112.98 124.26 52.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 64.430000000000007 110.87 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -113.73 125.87 54.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 74.230000000000004 110.925 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.48 126.9 23.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 72.340000000000003 110.91 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -102.09 89.75 3.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 73.129999999999995 110.896 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.501 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.1 OUTLIER 170.72 -166.87 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.161 -0.472 . . . . 75.200000000000003 110.917 -179.873 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.404 ' HB ' ' CE1' ' A' ' 54' ' ' TYR . 1.0 OUTLIER -51.98 172.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 70.409999999999997 111.102 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -86.06 50.08 1.91 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 52.149999999999999 110.897 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.404 ' CE1' ' HB ' ' A' ' 52' ' ' ILE . 2.1 p90 174.88 45.12 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.474 . . . . 62.420000000000002 110.905 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.22 -150.14 18.08 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.724 -0.75 . . . . 54.43 112.465 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.501 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 87.37 -171.51 42.06 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.689 -0.767 . . . . 71.030000000000001 112.497 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.47 112.39 17.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.817 0.342 . . . . 73.120000000000005 110.886 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -79.23 101.04 7.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 74.219999999999999 110.943 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -133.86 107.54 7.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.119 -0.491 . . . . 71.310000000000002 110.914 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -83.85 154.21 23.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 74.340000000000003 110.849 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.549 HD12 ' H ' ' A' ' 62' ' ' GLY . 14.8 tp -99.34 148.34 24.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 44.520000000000003 110.934 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.65 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -129.55 -165.16 11.61 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.723 -0.751 . . . . 61.100000000000001 112.489 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.26 89.73 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.667 2.245 . . . . 64.140000000000001 112.339 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.32 171.18 40.57 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.761 -0.733 . . . . 74.209999999999994 112.513 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.8 143.83 50.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.833 0.349 . . . . 71.340000000000003 110.898 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -152.55 149.03 28.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 74.310000000000002 110.951 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.2 p -130.33 82.44 2.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 41.439999999999998 110.845 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.601 ' HB2' ' HB2' ' A' ' 72' ' ' ALA . 40.4 m -86.66 147.07 26.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 63.140000000000001 110.819 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HB ' HG22 ' A' ' 36' ' ' ILE . 34.7 m -150.69 19.04 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.074 -0.512 . . . . 74.409999999999997 111.164 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -179.46 34.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 73.219999999999999 110.905 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.1 t -160.74 -40.84 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 73.219999999999999 110.851 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.601 ' HB2' ' HB2' ' A' ' 68' ' ' SER . . . -52.3 -54.25 33.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 73.120000000000005 111.111 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.459 ' O ' HD13 ' A' ' 74' ' ' ILE . . . 178.37 85.74 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.815 -0.707 . . . . 75.439999999999998 112.481 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.459 HD13 ' O ' ' A' ' 73' ' ' GLY . 13.9 mm -123.89 67.55 42.17 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.64 0.733 . . . . 72.109999999999999 111.132 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -74.35 -53.86 0.1 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.689 2.259 . . . . 75.010000000000005 112.377 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.3 t70 179.44 -74.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 51.340000000000003 110.855 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -93.04 -169.85 2.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 62.210000000000001 110.918 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.92 114.49 26.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 74.049999999999997 110.882 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -152.64 69.52 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 74.439999999999998 111.12 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.7 p -158.76 161.63 37.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 75.019999999999996 110.851 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.74 163.24 18.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 72.409999999999997 110.834 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -151.16 136.31 17.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 62.119999999999997 110.86 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -88.53 120.21 29.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 74.349999999999994 110.883 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -79.18 102.03 8.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 72.310000000000002 110.896 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 pt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 75.310000000000002 111.101 179.953 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.802 0.334 . . . . 63.149999999999999 110.906 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -81.02 139.0 36.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 72.340000000000003 110.859 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -163.12 88.29 0.59 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 64.319999999999993 111.129 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -84.58 169.53 14.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.425 . . . . 33.32 111.129 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -91.14 109.7 20.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 63.340000000000003 110.882 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.73 HG13 ' CH2' ' A' ' 46' ' ' TRP . 96.7 t -115.89 136.37 52.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 71.519999999999996 111.099 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.76 HG23 ' HB3' ' A' ' 40' ' ' LYS . 8.3 tt -131.35 110.66 17.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 74.230000000000004 111.145 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.4 t -127.09 143.13 41.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 73.430000000000007 111.132 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -97.1 140.36 31.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 73.219999999999999 110.925 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -99.24 35.6 1.89 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 61.329999999999998 110.914 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 175.18 -169.73 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 72.340000000000003 110.871 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 13' ' ' ASN . 6.5 t -63.64 159.52 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 61.310000000000002 111.112 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.441 ' N ' HG12 ' A' ' 12' ' ' VAL . 39.5 p30 -85.78 54.19 3.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 62.020000000000003 110.902 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.441 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.1 28.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 75.329999999999998 110.881 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.22 50.28 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.726 -0.749 . . . . 65.129999999999995 112.505 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.1 171.51 24.53 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.761 -0.733 . . . . 64.340000000000003 112.529 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.21 126.06 42.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.764 0.316 . . . . 72.530000000000001 110.906 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.7 p -118.29 156.5 28.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.27 -0.423 . . . . 72.299999999999997 110.824 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -111.03 107.97 17.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 73.420000000000002 110.877 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -117.69 40.54 3.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 72.230000000000004 110.884 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.02 130.06 16.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 75.439999999999998 111.127 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 22' ' ' THR . 5.1 t -81.59 120.65 25.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.231 -0.441 . . . . 61.25 111.105 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.0 m -152.08 -82.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 73.209999999999994 110.857 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -174.54 72.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 63.229999999999997 110.849 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.16 162.59 53.85 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.572 0.701 . . . . 72.120000000000005 110.914 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.13 -15.71 22.92 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.67 2.247 . . . . 62.340000000000003 112.345 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.46 -80.13 1.03 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.75 -0.738 . . . . 63.539999999999999 112.5 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.548 ' HB2' ' CE1' ' A' ' 82' ' ' PHE . . . -147.65 -174.51 4.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.788 0.327 . . . . 63.149999999999999 111.153 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.97 19.08 9.84 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.708 -0.758 . . . . 72.310000000000002 112.501 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -148.07 68.19 1.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.809 0.338 . . . . 60.009999999999998 110.84 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -129.83 -176.18 3.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 64.209999999999994 110.899 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -175.14 -169.7 0.41 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.162 -0.472 . . . . 72.409999999999997 110.896 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -71.13 -28.18 64.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 63.119999999999997 110.878 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -98.17 39.71 1.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 75.409999999999997 110.885 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.429 ' O ' HG23 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -106.34 133.99 50.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 71.209999999999994 110.921 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.71 ' HB ' HG12 ' A' ' 69' ' ' VAL . 4.6 pt -155.23 128.92 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 61.350000000000001 111.103 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 84.8 p -167.34 -168.19 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 74.109999999999999 110.897 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.483 ' O ' HD12 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -125.13 152.72 44.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 75.129999999999995 110.871 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.483 HD12 ' O ' ' A' ' 38' ' ' SER . 1.3 mp -120.91 132.64 69.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 73.150000000000006 111.114 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.76 ' HB3' HG23 ' A' ' 7' ' ' ILE . 2.9 tttt -130.6 131.94 45.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 73.430000000000007 110.899 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.614 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 4.9 p -136.45 139.24 45.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 71.140000000000001 111.098 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.6 mmpp? -143.62 45.98 1.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 71.25 110.864 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.44 124.42 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 71.549999999999997 110.831 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.01 -150.0 8.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.748 -0.739 . . . . 61.299999999999997 112.487 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.6 p -147.57 144.74 28.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.797 0.332 . . . . 70.329999999999998 111.09 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.73 ' CH2' HG13 ' A' ' 6' ' ' VAL . 2.0 m0 -115.87 173.07 6.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 73.129999999999995 110.915 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -119.11 120.76 38.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.425 . . . . 71.409999999999997 110.84 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -109.63 125.73 52.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 60.039999999999999 110.838 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.83 143.91 37.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.074 -0.512 . . . . 74.239999999999995 110.879 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -107.93 88.5 2.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.077 -0.51 . . . . 45.109999999999999 110.918 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.414 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 171.78 -166.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 65.340000000000003 110.933 -179.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.609 HG22 ' H ' ' A' ' 53' ' ' ASN . 3.3 mm -78.79 171.52 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 73.040000000000006 111.091 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.609 ' H ' HG22 ' A' ' 52' ' ' ILE . 4.6 t-20 -74.66 57.83 0.77 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 64.140000000000001 110.878 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -151.01 -34.95 0.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 73.340000000000003 110.907 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -158.74 -141.91 3.26 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.731 -0.747 . . . . 50.25 112.489 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.414 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 106.53 -179.97 22.88 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.709 -0.757 . . . . 53.450000000000003 112.461 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.69 105.9 6.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.813 0.339 . . . . 65.209999999999994 110.89 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -76.73 106.99 8.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 63.119999999999997 110.913 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -138.29 106.98 5.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.113 -0.494 . . . . 74.519999999999996 110.897 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -90.32 141.35 28.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 74.319999999999993 110.881 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.561 HD21 ' CE3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -99.32 153.41 18.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 74.310000000000002 110.907 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -132.44 -168.4 12.01 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.729 -0.748 . . . . 52.530000000000001 112.487 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -46.48 101.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.645 2.23 . . . . 74.150000000000006 112.354 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.43 163.76 12.68 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.746 . . . . 70.409999999999997 112.516 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -127.52 138.43 52.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.91 0.386 . . . . 71.310000000000002 110.847 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -135.92 151.95 50.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 73.120000000000005 110.891 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 97.4 p -133.45 81.8 1.95 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 71.239999999999995 110.857 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.6 m -85.97 160.98 19.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 73.420000000000002 110.836 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.71 HG12 ' HB ' ' A' ' 36' ' ' ILE . 6.2 m -152.9 20.45 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 65.239999999999995 111.171 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -178.07 53.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 73.209999999999994 110.935 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.65 -35.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 74.310000000000002 110.851 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.97 -64.29 0.86 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 65.319999999999993 111.113 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 179.08 83.55 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.761 -0.733 . . . . 75.439999999999998 112.498 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.59 67.49 24.34 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.604 0.716 . . . . 73.409999999999997 111.171 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -80.3 -50.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.631 2.221 . . . . 74.319999999999993 112.342 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -179.56 -36.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 70.040000000000006 110.888 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -179.36 55.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 61.240000000000002 110.864 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.5 t -97.34 166.55 11.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 72.430000000000007 110.855 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.6 mt -106.16 153.51 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 73.230000000000004 111.167 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.2 p -149.98 155.91 40.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 73.239999999999995 110.835 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.38 158.15 29.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 74.140000000000001 110.839 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.548 ' CE1' ' HB2' ' A' ' 28' ' ' ALA . 2.6 p90 -150.48 135.41 17.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 75.5 110.867 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -95.1 130.8 41.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 63.130000000000003 110.833 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.668 ' HG3' HG21 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -97.28 131.64 43.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.464 . . . . 71.439999999999998 110.894 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.9 pt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 71.409999999999997 111.121 179.985 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.063 0 CA-C-O 120.831 0.348 . . . . 73.340000000000003 110.869 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.49 157.21 47.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 62.119999999999997 110.841 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.93 61.54 0.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 70.319999999999993 111.137 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -85.0 170.51 12.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 44.119999999999997 111.046 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.18 105.49 17.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 71.329999999999998 110.86 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.743 HG22 ' CZ2' ' A' ' 46' ' ' TRP . 98.5 t -110.32 116.03 51.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 60.109999999999999 111.169 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.728 HG23 ' HB3' ' A' ' 40' ' ' LYS . 7.9 tt -115.7 110.39 31.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 60.0 111.101 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 72.2 t -128.68 137.1 58.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 64.549999999999997 111.162 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -88.62 138.38 31.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.461 . . . . 75.439999999999998 110.949 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -96.0 47.85 1.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 61.5 110.846 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 173.29 -170.41 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 71.409999999999997 110.874 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 13' ' ' ASN . 4.9 t -64.61 161.51 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 75.400000000000006 111.092 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.461 ' N ' HG12 ' A' ' 12' ' ' VAL . 5.8 p30 -86.76 53.66 2.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 62.219999999999999 110.896 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.438 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.52 29.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 74.230000000000004 110.883 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.94 49.72 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.754 -0.736 . . . . 41.039999999999999 112.504 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.07 171.59 24.49 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.702 -0.761 . . . . 72.329999999999998 112.445 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.06 162.94 14.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.771 0.319 . . . . 75.040000000000006 110.903 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.0 p -145.1 153.52 41.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 41.299999999999997 110.879 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -142.27 119.82 11.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 72.450000000000003 110.887 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -102.33 41.05 1.26 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 64.430000000000007 110.802 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.43 -168.39 1.69 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 53.329999999999998 111.144 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.48 -169.58 1.97 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 74.010000000000005 111.125 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.3 m -83.51 4.36 28.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 75.439999999999998 110.851 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -84.48 -7.97 59.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 73.540000000000006 110.872 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.8 155.42 75.58 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.589 0.709 . . . . 64.420000000000002 110.893 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.13 75.83 2.73 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.625 2.216 . . . . 72.549999999999997 112.37 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.6 -69.19 1.42 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.746 -0.74 . . . . 44.210000000000001 112.48 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.513 ' HB1' ' OG ' ' A' ' 81' ' ' SER . . . -60.35 -171.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.345 . . . . 74.230000000000004 111.096 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.28 57.69 0.59 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.751 -0.738 . . . . 53.030000000000001 112.509 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -98.15 -169.96 1.89 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.358 . . . . 73.200000000000003 110.837 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -169.45 -170.73 1.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 72.230000000000004 110.834 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.64 106.58 0.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 43.439999999999998 110.922 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 51.91 50.82 17.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 71.450000000000003 110.893 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.87 39.65 3.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 73.409999999999997 110.813 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.17 102.64 4.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 65.209999999999994 110.931 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 69' ' ' VAL . 1.1 pt -153.36 103.91 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 73.439999999999998 111.136 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 78.7 p -167.74 -166.78 0.78 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 65.329999999999998 110.861 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.579 ' C ' HD12 ' A' ' 39' ' ' ILE . 0.7 OUTLIER -111.69 148.46 33.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 73.439999999999998 110.869 -179.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.579 HD12 ' C ' ' A' ' 38' ' ' SER . 1.6 mp -120.85 127.77 75.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 52.140000000000001 111.164 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.728 ' HB3' HG23 ' A' ' 7' ' ' ILE . 1.0 OUTLIER -126.82 133.18 50.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 75.019999999999996 110.924 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.541 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 8.4 p -143.55 139.02 26.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 74.109999999999999 111.167 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.6 mmpp? -142.77 40.27 1.53 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 74.010000000000005 110.879 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.49 135.04 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 73.510000000000005 110.89 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.14 -159.49 2.78 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.777 -0.725 . . . . 72.030000000000001 112.465 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.1 p -145.43 151.3 38.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.799 0.333 . . . . 54.350000000000001 111.133 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.743 ' CZ2' HG22 ' A' ' 6' ' ' VAL . 2.0 m0 -124.2 175.36 7.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 64.219999999999999 110.898 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.578 ' HD2' HD11 ' A' ' 85' ' ' ILE . 1.7 mpt_? -121.48 120.54 35.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 74.530000000000001 110.904 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -107.28 126.23 52.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 75.019999999999996 110.857 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.83 142.99 36.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 73.120000000000005 110.915 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.03 88.36 2.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 44.340000000000003 110.883 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.433 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 172.01 -169.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 75.400000000000006 110.921 -179.831 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 30.1 pt -69.82 172.62 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.106 -0.497 . . . . 54.399999999999999 111.127 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -78.05 56.37 1.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 72.319999999999993 110.889 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -150.93 -40.56 0.12 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.475 . . . . 73.219999999999999 110.927 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.43 -143.89 3.88 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.704 -0.76 . . . . 61.219999999999999 112.476 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.433 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 108.11 176.18 22.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.781 -0.723 . . . . 52.450000000000003 112.506 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.03 104.78 3.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.785 0.326 . . . . 71.200000000000003 110.826 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -76.54 107.49 8.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 75.099999999999994 110.888 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -138.13 106.3 5.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 70.239999999999995 110.958 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -88.83 140.52 29.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.261 -0.427 . . . . 61.119999999999997 110.843 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.542 HD21 ' CE3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -99.3 156.82 16.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 64.310000000000002 110.934 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -131.54 -173.17 13.27 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.699 -0.762 . . . . 54.310000000000002 112.509 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -46.21 101.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.691 2.261 . . . . 71.409999999999997 112.307 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 158.74 157.39 8.47 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.713 -0.756 . . . . 62.420000000000002 112.457 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -117.68 148.24 42.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.83 0.348 . . . . 71.540000000000006 110.909 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -160.28 160.06 32.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.161 -0.472 . . . . 61.409999999999997 110.925 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.2 p -115.22 80.27 1.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.092 -0.504 . . . . 63.340000000000003 110.871 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.817 ' HB2' ' HB2' ' A' ' 72' ' ' ALA . 14.7 m -86.26 84.69 7.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 73.049999999999997 110.881 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.493 ' O ' HG22 ' A' ' 36' ' ' ILE . 12.2 m -89.89 -6.3 10.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.492 . . . . 55.219999999999999 111.156 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -162.62 62.53 0.21 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.487 . . . . 64.109999999999999 110.902 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.68 -34.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 53.310000000000002 110.877 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.817 ' HB2' ' HB2' ' A' ' 68' ' ' SER . . . -50.82 -47.85 59.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 62.32 111.107 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.643 ' H ' HD13 ' A' ' 74' ' ' ILE . . . -178.25 40.4 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.668 -0.777 . . . . 71.519999999999996 112.424 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.643 HD13 ' H ' ' A' ' 73' ' ' GLY . 0.0 OUTLIER -133.48 67.66 76.02 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.625 0.726 . . . . 72.329999999999998 111.156 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -81.77 -70.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.682 2.255 . . . . 74.109999999999999 112.329 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.473 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 1.9 t0 -94.17 -0.47 55.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 74.439999999999998 110.901 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 76' ' ' ASP . 5.6 m-20 81.07 89.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 73.340000000000003 110.844 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.9 m -146.04 -169.93 3.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 72.299999999999997 110.866 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.1 mt -76.23 153.31 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 65.329999999999998 111.162 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.6 t -149.05 157.42 43.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 73.129999999999995 110.872 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.513 ' OG ' ' HB1' ' A' ' 28' ' ' ALA . 0.3 OUTLIER -162.37 159.54 25.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 43.039999999999999 110.89 -179.795 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -150.83 136.12 17.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 60.409999999999997 110.887 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -87.44 121.62 30.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 73.349999999999994 110.926 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -79.7 93.41 5.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 75.439999999999998 110.96 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.578 HD11 ' HD2' ' A' ' 47' ' ' ARG . 1.8 pt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.438 . . . . 75.209999999999994 111.159 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 ttm . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.787 0.327 . . . . 71.430000000000007 110.904 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.33 163.01 24.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 62.399999999999999 110.849 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -165.4 66.19 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 41.009999999999998 111.111 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -148.83 94.33 2.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.463 . . . . 62.32 111.075 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.96 121.06 28.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 71.439999999999998 110.884 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.4 m -116.28 138.15 47.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 73.299999999999997 111.1 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.815 HG23 ' HB3' ' A' ' 40' ' ' LYS . 3.6 tp -101.18 110.05 27.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 72.530000000000001 111.141 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.6 t -129.89 140.83 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 42.310000000000002 111.133 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -93.43 138.83 31.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 73.319999999999993 110.94 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -93.47 42.39 1.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 73.329999999999998 110.842 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 175.13 -169.5 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 73.030000000000001 110.842 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 13' ' ' ASN . 5.8 t -64.1 160.61 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 75.040000000000006 111.122 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.442 ' N ' HG12 ' A' ' 12' ' ' VAL . 14.1 t30 -86.44 53.89 2.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 61.229999999999997 110.871 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.444 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.23 28.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 64.109999999999999 110.903 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.0 50.34 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.764 -0.731 . . . . 71.049999999999997 112.516 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.15 171.71 23.79 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.772 -0.728 . . . . 53.43 112.54 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.51 149.84 23.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.822 0.344 . . . . 72.549999999999997 110.848 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -131.32 141.62 49.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 62.509999999999998 110.895 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -136.44 152.3 50.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 74.430000000000007 110.861 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -140.93 77.57 1.6 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 71.549999999999997 110.856 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.43 152.86 28.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 44.009999999999998 111.137 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.5 p -94.3 45.03 1.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 55.200000000000003 111.14 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.55 -172.05 1.36 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 73.25 110.886 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.42 108.38 1.32 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 75.310000000000002 110.869 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.92 162.58 61.79 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.581 0.705 . . . . 65.030000000000001 110.903 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -47.92 105.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.687 2.258 . . . . 71.510000000000005 112.375 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.52 174.75 0.36 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.797 -0.716 . . . . 72.519999999999996 112.502 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.587 ' HB3' ' HA ' ' A' ' 81' ' ' SER . . . -60.07 -172.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.852 0.358 . . . . 44.039999999999999 111.051 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.54 112.01 2.41 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.777 -0.725 . . . . 44.140000000000001 112.493 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.03 -170.06 2.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.772 0.32 . . . . 63.140000000000001 110.885 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.08 179.24 0.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 64.549999999999997 110.923 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.2 mp -81.57 123.19 28.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.169 -0.469 . . . . 74.340000000000003 110.911 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 52.05 64.9 1.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 74.540000000000006 110.864 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -175.32 48.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 74.239999999999995 110.882 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.79 103.1 4.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 75.200000000000003 110.879 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.434 ' HB ' HG12 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -147.43 124.12 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 74.129999999999995 111.124 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.6 p -167.48 -168.34 1.02 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 54.219999999999999 110.844 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.515 ' C ' HD12 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -127.44 158.14 38.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 45.310000000000002 110.844 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.515 HD12 ' C ' ' A' ' 38' ' ' SER . 2.5 mp -120.92 140.07 46.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 54.0 111.154 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.815 ' HB3' HG23 ' A' ' 7' ' ' ILE . 15.1 tttt -130.05 119.53 23.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 64.340000000000003 110.83 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.647 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 4.9 p -114.12 139.28 40.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 65.239999999999995 111.104 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.86 39.69 1.82 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 73.219999999999999 110.928 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.2 114.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 64.019999999999996 110.871 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 60.65 -143.06 48.19 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.733 -0.746 . . . . 65.230000000000004 112.51 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.475 HG22 ' HA2' ' A' ' 62' ' ' GLY . 67.9 p -150.1 154.79 38.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.793 0.33 . . . . 55.530000000000001 111.14 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.647 ' CZ2' HG23 ' A' ' 41' ' ' VAL . 1.7 m0 -124.31 176.95 6.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.432 . . . . 74.329999999999998 110.908 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -126.49 130.8 51.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 74.540000000000006 110.84 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -115.33 126.34 54.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 75.329999999999998 110.897 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.9 126.78 20.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 73.120000000000005 110.948 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -102.89 89.56 3.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 71.430000000000007 110.902 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.472 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.1 OUTLIER 171.44 -166.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.191 -0.459 . . . . 63.420000000000002 110.959 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.401 HG13 ' H ' ' A' ' 52' ' ' ILE . 1.0 OUTLIER -52.19 173.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 55.439999999999998 111.112 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -86.32 50.15 1.93 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 74.430000000000007 110.914 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 22.3 p90 176.89 41.14 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.471 . . . . 75.439999999999998 110.946 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 165.1 -155.97 27.68 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.722 -0.752 . . . . 25.440000000000001 112.47 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.472 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 96.13 -171.33 28.26 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.724 -0.75 . . . . 74.129999999999995 112.469 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -80.93 108.68 14.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.869 0.366 . . . . 72.239999999999995 110.878 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -78.19 109.31 12.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 73.439999999999998 110.911 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -138.18 108.1 6.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 73.349999999999994 110.89 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -94.93 152.87 17.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 73.430000000000007 110.884 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.641 HD11 ' CE3' ' A' ' 46' ' ' TRP . 1.5 pt? -116.09 138.48 51.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 75.5 110.934 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.475 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -111.21 -170.14 19.05 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.729 -0.748 . . . . 43.420000000000002 112.461 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -46.99 99.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.628 2.219 . . . . 65.040000000000006 112.357 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.46 169.09 19.49 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.742 . . . . 72.510000000000005 112.544 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -99.5 146.22 26.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 62.210000000000001 110.875 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -130.38 151.57 50.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 73.439999999999998 110.883 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.5 t -119.11 93.23 4.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.087 -0.506 . . . . 55.25 110.846 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.814 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 0.7 OUTLIER -84.95 94.61 8.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.091 -0.504 . . . . 75.129999999999995 110.813 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.434 HG12 ' HB ' ' A' ' 36' ' ' ILE . 35.8 m -150.6 32.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.492 . . . . 71.150000000000006 111.119 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.449 ' HA ' HD11 ' A' ' 74' ' ' ILE . 1.1 pt-20 -171.41 30.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.463 . . . . 72.099999999999994 110.904 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.47 -67.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 71.310000000000002 110.881 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.814 ' HB3' ' HB3' ' A' ' 68' ' ' SER . . . -74.51 -34.85 63.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 72.450000000000003 111.107 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -65.8 -48.0 70.71 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.726 -0.749 . . . . 74.420000000000002 112.448 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.449 HD11 ' HA ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -113.88 74.17 2.49 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.604 0.716 . . . . 73.420000000000002 111.148 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.18 -49.06 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.681 2.254 . . . . 75.329999999999998 112.38 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -175.26 -62.5 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 73.420000000000002 110.859 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -142.09 -95.68 0.13 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 73.430000000000007 110.885 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.85 52.05 1.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 62.409999999999997 110.885 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.69 85.77 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.087 -0.506 . . . . 63.009999999999998 111.14 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 79.2 p -163.19 154.07 16.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.459 . . . . 73.109999999999999 110.868 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.587 ' HA ' ' HB3' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -165.53 160.76 18.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 72.239999999999995 110.832 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -150.16 135.77 18.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 75.310000000000002 110.89 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.436 ' NH1' HD13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -91.1 120.37 32.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 75.409999999999997 110.879 -179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -86.83 98.82 11.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 65.129999999999995 110.927 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.436 HD13 ' NH1' ' A' ' 83' ' ' ARG . 1.1 pt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 75.109999999999999 111.119 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mtp . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.794 0.331 . . . . 71.219999999999999 110.885 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -111.32 124.63 52.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 64.510000000000005 110.836 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.85 57.04 0.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 71.030000000000001 111.122 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -154.23 44.12 0.55 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 63.219999999999999 111.113 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -87.32 96.28 10.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.226 -0.443 . . . . 72.420000000000002 110.897 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.8 m -117.16 138.51 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 75.349999999999994 111.114 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.764 HG23 ' HB3' ' A' ' 40' ' ' LYS . 6.8 tt -99.49 110.38 26.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 73.450000000000003 111.121 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 m -122.89 159.73 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 64.010000000000005 111.134 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -111.66 139.94 46.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.162 -0.472 . . . . 71.530000000000001 110.914 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -100.1 28.51 4.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 61.409999999999997 110.895 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 175.87 -169.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 64.310000000000002 110.836 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 13' ' ' ASN . 10.8 t -62.98 157.37 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 54.450000000000003 111.094 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.415 ' N ' HG12 ' A' ' 12' ' ' VAL . 17.8 p30 -83.22 54.88 2.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 72.25 110.905 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.443 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -177.34 27.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 75.200000000000003 110.886 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.24 45.63 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.76 -0.733 . . . . 65.120000000000005 112.493 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.27 173.68 23.67 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.778 -0.725 . . . . 64.310000000000002 112.512 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.62 146.17 26.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.821 0.343 . . . . 51.119999999999997 110.866 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.0 p -117.15 162.89 17.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 70.319999999999993 110.834 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -118.55 135.81 54.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 74.030000000000001 110.901 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.4 p30 -147.2 42.13 1.09 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 73.129999999999995 110.876 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.57 158.7 25.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 75.349999999999994 111.111 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.1 m -138.68 70.85 1.38 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.456 . . . . 63.299999999999997 111.105 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.6 m -155.86 -82.6 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 61.450000000000003 110.872 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -179.14 101.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 74.430000000000007 110.881 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -80.16 161.94 63.54 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.598 0.713 . . . . 64.219999999999999 110.912 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.53 -170.54 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.715 2.277 . . . . 61.219999999999999 112.335 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.91 -98.41 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.749 -0.738 . . . . 34.439999999999998 112.44 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.554 ' HB2' ' CE1' ' A' ' 82' ' ' PHE . . . -173.84 154.7 2.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 70.340000000000003 111.063 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 177.3 155.97 14.99 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.729 -0.748 . . . . 60.119999999999997 112.457 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -174.74 -169.78 0.44 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.814 0.34 . . . . 75.030000000000001 110.852 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.0 167.67 6.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 64.439999999999998 110.923 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.694 HD23 ' O ' ' A' ' 76' ' ' ASP . 5.2 mp -65.12 -87.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 61.439999999999998 110.852 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -95.11 70.33 3.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 72.310000000000002 110.88 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -154.13 59.53 0.71 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 54.32 110.856 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.74 119.62 39.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 73.420000000000002 110.862 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.408 ' CB ' HG23 ' A' ' 69' ' ' VAL . 3.9 tt -174.14 102.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 72.019999999999996 111.143 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.4 p -169.21 -167.53 0.73 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 74.120000000000005 110.845 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.565 ' C ' HD12 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -127.36 152.0 48.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.102 -0.499 . . . . 55.509999999999998 110.835 -179.815 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.565 HD12 ' C ' ' A' ' 38' ' ' SER . 1.6 mp -120.99 137.93 53.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 75.519999999999996 111.153 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.764 ' HB3' HG23 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -137.35 119.69 15.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.467 . . . . 65.319999999999993 110.909 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.59 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 4.1 p -109.11 139.08 33.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 54.219999999999999 111.168 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.05 39.55 2.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 71.019999999999996 110.859 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.64 110.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.435 . . . . 55.219999999999999 110.859 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 56.99 -142.13 42.32 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.689 -0.767 . . . . 74.430000000000007 112.47 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.765 HG22 ' HA2' ' A' ' 62' ' ' GLY . 49.5 p -144.86 160.21 41.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.764 0.316 . . . . 54.409999999999997 111.14 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.712 ' CE3' HD11 ' A' ' 61' ' ' LEU . 1.7 m0 -123.22 -179.99 4.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 75.140000000000001 110.866 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.26 115.84 16.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 74.030000000000001 110.899 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -100.68 127.89 46.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 75.319999999999993 110.896 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.14 126.28 19.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 71.010000000000005 110.93 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -103.05 89.62 3.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 70.430000000000007 110.85 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.445 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 173.81 -171.82 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 72.209999999999994 110.904 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.6 tp -57.6 160.64 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 73.329999999999998 111.123 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -74.95 55.5 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 75.349999999999994 110.88 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -153.93 -38.27 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 74.140000000000001 110.892 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -146.61 -140.4 3.44 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 74.129999999999995 112.491 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.445 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 106.93 -175.33 20.61 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.764 -0.731 . . . . 62.439999999999998 112.51 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.7 106.48 7.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 71.510000000000005 110.873 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -79.52 109.23 13.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 73.219999999999999 110.937 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -138.07 108.32 6.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.084 -0.507 . . . . 72.219999999999999 110.951 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.66 157.37 16.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.286 -0.415 . . . . 71.299999999999997 110.87 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.712 HD11 ' CE3' ' A' ' 46' ' ' TRP . 1.6 pt? -121.36 153.98 37.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 74.200000000000003 110.916 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.765 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -121.12 179.32 16.32 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.751 -0.737 . . . . 62.210000000000001 112.496 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -43.97 104.82 0.06 OUTLIER 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.674 2.249 . . . . 72.540000000000006 112.35 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.52 162.59 11.43 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.731 -0.747 . . . . 72.519999999999996 112.488 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -81.11 174.0 12.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.843 0.354 . . . . 72.439999999999998 110.894 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -160.89 99.65 1.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 74.239999999999995 110.895 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.1 p -97.46 65.65 1.95 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.08 -0.509 . . . . 62.310000000000002 110.865 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.6 p -86.93 152.19 22.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 65.219999999999999 110.859 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 69' ' ' VAL . 6.1 p -163.61 23.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.113 -0.494 . . . . 62.229999999999997 111.114 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 177.25 35.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 50.329999999999998 110.908 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.95 -40.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 62.310000000000002 110.863 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.29 -50.1 70.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.1 -0.5 . . . . 75.409999999999997 111.091 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.443 ' C ' ' HD3' ' A' ' 75' ' ' PRO . . . 165.95 101.26 0.15 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 44.329999999999998 112.492 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.1 mm -113.29 74.83 2.11 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.604 0.716 . . . . 64.519999999999996 111.144 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.443 ' HD3' ' C ' ' A' ' 73' ' ' GLY . 70.1 Cg_endo -79.48 -165.62 0.35 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.665 2.243 . . . . 63.420000000000002 112.311 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.694 ' O ' HD23 ' A' ' 32' ' ' LEU . 3.7 m-20 -145.23 40.58 1.23 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.436 . . . . 72.209999999999994 110.853 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -175.9 -171.63 0.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 64.230000000000004 110.866 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 61.8 p -97.24 81.55 3.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 70.040000000000006 110.863 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -152.07 66.98 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 71.420000000000002 111.122 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 91.5 p -166.28 145.66 5.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 72.420000000000002 110.848 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.455 ' HA ' ' HB3' ' A' ' 28' ' ' ALA . 0.7 OUTLIER -163.93 165.62 22.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 74.430000000000007 110.804 -179.816 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.554 ' CE1' ' HB2' ' A' ' 28' ' ' ALA . 4.4 p90 -150.6 143.03 24.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 61.509999999999998 110.871 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -79.91 171.98 14.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 75.329999999999998 110.87 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -148.04 105.94 3.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 65.349999999999994 110.907 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.6 pt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 74.150000000000006 111.147 179.947 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mtt . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.75 0.309 . . . . 71.049999999999997 110.889 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -97.65 135.7 39.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 54.399999999999999 110.942 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.91 95.32 8.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 73.299999999999997 111.115 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -167.5 141.87 3.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 52.210000000000001 111.138 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -88.16 96.26 10.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 75.349999999999994 110.853 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.791 HG13 ' CH2' ' A' ' 46' ' ' TRP . 61.1 t -112.06 119.8 60.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 72.510000000000005 111.135 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.762 HG23 ' HB3' ' A' ' 40' ' ' LYS . 7.9 tt -123.76 110.19 25.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 51.530000000000001 111.111 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.0 m -126.82 142.25 43.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 75.319999999999993 111.102 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -92.26 141.6 28.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.177 -0.465 . . . . 71.109999999999999 110.923 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -96.42 44.37 1.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 74.230000000000004 110.91 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 172.95 -170.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 70.099999999999994 110.829 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 13' ' ' ASN . 5.1 t -64.47 161.27 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 73.5 111.129 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.46 ' N ' HG12 ' A' ' 12' ' ' VAL . 8.4 p-10 -86.75 53.74 2.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 60.420000000000002 110.919 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.445 ' CG ' ' O ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.41 28.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 74.099999999999994 110.879 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.88 47.11 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.762 -0.732 . . . . 54.329999999999998 112.492 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.08 171.61 24.48 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.711 -0.757 . . . . 63.420000000000002 112.506 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 ptpt -92.64 164.11 13.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.794 0.33 . . . . 72.120000000000005 110.91 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.0 p -138.98 160.33 40.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 55.340000000000003 110.833 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -121.1 110.11 15.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 72.200000000000003 110.86 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.92 48.38 0.97 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 61.340000000000003 110.838 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -98.27 149.12 22.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 72.310000000000002 111.119 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.1 m -92.36 43.69 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 63.399999999999999 111.095 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.57 -176.12 5.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 70.140000000000001 110.875 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -73.39 109.72 7.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.142 -0.481 . . . . 71.319999999999993 110.876 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.11 162.6 61.25 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.604 0.716 . . . . 73.340000000000003 110.897 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.23 106.17 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.703 2.269 . . . . 62.310000000000002 112.334 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.43 167.02 1.01 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.704 -0.76 . . . . 70.319999999999993 112.5 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.06 67.9 3.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.804 0.335 . . . . 74.230000000000004 111.094 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.24 -47.01 2.48 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.75 -0.738 . . . . 64.400000000000006 112.493 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.596 ' O ' ' CB ' ' A' ' 31' ' ' ASN . 12.9 m-20 -65.77 -171.36 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.814 0.34 . . . . 74.420000000000002 110.887 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.596 ' CB ' ' O ' ' A' ' 30' ' ' ASP . 2.2 t-20 90.88 175.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 74.439999999999998 110.874 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -153.6 63.7 0.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 70.109999999999999 110.896 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 53.5 t30 62.77 25.44 15.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 73.530000000000001 110.858 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -140.13 46.4 1.84 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 74.439999999999998 110.935 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.81 133.47 34.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 64.319999999999993 110.884 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.495 ' HA ' HG12 ' A' ' 69' ' ' VAL . 1.1 pt -152.46 118.08 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 74.409999999999997 111.091 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.8 p -167.54 -164.46 0.58 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 63.119999999999997 110.859 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.591 ' O ' HD12 ' A' ' 39' ' ' ILE . 0.7 OUTLIER -118.13 150.32 39.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 73.530000000000001 110.882 -179.836 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.591 HD12 ' O ' ' A' ' 38' ' ' SER . 1.5 mp -121.57 117.0 51.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 70.099999999999994 111.142 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.762 ' HB3' HG23 ' A' ' 7' ' ' ILE . 4.2 tttp -113.75 127.81 56.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 74.450000000000003 110.913 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.785 HG13 ' CZ2' ' A' ' 46' ' ' TRP . 6.2 t -122.33 139.31 49.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 74.109999999999999 111.134 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -151.99 39.76 0.62 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 74.140000000000001 110.893 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.5 t 179.48 115.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 71.239999999999995 110.863 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 51.74 -153.84 5.08 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.72 -0.752 . . . . 55.310000000000002 112.497 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.801 HG22 ' HA2' ' A' ' 62' ' ' GLY . 37.7 p -138.07 158.15 44.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.774 0.321 . . . . 62.210000000000001 111.113 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.791 ' CH2' HG13 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -125.12 170.84 10.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 74.109999999999999 110.942 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -115.44 126.42 54.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 73.319999999999993 110.892 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -112.14 127.15 55.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 72.140000000000001 110.88 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.26 137.41 34.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 71.209999999999994 110.937 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -112.25 87.9 2.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 60.039999999999999 110.867 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.417 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 170.45 -171.74 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.18 -0.463 . . . . 71.329999999999998 110.936 -179.862 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.4 pt -55.0 174.35 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 61.119999999999997 111.107 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -87.63 37.84 0.81 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 71.049999999999997 110.878 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -151.86 18.67 0.69 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 72.109999999999999 110.923 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.05 -154.51 23.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 50.100000000000001 112.517 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.417 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 106.9 178.93 22.81 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.746 -0.74 . . . . 61.240000000000002 112.494 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.85 103.75 6.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.35 . . . . 61.039999999999999 110.868 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -76.67 110.37 11.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 70.230000000000004 110.92 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -138.11 105.82 5.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.126 -0.488 . . . . 73.349999999999994 110.925 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -90.46 133.58 34.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 44.240000000000002 110.893 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.616 HD21 ' CE3' ' A' ' 46' ' ' TRP . 0.8 OUTLIER -99.06 165.02 11.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 72.510000000000005 110.885 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.801 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -128.7 -166.46 11.98 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.779 -0.724 . . . . 70.319999999999993 112.518 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.67 118.05 4.88 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.688 2.259 . . . . 55.210000000000001 112.313 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.96 156.31 7.76 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.797 -0.716 . . . . 61.32 112.53 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -117.99 139.17 51.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 73.409999999999997 110.892 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.597 ' OH ' HD12 ' A' ' 61' ' ' LEU . 2.9 p90 -160.2 160.12 32.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.115 -0.493 . . . . 64.530000000000001 110.896 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.5 m -112.43 81.7 1.52 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.053 -0.521 . . . . 65.420000000000002 110.844 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.2 m -84.98 149.03 25.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 65.329999999999998 110.874 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.495 HG12 ' HA ' ' A' ' 36' ' ' ILE . 6.0 m -152.99 22.55 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 62.149999999999999 111.129 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.435 ' HA ' HD11 ' A' ' 74' ' ' ILE . 0.9 OUTLIER -165.45 60.31 0.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 62.350000000000001 110.871 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.56 -33.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 73.200000000000003 110.89 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.3 -63.81 1.0 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 62.140000000000001 111.092 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.7 79.89 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 72.430000000000007 112.486 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.435 HD11 ' HA ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -140.69 67.23 29.16 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.62 0.724 . . . . 72.349999999999994 111.136 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -80.31 -35.3 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.655 2.237 . . . . 74.299999999999997 112.343 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -179.2 -34.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 63.009999999999998 110.877 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -140.67 164.83 29.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 74.019999999999996 110.864 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.557 ' O ' HD13 ' A' ' 79' ' ' ILE . 12.2 t -68.3 87.38 0.29 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 72.120000000000005 110.855 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.557 HD13 ' O ' ' A' ' 78' ' ' SER . 26.1 mm -139.03 68.51 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 71.25 111.145 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.8 p -146.83 165.17 30.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 61.340000000000003 110.837 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.6 157.73 14.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 65.510000000000005 110.849 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -150.8 136.57 18.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.126 -0.488 . . . . 64.140000000000001 110.901 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.69 120.09 32.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 63.350000000000001 110.815 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.73 ' HG2' HG11 ' A' ' 6' ' ' VAL . 4.4 mt-30 -79.4 97.67 6.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 73.540000000000006 110.936 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 pt . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 72.010000000000005 111.101 179.995 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.2 mtm . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.822 0.344 . . . . 75.129999999999995 110.909 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -101.37 155.51 18.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 63.329999999999998 110.893 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -163.67 113.99 1.32 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 64.150000000000006 111.116 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -169.85 119.73 0.64 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 74.420000000000002 111.137 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -84.99 96.45 9.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 62.109999999999999 110.86 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.798 HG11 ' HG2' ' A' ' 84' ' ' GLN . 84.2 t -109.02 120.04 59.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 75.109999999999999 111.15 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.441 HG23 ' O ' ' A' ' 7' ' ' ILE . 9.0 tt -128.84 111.54 23.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 65.310000000000002 111.107 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 m -131.21 161.56 40.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 73.319999999999993 111.12 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -114.21 148.29 37.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 64.230000000000004 110.937 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -102.24 40.68 1.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 72.420000000000002 110.897 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 172.79 -171.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 73.129999999999995 110.893 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.446 HG12 ' N ' ' A' ' 13' ' ' ASN . 6.1 t -63.97 160.15 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.429 . . . . 73.439999999999998 111.134 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.446 ' N ' HG12 ' A' ' 12' ' ' VAL . 7.7 t30 -85.79 53.96 2.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 74.129999999999995 110.903 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.419 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.25 28.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 71.530000000000001 110.878 -179.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.02 44.38 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.772 -0.728 . . . . 63.130000000000003 112.477 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.02 172.04 24.28 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.765 -0.731 . . . . 33.130000000000003 112.484 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.33 160.33 14.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.793 0.33 . . . . 72.25 110.87 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.1 p -136.37 164.56 27.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 73.040000000000006 110.838 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -123.14 113.91 19.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 63.030000000000001 110.871 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -127.37 67.38 1.3 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 74.439999999999998 110.866 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.78 150.96 23.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 72.099999999999994 111.096 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.6 p -93.89 40.06 1.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 43.439999999999998 111.153 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.8 m -93.94 20.3 7.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 65.129999999999995 110.855 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.2 t0 59.77 96.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 63.329999999999998 110.88 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 -80.06 162.34 62.32 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.654 0.74 . . . . 73.150000000000006 110.841 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -73.05 -170.91 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.7 2.266 . . . . 64.200000000000003 112.316 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.37 167.85 43.59 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.772 -0.727 . . . . 51.049999999999997 112.465 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.11 107.67 19.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.883 0.373 . . . . 54.229999999999997 111.071 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.41 86.39 1.82 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.771 -0.728 . . . . 74.319999999999993 112.466 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -141.88 30.11 1.66 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.813 0.34 . . . . 74.450000000000003 110.887 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 -130.88 -86.61 0.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 72.120000000000005 110.871 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.71 176.55 10.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 72.349999999999994 110.906 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -63.17 98.8 0.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 74.340000000000003 110.865 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -171.28 59.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 61.119999999999997 110.853 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.13 113.15 19.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 74.420000000000002 110.861 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.486 HG13 HG12 ' A' ' 69' ' ' VAL . 1.5 tt -176.77 107.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 72.530000000000001 111.151 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 83.3 p -167.88 -166.14 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 74.120000000000005 110.909 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.656 ' O ' HD12 ' A' ' 39' ' ' ILE . 0.8 OUTLIER -114.57 141.49 47.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 71.329999999999998 110.885 -179.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.656 HD12 ' O ' ' A' ' 38' ' ' SER . 1.6 mp -124.71 118.16 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 42.329999999999998 111.092 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -123.61 135.02 53.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 73.140000000000001 110.888 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.775 HG13 ' CZ2' ' A' ' 46' ' ' TRP . 4.7 t -129.17 139.57 51.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 72.329999999999998 111.143 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.99 39.35 1.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 70.209999999999994 110.907 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.8 t 177.84 120.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 70.310000000000002 110.851 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.14 -152.94 6.21 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.747 -0.74 . . . . 72.450000000000003 112.446 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.6 HG22 ' HA2' ' A' ' 62' ' ' GLY . 42.6 p -142.4 159.37 42.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.345 . . . . 53.530000000000001 111.139 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.775 ' CZ2' HG13 ' A' ' 41' ' ' VAL . 1.5 m0 -123.78 176.55 6.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 71.299999999999997 110.916 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -123.84 122.03 36.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 61.229999999999997 110.86 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -107.55 125.87 51.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 75.25 110.857 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.28 126.91 20.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 73.230000000000004 110.888 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -100.69 89.91 4.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 65.519999999999996 110.864 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.472 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.1 OUTLIER 170.76 -167.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 75.510000000000005 110.921 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -52.26 173.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.478 . . . . 74.420000000000002 111.15 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -86.56 50.28 1.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 65.200000000000003 110.874 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 22.2 p90 176.98 40.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 65.439999999999998 110.903 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.92 -157.71 30.26 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.747 -0.74 . . . . 63.340000000000003 112.533 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.472 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 95.42 -171.59 29.5 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.742 -0.742 . . . . 72.099999999999994 112.488 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.51 106.77 11.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.816 0.341 . . . . 72.129999999999995 110.896 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -77.72 109.47 11.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 70.129999999999995 110.883 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.9 t90 -138.04 105.38 5.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.115 -0.493 . . . . 71.540000000000006 110.892 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -89.41 135.61 33.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 64.329999999999998 110.91 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.592 HD21 ' CE3' ' A' ' 46' ' ' TRP . 0.8 OUTLIER -98.99 164.71 12.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.222 -0.445 . . . . 64.340000000000003 110.955 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.6 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -130.54 -174.92 13.82 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.745 -0.741 . . . . 62.409999999999997 112.52 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.54 117.04 3.26 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.708 2.272 . . . . 64.519999999999996 112.287 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.84 155.48 7.47 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.742 -0.742 . . . . 61.420000000000002 112.477 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -113.63 134.93 54.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 64.439999999999998 110.871 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.474 ' OH ' HD12 ' A' ' 61' ' ' LEU . 5.3 p90 -159.48 159.98 34.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 72.299999999999997 110.922 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 m -108.26 101.41 10.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 75.510000000000005 110.916 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.93 135.21 34.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 74.5 110.822 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.486 HG12 HG13 ' A' ' 36' ' ' ILE . 22.9 m -149.81 24.26 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 73.219999999999999 111.146 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.433 ' HG2' HG23 ' A' ' 69' ' ' VAL . 0.1 OUTLIER 173.21 -16.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 71.209999999999994 110.861 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.9 t -80.76 -23.95 39.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 74.010000000000005 110.827 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -83.62 -63.62 1.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 50.020000000000003 111.108 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.582 ' C ' HD13 ' A' ' 74' ' ' ILE . . . 166.95 124.14 0.7 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.74 -0.743 . . . . 64.409999999999997 112.488 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.582 HD13 ' C ' ' A' ' 73' ' ' GLY . 4.1 mm -122.33 69.8 31.96 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.625 0.726 . . . . 73.120000000000005 111.13 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -78.72 -166.34 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.702 2.268 . . . . 72.349999999999994 112.362 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.62 -29.84 27.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 73.519999999999996 110.847 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -143.65 162.62 35.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 72.340000000000003 110.863 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.59 119.19 10.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 62.32 110.844 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.2 pt -153.36 24.61 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 70.519999999999996 111.158 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.8 t -110.76 164.57 12.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 72.349999999999994 110.869 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.2 m -165.46 157.33 14.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 65.420000000000002 110.881 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -150.67 135.88 17.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 74.549999999999997 110.846 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.0 mmt85 -90.7 120.8 32.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 74.439999999999998 110.846 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.798 ' HG2' HG11 ' A' ' 6' ' ' VAL . 23.2 mt-30 -79.55 94.38 5.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 74.310000000000002 110.875 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 75.010000000000005 111.111 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 ptt? . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.827 0.346 . . . . 62.409999999999997 110.927 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -80.0 120.54 24.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 64.010000000000005 110.848 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.95 76.0 9.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 64.129999999999995 111.076 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.458 ' HB1' ' CD1' ' A' ' 85' ' ' ILE . . . -177.45 39.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 44.450000000000003 111.092 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.54 130.6 38.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 63.130000000000003 110.88 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.758 HG13 ' CZ2' ' A' ' 46' ' ' TRP . 76.2 t -116.11 127.02 73.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 63.340000000000003 111.13 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.437 HG23 ' O ' ' A' ' 7' ' ' ILE . 7.8 tt -123.14 110.89 27.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 74.219999999999999 111.138 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.1 t -124.54 140.39 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 74.349999999999994 111.103 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -90.7 139.97 30.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 75.120000000000005 110.932 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.33 35.42 1.78 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 60.100000000000001 110.917 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 177.21 -169.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.127 -0.488 . . . . 71.439999999999998 110.871 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.446 HG12 ' N ' ' A' ' 13' ' ' ASN . 5.3 t -63.77 160.28 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.211 -0.449 . . . . 73.129999999999995 111.111 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.446 ' N ' HG12 ' A' ' 12' ' ' VAL . 44.8 t30 -86.31 54.26 3.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 64.540000000000006 110.897 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.441 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.24 28.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 74.409999999999997 110.928 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.86 52.46 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.744 -0.741 . . . . 33.140000000000001 112.516 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.2 171.72 24.49 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.788 -0.72 . . . . 44.030000000000001 112.518 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.62 126.48 42.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.813 0.339 . . . . 74.129999999999995 110.883 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 82.1 p -118.0 151.98 36.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 75.200000000000003 110.907 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -109.11 133.64 52.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 70.329999999999998 110.911 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -130.54 41.01 3.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 53.310000000000002 110.862 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.96 151.77 23.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 54.32 111.053 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.2 m -80.14 63.14 4.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.223 -0.444 . . . . 64.400000000000006 111.148 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.2 p -148.7 -82.52 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 64.299999999999997 110.826 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -77.54 60.08 2.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.495 . . . . 64.430000000000007 110.848 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -158.72 68.23 3.43 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.572 0.701 . . . . 73.120000000000005 110.964 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -70.18 -173.1 0.71 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.664 2.243 . . . . 73.099999999999994 112.385 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.28 -176.31 47.49 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.719 -0.753 . . . . 51.109999999999999 112.485 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.667 ' HB3' ' HA ' ' A' ' 81' ' ' SER . . . -90.8 73.38 6.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.85 0.357 . . . . 75.019999999999996 111.122 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.52 -99.7 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.686 -0.769 . . . . 74.519999999999996 112.493 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -78.33 65.01 3.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.861 0.363 . . . . 74.230000000000004 110.845 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -64.1 179.37 0.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 55.409999999999997 110.899 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -164.52 -177.49 4.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 74.25 110.907 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -92.07 10.62 28.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 61.439999999999998 110.909 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -106.24 40.06 1.68 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 74.439999999999998 110.86 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.06 136.47 33.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 73.299999999999997 110.911 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.449 ' O ' HG23 ' A' ' 36' ' ' ILE . 7.4 tt -152.29 102.0 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 75.25 111.135 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.9 p -171.81 -165.63 0.38 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 62.399999999999999 110.835 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.556 ' O ' HD12 ' A' ' 39' ' ' ILE . 31.3 t -128.91 156.03 44.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 72.450000000000003 110.879 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.556 HD12 ' O ' ' A' ' 38' ' ' SER . 1.5 mp -121.04 140.54 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 71.409999999999997 111.12 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -141.59 119.39 11.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 64.219999999999999 110.879 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.485 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 13.9 p -119.97 139.64 46.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 72.409999999999997 111.115 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.76 38.23 1.65 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 72.030000000000001 110.922 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 172.86 110.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.234 -0.439 . . . . 63.520000000000003 110.831 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.17 -158.22 39.87 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.729 -0.748 . . . . 71.019999999999996 112.491 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.9 p -150.68 127.58 11.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.74 0.305 . . . . 72.510000000000005 111.177 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.758 ' CZ2' HG13 ' A' ' 6' ' ' VAL . 0.5 OUTLIER -94.15 164.78 12.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 65.420000000000002 110.947 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -119.86 117.18 27.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.302 -0.408 . . . . 74.019999999999996 110.903 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -105.41 125.69 51.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 64.310000000000002 110.878 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -141.08 125.83 17.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 74.540000000000006 110.87 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.23 88.57 3.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 75.329999999999998 110.92 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 175.92 174.33 0.31 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.135 -0.484 . . . . 71.109999999999999 110.9 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.056 HG22 HD12 ' A' ' 79' ' ' ILE . 26.6 pt -52.39 172.88 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 75.5 111.111 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -76.75 56.47 1.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 64.439999999999998 110.902 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -149.92 -69.94 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 63.530000000000001 110.918 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.82 -135.97 5.83 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.738 -0.744 . . . . 70.019999999999996 112.523 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.7 176.61 23.11 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.806 -0.711 . . . . 72.219999999999999 112.472 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.36 103.32 8.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.848 0.356 . . . . 71.140000000000001 110.89 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -77.55 106.53 9.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 74.420000000000002 110.914 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -134.79 106.7 7.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.085 -0.507 . . . . 73.310000000000002 110.941 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -92.19 136.63 33.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 72.150000000000006 110.851 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.721 HD21 ' CE3' ' A' ' 46' ' ' TRP . 1.2 pp -100.26 140.91 33.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 71.319999999999993 110.936 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -122.45 -165.24 12.4 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.735 -0.745 . . . . 52.109999999999999 112.495 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -40.43 104.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.632 2.221 . . . . 73.150000000000006 112.354 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.88 164.35 13.16 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.788 -0.72 . . . . 64.239999999999995 112.539 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.08 148.49 50.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.898 0.38 . . . . 74.519999999999996 110.88 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -153.57 139.1 17.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 64.129999999999995 110.879 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.7 m -122.73 71.67 1.04 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 63.119999999999997 110.894 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 44.7 m -89.61 171.95 9.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 64.340000000000003 110.878 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.455 ' O ' HG13 ' A' ' 69' ' ' VAL . 4.2 p -162.4 23.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 61.119999999999997 111.107 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.424 ' HA ' HD11 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -174.88 35.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 71.230000000000004 110.87 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.9 t -157.81 -40.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 44.520000000000003 110.873 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.27 -61.74 1.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 72.349999999999994 111.135 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.02 94.44 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.718 -0.753 . . . . 74.120000000000005 112.483 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.424 HD11 ' HA ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -147.17 64.28 8.73 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.584 0.707 . . . . 61.530000000000001 111.152 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -80.86 -47.32 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.716 2.277 . . . . 53.520000000000003 112.316 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -174.0 -168.4 0.41 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 71.420000000000002 110.852 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -84.62 53.06 2.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 64.040000000000006 110.891 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.7 m -99.01 -169.63 1.8 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 72.049999999999997 110.831 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 1.056 HD12 HG22 ' A' ' 52' ' ' ILE . 4.8 mt -82.18 137.39 21.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 74.219999999999999 111.111 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.13 143.12 18.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 74.219999999999999 110.881 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.667 ' HA ' ' HB3' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -162.18 168.27 22.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 72.239999999999995 110.828 -179.801 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -150.82 135.6 17.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 73.129999999999995 110.879 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.0 130.62 34.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 65.099999999999994 110.884 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.748 ' HG2' HG21 ' A' ' 6' ' ' VAL . 5.8 mt-30 -79.94 108.69 13.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 75.230000000000004 110.923 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.458 ' CD1' ' HB1' ' A' ' 4' ' ' ALA . 13.3 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 51.140000000000001 111.118 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.762 0.315 . . . . 70.519999999999996 110.871 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -91.97 177.74 6.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 63.439999999999998 110.878 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -165.34 77.6 0.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 64.040000000000006 111.072 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 24' ' ' ASP . . . -167.32 108.39 0.62 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 64.319999999999993 111.137 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -89.49 104.88 17.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 63.409999999999997 110.908 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.73 HG13 ' CH2' ' A' ' 46' ' ' TRP . 87.5 t -116.77 128.46 74.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 73.409999999999997 111.142 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.716 HG23 ' HB3' ' A' ' 40' ' ' LYS . 8.9 tt -128.86 110.72 21.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 62.340000000000003 111.129 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 83.0 t -129.79 144.37 38.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 70.329999999999998 111.183 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -103.11 133.86 47.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 71.319999999999993 110.937 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -94.26 48.02 1.22 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.489 . . . . 75.400000000000006 110.86 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 174.26 -169.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 74.150000000000006 110.841 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.454 HG12 ' N ' ' A' ' 13' ' ' ASN . 4.8 t -64.83 161.23 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 73.109999999999999 111.13 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.454 ' N ' HG12 ' A' ' 12' ' ' VAL . 19.4 p-10 -87.93 54.11 2.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 75.319999999999993 110.87 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.432 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -176.96 28.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 62.130000000000003 110.837 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.41 50.67 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.749 -0.739 . . . . 60.450000000000003 112.477 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.08 171.62 24.48 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.707 -0.759 . . . . 54.409999999999997 112.455 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.38 163.46 14.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.767 0.318 . . . . 72.430000000000007 110.919 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.2 p -149.63 157.63 43.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 65.040000000000006 110.865 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -109.58 106.32 15.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 63.520000000000003 110.874 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -124.45 69.73 1.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.115 -0.493 . . . . 60.5 110.855 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -120.67 160.23 23.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 64.299999999999997 111.086 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.9 t -93.56 40.82 1.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 62.240000000000002 111.168 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.2 m -145.49 25.04 1.37 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 74.340000000000003 110.89 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.488 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 24.3 m-20 54.91 -174.22 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.1 -0.5 . . . . 73.319999999999993 110.825 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.98 159.23 73.51 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.62 0.724 . . . . 72.420000000000002 110.916 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -80.65 -169.12 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.729 2.286 . . . . 62.549999999999997 112.365 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.52 108.64 2.55 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.755 -0.736 . . . . 72.219999999999999 112.471 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.85 -86.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.865 0.365 . . . . 73.450000000000003 111.089 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.54 98.66 0.28 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 60.140000000000001 112.533 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -60.74 -171.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.833 0.349 . . . . 71.340000000000003 110.83 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.85 -172.3 2.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 71.099999999999994 110.934 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.9 mp -61.86 102.25 0.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 71.030000000000001 110.907 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 63.74 20.92 12.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 72.120000000000005 110.863 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -99.78 39.66 1.3 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 75.340000000000003 110.843 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.86 102.39 11.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 72.049999999999997 110.89 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.451 HG13 HG12 ' A' ' 69' ' ' VAL . 7.3 tt 179.1 102.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 75.109999999999999 111.142 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 52.2 p -168.35 -168.5 0.94 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 75.329999999999998 110.845 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.522 ' O ' HD12 ' A' ' 39' ' ' ILE . 0.6 OUTLIER -120.9 145.07 48.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.478 . . . . 74.019999999999996 110.867 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.601 HG21 HD22 ' A' ' 61' ' ' LEU . 1.4 mp -121.26 123.07 69.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 65.420000000000002 111.154 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.716 ' HB3' HG23 ' A' ' 7' ' ' ILE . 3.9 tttt -117.06 129.18 55.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 72.409999999999997 110.906 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.455 HG11 ' HG ' ' A' ' 61' ' ' LEU . 4.7 p -144.98 139.81 22.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 71.129999999999995 111.124 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.52 39.93 1.72 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 75.439999999999998 110.952 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 179.78 139.04 0.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 72.450000000000003 110.815 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 53.31 -165.35 1.88 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.77 -0.729 . . . . 71.120000000000005 112.485 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.466 HG22 ' HA2' ' A' ' 62' ' ' GLY . 68.5 p -144.98 144.71 31.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.79 0.329 . . . . 62.530000000000001 111.151 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.73 ' CH2' HG13 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -124.2 136.25 54.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.439 . . . . 64.209999999999994 110.953 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -79.96 125.56 29.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 52.009999999999998 110.857 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -113.21 124.89 53.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 75.420000000000002 110.841 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.87 126.73 20.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 74.409999999999997 110.963 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -95.4 88.8 5.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 73.319999999999993 110.874 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.443 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 172.14 -169.72 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.155 -0.475 . . . . 73.200000000000003 110.91 -179.872 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.0 pt -69.74 172.7 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.09 -0.505 . . . . 54.520000000000003 111.144 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -78.8 56.21 1.85 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 55.130000000000003 110.876 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -151.4 -40.6 0.12 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 75.439999999999998 110.868 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.51 -144.81 4.03 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.698 -0.763 . . . . 73.409999999999997 112.437 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.443 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 108.39 175.38 21.88 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.715 -0.755 . . . . 73.430000000000007 112.488 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -66.93 106.45 1.92 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.844 0.355 . . . . 74.319999999999993 110.857 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -77.96 103.17 7.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 71.310000000000002 110.92 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 3.0 t90 -137.6 109.28 7.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.156 -0.475 . . . . 63.240000000000002 110.949 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -84.69 144.92 28.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 73.530000000000001 110.837 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.601 HD22 HG21 ' A' ' 39' ' ' ILE . 11.5 tp -99.53 137.34 38.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.229 -0.441 . . . . 74.010000000000005 110.939 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.466 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -115.16 -162.32 13.58 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.739 . . . . 52.340000000000003 112.449 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -64.03 100.89 0.32 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.678 2.252 . . . . 71.120000000000005 112.335 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 158.48 157.44 8.48 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.753 -0.737 . . . . 51.350000000000001 112.485 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.05 136.67 54.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.893 0.377 . . . . 73.140000000000001 110.905 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -135.79 138.34 42.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 74.049999999999997 110.902 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 m -114.25 75.32 0.92 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 65.219999999999999 110.846 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 40.7 t -86.21 152.41 22.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 73.420000000000002 110.829 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.451 HG12 HG13 ' A' ' 36' ' ' ILE . 16.7 m -149.64 23.59 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 63.329999999999998 111.093 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 178.06 -16.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.477 . . . . 65.230000000000004 110.873 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.11 -32.18 64.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 64.109999999999999 110.851 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.52 -65.71 0.79 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 71.040000000000006 111.112 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.735 ' O ' HD13 ' A' ' 74' ' ' ILE . . . 166.49 114.03 0.29 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.745 -0.74 . . . . 72.209999999999994 112.485 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.735 HD13 ' O ' ' A' ' 73' ' ' GLY . 7.0 mm -130.54 67.23 80.04 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.671 0.748 . . . . 70.519999999999996 111.173 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -81.72 -74.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.721 2.28 . . . . 71.25 112.327 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.498 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 4.9 t70 177.44 87.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 75.219999999999999 110.861 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 76' ' ' ASP . 9.0 t-20 83.67 131.11 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 73.310000000000002 110.927 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -179.6 151.75 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 62.350000000000001 110.88 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.6 mt -108.55 153.44 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 51.409999999999997 111.084 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.6 p -154.88 158.87 39.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 73.010000000000005 110.871 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.59 157.32 27.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.495 . . . . 63.140000000000001 110.856 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -150.72 135.78 17.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 75.430000000000007 110.884 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.6 mmm-85 -93.49 126.56 38.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 72.109999999999999 110.878 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.553 ' CG ' HG21 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -91.23 131.48 36.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 60.100000000000001 110.958 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.9 pt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 74.420000000000002 111.115 179.976 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.806 0.336 . . . . 72.530000000000001 110.827 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -161.69 -169.13 2.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 72.439999999999998 110.889 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.19 -146.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 53.25 111.107 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.15 133.72 36.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 71.349999999999994 111.088 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -87.36 99.95 12.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 73.109999999999999 110.871 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.762 HG13 ' CH2' ' A' ' 46' ' ' TRP . 99.4 t -106.84 121.77 60.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.485 . . . . 75.150000000000006 111.12 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.445 HG23 ' O ' ' A' ' 7' ' ' ILE . 9.0 tt -123.38 112.17 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 74.0 111.123 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.402 HG13 HG13 ' A' ' 39' ' ' ILE . 17.1 t -128.71 136.88 58.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 74.299999999999997 111.093 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -89.06 140.91 28.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 74.420000000000002 110.908 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -97.09 38.43 1.24 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 72.299999999999997 110.909 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 175.08 -169.53 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.482 . . . . 72.230000000000004 110.891 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.449 HG12 ' N ' ' A' ' 13' ' ' ASN . 4.8 t -63.9 161.39 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 42.229999999999997 111.143 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.449 ' N ' HG12 ' A' ' 12' ' ' VAL . 2.8 t-20 -87.35 54.19 3.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 73.450000000000003 110.905 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.439 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.2 28.56 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 71.239999999999995 110.898 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.6 47.8 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.766 -0.731 . . . . 52.219999999999999 112.497 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.92 171.98 24.27 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.748 -0.739 . . . . 53.439999999999998 112.49 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.56 160.95 17.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.818 0.342 . . . . 73.150000000000006 110.865 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 78.4 p -138.24 155.76 48.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 74.450000000000003 110.874 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -117.24 104.65 11.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 64.549999999999997 110.854 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -105.34 40.01 1.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 74.239999999999995 110.868 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -127.98 -166.2 1.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 45.149999999999999 111.081 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.5 t -78.79 -170.76 2.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 62.240000000000002 111.136 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.4 m -77.16 59.38 1.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 42.530000000000001 110.9 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.1 -37.11 9.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.491 . . . . 73.219999999999999 110.893 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.97 162.96 60.27 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.565 0.697 . . . . 73.140000000000001 110.893 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -47.49 100.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.34 0.111 0 C-N-CA 122.669 2.246 . . . . 64.329999999999998 112.342 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.91 -97.64 1.02 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.744 -0.741 . . . . 64.349999999999994 112.488 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.513 ' HB1' ' OG ' ' A' ' 81' ' ' SER . . . -83.44 60.85 5.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.778 0.323 . . . . 70.209999999999994 111.089 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 177.39 67.5 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.722 -0.751 . . . . 53.32 112.472 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -176.98 92.16 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.79 0.328 . . . . 63.409999999999997 110.871 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -174.08 176.43 2.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 64.439999999999998 110.873 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.407 HD23 ' N ' ' A' ' 33' ' ' ASN . 0.4 OUTLIER -176.65 -85.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 70.019999999999996 110.941 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.436 ' OD1' HG22 ' A' ' 74' ' ' ILE . 55.8 t30 -146.68 22.27 1.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 43.100000000000001 110.882 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -133.46 39.81 3.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 73.230000000000004 110.887 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.86 102.81 11.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 73.230000000000004 110.863 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.403 HG22 ' CB ' ' A' ' 69' ' ' VAL . 1.1 pt -148.89 103.96 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 61.25 111.118 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 79.3 p -167.7 -165.76 0.68 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 70.310000000000002 110.847 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.558 ' C ' HD12 ' A' ' 39' ' ' ILE . 0.9 OUTLIER -123.61 148.48 46.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 52.009999999999998 110.874 -179.819 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.558 HD12 ' C ' ' A' ' 38' ' ' SER . 1.6 mp -121.02 139.07 49.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 54.100000000000001 111.141 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -141.97 134.3 27.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 75.040000000000006 110.881 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.48 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 11.0 p -135.57 138.95 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 74.219999999999999 111.13 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.14 39.48 2.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 63.420000000000002 110.874 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.431 ' H ' HG22 ' A' ' 41' ' ' VAL . 0.3 OUTLIER 178.57 110.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 74.430000000000007 110.865 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.89 -157.41 53.51 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.739 -0.743 . . . . 65.519999999999996 112.428 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.487 HG22 ' HA2' ' A' ' 62' ' ' GLY . 72.7 p -150.24 135.96 18.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.757 0.313 . . . . 70.319999999999993 111.161 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.762 ' CH2' HG13 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -99.63 168.75 9.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 63.119999999999997 110.911 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -115.05 123.29 48.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 75.209999999999994 110.9 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.412 ' HD2' HD23 ' A' ' 61' ' ' LEU . 1.6 m-85 -110.15 123.58 50.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 72.409999999999997 110.89 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.87 126.61 20.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 73.530000000000001 110.902 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -102.62 89.86 3.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 64.5 110.89 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.535 ' HA ' HG22 ' A' ' 79' ' ' ILE . 0.1 OUTLIER 172.05 -166.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.477 . . . . 71.310000000000002 110.937 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.479 HG22 ' N ' ' A' ' 53' ' ' ASN . 5.8 mm -54.98 164.57 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 75.409999999999997 111.131 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.479 ' N ' HG22 ' A' ' 52' ' ' ILE . 59.4 m-20 -80.17 51.9 1.47 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 73.030000000000001 110.886 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.433 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 1.9 p90 -179.47 27.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.482 . . . . 73.230000000000004 110.931 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.33 -164.86 37.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.745 -0.74 . . . . 72.040000000000006 112.457 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.452 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 107.55 -169.68 14.87 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.757 -0.735 . . . . 65.420000000000002 112.488 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.17 105.02 12.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.356 . . . . 71.400000000000006 110.891 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -78.06 108.4 11.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 75.239999999999995 110.945 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -138.11 106.17 5.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.149 -0.478 . . . . 72.439999999999998 110.923 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -93.41 138.41 31.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.436 . . . . 75.230000000000004 110.878 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.64 HD21 ' CE3' ' A' ' 46' ' ' TRP . 1.2 pp -103.13 142.71 33.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 61.219999999999999 110.925 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.487 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -122.77 -162.85 11.65 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.753 -0.737 . . . . 50.310000000000002 112.52 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -45.5 101.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.655 2.237 . . . . 62.439999999999998 112.39 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 163.62 171.53 29.98 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.736 . . . . 72.209999999999994 112.524 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -133.84 143.92 48.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.847 0.356 . . . . 61.229999999999997 110.867 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -151.89 140.12 20.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.484 . . . . 72.409999999999997 110.942 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.8 p -124.29 72.6 1.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 73.299999999999997 110.841 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.8 t -86.06 168.97 13.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 64.030000000000001 110.891 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.403 ' CB ' HG22 ' A' ' 36' ' ' ILE . 12.9 m -152.28 23.53 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 44.25 111.132 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.568 ' HA ' HD13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -176.08 57.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 61.509999999999998 110.879 -179.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 t -175.99 -43.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 65.109999999999999 110.872 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.71 -66.09 0.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 75.540000000000006 111.124 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -176.89 93.32 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.716 -0.754 . . . . 71.200000000000003 112.462 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.568 HD13 ' HA ' ' A' ' 70' ' ' GLU . 3.3 mp -128.35 67.91 76.31 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.657 0.741 . . . . 73.329999999999998 111.109 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -76.98 -166.12 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.684 2.256 . . . . 71.519999999999996 112.37 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -91.4 -24.23 19.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 64.329999999999998 110.892 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -141.78 172.45 12.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 75.030000000000001 110.91 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.645 ' O ' HD13 ' A' ' 79' ' ' ILE . 1.0 OUTLIER -67.74 88.14 0.24 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 53.039999999999999 110.868 -179.878 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.645 HD13 ' O ' ' A' ' 78' ' ' SER . 23.9 mm -134.91 61.81 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 74.219999999999999 111.177 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.8 t -163.02 156.17 19.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 64.329999999999998 110.892 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.513 ' OG ' ' HB1' ' A' ' 28' ' ' ALA . 0.6 OUTLIER -165.54 159.32 16.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 72.010000000000005 110.917 -179.803 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -150.4 135.77 17.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 71.140000000000001 110.877 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -94.27 118.35 31.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 71.439999999999998 110.92 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.586 ' HB3' HG21 ' A' ' 6' ' ' VAL . 39.8 mt-30 -79.66 93.0 5.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.458 . . . . 70.150000000000006 110.899 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 pt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 61.200000000000003 111.115 179.965 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.811 0.338 . . . . 73.099999999999994 110.899 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -148.39 170.45 17.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 54.329999999999998 110.917 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -160.68 106.11 1.44 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 61.530000000000001 111.112 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -161.89 132.61 5.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 45.329999999999998 111.092 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.576 ' HB3' HG23 ' A' ' 22' ' ' THR . 0.0 OUTLIER -88.62 115.4 26.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 64.430000000000007 110.875 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.9 m -112.13 138.64 40.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 74.409999999999997 111.166 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.82 HG23 ' HB3' ' A' ' 40' ' ' LYS . 2.7 tp -105.34 110.97 32.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 64.129999999999995 111.135 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.604 HG12 HD13 ' A' ' 39' ' ' ILE . 3.0 m -131.25 165.0 32.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 75.310000000000002 111.067 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -117.3 142.7 46.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 73.239999999999995 110.916 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -101.45 37.72 1.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.495 . . . . 72.540000000000006 110.889 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 174.02 -170.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.483 . . . . 74.120000000000005 110.816 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.438 HG12 ' N ' ' A' ' 13' ' ' ASN . 5.1 t -64.12 160.37 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 74.409999999999997 111.103 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.438 ' N ' HG12 ' A' ' 12' ' ' VAL . 11.6 p-10 -87.32 54.5 3.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 70.409999999999997 110.924 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.441 ' CG ' ' O ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -176.91 28.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 64.329999999999998 110.883 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.9 46.16 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.786 -0.721 . . . . 75.430000000000007 112.548 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.19 172.01 24.36 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.718 -0.753 . . . . 33.530000000000001 112.484 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.42 152.26 22.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.782 0.325 . . . . 60.149999999999999 110.93 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.62 148.92 49.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 72.150000000000006 110.868 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -102.29 104.29 14.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 65.140000000000001 110.898 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -122.72 53.29 1.28 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 72.200000000000003 110.858 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -139.49 140.56 37.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 62.140000000000001 111.078 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.576 HG23 ' HB3' ' A' ' 5' ' ' GLU . 3.0 m -80.44 69.33 6.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 74.349999999999994 111.093 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.6 t -145.51 -170.05 3.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 74.409999999999997 110.812 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -90.02 77.23 6.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.124 -0.489 . . . . 65.120000000000005 110.866 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -80.07 162.32 62.38 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.582 0.706 . . . . 65.140000000000001 110.926 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -57.18 95.97 0.07 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.67 2.246 . . . . 70.549999999999997 112.314 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.34 -101.72 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.745 -0.74 . . . . 74.450000000000003 112.45 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.404 ' HB1' ' HA ' ' A' ' 81' ' ' SER . . . -91.06 -175.08 4.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.881 0.372 . . . . 52.130000000000003 111.085 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.67 83.87 1.76 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.746 -0.74 . . . . 53.420000000000002 112.5 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -98.12 179.82 4.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.768 0.318 . . . . 73.0 110.892 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -108.19 165.76 11.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 62.509999999999998 110.902 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.1 mp -56.21 124.48 18.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 71.120000000000005 110.938 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 51.91 46.24 26.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.457 . . . . 73.349999999999994 110.893 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.53 39.93 3.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 62.420000000000002 110.882 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.594 ' O ' HD12 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -102.94 102.84 12.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 71.140000000000001 110.931 179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.466 HG13 HG12 ' A' ' 69' ' ' VAL . 7.4 tt -179.59 103.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 72.519999999999996 111.156 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 82.5 p -168.23 -166.92 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 75.319999999999993 110.869 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.9 t -115.35 168.22 10.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 75.209999999999994 110.879 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.617 HG21 HD22 ' A' ' 61' ' ' LEU . 0.4 OUTLIER -145.41 139.21 21.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 74.239999999999995 111.173 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.82 ' HB3' HG23 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -139.9 119.65 13.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 72.010000000000005 110.892 179.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.681 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 2.6 p -113.94 139.05 41.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 45.509999999999998 111.134 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -138.04 45.26 2.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 65.310000000000002 110.908 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.72 113.68 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 73.5 110.861 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.23 -135.75 35.8 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.742 -0.742 . . . . 65.319999999999993 112.466 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.459 HG22 ' HA2' ' A' ' 62' ' ' GLY . 67.4 p -150.06 150.13 31.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.732 0.301 . . . . 64.310000000000002 111.166 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.681 ' CZ2' HG23 ' A' ' 41' ' ' VAL . 2.7 m0 -117.74 171.38 8.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.247 -0.433 . . . . 75.409999999999997 110.897 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.7 mpp_? -113.85 119.73 38.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 74.25 110.909 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -108.59 126.71 53.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 61.229999999999997 110.9 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.24 126.29 19.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 65.420000000000002 110.922 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -98.44 89.54 4.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 73.439999999999998 110.88 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.447 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 172.54 -168.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.116 -0.493 . . . . 71.209999999999994 110.934 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.499 HG22 ' H ' ' A' ' 53' ' ' ASN . 5.6 mm -69.82 165.98 2.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 54.530000000000001 111.137 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.499 ' H ' HG22 ' A' ' 52' ' ' ILE . 2.8 m-80 -74.83 56.69 0.74 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 70.439999999999998 110.902 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -153.09 -39.15 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 65.150000000000006 110.905 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -147.99 -142.36 3.65 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.757 -0.735 . . . . 72.299999999999997 112.523 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.447 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 106.55 -178.09 22.32 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.789 -0.72 . . . . 71.319999999999993 112.492 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -76.72 108.72 9.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.798 0.332 . . . . 74.549999999999997 110.884 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -78.29 100.26 6.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 74.030000000000001 110.903 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -133.41 107.53 8.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 74.040000000000006 110.923 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.88 148.14 27.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 64.25 110.862 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.617 HD22 HG21 ' A' ' 39' ' ' ILE . 8.7 tp -99.52 136.5 39.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 72.439999999999998 110.913 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.459 ' HA2' HG22 ' A' ' 45' ' ' THR . . . -112.93 176.34 17.45 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.708 -0.758 . . . . 74.239999999999995 112.479 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -46.74 100.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.727 2.284 . . . . 74.329999999999998 112.334 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.46 164.6 14.99 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.746 -0.74 . . . . 70.420000000000002 112.506 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -118.52 146.94 44.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.829 0.347 . . . . 74.310000000000002 110.9 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -146.19 140.15 26.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 74.329999999999998 110.867 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.48 73.88 1.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.095 -0.502 . . . . 71.230000000000004 110.858 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 45.7 t -85.06 156.23 21.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 61.43 110.84 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.466 HG12 HG13 ' A' ' 36' ' ' ILE . 27.9 m -149.96 26.27 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.114 -0.494 . . . . 74.150000000000006 111.096 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 173.15 -16.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 75.349999999999994 110.884 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.02 -23.95 41.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 71.219999999999999 110.85 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.79 -71.0 0.54 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 53.340000000000003 111.114 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.609 ' O ' HD13 ' A' ' 74' ' ' ILE . . . 166.79 124.54 0.72 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.781 -0.724 . . . . 65.319999999999993 112.502 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.609 HD13 ' O ' ' A' ' 73' ' ' GLY . 4.4 mm -123.64 68.08 41.02 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.626 0.727 . . . . 73.109999999999999 111.111 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -79.38 -166.18 0.39 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.724 2.283 . . . . 63.340000000000003 112.332 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.62 14.81 14.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 64.129999999999995 110.874 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -157.36 113.94 2.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 74.230000000000004 110.89 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.7 m -92.28 45.0 1.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 71.5 110.855 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.4 mm -76.51 66.26 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 61.420000000000002 111.091 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.1 168.92 9.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 75.120000000000005 110.82 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.404 ' HA ' ' HB1' ' A' ' 28' ' ' ALA . 0.3 OUTLIER -165.69 155.26 12.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 75.120000000000005 110.908 -179.802 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -151.13 135.96 17.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 62.109999999999999 110.9 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.5 mmm-85 -95.79 126.18 40.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 73.019999999999996 110.902 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -79.26 97.03 6.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 71.030000000000001 110.909 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 63.140000000000001 111.154 179.981 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.752 0.31 . . . . 71.340000000000003 110.896 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -115.68 171.71 7.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 54.409999999999997 110.886 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.87 79.4 0.78 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 32.049999999999997 111.14 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.25 168.38 27.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 63.229999999999997 111.091 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.704 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 14.7 mt-10 -90.2 92.96 9.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 73.219999999999999 110.897 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.789 HG13 ' CH2' ' A' ' 46' ' ' TRP . 89.5 t -119.79 133.35 66.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 75.099999999999994 111.159 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.458 HG23 ' HB3' ' A' ' 40' ' ' LYS . 7.0 tt -122.29 109.87 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 63.119999999999997 111.133 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.62 HG12 HD13 ' A' ' 39' ' ' ILE . 4.0 m -132.19 164.77 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.182 -0.463 . . . . 63.340000000000003 111.153 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -113.4 138.73 49.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 73.530000000000001 110.99 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -100.73 38.21 1.57 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 71.450000000000003 110.888 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.433 ' HB3' ' HA3' ' A' ' 16' ' ' GLY . 0.3 OUTLIER 169.26 -173.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 75.299999999999997 110.892 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 13' ' ' ASN . 4.8 t -66.02 160.55 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.254 -0.43 . . . . 62.340000000000003 111.109 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.44 ' N ' HG12 ' A' ' 12' ' ' VAL . 18.9 t30 -88.67 54.77 3.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 73.239999999999995 110.895 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.419 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -176.55 28.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 72.120000000000005 110.917 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.56 43.63 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.73 -0.748 . . . . 41.530000000000001 112.5 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.433 ' HA3' ' HB3' ' A' ' 11' ' ' HIS . . . -142.69 172.14 24.52 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.777 -0.725 . . . . 64.120000000000005 112.509 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.2 123.6 34.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.797 0.332 . . . . 75.209999999999994 110.905 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.3 p -121.24 135.17 55.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 65.310000000000002 110.862 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 19' ' ' PHE . 0.8 OUTLIER -124.85 136.73 54.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.15 -0.477 . . . . 75.109999999999999 110.878 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.94 -163.08 0.38 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 71.439999999999998 110.828 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.704 ' HB1' ' HA ' ' A' ' 5' ' ' GLU . . . -78.56 98.69 6.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 74.430000000000007 111.055 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -178.81 179.22 0.72 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 51.130000000000003 111.103 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.6 m -65.13 91.72 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 65.129999999999995 110.859 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.17 -78.54 0.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 65.400000000000006 110.843 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -153.36 67.53 6.22 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.582 0.706 . . . . 74.140000000000001 110.904 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -85.85 70.09 4.81 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.669 2.246 . . . . 72.329999999999998 112.341 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 163.01 111.56 0.26 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.759 -0.734 . . . . 65.209999999999994 112.498 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.38 124.31 35.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.84 0.352 . . . . 72.25 111.142 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.37 -58.18 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.777 -0.725 . . . . 74.5 112.491 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -71.91 80.53 0.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.825 0.345 . . . . 63.140000000000001 110.877 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -129.81 -169.95 2.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 71.219999999999999 110.911 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -168.33 -169.01 1.01 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 53.329999999999998 110.929 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -54.07 -27.55 33.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 72.25 110.877 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.413 ' C ' HD13 ' A' ' 36' ' ' ILE . 5.2 m-20 -82.73 58.74 4.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 75.319999999999993 110.844 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.52 102.22 14.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 65.510000000000005 110.91 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.413 HD13 ' C ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -147.96 111.46 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 62.119999999999997 111.157 179.905 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.7 p -167.25 -166.46 0.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 62.329999999999998 110.871 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 t -117.61 159.38 23.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 72.349999999999994 110.882 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.62 HD13 HG12 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -139.53 140.96 36.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 64.230000000000004 111.155 179.917 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.458 ' HB3' HG23 ' A' ' 7' ' ' ILE . 9.4 tttt -151.0 147.75 27.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 72.400000000000006 110.892 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.59 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 3.6 p -136.03 130.98 49.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 61.119999999999997 111.135 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.03 39.51 3.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 74.310000000000002 110.837 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.442 ' H ' HG22 ' A' ' 41' ' ' VAL . 0.4 OUTLIER 178.59 110.63 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 60.109999999999999 110.888 -179.92 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.85 -147.86 48.61 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.739 . . . . 54.020000000000003 112.508 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.5 p -150.35 147.82 28.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.762 0.315 . . . . 71.430000000000007 111.123 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.789 ' CH2' HG13 ' A' ' 6' ' ' VAL . 2.0 m0 -118.08 174.84 5.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 74.040000000000006 110.942 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -124.66 129.13 49.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 64.400000000000006 110.858 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.484 ' HD2' HD22 ' A' ' 61' ' ' LEU . 1.6 m-85 -113.57 128.38 56.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 51.149999999999999 110.862 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.33 126.19 19.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.486 . . . . 71.450000000000003 110.928 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -101.09 88.9 3.63 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.074 -0.512 . . . . 62.439999999999998 110.873 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.448 ' HA ' HG22 ' A' ' 79' ' ' ILE . 0.2 OUTLIER 172.04 -171.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 74.450000000000003 110.918 -179.857 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.7 pt -54.97 174.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.499 . . . . 75.439999999999998 111.11 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -87.9 37.86 0.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 70.120000000000005 110.909 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -151.74 18.63 0.7 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 64.349999999999994 110.926 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.07 -152.34 18.95 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.74 -0.743 . . . . 52.229999999999997 112.487 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.401 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 107.29 176.25 22.66 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.749 -0.739 . . . . 52.450000000000003 112.478 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.49 109.42 6.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.812 0.339 . . . . 75.140000000000001 110.857 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -77.59 108.35 10.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 73.0 110.899 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -138.44 107.17 5.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.06 -0.518 . . . . 74.230000000000004 110.925 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -91.28 157.72 16.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 62.130000000000003 110.859 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.653 HD21 ' HB2' ' A' ' 46' ' ' TRP . 1.8 pt? -119.97 149.61 41.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 64.109999999999999 110.934 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -124.81 -173.97 13.88 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.728 -0.748 . . . . 53.530000000000001 112.525 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -43.97 101.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.731 2.287 . . . . 64.340000000000003 112.329 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 158.92 162.4 11.93 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.749 -0.738 . . . . 52.149999999999999 112.495 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.13 147.5 41.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.899 0.381 . . . . 72.040000000000006 110.882 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -132.64 160.4 36.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 74.200000000000003 110.913 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 95.8 p -140.09 62.82 1.49 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 73.430000000000007 110.889 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 71.0 m -85.8 145.81 27.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.488 . . . . 71.129999999999995 110.836 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.411 HG23 ' HG2' ' A' ' 70' ' ' GLU . 35.9 m -150.6 18.44 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.487 . . . . 64.239999999999995 111.127 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.411 ' HG2' HG23 ' A' ' 69' ' ' VAL . 1.7 pt-20 179.3 38.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 71.230000000000004 110.841 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.53 -46.71 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.471 . . . . 70.120000000000005 110.866 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.32 -45.86 62.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.506 . . . . 21.129999999999999 111.077 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.712 ' O ' HD13 ' A' ' 74' ' ' ILE . . . 166.93 103.68 0.17 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.769 -0.729 . . . . 73.040000000000006 112.473 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.712 HD13 ' O ' ' A' ' 73' ' ' GLY . 15.0 mm -131.52 74.02 78.85 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.626 0.727 . . . . 71.310000000000002 111.095 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -77.59 -158.54 0.09 OUTLIER 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.709 2.272 . . . . 52.100000000000001 112.328 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -75.97 -22.71 55.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 71.120000000000005 110.868 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -158.65 -169.54 2.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 73.109999999999999 110.89 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.0 t -57.82 -95.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 71.120000000000005 110.888 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.448 HG22 ' HA ' ' A' ' 51' ' ' TYR . 2.2 mp 50.91 59.89 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 74.540000000000006 111.092 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 66.1 p -159.41 158.61 32.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 75.409999999999997 110.842 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.73 159.63 16.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 70.409999999999997 110.867 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -150.14 135.8 18.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 75.120000000000005 110.872 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.2 mmt-85 -90.48 117.4 29.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 65.439999999999998 110.904 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -82.28 91.85 6.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 65.200000000000003 110.909 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 74.400000000000006 111.11 179.945 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.043 0 CA-C-O 120.854 0.359 . . . . 75.340000000000003 110.896 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -133.82 178.55 6.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 70.540000000000006 110.854 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.82 85.51 0.9 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 43.030000000000001 111.114 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -167.0 122.19 1.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 71.129999999999995 111.105 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.85 98.11 11.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.239 -0.437 . . . . 63.25 110.878 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.738 HG21 ' HB3' ' A' ' 84' ' ' GLN . 54.3 t -102.02 119.43 50.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 72.310000000000002 111.102 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.546 HG23 ' HB3' ' A' ' 40' ' ' LYS . 8.3 tt -120.96 109.51 25.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 65.409999999999997 111.135 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.8 t -126.41 141.37 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 65.319999999999993 111.153 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -96.04 134.6 38.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.179 -0.464 . . . . 63.350000000000001 110.892 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -94.35 44.23 1.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 70.329999999999998 110.916 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 174.79 -170.31 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 73.230000000000004 110.884 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 13' ' ' ASN . 6.4 t -63.99 160.5 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 74.540000000000006 111.16 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.453 ' N ' HG12 ' A' ' 12' ' ' VAL . 53.0 t-20 -85.41 53.61 2.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 73.140000000000001 110.855 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.453 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.59 28.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 65.420000000000002 110.849 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.55 44.33 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.721 -0.752 . . . . 44.409999999999997 112.5 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -134.98 171.41 22.45 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.74 -0.743 . . . . 74.25 112.467 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.5 161.99 13.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.751 0.31 . . . . 72.109999999999999 110.92 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.7 p -151.11 155.34 38.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 53.520000000000003 110.84 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -136.34 136.7 39.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 64.409999999999997 110.858 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.7 68.03 0.66 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 72.349999999999994 110.867 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -151.72 167.21 28.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 34.100000000000001 111.093 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 m -144.97 40.73 1.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 62.030000000000001 111.134 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.1 t -172.31 36.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 41.43 110.879 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -155.72 -44.19 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.48 . . . . 53.229999999999997 110.879 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -83.05 162.24 55.25 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.625 0.726 . . . . 74.310000000000002 110.917 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.25 -173.18 1.2 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.694 2.263 . . . . 74.239999999999995 112.369 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.74 -104.57 0.71 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.695 -0.764 . . . . 64.239999999999995 112.528 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.654 ' HB2' ' CE1' ' A' ' 82' ' ' PHE . . . -150.91 158.2 43.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.82 0.343 . . . . 60.149999999999999 111.107 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.58 126.65 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.776 -0.726 . . . . 72.450000000000003 112.498 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -152.21 25.03 0.63 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.832 0.349 . . . . 63.140000000000001 110.903 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -174.18 -169.89 0.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 73.319999999999993 110.875 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.14 166.14 0.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 73.219999999999999 110.91 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -68.02 87.62 0.26 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.467 . . . . 73.319999999999993 110.906 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -176.02 88.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 74.299999999999997 110.827 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.588 ' HD2' ' HB3' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -130.69 168.11 17.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 53.43 110.891 179.966 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 36' ' ' ILE . 1.2 tt -162.01 115.55 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 74.329999999999998 111.13 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.9 p -167.22 -167.55 0.93 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 70.209999999999994 110.906 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.562 ' O ' HD12 ' A' ' 39' ' ' ILE . 32.3 t -123.6 150.08 44.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 62.539999999999999 110.867 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.562 HD12 ' O ' ' A' ' 38' ' ' SER . 1.5 mp -120.91 115.18 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 43.299999999999997 111.117 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.546 ' HB3' HG23 ' A' ' 7' ' ' ILE . 10.6 tttm -109.88 119.26 38.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.465 . . . . 75.299999999999997 110.918 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.775 HG22 ' CZ3' ' A' ' 46' ' ' TRP . 17.2 t -102.89 139.16 24.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 72.019999999999996 111.114 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.71 39.84 0.72 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 74.140000000000001 110.896 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 179.38 111.66 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 71.109999999999999 110.842 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.34 -142.22 24.55 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.674 -0.774 . . . . 52.539999999999999 112.523 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 t -149.84 124.17 9.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.795 0.331 . . . . 71.420000000000002 111.12 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.775 ' CZ3' HG22 ' A' ' 41' ' ' VAL . 0.5 OUTLIER -87.14 -177.08 5.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 74.530000000000001 110.922 179.961 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.25 119.95 19.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.453 . . . . 72.120000000000005 110.83 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -101.64 133.59 46.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 73.439999999999998 110.855 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.72 126.47 20.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.104 -0.498 . . . . 75.510000000000005 110.898 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -105.49 88.85 2.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.079 -0.51 . . . . 72.299999999999997 110.917 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.482 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 171.63 -168.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 71.109999999999999 110.938 -179.838 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.471 HG22 ' N ' ' A' ' 53' ' ' ASN . 18.9 mm -54.97 158.63 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 53.409999999999997 111.138 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.471 ' N ' HG22 ' A' ' 52' ' ' ILE . 47.4 p-10 -76.38 58.2 1.28 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 74.030000000000001 110.945 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -167.19 -31.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.163 -0.471 . . . . 52.520000000000003 110.928 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -142.26 -152.56 5.72 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.737 -0.744 . . . . 72.310000000000002 112.467 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.482 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 108.98 -174.5 18.45 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.773 -0.727 . . . . 70.319999999999993 112.471 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.89 127.04 31.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.8 0.333 . . . . 74.5 110.901 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -96.66 108.12 20.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.236 -0.438 . . . . 54.039999999999999 110.904 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -138.08 106.74 5.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.093 -0.503 . . . . 74.400000000000006 110.914 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -95.47 157.34 15.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 63.509999999999998 110.867 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.494 HD23 ' H ' ' A' ' 61' ' ' LEU . 2.6 pt? -135.96 139.1 42.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 52.439999999999998 110.916 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.52 -165.64 27.38 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.734 -0.746 . . . . 62.130000000000003 112.465 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -56.67 115.85 2.78 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.684 2.256 . . . . 50.219999999999999 112.346 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.7 151.42 5.89 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.733 -0.746 . . . . 73.209999999999994 112.504 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -79.96 155.01 27.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.845 0.355 . . . . 74.140000000000001 110.897 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -160.31 149.5 17.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.126 -0.488 . . . . 72.510000000000005 110.924 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.9 p -108.12 84.26 1.92 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 70.340000000000003 110.872 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.733 ' HB2' ' HB2' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -85.4 117.12 24.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 73.140000000000001 110.873 -179.86 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.7 m -146.34 10.32 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 73.439999999999998 111.117 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -157.52 17.65 0.27 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 73.530000000000001 110.9 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -165.68 21.67 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 75.299999999999997 110.869 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.733 ' HB2' ' HB2' ' A' ' 68' ' ' SER . . . -89.51 -34.67 16.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 35.539999999999999 111.101 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.607 ' H ' HD13 ' A' ' 74' ' ' ILE . . . 165.97 41.31 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.78 -0.724 . . . . 54.210000000000001 112.495 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.607 HD13 ' H ' ' A' ' 73' ' ' GLY . 0.1 OUTLIER -122.45 63.13 17.92 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.62 0.724 . . . . 65.409999999999997 111.102 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.499 ' HD3' ' C ' ' A' ' 73' ' ' GLY . 71.6 Cg_endo -81.41 -47.61 0.07 OUTLIER 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.703 2.268 . . . . 54.119999999999997 112.316 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.472 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 9.3 t70 179.36 87.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 63.43 110.86 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.472 ' CB ' ' O ' ' A' ' 76' ' ' ASP . 5.4 m-20 81.41 -168.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 71.400000000000006 110.907 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.503 ' O ' HD13 ' A' ' 79' ' ' ILE . 0.7 OUTLIER -75.08 71.72 2.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 63.439999999999998 110.869 -179.85 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.503 HD13 ' O ' ' A' ' 78' ' ' SER . 23.4 mm -141.79 69.64 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 72.25 111.184 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -165.99 152.59 9.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 63.520000000000003 110.834 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.71 171.54 12.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 73.109999999999999 110.841 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.654 ' CE1' ' HB2' ' A' ' 28' ' ' ALA . 2.9 p90 -152.07 135.9 16.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.134 -0.485 . . . . 75.349999999999994 110.905 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 30.5 mmm180 -98.78 116.37 30.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 72.040000000000006 110.904 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.738 ' HB3' HG21 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -83.63 103.56 13.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 74.430000000000007 110.92 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.1 pt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 75.099999999999994 111.11 179.982 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.815 0.341 . . . . 64.439999999999998 110.93 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -93.68 160.91 14.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 71.400000000000006 110.884 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -160.77 84.75 0.69 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 75.340000000000003 111.086 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.61 134.68 34.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 70.150000000000006 111.08 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -91.65 98.99 11.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 62.32 110.846 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.501 HG11 ' HG2' ' A' ' 84' ' ' GLN . 4.0 m -115.67 138.56 45.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.501 . . . . 63.229999999999997 111.136 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.823 HG23 ' HB3' ' A' ' 40' ' ' LYS . 1.1 tt -102.32 110.44 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 73.349999999999994 111.101 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.651 HG12 HD13 ' A' ' 39' ' ' ILE . 3.3 m -137.32 159.43 35.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 70.310000000000002 111.123 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -114.0 144.33 43.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 74.019999999999996 110.95 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.31 41.56 1.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 75.549999999999997 110.855 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 172.69 -170.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 64.049999999999997 110.826 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.451 HG12 ' N ' ' A' ' 13' ' ' ASN . 7.3 t -63.61 159.97 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 62.149999999999999 111.076 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.451 ' N ' HG12 ' A' ' 12' ' ' VAL . 58.6 t30 -85.74 53.87 2.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 61.0 110.883 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.438 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -177.11 28.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 72.310000000000002 110.856 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.57 41.14 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.732 . . . . 53.140000000000001 112.462 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -137.13 171.54 23.06 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.776 -0.726 . . . . 72.430000000000007 112.485 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.35 161.7 16.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.83 0.348 . . . . 72.400000000000006 110.893 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -139.07 166.9 23.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 75.400000000000006 110.86 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -129.44 113.48 14.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 71.239999999999995 110.944 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -121.04 50.01 1.42 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 73.5 110.884 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -125.25 143.76 50.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 73.040000000000006 111.114 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.8 t -100.18 39.92 1.3 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 65.420000000000002 111.13 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.2 t -92.98 -82.66 0.33 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.45 . . . . 72.310000000000002 110.888 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.79 88.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.141 -0.482 . . . . 63.450000000000003 110.873 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -80.18 162.17 62.65 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.604 0.716 . . . . 63.32 110.91 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -74.16 -173.36 1.41 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.749 2.299 . . . . 74.349999999999994 112.366 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.7 177.63 49.88 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.763 -0.732 . . . . 74.209999999999994 112.515 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.98 122.89 34.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.812 0.339 . . . . 71.019999999999996 111.096 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.47 119.1 3.83 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.765 -0.731 . . . . 71.319999999999993 112.494 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -159.58 44.11 0.23 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.87 0.367 . . . . 74.450000000000003 110.872 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -174.2 173.58 3.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 51.020000000000003 110.914 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.2 tp -60.98 -167.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 65.420000000000002 110.882 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -52.58 102.75 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 74.519999999999996 110.911 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -167.3 39.73 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 62.350000000000001 110.839 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.85 108.97 15.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 53.140000000000001 110.896 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.74 HD12 ' HB ' ' A' ' 69' ' ' VAL . 0.9 OUTLIER -168.98 102.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 73.519999999999996 111.126 179.921 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.4 p -168.11 -167.6 0.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 73.219999999999999 110.879 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.7 t -126.66 157.86 37.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 74.340000000000003 110.866 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.651 HD13 HG12 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -129.69 138.06 55.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 63.450000000000003 111.113 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.823 ' HB3' HG23 ' A' ' 7' ' ' ILE . 12.1 tttt -136.03 124.31 23.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 72.409999999999997 110.853 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.684 HG23 ' CZ2' ' A' ' 46' ' ' TRP . 3.5 p -120.3 139.5 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.436 . . . . 73.310000000000002 111.134 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -142.89 40.37 1.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 70.239999999999995 110.892 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.57 117.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 72.439999999999998 110.842 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 51.76 -151.45 6.84 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.696 -0.764 . . . . 54.130000000000003 112.523 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.7 p -136.62 155.95 49.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.763 0.316 . . . . 61.439999999999998 111.132 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.684 ' CZ2' HG23 ' A' ' 41' ' ' VAL . 2.2 m0 -123.74 175.65 6.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 75.540000000000006 110.916 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.51 ' HD2' HD11 ' A' ' 85' ' ' ILE . 3.7 mpp_? -123.72 122.71 38.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 74.540000000000006 110.888 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -107.52 128.64 54.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 75.530000000000001 110.934 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.13 127.92 21.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 75.040000000000006 110.923 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -99.1 87.05 3.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.505 . . . . 65.010000000000005 110.853 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.411 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 170.23 -170.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.167 -0.47 . . . . 72.310000000000002 110.951 -179.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.1 pt -54.68 174.31 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 64.340000000000003 111.139 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -87.41 36.95 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 74.010000000000005 110.945 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -151.85 19.01 0.69 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 65.230000000000004 110.925 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.61 -156.89 27.63 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.788 -0.72 . . . . 75.420000000000002 112.504 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.411 ' HA3' ' HB2' ' A' ' 51' ' ' TYR . . . 107.09 176.29 22.8 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.677 -0.773 . . . . 74.239999999999995 112.496 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -69.81 103.96 2.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.833 0.349 . . . . 73.120000000000005 110.872 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -75.05 108.4 7.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 75.329999999999998 110.957 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -138.1 106.21 5.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.138 -0.483 . . . . 75.530000000000001 110.953 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -88.49 138.41 31.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 71.430000000000007 110.845 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.557 HD21 ' CE3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -99.18 159.44 14.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 65.299999999999997 110.928 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -128.85 175.77 18.62 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.706 -0.759 . . . . 54.340000000000003 112.483 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.412 ' HA ' HG13 ' A' ' 41' ' ' VAL . 78.4 Cg_exo -42.51 107.77 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.657 2.238 . . . . 72.010000000000005 112.382 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.79 159.48 9.39 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.739 . . . . 61.439999999999998 112.489 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -102.6 144.69 30.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.843 0.354 . . . . 73.109999999999999 110.904 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -137.17 145.09 43.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.118 -0.492 . . . . 73.209999999999994 110.917 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.1 m -133.8 67.51 1.52 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 54.310000000000002 110.838 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.63 ' CB ' ' HB2' ' A' ' 72' ' ' ALA . 10.9 m -84.99 145.11 27.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 72.530000000000001 110.866 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.74 ' HB ' HD12 ' A' ' 36' ' ' ILE . 20.6 m -149.97 19.74 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 73.209999999999994 111.118 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -179.5 38.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 62.409999999999997 110.879 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.34 -39.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 71.299999999999997 110.894 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.63 ' HB2' ' CB ' ' A' ' 68' ' ' SER . . . -53.17 -44.47 67.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 50.210000000000001 111.073 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.592 ' O ' HD13 ' A' ' 74' ' ' ILE . . . 167.41 93.79 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.787 -0.721 . . . . 75.209999999999994 112.518 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.592 HD13 ' O ' ' A' ' 73' ' ' GLY . 5.7 mm -123.98 67.27 42.37 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.613 0.72 . . . . 73.430000000000007 111.129 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -80.07 -166.38 0.41 Allowed 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.727 2.285 . . . . 72.109999999999999 112.376 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -57.67 -70.15 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.419 . . . . 64.340000000000003 110.876 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -96.68 -95.54 0.2 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 74.239999999999995 110.846 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.4 p -178.18 -95.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 73.239999999999995 110.836 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.5 mm 56.23 54.92 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 74.049999999999997 111.152 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.6 m -108.07 164.2 12.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 70.349999999999994 110.862 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.3 p -165.54 153.68 11.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 65.319999999999993 110.831 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -151.25 135.47 16.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 71.450000000000003 110.888 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.47 119.69 32.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 75.299999999999997 110.883 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.501 ' HG2' HG11 ' A' ' 6' ' ' VAL . 20.5 mt-30 -79.7 92.01 5.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 61.229999999999997 110.899 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.51 HD11 ' HD2' ' A' ' 47' ' ' ARG . 1.1 pt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 71.439999999999998 111.186 179.933 . . . . . . . . 1 1 . 1 stop_ save_